SampleID,gdc_file_uuid,filename,age_at_diagnosis,aliquot_uuid,case_uuid,days_to_death,disease_type,ethnicity,experimental_strategy,gender,investigation,platform,primary_site,race,reference_genome,sample_type,sample_uuid,vital_status,tissue_source_site_label,data_submitting_center_label,country_of_sample_procurement,histological_diagnosis_label,pathologic_t_label,pathologic_n_label,pathologic_stage_label,icd03_histology_label,icd03_histology_site,icd10,portion_is_ffpe,new_tumor_event_after_initial_trtmt,primary_therapy_outcome_success_label,portion_weight,aliquot_concentration,analyte_A260A280Ratio,analyte_amount,analyte_type_label,radiation_therapy_code_label,radiation_therapy_site_label,radiation_therapy_type_label,year_of_diagnosis,vital_status_label
s12507,32EFFBDC-7D3B-4AD8-9245-1A253CBE1FF3,TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted.bam,32,229AD821-4BB0-4046-B5E6-6193005D3C8A,a6d37f61-beca-46ea-a59a-62257475ac77,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,32AEF736-82A4-4813-A272-86EF160E7D56,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.88,59.66,DNA,,,,2011.0,Alive
s12612,49AE611A-3F69-49D4-8657-6DBDF1EA4466,UNCID_2504190.23cfc123-e7e9-4e13-bbcf-4ec06d0bf378.sorted_genome_alignments.bam,54,23CFC123-E7E9-4E13-BBCF-4EC06D0BF378,812a2d18-c43b-4484-8a8d-234056a0e90b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,567DB7D7-CBD2-4643-9644-9E2A38EDED7A,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.89,36.4,RNA,,,,2013.0,Alive
s12603,AFE23970-25F4-43E6-A354-E92284355905,UNCID_1896766.0e963a64-2e40-4117-b4fa-4061d16aabae.sorted_genome_alignments.bam,34,0E963A64-2E40-4117-B4FA-4061D16AABAE,e9949320-ad37-4542-98c1-b72df60b1668,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,26446AEC-2035-4EAB-BA3F-8807B64F7583,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.78,37.22,RNA,49B24A3C-39D8-47DB-8F92-1C30F1A13DD1,Primary Tumor Field,Systemic,2004.0,Alive
s12539,9300A8C6-32B1-482A-95C7-60C2F221659F,UNCID_1209363.7ddfe620-b0a4-4b06-8568-1e6e03ba3f76.sorted_genome_alignments.bam,36,7DDFE620-B0A4-4B06-8568-1E6E03BA3F76,2f9ed09d-2626-4c23-ba47-1850d36f812a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,343311B1-D586-4F92-9984-32AF1AFB1F62,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.85,31.33,RNA,1C5B2B34-804B-467C-B457-46716ED4C490,Not available,Systemic,2009.0,Alive
s12600,EA0F6C38-0683-4A32-B9C5-E6BF12E65F97,UNCID_1815603.5fb19476-c09c-450c-af54-8573971769b1.sorted_genome_alignments.bam,70,5FB19476-C09C-450C-AF54-8573971769B1,39e68907-3ffb-4ca1-a955-db5fa2f0deb1,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F905970F-9D60-44D9-AC7B-A23B6EF81548,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.83,25.46,RNA,6BC6849B-4407-4376-AFBA-8010A50897AE,Primary Tumor Field,Systemic,2011.0,Alive
s12519,A16EF214-00F5-4385-81E9-E66DA356395C,TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted.bam,47,4AE46D2E-BA86-426F-A127-4C1AAF92AB5B,e632b443-cf6a-4592-96c6-c3493ec86fea,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,A5DE766B-9CCC-4B56-8D9B-25704C1C91D0,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.98,72.49,DNA,,,,2007.0,Alive
s12572,A344BBCD-2668-4310-8CCB-1C08307D2CB3,UNCID_1565370.9CE6D6B5-0457-4127-99C8-0A5632B8BEE2.sorted_genome_alignments.bam,63,9CE6D6B5-0457-4127-99C8-0A5632B8BEE2,cfdd2155-57a9-499c-92e1-fb82b577b050,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,56E31332-09FB-4305-8EE8-ADC568B393F3,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.74,7.6,RNA,,,,2011.0,Alive
s12504,C5097AAD-061C-40D4-AA81-A97FE09D13F6,G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.bam,37,17A66D24-DE77-4F2A-A8AD-D2C6A69E7671,a65ec434-9ae0-453f-b440-08bf25558fd1,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,4D6A2D9E-EC25-4040-A696-2D8D5D5C392E,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,,36.94,DNA,,,,2011.0,Alive
s12563,00E327FB-FB17-4E1B-A067-32B6676F2B48,UNCID_1350906.bc4a51f7-cfa6-4a06-ac97-3de942b9909e.sorted_genome_alignments.bam,68,BC4A51F7-CFA6-4A06-AC97-3DE942B9909E,c63936dd-39fd-41fa-a9f6-18b18303ef05,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,EAD007DB-6CD8-44CF-BB5B-BEA7B52448B2,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.72,45.94,RNA,,,,2011.0,Alive
s12513,F42AA2A6-4ACD-4650-AEA7-C83FBDDF27D2,TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted.bam,37,76DCBA6C-0992-44BB-9492-3023A2430CC4,0b170ed4-d919-466b-b765-47878b865aed,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,6883BA87-9184-40D7-840B-603B15D73F7A,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,2.0,48.83,DNA,,,,2009.0,Alive
s12524,BD558097-490F-4EE3-AF4A-093FD4AEBAF1,TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted.bam,52,3490DBDC-8BFC-476F-BC1F-2D142365D9A2,4481d84d-109e-44a0-bcb4-e6e61bdce796,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,7D90939F-BAB7-4A39-8D57-79540142BB63,Alive,Johns Hopkins,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1b,Stage IVA,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.93,63.41,DNA,56A0A56D-15DE-446B-AFC6-27E2AD480D39,Primary Tumor Field,Systemic,2010.0,Alive
s12578,A47D9089-B24A-4446-9CF5-0A36922E8A10,UNCID_1652912.C5B06E27-6E58-4555-84D9-B14078219E18.sorted_genome_alignments.bam,43,C5B06E27-6E58-4555-84D9-B14078219E18,785803bb-42a8-4afb-b7b4-58c114894408,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,F5EBEFBE-50FA-465A-A355-2C099941039D,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N1b,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,20.0,0.17,1.77,19.76,RNA,EBEC2900-84A5-4052-8A2E-E3A0C2CE3841,Primary Tumor Field,Systemic,2008.0,Alive
s12508,3D2BE877-3825-44B4-99B1-B3C314E68C0C,TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted.bam,46,F353E9F5-A869-4BE1-ACC4-A832D77285D4,6ba76174-620e-4851-857a-d0adbfd6f3e6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D9689254-AFE2-4544-AF54-E02670BD5EBD,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.81,46.06,DNA,C1F67B66-1827-471B-95E5-F27DD175087F,Primary Tumor Field,Systemic,2011.0,Alive
s12589,56B5F742-07BF-4D3A-A390-DDF13AE8E604,UNCID_1654481.E3806569-B487-4F9F-AE56-837EC20246B9.sorted_genome_alignments.bam,50,E3806569-B487-4F9F-AE56-837EC20246B9,2dcdf9a1-9437-4515-88c1-1c17d6b6418c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A8B1D7AA-B856-4B9C-89F3-1A129ADD9A3D,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,26.66,RNA,78F554B3-084A-4671-A5AC-2A89D41EB272,Primary Tumor Field,Systemic,2011.0,Alive
s12590,3C0E4E05-98FF-4E01-8445-EBC98477A561,UNCID_1657214.A9522B26-CB18-4BDE-B2A4-8EF4701C29D8.sorted_genome_alignments.bam,45,A9522B26-CB18-4BDE-B2A4-8EF4701C29D8,861f94ce-45ff-4588-addb-e1ea48878c2e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,913D384C-657A-4AE0-9E8E-E9BDB77D140E,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.16,2.05,13.86,RNA,DF7057DE-8110-4940-8335-4650CC0210A5,Not available,Systemic,2001.0,Alive
s12565,1F128F6D-DCB3-4E62-B5F0-975E99D3471F,UNCID_1361337.303a2167-c633-4d5b-9acb-93003b9c5d0f.sorted_genome_alignments.bam,53,303A2167-C633-4D5B-9ACB-93003B9C5D0F,3dcee02c-a3d2-4188-a072-4d36c8a7e8fd,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,619991FD-3583-4667-974B-15999E4D24B8,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.77,44.88,RNA,2D84A26B-DBD1-43A4-8F2C-5C7E1A6C8851,Primary Tumor Field,Systemic,2008.0,Alive
s12499,2EF29DAE-4708-441B-AB7F-4F8EF4462A47,G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.bam,69,D692ECD0-2433-426B-9AF2-A30C44A80F7C,8a233b01-2959-467f-8950-02be16309156,174.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,5297F55C-3A46-47ED-8ACC-03333AC26473,Dead,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage IV,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,33.29,DNA,,,,2005.0,Dead
s12501,56CAD7AF-D64E-4A7F-9D2E-206CBB921C3F,G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.bam,85,1924D200-6929-4EEF-8A7F-317F8FBAB915,c7a2f394-3e3f-4c90-9f1e-f2be3e5b0d6b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1b,N0,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,20.0,0.08,,32.87,DNA,,,,2010.0,Alive
s12557,51CB736D-059A-455F-AF8A-6F4A8CE1D52F,UNCID_1326169.95429e9c-6a48-4ed5-a4a1-44e0880d5cf4.sorted_genome_alignments.bam,42,95429E9C-6A48-4ED5-A4A1-44E0880D5CF4,c83fb5e6-8af3-47e4-ae48-cee92dff9db7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,882E6F53-CA5F-401F-BB95-361E5CDE13CA,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.85,86.98,RNA,3B079B31-A5EA-4719-B274-932FD26C61C6,Primary Tumor Field,Systemic,2010.0,Alive
s12609,5697BD91-CB08-4E5D-B8DC-95F23D953E1F,UNCID_2039248.04e39981-d4c9-413e-8625-bd7aebf53876.sorted_genome_alignments.bam,61,04E39981-D4C9-413E-8625-BD7AEBF53876,a4a217c1-66e8-4cc5-805a-1172ce5da721,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D3C59D4C-E370-45EC-800B-E6AAA05D2BDF,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,22.51,RNA,B4264606-71A3-425C-9D1A-06BC1C32886D,Primary Tumor Field,Systemic,2012.0,Alive
s12543,1320ED4F-DC2C-40AC-A519-4FCA6F3AD4F7,UNCID_1215247.5c2bec57-d1a5-4929-9cb8-eb3cb46f2ff5.sorted_genome_alignments.bam,56,5C2BEC57-D1A5-4929-9CB8-EB3CB46F2FF5,c53167d4-14da-40cc-b30a-35eb3967b8df,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,A988FC4F-A98E-4BA0-B648-7B416CBB0ABE,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.76,65.16,RNA,5D48A42D-B088-43B0-A25C-50EE39DD7B7E,Primary Tumor Field,Systemic,2011.0,Alive
s12594,448CF7F7-DCE1-4741-B32A-E1AE7B92EE9D,UNCID_1660100.2C8CB0D0-2E13-4EC6-B097-F82645D47B2E.sorted_genome_alignments.bam,55,2C8CB0D0-2E13-4EC6-B097-F82645D47B2E,2b84cfbc-7cf6-4cb1-a1e3-ba85dafb89f4,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,319E3498-D5FB-4142-A09F-ABA779DBC094,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.78,18.42,RNA,,,,2011.0,Alive
s12535,F6EC340C-1C9C-4C8D-9266-4728709A90E6,TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted.bam,39,BF118D4C-A2DF-4617-92E2-3475E07D9BE7,a09b20b5-c187-4632-b996-0d5314a9885c,,Thyroid Carcinoma,Not available,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,EFDAD0C2-A44D-48F8-A908-E8C9747E78B8,Alive,Mayo Clinic,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,,48.6,DNA,F2BAB745-CD60-4D3D-BB22-67026F70E63F,Primary Tumor Field,Systemic,2012.0,Alive
s12584,B11E3183-3192-4459-BA2F-8E1272B2A721,UNCID_1655699.75EF1CC4-96BC-4721-A271-FD699A3F8E04.sorted_genome_alignments.bam,38,75EF1CC4-96BC-4721-A271-FD699A3F8E04,cac8246a-a806-4945-898a-105cd88b2752,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,DFE93AC9-2320-42AC-A308-384A04C0EC6D,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1a,N0,Stage I,Mar-40,C73.9,C73,NO,YES,Not available,30.0,0.16,1.82,65.45,RNA,,,,2011.0,Alive
s12537,C20908B8-930A-415B-BB8F-118FC740A63D,UNCID_1033008.49fb1ab4-cd04-4985-99ee-2ddef8685cdc.sorted_genome_alignments.bam,51,49FB1AB4-CD04-4985-99EE-2DDEF8685CDC,13c97cfb-eea2-4ae8-9209-c967d9642cef,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,56FA075B-09E2-4DB9-A997-0B7EB2198B6C,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.86,54.27,RNA,EA56894A-12EB-48AD-90DD-B0D03418F414,Primary Tumor Field,Systemic,2011.0,Alive
s12562,587664DA-708B-4BF9-9E15-8CAE5775660D,UNCID_1346799.101cc04a-333d-42cd-ad71-4102fd8b8828.sorted_genome_alignments.bam,38,101CC04A-333D-42CD-AD71-4102FD8B8828,af546062-0960-41f0-9ed1-6acecbad99f3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,74B9C0C8-EF36-4194-AB8C-D81D61A39705,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.84,48.24,RNA,980D4D2F-630B-400C-9BEE-4E71895838ED,Primary Tumor Field,Systemic,2011.0,Alive
s12576,C73B02C7-E7A0-429F-918F-9F177FA83543,UNCID_1565706.D291F0D0-18A9-45C7-B545-9C260FCBF864.sorted_genome_alignments.bam,36,D291F0D0-18A9-45C7-B545-9C260FCBF864,faa51172-60ec-48d8-9224-36bfda1d27e0,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2884B621-DCE7-4A50-AB33-144FDCDA7497,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.71,68.54,RNA,,,,2002.0,Alive
s12610,D4B9D46F-6B02-4E30-B954-0CFF62FEB315,UNCID_2083369.ef9e7c11-fee1-41ef-98e0-cfc3ba97e403.sorted_genome_alignments.bam,52,EF9E7C11-FEE1-41EF-98E0-CFC3BA97E403,89c72f0e-e724-4826-bb9c-d7524d1b1258,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,2B19C88D-9BC3-4C86-AAEB-77F523F7FE50,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.88,40.73,RNA,FB8BE626-06E2-4B82-9C71-C71AD9FA5926,Primary Tumor Field,Systemic,2011.0,Alive
s12532,DDDFB702-CB09-4A5F-B023-B31D89EC07A8,TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.bam,41,8358E269-BD6E-4189-86AB-520C84405DAA,0314b145-2f3a-4a90-a580-375b5f0a63a4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,1A9E811D-1C60-409C-A7D2-1D58AFA473E9,Alive,Christiana Healthcare,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,,62.17,DNA,88D9F01C-DF4B-4DED-8BAB-76EB446CA357,Not available,Systemic,2011.0,Alive
s12561,3487EA49-F4B3-41BE-AFFE-72E48B11D2A2,UNCID_1342245.27782ad0-f3c6-43a3-8123-199ebdd92c25.sorted_genome_alignments.bam,18,27782AD0-F3C6-43A3-8123-199EBDD92C25,f69ff5fb-7e0b-4b16-9fc9-498379b11562,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D03E9110-87E8-4B9C-93C9-BA306B5E9DEE,Alive,Asterand,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.86,43.54,RNA,CA813964-632D-4F05-85CA-0826F1C8FF19,Regional site,Systemic,2011.0,Alive
s12599,107A3506-5007-4B38-BCDD-2094EB47F440,UNCID_1815546.efa4eabe-882d-48fc-b422-0d612ff64a12.sorted_genome_alignments.bam,76,EFA4EABE-882D-48FC-B422-0D612FF64A12,6b529fb3-0b1b-4d3b-9309-bfcb063dbb71,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D0E73F50-D2B4-4130-B9E0-C585BB0C93A5,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,NX,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.65,32.41,RNA,,,,2012.0,Alive
s12606,F5E1B4AE-EEF3-48D0-8C70-981E8786DDB7,UNCID_1901691.27ecc5f8-6232-48bb-8a1f-fa46af7a9309.sorted_genome_alignments.bam,71,27ECC5F8-6232-48BB-8A1F-FA46AF7A9309,cd0c33c3-4427-471d-979e-79dc43f3a018,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6E4A272F-83BF-4E5B-948F-AABFA30B685A,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.15,1.89,57.54,RNA,97FA160E-C63F-49AE-A319-A192A979C2EA,Primary Tumor Field,Systemic,2011.0,Alive
s12553,CBA42AC5-412F-4A5F-A672-F73FB4BC9FA6,UNCID_1323767.c49edbbf-9eaf-4574-9941-1546d0779e70.sorted_genome_alignments.bam,61,C49EDBBF-9EAF-4574-9941-1546D0779E70,19378727-e0a6-4898-b2d0-f12241616870,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,E18AB48C-97FC-4DE0-9895-D58AA1AEDEF1,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.78,60.66,RNA,,,,2011.0,Alive
s12540,86A70A1D-96AC-4416-8DD4-16D70DC755FD,UNCID_1212966.c687adc4-afe5-4db9-a488-ff52735ab090.sorted_genome_alignments.bam,65,C687ADC4-AFE5-4DB9-A488-FF52735AB090,061fab24-727a-4551-a205-89eeb9f530ea,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,094CF919-3E36-4D9E-9D37-A00AE04736EE,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1b,N1a,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.16,1.8,26.58,RNA,8765254F-AF58-4042-B22B-189741931A2E,Primary Tumor Field,Systemic,2011.0,Alive
s12551,0C480D93-5100-4C21-807F-ED2423F81ABB,UNCID_1322004.c51d483d-2610-43c7-9c06-dfcf4ddff9aa.sorted_genome_alignments.bam,70,C51D483D-2610-43C7-9C06-DFCF4DDFF9AA,dd981e11-4b49-447e-8ebc-d9db4b55ce9b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,CDD2763F-2F60-4DAA-AECF-E9A9DC27360D,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.79,27.02,RNA,,,,2009.0,Alive
s12564,366D3431-3AAF-4CD6-983A-4167C4ADAD60,UNCID_1361856.711566ef-6200-4bc2-8c5b-ec74ed14b91d.sorted_genome_alignments.bam,20,711566EF-6200-4BC2-8C5B-EC74ED14B91D,cd73c807-a74e-46a8-9855-92de33da9b0d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,5DC78784-FA9E-4415-812A-8D2C537DC15F,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,10.0,0.16,1.82,24.37,RNA,7DA5C496-4B80-4D69-AD1D-CE65143ED6AD,Not available,Systemic,2006.0,Alive
s12596,1A3C77C6-1180-4FDF-9687-DE66C6BA1BC9,UNCID_1665182.FEA9C2BF-A2B5-44FE-BCCC-20C99837CFAB.sorted_genome_alignments.bam,19,FEA9C2BF-A2B5-44FE-BCCC-20C99837CFAB,ea859a83-00c3-40b2-97c1-fb24ad027ea6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6937BEB3-2941-40F5-82DF-F7EB8DBC10B8,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.83,55.75,RNA,8E5C611A-6B97-4DA8-9E44-C3AC347356F0,Regional site,Systemic,2008.0,Alive
s12528,7EAFBE04-60BE-48A5-8E8A-937B1DDE35E8,TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted.bam,26,F3F4F8FB-6FAD-46B7-85D0-C591EB926DD7,c781b49e-d08f-49e6-b774-7cfe4100e92d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,377A0CBF-6A82-43FA-BC95-DADECED8916D,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.0,74.82,DNA,27C874F7-FC72-4555-9473-D7B86F66A600,Primary Tumor Field,RADIOISOTOPES,2002.0,Alive
s12556,46E7100D-E2C2-44AA-B82F-8DF3DF2A5708,UNCID_1327068.82644c32-bf20-4ba5-ad71-aa54c62a4bd8.sorted_genome_alignments.bam,82,82644C32-BF20-4BA5-AD71-AA54C62A4BD8,fc70a652-7925-4759-8e1f-05fd56829df4,1023.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E44BAB87-DAB4-4C6E-B6E3-51B8641ED67E,Dead,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,2.0,75.06,RNA,EA2C5F69-25B9-453A-A259-92B089499FD6,Primary Tumor Field,RADIOISOTOPES,2005.0,Dead
s12538,6858726C-85C0-46DB-A27D-8C99D6D749F6,UNCID_1209178.2f1c17bf-53ac-4537-af66-0d5253a53355.sorted_genome_alignments.bam,46,2F1C17BF-53AC-4537-AF66-0D5253A53355,fd25e4e6-f017-4c07-b109-d8a5eea8763c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1E252534-D457-4A24-AEA1-1BC334C881F7,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.16,1.78,56.71,RNA,,,,2011.0,Alive
s12555,6CC4893D-CF46-4B68-BAF0-3C240A1929E8,UNCID_1328609.d603ef6d-a51b-4210-af30-b2ff234a1a7a.sorted_genome_alignments.bam,54,D603EF6D-A51B-4210-AF30-B2FF234A1A7A,b55375c3-9ef2-4d2f-9c29-224e746931c4,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,582C3030-1F23-4535-9C8B-6B594E656AF4,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage III,Mar-90,C73.9,C73,NO,,Not available,20.0,0.18,1.86,43.42,RNA,,,,2010.0,Alive
s12568,BCDB376A-3946-4D00-9354-26F41D1CC282,UNCID_1456127.a7a78978-b6a4-4f2e-bb14-7ae36613eefd.sorted_genome_alignments.bam,54,A7A78978-B6A4-4F2E-BB14-7AE36613EEFD,8beee000-ecab-4a49-9c9d-bb8e677ae199,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,83A66A9D-916A-44E8-A7E6-A1385DB504DB,Alive,University of Pittsburgh,University of North Carolina,United States,Other  specify,T2,N0,Stage II,Mar-35,C73.9,C73,NO,,Not available,30.0,0.15,1.88,31.5,RNA,,,,2010.0,Alive
s12498,3FA6F792-4048-42A5-990B-A50E3E20FA7A,G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.bam,75,66EB4833-1B87-4FD9-A53D-26DC7AD6DE29,4fc8e011-4433-4537-b03f-457a3a70240f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,BB98FF62-4CD8-46D6-9A85-8439265BE40B,Alive,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage IV,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,55.8,DNA,B917243E-F5D9-44B1-A5B3-DF1BE9879441,Regional site,Systemic,2010.0,Alive
s12593,1EA1B73B-236F-4056-AE91-748131590D96,UNCID_1660965.2D5E9D92-0FE5-4D07-B9E0-6F26D9E0A266.sorted_genome_alignments.bam,51,2D5E9D92-0FE5-4D07-B9E0-6F26D9E0A266,29c4319c-3ead-42b1-810d-418da8d515c4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8C112A5F-AE83-4B13-8E00-802382729344,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,11.42,RNA,FE74EC84-EEA7-4254-AE6F-E44A6A759759,Primary Tumor Field,Systemic,2011.0,Alive
s12569,FCFA37D1-9A40-462E-864C-8E5BE9531AAF,UNCID_1457896.4867f104-911a-4bda-8815-367bf28dff9d.sorted_genome_alignments.bam,37,4867F104-911A-4BDA-8815-367BF28DFF9D,dffef9e8-5b69-43d9-a95b-0744daa38d1d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2DC7CCE6-0A73-4B48-8723-1A2511C5B295,Alive,Roswell Park,University of North Carolina,United States,Other  specify,T3,N1a,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.75,25.01,RNA,ABAAD4CF-5BFE-4155-9BA3-42E3343E9C01,Primary Tumor Field,Systemic,2007.0,Alive
s12518,FB31D05F-8A2E-416D-92B9-FD333E80561F,TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted.bam,34,C1FE07E8-83AC-47A7-B8E5-FA62DE03BB17,90507baa-b716-4bcf-a18e-9d8ae97d809a,,Thyroid Carcinoma,HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,61367375-8317-4CAE-86CF-2FD65AB8ABC8,Alive,MD Anderson,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,,40.31,DNA,1BD81C7D-3066-4A7B-A688-974E0A6B8D59,Primary Tumor Field,Systemic,2003.0,Alive
s12558,62BD0243-B9E6-4A97-8DAA-A04D46BCE8E3,UNCID_1325494.a38de7c6-26c2-4a7e-90e5-79b778de8b5d.sorted_genome_alignments.bam,40,A38DE7C6-26C2-4A7E-90E5-79B778DE8B5D,154b4e7f-06f9-4813-beab-232227229f8b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5D469ADF-AC99-4935-AE91-BD7A12446085,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.75,26.78,RNA,C38E5884-128C-4FBD-B347-AFE6802657E7,Not available,Systemic,2004.0,Alive
s12541,2528EECF-68BC-4FF9-A5DD-CA2BBE973730,UNCID_1213082.b769a631-6c4c-43aa-821b-b10cd4bba51b.sorted_genome_alignments.bam,56,B769A631-6C4C-43AA-821B-B10CD4BBA51B,d4c68c1c-a3f3-4e0c-b555-d457378a1d24,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D1612961-A709-487B-A4D1-CE42F0B9AA54,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.87,22.94,RNA,,,,2010.0,Alive
s12554,C84DBDFA-3AA7-4C55-9F12-D551AE4F5D9B,UNCID_1322374.c99f401e-8e9e-4302-8b5e-e6a699b43b6b.sorted_genome_alignments.bam,33,C99F401E-8E9E-4302-8B5E-E6A699B43B6B,80420c04-709b-4ab2-a88c-1e22b3a09b9c,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,DD441612-6DDF-4A8D-92F5-818D564D38C9,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.82,30.44,RNA,54E4ACAE-E5CB-4376-818D-36B60EEF4698,Primary Tumor Field,Systemic,2011.0,Alive
s12577,2C205591-E08E-454B-893A-8AB28557735D,UNCID_1573875.0C8A92AE-0B90-471A-9EF8-FA8E42F6204D.sorted_genome_alignments.bam,52,0C8A92AE-0B90-471A-9EF8-FA8E42F6204D,59221e3a-2927-40bf-a38d-4a5843ea179b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,67A68931-520A-4D95-BD5E-99896AAA133B,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1a,NX,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.77,15.46,RNA,,,,2012.0,Alive
s12592,A253F15B-93F9-4AA8-83F9-074E883841AA,UNCID_1661802.CF7BE099-A25C-4258-AB16-740ECE414172.sorted_genome_alignments.bam,33,CF7BE099-A25C-4258-AB16-740ECE414172,05a8268a-6b33-429b-8638-8c9bb366ef28,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,955243D6-118F-41B7-BC8A-D3DDF7AD00B6,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.9,44.3,RNA,B922582E-4870-41F5-B3DB-099C8693CB7C,Primary Tumor Field,Systemic,2004.0,Alive
s12598,CC6290BB-DE1E-4632-B95E-F4BF89F04BB4,UNCID_1728401.17f52efc-8576-41cc-9ae0-e76c860ea47c.sorted_genome_alignments.bam,23,17F52EFC-8576-41CC-9AE0-E76C860EA47C,f12fa57b-3427-45fe-994b-602f498b68da,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,18761057-8D3E-4494-BE02-A1C5D5650C00,Alive,Asterand,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.8,36.75,RNA,,,,2011.0,Alive
s12544,5C30AF0D-5426-419E-9567-D93939E4286A,UNCID_1215841.912946d6-1149-4dac-a01f-36793f9ab0c9.sorted_genome_alignments.bam,76,912946D6-1149-4DAC-A01F-36793F9AB0C9,290be61a-84ef-4bed-8e37-b432cba6c88e,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,14608E17-A38D-4F0E-9CA7-7922C8984FF1,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.83,54.01,RNA,,,,2010.0,Alive
s12595,383D871D-0647-4A15-8FB6-AC6DCA52A39E,UNCID_1660801.6F0967E7-B8AB-42D8-AABB-77D59C54EB74.sorted_genome_alignments.bam,32,6F0967E7-B8AB-42D8-AABB-77D59C54EB74,b30f5b13-8cc9-48a0-93ea-3d49ce8a7d0d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,390381CF-49D5-4CAF-92E2-1316746CFA1D,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,44.18,RNA,56005D45-795D-46BF-89F8-588186A1E38F,Regional site,Systemic,2010.0,Alive
s12608,5E6E048C-33F2-49CA-A067-278C53A41885,UNCID_1926082.a9574e45-5dee-46f3-87db-f7e859b67cab.sorted_genome_alignments.bam,49,A9574E45-5DEE-46F3-87DB-F7E859B67CAB,2501ee46-8d38-448b-8765-e9c9706cbbe8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C92FC4E3-7A96-4000-A969-AA894CA58A33,Alive,University of Pittsburgh,University of North Carolina,United States,Other  specify,T1b,N0,Stage I,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.86,59.74,RNA,6C065D3A-DB37-46BE-9030-694D189B37B8,Not available,Systemic,2010.0,Alive
s12605,0AF338DA-36FF-49B3-AE57-79316C1B70CA,UNCID_1902419.8e124018-d6a5-47f8-9486-4c0fb0c7a622.sorted_genome_alignments.bam,35,8E124018-D6A5-47F8-9486-4C0FB0C7A622,50ec4170-29ea-4ee9-8ce7-67ec78d1dc76,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,DD665CD1-DC08-4E3E-87FF-893DB7D3DEBF,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,NX,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.8,38.82,RNA,64EF9E5F-3406-4A7C-B090-2BA102BE9A4B,Primary Tumor Field,Systemic,2009.0,Alive
s12602,AB56752A-CE6F-407A-86D8-7BC989778439,UNCID_1880530.8b92ac31-d481-4d26-b25b-143f65785939.sorted_genome_alignments.bam,61,8B92AC31-D481-4D26-B25B-143F65785939,e0174496-d774-4417-81d1-cb16771760ad,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,86D5D48C-24B6-4D76-B85F-F96A6E16316A,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,43.13,RNA,D107484B-FCD8-4105-A6D0-BE7BAF783492,Primary Tumor Field,Systemic,2011.0,Alive
s12505,9BD9796F-01F5-45D5-837B-B0BECE0995F4,TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted.bam,54,14EE09BE-144A-4461-8F5A-A738CC5D955E,8beee000-ecab-4a49-9c9d-bb8e677ae199,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,83A66A9D-916A-44E8-A7E6-A1385DB504DB,Alive,University of Pittsburgh,Harvard Medical School,United States,Other  specify,T2,N0,Stage II,Mar-35,C73.9,C73,NO,,Not available,30.0,0.17,2.02,67.32,DNA,,,,2010.0,Alive
s12530,CA8AAA05-1546-46A2-AEE9-1AD97CADF087,TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.bam,44,AD42DF5B-2665-4CA1-8049-943F684B6BFD,5eb0d577-223b-4409-89d1-5c5d196affc3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,213BE6EE-1E61-4FA0-9B73-66B696086397,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,2.05,72.56,DNA,9CB6DD51-6B74-475E-9CCF-D65EEFFB2F93,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12586,D8C46806-CC3A-4B5F-882A-2F25BC5C8024,UNCID_1654161.4B93192A-1C4E-4B25-B732-36F5484F44C3.sorted_genome_alignments.bam,39,4B93192A-1C4E-4B25-B732-36F5484F44C3,28aef3ae-5375-4139-9b4e-5569eb394c88,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,D329FEBC-8955-4843-9DB8-AE21DF06C2F7,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.79,27.11,RNA,,,,2011.0,Alive
s12611,DC619E42-EE4F-4845-878C-D0FE7546325D,UNCID_2083612.371eb875-89ad-4a91-a2b5-ba98c0ce2ef1.sorted_genome_alignments.bam,79,371EB875-89AD-4A91-A2B5-BA98C0CE2EF1,4ec2bb20-2190-4c37-8aaa-4086fef1fbb6,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F1D3E0BD-0A0B-4328-9C9E-229ADB972282,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.89,51.73,RNA,3161E5AE-C55E-4C5B-8670-3C6D3D45B2C3,Primary Tumor Field,Systemic,2011.0,Alive
s12521,54060B82-DDF3-4449-AA9C-BAAA4D66F1B7,TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted.bam,32,DEC98438-085F-40C3-8751-D50BA12C8584,762eddb5-1b47-4b79-b20a-1edfb07c0705,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,95D077B1-E4F3-48EA-84BC-F663FD438693,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.89,104.75,DNA,,,,2010.0,Alive
s12552,137D2BAA-2CB9-440A-86CE-63D5F15276D3,UNCID_1323893.e83e16e4-f792-46d1-840b-0deef301fbf9.sorted_genome_alignments.bam,51,E83E16E4-F792-46D1-840B-0DEEF301FBF9,2106f0cd-cb3c-4568-bdc5-197ee11f2337,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9BD1FDE8-2000-4AD1-A4FA-D370379DEAC6,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.17,1.83,45.4,RNA,FD29D747-3086-4753-8474-4D747D19B4EC,Regional site,Systemic,1999.0,Alive
s12581,63A044E0-0B19-4397-9330-CB518544BF38,UNCID_1652723.1EFC2B34-1BB6-4A6E-993B-151D44F3B2ED.sorted_genome_alignments.bam,57,1EFC2B34-1BB6-4A6E-993B-151D44F3B2ED,f3665b89-957b-4d7b-b67f-39615c47d28b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3BAB28AA-FD05-419C-9CAF-B3C7543A7690,Alive,Asterand,University of North Carolina,Russia,Thyroid Papillary Carcinoma - Classical/usual,T4a,N0,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.84,29.35,RNA,50EF4A7A-8DA2-4409-A79E-54F31C9B48BE,Primary Tumor Field,External,2011.0,Alive
s12571,539AE266-05C9-46B6-A8B0-A51C5BCEFF23,UNCID_1498875.059efd3b-2527-4648-9334-498262fb56dc.sorted_genome_alignments.bam,33,059EFD3B-2527-4648-9334-498262FB56DC,7deedeba-f05b-453c-9df1-eeb20b0ec72e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D717EECF-11DC-4E15-851A-9EA18332A48B,Alive,ABS - IUPUI,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.86,46.95,RNA,D3271F10-C2B0-4855-8BE9-26B8D2F0F5EA,Primary Tumor Field,Internal,2011.0,Alive
s12545,9135EC22-D77B-4D69-A81D-787163EA1D59,UNCID_1229575.ee665717-a903-44bc-8eaa-afb46bd4edf0.sorted_genome_alignments.bam,45,EE665717-A903-44BC-8EAA-AFB46BD4EDF0,3b48cc5e-3396-4dd5-893d-54b75b98b016,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4DCA97A5-B0E5-4383-8CC5-B6FF07741647,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.86,35.72,RNA,,,,2010.0,Alive
s12591,07C6F5A1-A9D8-46BF-8951-5A4E6E39DD89,UNCID_1660450.1D531770-F138-4CDE-A7CA-D3DF996FBB5C.sorted_genome_alignments.bam,46,1D531770-F138-4CDE-A7CA-D3DF996FBB5C,a3765a2b-ff09-4dec-b990-65529345214e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,DA672213-5B05-4A9A-8846-71CC5FC1DEA0,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.18,1.82,19.19,RNA,,,,2010.0,Alive
s12548,78F9FEB9-3A02-4EDA-BEDC-3AC254E8BAD0,UNCID_1258486.2a276a7e-a3e3-48df-b427-f32f70606152.sorted_genome_alignments.bam,56,2A276A7E-A3E3-48DF-B427-F32F70606152,e23cd75a-06ad-4da0-b19b-b812b0f6c1b9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B1E8D535-2DCD-4E24-B117-C263FB0CABC9,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.86,62.75,RNA,A14FD538-F2EE-4FD5-9333-C1968B53155C,Not available,Systemic,2008.0,Alive
s12560,F6AAECAB-CC51-4916-B96B-CBB4905473B0,UNCID_1339406.e6d254f4-3c38-4faa-8cc3-253b87bd643a.sorted_genome_alignments.bam,29,E6D254F4-3C38-4FAA-8CC3-253B87BD643A,acb3b9db-16e9-40f5-87a9-9df9d4ceee54,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5D1D84D0-9A03-4381-9CF1-E460B3617AAA,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.85,55.63,RNA,D8D4F07B-9B20-46FE-A3BC-26CDE7172AC0,Not available,Systemic,2010.0,Alive
s12575,C52E06FA-BA96-4EFA-A2F1-102C993456BF,UNCID_1565726.5BB6BF4F-84AF-4B86-9292-E56153B2A401.sorted_genome_alignments.bam,33,5BB6BF4F-84AF-4B86-9292-E56153B2A401,fb14bd0d-b356-42a4-a0e9-2fcdada8f76b,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,BEAA3DE4-C835-4181-A749-F2C61EAACC2D,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.77,63.11,RNA,C32EAB3C-2C6A-4847-BCA9-E061FA844832,Primary Tumor Field,Systemic,2010.0,Alive
s12607,C45A789B-8319-4D5B-8A18-40A2A5DCD712,UNCID_1917914.f929972c-1b5a-4fdb-b992-f69eb572496d.sorted_genome_alignments.bam,43,F929972C-1B5A-4FDB-B992-F69EB572496D,a3f87411-0a7b-4415-ba17-8edcc2639f6c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2EBA8B5D-24A9-4B18-87D2-32DE38C9BBE3,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.91,40.9,RNA,,,,2010.0,Alive
s12550,3C8DBBF6-0AAA-44D2-A351-6F08C4527BAE,UNCID_1270488.08919a76-5d54-46f7-84ac-9f04838ea0ed.sorted_genome_alignments.bam,20,08919A76-5D54-46F7-84AC-9F04838EA0ED,da201150-748e-4b74-bb35-10c995e26079,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A8307181-67CE-4A79-8D23-76CEEE1D2761,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.8,47.35,RNA,,,,2010.0,Alive
s12597,F4C05EFC-DAD2-47AC-9A3E-94902DF9BBE8,UNCID_1665123.36618B4C-C4DA-4513-A4B7-6579F3CFFEB2.sorted_genome_alignments.bam,57,36618B4C-C4DA-4513-A4B7-6579F3CFFEB2,aa3ce865-4bc1-4cca-9ba8-35ff4c5e165e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,380AD5E3-0CB9-484E-9A9F-FADC9B3E4B84,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,2.0,15.2,RNA,,,,2012.0,Alive
s12567,4906C76D-3A54-47D5-B8EF-292B6FCFE9F8,UNCID_1455569.aa9f2d19-a6b8-4d4c-8868-c6c5e1fd0e75.sorted_genome_alignments.bam,49,AA9F2D19-A6B8-4D4C-8868-C6C5E1FD0E75,63e8c48e-f01b-4a7f-87e2-30607a2c8f6c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,598609C8-F823-4740-88C6-25B1A94D08AA,Alive,Roswell Park,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.8,23.92,RNA,2B077CF8-13CE-4726-8017-95D6693FF7C2,Primary Tumor Field,Systemic,2010.0,Alive
s12525,2E9FB20E-CC3D-4AA3-A188-6695DC2532A3,TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted.bam,28,1A00F009-28F5-406B-8F47-4BB9D55D25D6,ebccfb5f-c0a8-4263-aaff-b5dd83585191,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,0CD93B1F-1CBB-4C1E-A4F6-940F95C41683,Alive,Johns Hopkins,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.71,26.49,DNA,FEC020ED-7460-4310-A172-A799B97AAB21,Not available,Systemic,2009.0,Alive
s12570,7734C357-1F12-4912-A2D4-AD05476184D0,UNCID_1457875.280de9cb-d098-46e8-b0ae-ccee52d8e5e4.sorted_genome_alignments.bam,24,280DE9CB-D098-46E8-B0AE-CCEE52D8E5E4,34d4cc10-b868-4e85-96a5-8680fc729e34,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3D0E6324-8647-46BE-99A3-4EA26E309500,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,55.22,RNA,84C53C6B-7527-4364-86E6-09A2D808CD75,Not available,Systemic,2011.0,Alive
s12514,EAF940DB-08D0-4DC4-B390-0576523FB2F5,TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted.bam,30,E86091EB-6DCC-479B-BAFD-3DABA65787EC,6ad260ad-769a-4f3c-bd07-927adf6b2338,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,EB4FEEBB-293E-43E3-A2ED-344B17D180B3,Alive,University of North Carolina,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.14,2.03,63.0,DNA,0A404AB4-7AD5-47FB-85B0-DC771E77C3A0,Not available,Systemic,2010.0,Alive
s12542,543A404A-16DE-44EA-90B1-315498950062,UNCID_1215849.90c1c52d-0d8b-41d3-82c7-e4773c95a22c.sorted_genome_alignments.bam,21,90C1C52D-0D8B-41D3-82C7-E4773C95A22C,99ac4f2e-2e63-4f1e-af0f-8f23a2caf999,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,A870F5CA-F049-48C1-AFAC-B788A3111086,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.87,58.98,RNA,A00859AB-D428-4EE5-ACB6-DB9BF1032399,Primary Tumor Field,Systemic,2010.0,Alive
s12588,7F3A3E0B-2AA0-4BFD-8A17-A6A382E147C2,UNCID_1654232.60A442F5-072E-40D2-9945-380FA5375B2E.sorted_genome_alignments.bam,83,60A442F5-072E-40D2-9945-380FA5375B2E,00d588e3-3db6-4cf3-9def-34d941e8cdb0,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,30FF16F0-38DC-452F-B088-43EF6BE19B57,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,37.36,RNA,9EBE5125-D09F-4813-B934-F60F56AF2FA4,Primary Tumor Field,Systemic,2009.0,Alive
s12604,7BBFFC5C-7E18-4611-B829-253D5C9C8CDB,UNCID_1900439.b08d8be0-f28a-474a-991f-e7764e16b311.sorted_genome_alignments.bam,49,B08D8BE0-F28A-474A-991F-E7764E16B311,e94dfd42-4fe4-48e9-aa62-422ae071413f,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,402BD26A-E355-48C9-9B39-FBB99FB2366A,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.78,43.62,RNA,67248CA1-0BB4-496F-98AB-4D0D63D8F030,Primary Tumor Field,Systemic,2011.0,Alive
s12546,62EAC368-C84B-4E22-B719-1C9DB4E0AC78,UNCID_1234064.0f785f8d-8c49-4940-9c60-31ad29c844d5.sorted_genome_alignments.bam,58,0F785F8D-8C49-4940-9C60-31AD29C844D5,0fe3b19a-f5e4-497e-92da-32ff6c77b066,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D17746B4-EDEA-45DB-9AD1-5EE4973F007C,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.86,76.31,RNA,,,,2010.0,Alive
s12559,6040301E-F771-417E-92C7-D40AFC51F507,UNCID_1329076.eec1dd96-abdb-4198-a4a1-24f112c24b71.sorted_genome_alignments.bam,55,EEC1DD96-ABDB-4198-A4A1-24F112C24B71,7a45cbc2-9fbe-49f9-9d70-f8dc82829769,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3A8F4B4F-241A-43FD-BB83-B8F147800A5C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.75,13.74,RNA,,,,2006.0,Alive
s12503,AF5F8467-77AF-435F-B962-DB1A207085E3,G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.bam,50,3F039593-91D1-43CB-A06B-41E92F7E8D20,3e787a0e-b5d2-401e-b1e5-077376090b3a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,27B0FF79-4213-4B57-B6E0-A393B8983D20,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,1.95,78.88,DNA,0CEEFC3F-1F30-4015-938A-B3B17995CEAC,Primary Tumor Field,Systemic,2010.0,Alive
s12573,BE48A66C-A752-4E0A-804B-46C7EEBC9103,UNCID_1559807.23E64279-3952-49D7-BCFA-7F1EAD36304C.sorted_genome_alignments.bam,72,23E64279-3952-49D7-BCFA-7F1EAD36304C,dde7ade8-de24-467f-855d-a422bbede407,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,ADB988D4-2513-45C9-AA81-56B1FEAA2958,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage III,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.16,1.8,35.91,RNA,414636AD-8887-46D0-8F1A-7E62097AE4B5,Distant Recurrence,External,2002.0,Alive
s12601,421A744B-0EFC-4019-9D20-78B5DB7DA2C6,UNCID_1815879.58275e37-85f2-471c-8afe-fb426f7ce8c1.sorted_genome_alignments.bam,27,58275E37-85F2-471C-8AFE-FB426F7CE8C1,a5406575-c840-475a-ab1b-e1a159413fbd,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,5185F8FD-3CAC-4CF0-9341-174529286656,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,2.0,40.15,RNA,,,,2011.0,Alive
s12566,41BF410E-1D16-4918-A0EC-E974C0F9E52A,UNCID_1376223.79cc211c-8723-4f0b-bc32-89b3efcc8577.sorted_genome_alignments.bam,44,79CC211C-8723-4F0B-BC32-89B3EFCC8577,c115df9d-cec4-4d7a-87f0-36a5c1f1d51f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9E9851C2-FF6C-422D-A084-535E64D21CDA,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage I,Mar-44,C73.9,C73,NO,,Not available,30.0,0.15,1.83,53.75,RNA,,,,2010.0,Alive
s12547,F33CAD09-093B-46BA-B4DE-7A559841970F,UNCID_1234596.b477c725-8d74-40ed-b4ee-27341a354fd1.sorted_genome_alignments.bam,70,B477C725-8D74-40ED-B4EE-27341A354FD1,3cd2d4bd-8256-42fa-8272-db379d598007,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C84F79EF-C51A-4627-A58C-E8E1F226CE7F,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.18,1.85,76.86,RNA,90AA43F0-1F1C-48C3-AC07-71EA74EB09D3,Primary Tumor Field,Systemic,2010.0,Alive
s12582,EC84D124-B66C-4C40-8EF4-54A5B1348504,UNCID_1653028.77A2CB06-217F-4F5D-A799-D0CFDC244DE1.sorted_genome_alignments.bam,54,77A2CB06-217F-4F5D-A799-D0CFDC244DE1,76c4d298-6f17-4f11-a706-cd844a0e0914,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,FBC09916-A53C-4D56-8CD5-259E8918F3DE,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.15,1.78,36.7,RNA,B2B8F475-39AE-4F2F-AE93-4DF601454E1F,Primary Tumor Field,Systemic,2011.0,Alive
s12549,B0337ECD-7BE5-40D1-AB92-2AFA763D4DC2,UNCID_1279691.02438862-cd89-48db-a2d0-1f07678d5673.sorted_genome_alignments.bam,70,02438862-CD89-48DB-A2D0-1F07678D5673,e4b08e66-0772-4956-8670-e5c6553eecbe,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,2.0,43.9,RNA,,,,2010.0,Alive
s12044,1A3435EF-1D3F-49B0-9489-C31BDBA5B8F5,UNCID_1560103.69B918B2-61B4-42A1-9F60-D9743936CB81.sorted_genome_alignments.bam,24,69B918B2-61B4-42A1-9F60-D9743936CB81,c9c00e4f-4092-400e-aebb-3d9961be0f0e,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,0294330F-EE3D-41D2-8BA2-89C941230917,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1a,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.68,26.38,RNA,,,,2010.0,Alive
s12052,AA0D7429-7E00-447D-A75D-119BE5A580F1,UNCID_1656109.8DE3CF71-A0C4-4F4C-8341-E9BB406D757A.sorted_genome_alignments.bam,44,8DE3CF71-A0C4-4F4C-8341-E9BB406D757A,8e9c3621-bc43-40d0-bb2d-0c8b7ade37c2,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,30306ACC-14AA-44AF-BCF7-D17BAF6165E6,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.15,1.85,46.65,RNA,8D38911D-5ABE-4CB8-8F04-3ACF72B413E9,Primary Tumor Field,Systemic,2011.0,Alive
s12074,74A02A23-776D-49FD-9EBF-6D82CF742602,UNCID_1906589.00775634-c7a2-4336-83aa-4da2dc58d375.sorted_genome_alignments.bam,19,00775634-C7A2-4336-83AA-4DA2DC58D375,8aa99f35-c644-4f91-9eff-a5d3fae758b0,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,17952842-3447-4A38-90F4-D25B90C3233A,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.89,46.41,RNA,,,,2010.0,Alive
s12038,81503214-E13A-413C-8604-7ED4F75F22DA,UNCID_1457724.9f7b5c34-9a3c-4a6f-a8f2-65da0e6de5b9.sorted_genome_alignments.bam,34,9F7B5C34-9A3C-4A6F-A8F2-65DA0E6DE5B9,2fa2dd09-593a-4cde-97c7-61cdb8ba2bfe,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D7042C88-25CA-4EF7-9B42-435DC7368935,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,30.75,RNA,684AF36C-F094-407A-95E1-8CB725FC9306,Not available,Systemic,2001.0,Alive
s12046,7BA4B32A-BED9-48D2-A273-7846831F38E4,UNCID_1652909.476F4434-E85B-435D-9070-B5C0BF6ABBFF.sorted_genome_alignments.bam,28,476F4434-E85B-435D-9070-B5C0BF6ABBFF,8950691c-600f-4a90-adf6-42a8f129aa3e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,8859762A-5E78-4B31-B975-030A5CDDE4EE,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,26.38,RNA,1E8B7117-58C7-40D0-AD1A-2142ECB4A308,Not available,Not available,2008.0,Alive
s12049,D4F0048E-700B-4E04-A42E-4D594A29AB0B,UNCID_1655987.ED9566E3-E8A7-4B47-B4A2-60BCE3D9BA63.sorted_genome_alignments.bam,15,ED9566E3-E8A7-4B47-B4A2-60BCE3D9BA63,286c69b0-75ba-48d6-a26b-26077f101bbb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,DECEF015-1B00-4025-82D5-131674B1CE2A,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,47.18,RNA,EB42574D-EDC9-45B1-B866-1EF0AC90A495,Regional site,Systemic,2006.0,Alive
s12070,42EFC00F-5D2F-4CD6-8141-207C9E97E9F3,UNCID_1873688.d3eee6dd-5682-40a1-8ca8-6e2816512151.sorted_genome_alignments.bam,23,D3EEE6DD-5682-40A1-8CA8-6E2816512151,9ff3f335-69d1-4caa-a5c5-ee66f4f92d17,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6F108D89-6664-44E8-A02A-370DF9654169,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.77,21.34,RNA,,,,2011.0,Alive
s12069,7506EA0E-68F8-4657-9628-8B8DD0F7A93E,UNCID_1856652.bf6b3b00-4934-4662-a078-60dfa7a9e1fc.sorted_genome_alignments.bam,47,BF6B3B00-4934-4662-A078-60DFA7A9E1FC,1009a500-2a37-4aee-b7c3-049b5ce961a4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1E62380C-71D8-4FE9-AFFC-9FEC9FAF2480,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.93,41.48,RNA,BF0E3382-3DE7-4C0E-B23A-E31E708FD955,Primary Tumor Field,Systemic,2012.0,Alive
s12026,B2936E06-B031-4F1A-9B51-690672DB7027,UNCID_1324036.ff555cad-2ab4-425b-83b5-c56ac20905a8.sorted_genome_alignments.bam,68,FF555CAD-2AB4-425B-83B5-C56AC20905A8,b46d88e9-8477-4900-8da9-5e7dbded0653,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,CE24FE0A-5C4D-4FBE-A02C-76345EAA2892,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,10.0,0.17,1.82,8.92,RNA,C052CDB5-1C84-4CC7-A02C-FC9308706375,Primary Tumor Field,Systemic,2001.0,Alive
s12003,442F6193-A979-40E4-89DB-2E541D3EBDB7,TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted.bam,51,77A80565-1BC9-4F0A-AFB3-23955FE283EB,097b9cf1-ec0c-487c-9ade-2bdab12eb4ca,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,C29162A3-F162-4D32-AB9A-421BE1FEB13C,Alive,Johns Hopkins,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,NX,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.93,101.84,DNA,,,,2009.0,Alive
s11981,0CAC59EC-55CB-4769-BA6D-92C08A076186,G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.bam,44,007AAB66-2F07-459D-8952-3041D6EA24A8,e35b2928-8784-45d0-a71a-a2df161542fa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D1361CB2-6758-4A8C-AE97-8AD5192572FC,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.09,,27.76,DNA,E9D8269A-9DA8-4209-9EE8-66863B89BFBE,Primary Tumor Field,Systemic,2011.0,Alive
s12017,37401B86-496B-4E55-937B-228A276CB067,UNCID_1234454.ec82193f-8c29-4486-aa5d-0c1912608727.sorted_genome_alignments.bam,19,EC82193F-8C29-4486-AA5D-0C1912608727,7d11b016-c564-4fb5-9b85-1b1a0188006f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,FE462B39-830A-4BDB-ACB6-5FA0FDE0FBC2,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.92,37.52,RNA,7E91B7EE-A3AF-44AB-AC0F-77113387D8F6,Primary Tumor Field,RADIOISOTOPES,2005.0,Alive
s12048,8957CC53-0089-416D-8124-7E93CAE1DC54,UNCID_1650607.3F73B2D7-1C70-4A7D-A742-E3F6E9B77CCC.sorted_genome_alignments.bam,38,3F73B2D7-1C70-4A7D-A742-E3F6E9B77CCC,d5ea6520-e446-43d2-9883-441f70d80359,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,BD7107D8-E336-4A95-B2EB-80FC597CF7D4,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.79,21.6,RNA,,,,2012.0,Alive
s12068,6604B5E8-9E0E-4514-A7B9-3B83B3CD78A7,UNCID_1722396.811B2337-58EC-416A-9C72-7E89A05459CE.sorted_genome_alignments.bam,26,811B2337-58EC-416A-9C72-7E89A05459CE,2cae34a6-73a0-4a67-8dcc-051468c41389,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2D7FF8FF-DE00-4C54-8096-46A2DC0729E4,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,38.88,RNA,,,,2012.0,Alive
s12081,AA076AF8-35DD-4225-A4C4-D49C84323B5E,UNCID_2503778.f2a5dbac-1f1f-48c0-8cb7-2b5df939c7c7.sorted_genome_alignments.bam,36,F2A5DBAC-1F1F-48C0-8CB7-2B5DF939C7C7,2378935d-aebd-4f6f-b31b-53bc6bd59bf9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,8D3F3BF4-89C6-4036-BB36-89BC9EBCEB7E,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,2.23,21.0,RNA,,,,2013.0,Alive
s12004,004A2D8A-2DAC-4E95-B287-DDE59C5F0561,TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted.bam,36,BA986EBD-8E2D-4BAF-AC16-FCEB1286F590,dffc4f7a-c67a-4ac5-a338-717dffde686d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D68C3B99-CB82-48BD-A1F8-BEE0A9A9E8C3,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.88,71.81,DNA,2A0BA6DD-DE0D-4EF4-9DE9-52FFD3BFE727,Primary Tumor Field,RADIOISOTOPES,2005.0,Alive
s12034,97FDA0B8-C0F4-43EE-A82A-9A5CC888F2D7,UNCID_1376046.9a367db3-3cbf-4231-b6ea-686981433787.sorted_genome_alignments.bam,44,9A367DB3-3CBF-4231-B6EA-686981433787,e35b2928-8784-45d0-a71a-a2df161542fa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D1361CB2-6758-4A8C-AE97-8AD5192572FC,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.16,1.8,23.83,RNA,E9D8269A-9DA8-4209-9EE8-66863B89BFBE,Primary Tumor Field,Systemic,2011.0,Alive
s12010,562CE291-12C7-4F9F-8B4F-173E776D9D90,UNCID_1034287.eb23bf14-0f53-4e8c-9d50-2d9743a620c3.sorted_genome_alignments.bam,44,EB23BF14-0F53-4E8C-9D50-2D9743A620C3,77bb90f0-e923-4e28-bb88-4d6b420e0b5c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6CBA95AD-2702-4F50-8B1E-BECDAF014B83,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.83,40.84,RNA,57736579-40D4-464A-8A55-C484C7E19271,Primary Tumor Field,Systemic,2011.0,Alive
s12002,893B646B-2FC5-4163-905E-37BFEB036280,TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted.bam,33,7DE80DCB-BBFD-4D87-AD80-EE29258EFFD1,8023d4c9-b56d-417a-9a52-d45b59c756ed,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,0C601625-ED21-47E5-BC3D-A0057D6A148F,Alive,Johns Hopkins,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.96,54.33,DNA,4889493C-3F2E-49B8-84CE-65998C5B19C8,Primary Tumor Field,Systemic,2010.0,Alive
s12036,1031A9E1-7C9D-46E9-9E09-1083C2FFB0C6,UNCID_1457722.08096d6f-0f8c-4107-b86a-61eb10feaddd.sorted_genome_alignments.bam,49,08096D6F-0F8C-4107-B86A-61EB10FEADDD,085ffcdc-8600-42e2-852a-506465f716a2,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,620B21C9-AC06-4154-A941-2532C775C6D8,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.85,43.2,RNA,32F39867-B66A-40FA-AE1D-D3EA8BACA0DB,Primary Tumor Field,Systemic,2011.0,Alive
s11973,FE7C5F35-ECEA-4165-8FA8-7A178959B096,G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.bam,49,64C2E6A0-2341-49C4-A6DD-656E7BB505DD,2501ee46-8d38-448b-8765-e9c9706cbbe8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,C92FC4E3-7A96-4000-A969-AA894CA58A33,Alive,University of Pittsburgh,Broad Institute of MIT and Harvard,United States,Other  specify,T1b,N0,Stage I,Mar-44,C73.9,C73,NO,,Not available,30.0,0.09,1.93,110.16,DNA,6C065D3A-DB37-46BE-9030-694D189B37B8,Not available,Systemic,2010.0,Alive
s12056,6716A077-BD14-4E58-9985-D2782127020A,UNCID_1657159.23642A6A-168A-4294-9AC9-2DD73477AE04.sorted_genome_alignments.bam,34,23642A6A-168A-4294-9AC9-2DD73477AE04,80aeb61d-21cf-4804-90ea-5d22eb06e299,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,99D4FDD0-1860-4225-BA61-E3808DBF51B3,Alive,Christiana Healthcare,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,44.29,RNA,639145B8-FBF3-4F9D-AA2A-6CE5B31A7CB3,Not available,Systemic,2012.0,Alive
s12071,592C49B1-E094-442E-8FFC-2BC2DB0D602A,UNCID_1880774.1fb352e1-4be2-4db6-b5aa-44361582117d.sorted_genome_alignments.bam,35,1FB352E1-4BE2-4DB6-B5AA-44361582117D,dd478399-d2ec-4ae4-a82a-b0258d24d088,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,ADE34F09-379D-463E-A9B1-C9C50E565AFB,Alive,BLN - Baylor,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.87,65.93,RNA,41D9DAF9-E71B-4E46-B0C9-ED26ACB04DDD,Primary Tumor Field,Systemic,2011.0,Alive
s12066,EF3E9DA5-3C37-4B00-91E6-E262667462EF,UNCID_1668740.CDEE4003-1526-465C-A028-270254F22141.sorted_genome_alignments.bam,56,CDEE4003-1526-465C-A028-270254F22141,b82e08e3-ae79-404a-a501-0d501df84b8b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,9AF66F6C-9549-4D2C-995C-F6424C6A6C21,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T4a,N1b,Stage IVA,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.17,1.86,30.92,RNA,7A085DD3-0EB6-40DA-A853-0F5CB7E9C0CD,Primary Tumor Field,Systemic,2010.0,Alive
s12001,862B34F6-6D2E-4084-A468-F0BF4A755CC9,TCGA-EM-A3O9-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_6_rg.sorted.bam,40,5D9FCA63-9540-40DB-9841-66A273AF8D35,34b8d361-9c95-4f28-8e45-669defc5c3a7,,Thyroid Carcinoma,Not available,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,8CCE6685-0688-4923-97AF-AEF08B17CB58,Alive,University Health Network,MD Anderson - RPPA Core Facility (Proteomics),Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,,16.65,DNA,837C7B42-753C-4C53-9FF1-5FCE679E0426,Primary Tumor Field,Systemic,2011.0,Alive
s12009,8F5F6E5A-6274-4D57-8DBD-2DC9D5BC3544,TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted.bam,50,5F86B67F-ECBC-477C-B72A-F41F104E03A2,b983a678-b0ae-42c2-8f37-d6ecaf07413b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,E85B6BC8-C182-4483-8F53-F312D5A545CB,Alive,International Genomics Consortium,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,19.0,0.15,,10.86,DNA,,,,2012.0,Alive
s12043,F5FBF967-39B0-4DFD-8C58-29CA57D22245,UNCID_1560062.A2834ABA-B6C1-4E62-8682-D6FC9D093E49.sorted_genome_alignments.bam,19,A2834ABA-B6C1-4E62-8682-D6FC9D093E49,fef9c64f-5959-4da0-aaa2-66b56fc7b4c3,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,4F88157A-572E-4236-B956-206A9E227DEB,Alive,University Health Network,University of North Carolina,Canada,Other  specify,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.79,16.22,RNA,,,,2011.0,Alive
s12022,5CEE0CA6-7FB6-4DDE-96A5-918F4A5BC320,UNCID_1275986.627700fa-7b16-44cd-bf0c-0e503d70e9dd.sorted_genome_alignments.bam,42,627700FA-7B16-44CD-BF0C-0E503D70E9DD,2012869d-c169-4cea-aa09-c892fb79bbaa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,884C1978-00CF-4E48-BEF8-F03CA67D6C02,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.88,82.62,RNA,,,,2010.0,Alive
s12073,0C485733-AAE8-4A09-B708-7D61E12751F1,UNCID_1885594.6d95b2ca-976f-4ea4-ab5b-8ce5e846a6ef.sorted_genome_alignments.bam,64,6D95B2CA-976F-4EA4-AB5B-8CE5E846A6EF,a6bdba04-f27d-4cef-bd82-872fb8390e46,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,93A664B4-79E2-49C9-9FBF-E7CB63D1095A,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.74,11.13,RNA,,,,2011.0,Alive
s12016,7AB421B5-EA94-4633-AD98-E23F0C815A62,UNCID_1225058.7c6a1de1-d5d2-43b7-97fa-b5018cc31114.sorted_genome_alignments.bam,30,7C6A1DE1-D5D2-43B7-97FA-B5018CC31114,b1d71782-2443-43f3-bd0e-8b7220515cb6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,12FC3F30-08FB-47C6-92F1-009D961C1E94,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.91,51.41,RNA,AFB0715B-B724-4F23-BE14-48EEF798FE5A,Primary Tumor Field,RADIOISOTOPES,2006.0,Alive
s12079,E5E6E92D-5807-428D-A270-769A481459C1,UNCID_1902291.2491134e-0745-4877-bde0-ce919c4ce3f4.sorted_genome_alignments.bam,42,2491134E-0745-4877-BDE0-CE919C4CE3F4,511b5f28-709b-4e43-9efd-b2f425bba962,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,B6FCEFAA-2E33-4E15-B061-B14638C58A6C,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N1,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,67.89,RNA,E2A43F5B-E897-48C2-8BE7-59F3D1BC074E,Primary Tumor Field,Systemic,2012.0,Alive
s12075,60C2C87F-421F-4EF5-B235-61E249ED818E,UNCID_1901673.09cc958e-370f-4120-96df-896c7e602474.sorted_genome_alignments.bam,38,09CC958E-370F-4120-96DF-896C7E602474,da575651-8a69-4d08-aa0f-4a1891b0b44f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,7844D67D-D104-4CBD-88B5-2A86C9BAFCE6,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.93,55.54,RNA,,,,2011.0,Alive
s12060,F5A4EFE8-63B1-4384-8451-12091D730832,UNCID_1660573.F1526B61-BC90-46BE-BFBE-9279A247EF66.sorted_genome_alignments.bam,51,F1526B61-BC90-46BE-BFBE-9279A247EF66,69f621c8-de77-48c7-8939-4c887da9e6d8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D5A22241-ABB0-47E4-A651-7404FBD2C110,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,49.31,RNA,,,,2011.0,Alive
s11992,AB5FA454-36A6-4D10-BFDA-443DD6709CD8,TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted.bam,45,8A15A4FE-F286-422D-9D50-33ABBD885250,3b48cc5e-3396-4dd5-893d-54b75b98b016,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,4DCA97A5-B0E5-4383-8CC5-B6FF07741647,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.95,50.62,DNA,,,,2010.0,Alive
s11980,3F6DE736-5EC7-4E27-85A6-A39F216CE0BF,G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.bam,32,64A17D5B-8F40-4CCF-8F2F-E68C5FE6B1FF,acb80b76-2394-4250-8687-60e40e16e83b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,4D6855A8-076D-4F95-B6CE-2B250CE3087D,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,37.91,DNA,,,,2012.0,Alive
s11983,EDB95F67-9483-47E8-9B1F-0AAD36F1A1AC,G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.bam,55,4BAE2F08-DA75-4991-ACB8-5BA9912F9131,2b84cfbc-7cf6-4cb1-a1e3-ba85dafb89f4,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,319E3498-D5FB-4142-A09F-ABA779DBC094,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,,45.93,DNA,,,,2011.0,Alive
s12021,3A101ED7-6042-429F-94A2-E4631278F2EE,UNCID_1265851.89296277-231a-4808-bcd9-380af991cbf6.sorted_genome_alignments.bam,56,89296277-231A-4808-BCD9-380AF991CBF6,4d9de9a1-7df1-412e-9f16-15dd51b4c5f5,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,225B76AD-DB11-457A-9A77-E1F333895E5C,Alive,Asterand,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.93,19.42,RNA,,,,2011.0,Alive
s12080,0FA0F18D-9410-4702-B143-3CA56C440A31,UNCID_1910977.4e77399b-349d-47c9-b058-f1f1fc118a34.sorted_genome_alignments.bam,41,4E77399B-349D-47C9-B058-F1F1FC118A34,f9db9757-04d8-40bd-a58d-605f4255b0e6,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,336FDE82-0AC7-4953-99EA-7FB078EC264E,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.8,32.26,RNA,983A7B08-A726-4B34-8691-02CB7A332237,Primary Tumor Field,Systemic,2011.0,Alive
s12024,22F0FD3A-3B1D-406A-BC01-9DA3511A8DF2,UNCID_1324216.0ae133d7-0415-4b2b-988e-91cd6ce983ba.sorted_genome_alignments.bam,61,0AE133D7-0415-4B2B-988E-91CD6CE983BA,63986dd0-63ba-4ee5-aa25-8ff2cbb762d3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,179172F9-9BAA-47F2-9A55-D3DB3B23F9AD,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1b,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.16,1.77,6.91,RNA,95FBD7A7-CC69-4C87-B3AA-BDEFB7167BE9,Not available,Systemic,2001.0,Alive
s12047,D64D9868-2F07-4BBC-9D7F-548B97BF7E1C,UNCID_1652320.32E30D37-EAAD-411B-A008-F8B69FFD1624.sorted_genome_alignments.bam,61,32E30D37-EAAD-411B-A008-F8B69FFD1624,53ba15c0-780e-4153-a612-046f1b24b4b3,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F32B85C6-FDF1-456C-AF88-091BCB006C9F,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,2.09,10.98,RNA,,,,2012.0,Alive
s12041,9FB8F328-3C86-4B09-A2DA-981DEF3D1740,UNCID_1455741.89cc780a-8614-4dc5-8f8f-2e8a07384e47.sorted_genome_alignments.bam,57,89CC780A-8614-4DC5-8F8F-2E8A07384E47,8bea483b-ac43-4265-b2c4-0f031e539008,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6BA35AE2-9AC7-4305-AF69-C8614192FAA4,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.84,63.58,RNA,,,,2011.0,Alive
s12064,E9B82E29-0EAE-4CAC-96A6-34F23F686112,UNCID_1668725.66EBCE67-41F3-41CE-ACA4-AD4068159A1C.sorted_genome_alignments.bam,47,66EBCE67-41F3-41CE-ACA4-AD4068159A1C,754866ea-d5ca-451a-98e4-6e0c430d3652,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B9D3B3AB-2980-4904-BF78-6AA3C96DDD8F,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,1.81,51.16,RNA,60AA33FE-ECF2-4A75-AA51-8688417F6E60,Primary Tumor Field,Systemic,2002.0,Alive
s12030,E9853AA9-A4C8-44D8-B0DF-3AFC161CF8F6,UNCID_1359676.301b8477-c941-47d1-bfa9-01a11334ddcc.sorted_genome_alignments.bam,30,301B8477-C941-47D1-BFA9-01A11334DDCC,2cb43652-109b-4b59-9fcd-512903591f45,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A9B534C2-2BEF-4681-81F2-EBC6E93FE770,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.85,67.3,RNA,,,,2011.0,Alive
s12050,E2D1381C-760A-4588-9641-266783F0251F,UNCID_1653957.49A08D66-91CC-4DB0-BEED-DB9C9E4D9BD0.sorted_genome_alignments.bam,42,49A08D66-91CC-4DB0-BEED-DB9C9E4D9BD0,149b46a3-75de-44e1-ba73-bdc4ff379c7f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E4646123-1224-4056-A3EC-FD03255C5A4C,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.81,25.15,RNA,CB9DCBA9-C842-46A3-B47A-B5AF945D6E24,Regional site,Systemic,2006.0,Alive
s11990,BB0BF0E4-E29D-422A-879E-B8DC7F5C720B,TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted.bam,56,E28A1E8B-41A3-44C0-ADBC-6A203C92DDF5,d4c68c1c-a3f3-4e0c-b555-d457378a1d24,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D1612961-A709-487B-A4D1-CE42F0B9AA54,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.89,30.94,DNA,,,,2010.0,Alive
s12057,FF51856B-D2DD-4C13-B7F1-B9A6F7F30A84,UNCID_1662593.9ED1D311-747A-434E-9AB4-5DF6BC6B75DE.sorted_genome_alignments.bam,55,9ED1D311-747A-434E-9AB4-5DF6BC6B75DE,24cf6397-60ef-4635-81f0-78a67157aac0,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,8B048263-6C2F-4BF6-8F37-C69DA9F3839F,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,56.77,RNA,,,,2011.0,Alive
s11972,A59111E2-1F5E-429D-BB7F-4E413ED0BAEB,G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.bam,57,565E656C-D5E3-4FE4-A10C-2E9CA1E498B5,a00da907-e527-45f9-9afb-2fad2c7b0940,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,A2E3CA88-9FF0-44AD-8C5A-CA4C7B404DE6,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,,41.27,DNA,,,,2011.0,Alive
s12078,4204A700-E20F-4474-80F5-DFD386416261,UNCID_1902446.73d37bb3-e8d4-4347-9221-e79b0186d940.sorted_genome_alignments.bam,40,73D37BB3-E8D4-4347-9221-E79B0186D940,b7bafe7f-295c-4598-9cc8-49d785bd2218,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,487899C2-0E65-4AE4-A23A-08CF937D92AB,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1,Stage I,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.16,1.78,55.26,RNA,2CD8548F-0675-420B-B21E-5FBE82DC0FA1,Local Recurrence,Systemic,2006.0,Alive
s11991,267D7CAA-22FC-41BC-8EA9-EE910A0AC510,TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted.bam,61,FA0BE982-CE22-449F-9D2B-E688196BA8AE,fca0c7d9-5e6f-4aa7-ba04-5df2eb8ba398,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,E4B53CA1-D395-4FEA-A962-DFBD2B373A6B,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,10.0,0.15,1.97,14.32,DNA,,,,2009.0,Alive
s12018,68F5F063-1A57-4BBD-BFBD-04D3C6F0A788,UNCID_1234867.a292e3ff-5e63-4d77-8398-f3afa5c880cc.sorted_genome_alignments.bam,46,A292E3FF-5E63-4D77-8398-F3AFA5C880CC,6ba76174-620e-4851-857a-d0adbfd6f3e6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D9689254-AFE2-4544-AF54-E02670BD5EBD,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.88,27.94,RNA,C1F67B66-1827-471B-95E5-F27DD175087F,Primary Tumor Field,Systemic,2011.0,Alive
s12032,3ACCB117-B539-485A-AE38-629A194D79C6,UNCID_1358778.6b4ceb7e-f81c-44f2-a0d5-ae92f79c1378.sorted_genome_alignments.bam,39,6B4CEB7E-F81C-44F2-A0D5-AE92F79C1378,d2512fd6-9042-4a62-8b49-d483cb84b89d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,01079B02-AB3B-4F17-B54C-0F774AC572B2,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1,N0,Stage I,Mar-44,C73.9,C73,NO,,Not available,30.0,0.16,1.78,21.82,RNA,,,,2006.0,Alive
s12045,B6E3F02F-F764-4D48-A12E-05E0487B5801,UNCID_1565801.507e9f4a-c9b8-42f9-923c-d6061645e845.sorted_genome_alignments.bam,26,507E9F4A-C9B8-42F9-923C-D6061645E845,e4c85bdd-7b7c-414f-9503-647d9b825915,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8765B072-83E1-40B2-B1C9-15F38D799FC3,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.93,62.57,RNA,20037B6C-AC77-436D-9D5D-DCE67644F27B,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12082,AFE09A05-FD0C-4B0F-AC1F-8162634D5D8D,UNCID_2538134.804a719b-f3a3-44d4-95e3-13578b99706a.sorted_genome_alignments.bam,58,804A719B-F3A3-44D4-95E3-13578B99706A,7f9fad75-ac3e-4580-b949-80eed07a3230,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,5FEB200F-13FB-4A2F-9B21-7EF8DD3BB9ED,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,46.87,RNA,C86FC3C8-9C3B-4471-8D89-7507B6A46441,Primary Tumor Field,Systemic,2013.0,Alive
s12053,B8D92960-83A1-46AA-8603-F48F64E786C8,UNCID_1657396.5B552577-3C91-402E-B9AA-45D79FA77E22.sorted_genome_alignments.bam,57,5B552577-3C91-402E-B9AA-45D79FA77E22,905469d2-4c97-4293-a20c-1b1f0462a25d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,65414BA0-8800-4626-9488-10D79274CF32,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,7.0,0.15,1.83,10.47,RNA,,,,2011.0,Alive
s12037,E21BB8E0-8354-4526-9096-23F731F27822,UNCID_1455667.dcd75189-e96f-458a-bbb8-4fbf9c261f01.sorted_genome_alignments.bam,55,DCD75189-E96F-458A-BBB8-4FBF9C261F01,ef3dd880-7be4-46a8-93c2-7cba1a9cd24d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1C40E0AF-D029-4447-9C75-51E45DE8B9B0,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.78,39.45,RNA,F5381B8E-8173-4BA5-A22F-A10E36D5C7FE,Regional site,Systemic,2003.0,Alive
s11975,5C6477AE-68E1-4407-8F81-53F64006DF76,G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam,45,54426B1A-E0D3-4D8E-9E81-2D8E6B153B22,861f94ce-45ff-4588-addb-e1ea48878c2e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,913D384C-657A-4AE0-9E8E-E9BDB77D140E,Alive,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.08,,25.01,DNA,DF7057DE-8110-4940-8335-4650CC0210A5,Not available,Systemic,2001.0,Alive
s12031,F3BEEC47-988C-4A19-A32D-0A52EC13F55A,UNCID_1360484.86e606b2-d312-4a19-bfc3-d26c92bb530d.sorted_genome_alignments.bam,77,86E606B2-D312-4A19-BFC3-D26C92BB530D,f9d35f8e-ada4-4cc6-8227-28565ee531d2,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C3474541-D038-4163-80FD-ACF4CD3CE851,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.84,26.62,RNA,,,,2011.0,Alive
s12059,983BB55A-DB96-4F26-ADD0-907AF4D327F9,UNCID_1660228.2F59CBC7-724A-48D3-B02F-8DEDC49833FD.sorted_genome_alignments.bam,64,2F59CBC7-724A-48D3-B02F-8DEDC49833FD,52203ff5-57b2-4d56-8935-2ff1eb61d7b8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7AEC7C70-6A5A-48D5-A863-A8DB40D93097,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,30.77,RNA,,,,2011.0,Alive
s12067,CDDF3DC4-ED51-45ED-9B3E-DB193265FBA6,UNCID_1669495.0F291A80-E139-4876-B91F-A91CE3066580.sorted_genome_alignments.bam,44,0F291A80-E139-4876-B91F-A91CE3066580,7b46ee87-e976-41bf-bdf1-9bff58f8314e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,245C5A31-A8D2-4C79-88FF-579D9248DE6E,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.9,43.65,RNA,,,,2011.0,Alive
s12019,5EA0D06B-C44C-4759-ACEB-BD80AEDF9B19,UNCID_1242683.b854167d-42a2-4144-92ee-0229536d4cea.sorted_genome_alignments.bam,57,B854167D-42A2-4144-92EE-0229536D4CEA,f9ceffc0-d544-418d-b4a9-bd3c84e37026,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,B06B7493-F38A-493F-8B47-61E0FA4D111F,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage IVC,Mar-30,C73.9,C73,NO,,Not available,30.0,0.17,1.81,79.97,RNA,,,,2010.0,Alive
s11984,62705306-2AD4-4287-AC8D-CA27CF525430,G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.bam,49,07A7C634-BD9A-4FC2-B9FE-87B060EC3D1F,085ffcdc-8600-42e2-852a-506465f716a2,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,620B21C9-AC06-4154-A941-2532C775C6D8,Alive,University of North Carolina,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,,47.57,DNA,32F39867-B66A-40FA-AE1D-D3EA8BACA0DB,Primary Tumor Field,Systemic,2011.0,Alive
s12029,8298C17F-1F99-4C02-9F60-0FEE086CEAE0,UNCID_1324580.afa83e9d-ec92-45c7-b741-c78ff4523e5d.sorted_genome_alignments.bam,27,AFA83E9D-EC92-45C7-B741-C78FF4523E5D,5a6b9340-acde-4d97-8836-20ae29732851,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,ADA8729C-E37A-4F29-A32C-A8487BED4AA6,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.73,21.55,RNA,,,,2008.0,Alive
s12023,7DF11EA2-D5DA-40F4-B02E-7A57D800D0A3,UNCID_1321475.752db3dc-92ba-4a16-a8d0-41ce260cef62.sorted_genome_alignments.bam,31,752DB3DC-92BA-4A16-A8D0-41CE260CEF62,aa528913-cbbc-4e1d-b6d0-87f6a46bcbc9,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,74CD44B7-728E-4951-A7C7-67A82BC0F887,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.79,32.07,RNA,,,,2008.0,Alive
s12061,A04C4BCD-5CA3-4CB6-B578-A7E788246C1D,UNCID_1666085.3F6778E5-26ED-41BB-AC86-4AAAC7AB07A6.sorted_genome_alignments.bam,40,3F6778E5-26ED-41BB-AC86-4AAAC7AB07A6,8ed1b900-a8a8-4164-b96b-f060f15d7075,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0AD53C03-4BED-411D-BFAB-A17B82FB71BD,Alive,Christiana Healthcare,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,21.5,RNA,3B549E55-5C66-44DD-B6B3-544DFB6B000E,Not available,Systemic,2012.0,Alive
s11995,5D993DC5-0DFB-4F12-BD8B-C21A2C64577D,TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted.bam,52,528EC19A-8218-4E8F-B1E7-8A149F54A6BE,ca95a11c-b54c-409e-b9a0-da850945033d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,EFAD8B07-B295-468F-A836-F94029AEC777,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.95,104.83,DNA,,,,1999.0,Alive
s12063,45F73BE6-B14C-457A-B569-835CBDAD6484,UNCID_1664344.E2D953B8-350F-4D87-9BA6-2AEFEC4F1803.sorted_genome_alignments.bam,62,E2D953B8-350F-4D87-9BA6-2AEFEC4F1803,c8d62754-1601-40c0-98ef-e5bb94306b92,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2D7C3A2E-27D5-4851-9E5F-81E77AC2AC62,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,52.55,RNA,,,,2011.0,Alive
s12054,942DDB00-FBB6-42C0-9C9E-020C067C3D16,UNCID_1657766.63F9E0C0-A0FF-4172-B19E-F87C1EF1D62A.sorted_genome_alignments.bam,33,63F9E0C0-A0FF-4172-B19E-F87C1EF1D62A,8cfc2589-b0ad-4fe6-8420-8f6fe0178bcc,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,8133FCFE-ECC4-4503-B81E-00FDF6F87426,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.89,42.19,RNA,,,,2011.0,Alive
s12039,67CFB12B-20BF-4ECF-90A1-9F2FF97AE832,UNCID_1457564.677b46a9-5c2e-4815-bbc0-b334882c22a3.sorted_genome_alignments.bam,56,677B46A9-5C2E-4815-BBC0-B334882C22A3,77d5b246-33ba-4a96-9d73-06aca797653e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,457B11C0-3C36-4907-8C76-60E3861EBABB,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.13,1.8,9.27,RNA,,,,2010.0,Alive
s11987,122E0C7E-DA24-4121-907E-8B913B4E4147,TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted.bam,38,A5170F7D-F298-4330-8272-8DACFF7775A1,524a39ee-8fa3-418e-98a2-a6a90e9c8064,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,F4906B86-3971-4ED3-AC3C-69635311FB45,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,2.03,82.3,DNA,,,,2010.0,Alive
s12072,BE5122F6-DBD9-4636-9CD7-C36398DCED70,UNCID_1880909.3b668d39-d66d-472f-ba4a-e53fe34041e6.sorted_genome_alignments.bam,55,3B668D39-D66D-472F-BA4A-E53FE34041E6,899ed323-4fd1-4d8d-9c2f-c63d9b44e875,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C2BE2A8D-3A3E-48D7-8F4F-79BF85371B14,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,1.79,63.39,RNA,,,,2010.0,Alive
s12040,A3165F69-AD11-40B5-8D87-883A70B9985F,UNCID_1457702.93c42359-3615-406b-ad18-8b3f23d8eab5.sorted_genome_alignments.bam,34,93C42359-3615-406B-AD18-8B3F23D8EAB5,efbdedaa-4b02-40ac-b93c-9670c018cf7f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C6534BE5-F333-4AD5-BEC2-7C15C2683FAD,Alive,Roswell Park,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N1a,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.78,26.28,RNA,248EAEE0-B98C-457E-8E63-94659557E1AE,Primary Tumor Field,Systemic,2007.0,Alive
s12033,63ADF61B-573B-4EEE-B91C-E3D231D178BA,UNCID_1353857.c068f36c-8de2-4986-b296-c13c2ac613f4.sorted_genome_alignments.bam,53,C068F36C-8DE2-4986-B296-C13C2AC613F4,b597023c-ff84-44cc-bfcc-8bee64ca4cff,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,1BC248B6-2082-422F-BD1A-029C0461DCD1,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N1b,Stage IVA,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.8,34.57,RNA,C7498C17-A364-438F-A4FF-FEBB9BB4E9DA,Primary Tumor Field,Systemic,2011.0,Alive
s12058,F4FD8681-7BFF-4EEA-9CDC-12F623E5F088,UNCID_1660402.840AB30A-7BD1-4B9C-B098-86A8117182BD.sorted_genome_alignments.bam,66,840AB30A-7BD1-4B9C-B098-86A8117182BD,d92902ff-8023-411c-a7ca-1afcbb64937e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E8DD42F0-E8AE-4003-B6A7-941CCEDD14F0,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,38.3,RNA,,,,2011.0,Alive
s12076,9E7FAA33-8F1D-4CEF-80A7-9C3AB3D1CE51,UNCID_1901541.46b47792-13ed-49c3-9456-c22d0b920c34.sorted_genome_alignments.bam,34,46B47792-13ED-49C3-9456-C22D0B920C34,97384352-0e80-42c2-8a8b-7bdbda2b58ee,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,1E6EDFAE-4CA3-4F1D-9072-C14C6E3F9DFC,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1a,N1b,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,20.0,0.18,1.96,25.38,RNA,95A1434F-4834-481B-84AA-8AFAE7683043,Primary Tumor Field,Systemic,2012.0,Alive
s12065,ED96A3EF-ACFF-4CF5-94E2-DFC1902C7739,UNCID_1665209.7C023A70-C233-4A12-B0B5-69CAFDECA483.sorted_genome_alignments.bam,25,7C023A70-C233-4A12-B0B5-69CAFDECA483,4be84ffe-4b12-4b71-90bb-9ea0ca6947f8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,E252F9CE-8E6E-4005-ABFC-F4A0FFBD76D5,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.93,20.57,RNA,,,,2012.0,Alive
s12011,45BC7069-09DF-4D43-8667-482F66978F34,UNCID_1212419.47ae6c78-8a07-4298-b97c-f3744df297d3.sorted_genome_alignments.bam,29,47AE6C78-8A07-4298-B97C-F3744DF297D3,e8d74dbb-410c-4f8f-8e1f-2b2dd7634160,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1A705581-3B92-4648-A84F-3D964364A6C6,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.84,79.16,RNA,,,,2011.0,Alive
s12025,06CE1D74-A419-499B-9803-3D1964A8D9F3,UNCID_1324338.1156c53c-c2f9-48f5-a237-10e6416587fd.sorted_genome_alignments.bam,62,1156C53C-C2F9-48F5-A237-10E6416587FD,47bde6dd-fa41-4d1b-8b20-2a5a5cdb2769,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,7CB9D32C-5992-4F89-8E15-33A7B9CC1312,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.76,28.92,RNA,,,,2011.0,Alive
s12055,AFEC318A-6B0C-4D65-A19B-068110FF7DCE,UNCID_1660007.5BA03C4D-F473-48B0-872E-ACD901B75680.sorted_genome_alignments.bam,49,5BA03C4D-F473-48B0-872E-ACD901B75680,45eefba8-9f7c-49e9-a3f5-d13cfa264ff6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,90D4DD06-95C8-4114-8E99-433A28ADB7D4,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,21.89,RNA,,,,2010.0,Alive
s12035,807B8CBB-A1FF-4373-B17E-892EAC09C378,UNCID_1455325.44a2e59d-3084-49eb-9516-aac67072ff12.sorted_genome_alignments.bam,37,44A2E59D-3084-49EB-9516-AAC67072FF12,a65ec434-9ae0-453f-b440-08bf25558fd1,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,4D6A2D9E-EC25-4040-A696-2D8D5D5C392E,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.87,38.07,RNA,,,,2011.0,Alive
s12020,F66209CE-58B2-4763-AFDA-480DE8790DC4,UNCID_1245724.7ef09c3e-1bd5-48c9-81ae-6da842739027.sorted_genome_alignments.bam,24,7EF09C3E-1BD5-48C9-81AE-6DA842739027,12ecc0e5-8cb8-406e-ac9f-4f8c22b64fc1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,C7146F26-5C75-4A56-A94B-C8A03C15A6F1,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.67,63.54,RNA,,,,2009.0,Alive
s12028,E6B2E73D-2A49-46AB-9DE9-396EEC00C795,UNCID_1325495.f4be1314-d307-4146-9e49-05c368489b86.sorted_genome_alignments.bam,51,F4BE1314-D307-4146-9E49-05C368489B86,befa0ef5-d621-4866-904d-13341ea54aa1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,826410A8-74C4-4DBB-BDF3-EFACF056CAB9,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.8,33.79,RNA,,,,2011.0,Alive
s12174,9CF8F1BC-4F75-44A0-8DAA-356348650D99,UNCID_1654613.A4153890-D27B-4F55-A5E5-5204B7F59392.sorted_genome_alignments.bam,51,A4153890-D27B-4F55-A5E5-5204B7F59392,86b82345-6f4d-44fd-a9db-6f107de62f53,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,AF7B5868-2C11-4C74-8033-E914C987ECE6,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,11.15,RNA,,,,2012.0,Alive
s12188,BC6E73B8-658F-4C8A-B6F8-4668600B89BD,UNCID_1660162.135752CC-F7BC-4A55-9E4A-28A4B12A9699.sorted_genome_alignments.bam,55,135752CC-F7BC-4A55-9E4A-28A4B12A9699,8a476795-0e05-4da6-bbe1-ff7304da1b39,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,EF77EE63-3605-4FDB-B0FA-A1077AA771B9,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage III,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.16,2.05,15.28,RNA,B904A0A4-A659-4EA5-A92F-0536D638CA15,Not available,Systemic,2002.0,Alive
s12177,9C505C96-28F9-4824-9ED8-66876A9F6271,UNCID_1654528.5F1F0D7C-FC9B-43A3-9709-6682EAC9EC08.sorted_genome_alignments.bam,52,5F1F0D7C-FC9B-43A3-9709-6682EAC9EC08,188013d3-cefe-4861-b115-c34db1cf3831,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,40D58D71-5769-40A0-8379-89115234A36E,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,37.13,RNA,,,,2011.0,Alive
s12121,276539E6-E471-4DC2-96E7-0C80FB486AF1,TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted.bam,20,68FEC551-495D-47E6-BF85-FBD422FC68D6,4d1aec67-c345-4721-8ee8-356b0dff009b,,Thyroid Carcinoma,HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,1392A49C-87BC-45E7-B7D2-ACD53E921467,Alive,International Genomics Consortium,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.14,,44.16,DNA,16C8FBA0-9EAC-47B8-A864-C42F887F2892,Primary Tumor Field,Systemic,2011.0,Alive
s12128,042D298D-777B-4EF7-AD4E-5A24D9AF17BA,UNCID_1213347.d854dced-2ce0-415a-90b2-54d54ca31702.sorted_genome_alignments.bam,51,D854DCED-2CE0-415A-90B2-54D54CA31702,212aa9c4-610d-4286-9ca2-ae6c87b9bc0e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9ADF69C1-FCF7-46B2-B693-257788A8786C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.87,26.05,RNA,64516364-17CB-4005-9D15-18F51A9AB961,Primary Tumor Field,Systemic,2010.0,Alive
s12145,9150DB75-7FE4-42BE-BDA7-46BB3811EB5F,UNCID_1262399.365b57ee-a9a1-4165-ab1d-c24bebc87962.sorted_genome_alignments.bam,58,365B57EE-A9A1-4165-AB1D-C24BEBC87962,f3c73dc9-6280-4619-a629-b575fdbdb0ca,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B1775A45-D30D-42C3-91D8-53C662B4A974,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,2.02,59.99,RNA,B4432E1A-EF65-404A-92E9-4929D77E0DC8,Primary Tumor Field,Systemic,2010.0,Alive
s12182,6F398122-967B-4262-87B0-F6368EC33497,UNCID_1654797.63136B4D-1B36-4C2A-9A63-2EEAEB830CED.sorted_genome_alignments.bam,38,63136B4D-1B36-4C2A-9A63-2EEAEB830CED,93691bae-f1bd-437e-ae72-b50736d1e29a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,73BA5F01-96AE-414B-923A-DE9500F72E64,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.81,54.37,RNA,,,,2012.0,Alive
s12190,0A8F186A-FD49-40DA-A247-19D31D10D3C3,UNCID_1660264.04F1E2D6-DDA4-4346-978C-AA71CBFC880A.sorted_genome_alignments.bam,49,04F1E2D6-DDA4-4346-978C-AA71CBFC880A,82dd133b-691b-4bbf-b948-6270869d9b69,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4B998EBC-2894-46C7-B1A0-14A141D3FB89,Alive,Medical College of Georgia,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,20.0,0.16,1.84,38.12,RNA,,,,2011.0,Alive
s12204,CB0F477D-7B19-4F65-89A0-DE51B9DEFD33,UNCID_1900646.7c79678c-45ca-4c2c-b2db-11e00c3864f6.sorted_genome_alignments.bam,33,7C79678C-45CA-4C2C-B2DB-11E00C3864F6,0dc361b5-e755-4131-8766-d2c1375336d8,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,FD89B415-4F82-4B8E-9504-7CC0DA3E6888,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,1.83,50.51,RNA,,,,2011.0,Alive
s12134,DC452CF7-6439-46B3-B8CD-305BDB525536,UNCID_1217572.e19479cc-ab66-4398-9733-ff15a9b52af1.sorted_genome_alignments.bam,60,E19479CC-AB66-4398-9733-FF15A9B52AF1,8c5aef43-341e-4a37-84eb-fd730eb957c7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,CD19D6BB-21A4-409A-A7BA-A4521A03ABD3,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.86,40.47,RNA,,,,2010.0,Alive
s12136,AF4B9B53-BF1E-423B-A3DE-8BE2615D7D54,UNCID_1233651.8ba98907-ab03-4c9e-a900-e31aa16ff810.sorted_genome_alignments.bam,58,8BA98907-AB03-4C9E-A900-E31AA16FF810,0d497faf-2c1c-4173-a5fe-770cca73323c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,19DEE039-9C98-4D4A-8BAF-EEA1B6DDA8EB,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.9,58.26,RNA,6DC4430D-8AEE-440D-8E8A-6BA596D003B2,Primary Tumor Field,Systemic,2010.0,Alive
s12133,33EDDF56-B3F8-4FAA-AA54-C0EE1916E72E,UNCID_1216761.2a2472eb-3407-495a-b7c0-d4a73c99e669.sorted_genome_alignments.bam,66,2A2472EB-3407-495A-B7C0-D4A73C99E669,dc4d8468-6f34-40cb-a826-8d582cd86fde,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,145A474E-D262-468A-8DB7-EE9F1B7CE0A7,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.14,2.05,47.82,RNA,,,,2010.0,Alive
s12132,F2768B56-DEDA-4349-863B-7905400425A1,UNCID_1215052.8974350a-0e8b-4094-9ca5-72b61fe3b5a6.sorted_genome_alignments.bam,40,8974350A-0E8B-4094-9CA5-72B61FE3B5A6,618a1c29-5c26-46db-83d5-4799f9043cd3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E3DE38A0-9158-4F0C-BA79-A6BE5E392759,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.86,59.19,RNA,6ADA42D2-E009-41DA-B31C-A1647740D2E1,Not available,Systemic,2008.0,Alive
s12209,FB0390F6-B27A-4D22-9263-37E1F7398994,UNCID_1918656.f39fc113-7955-4dc6-989b-17614c53ea20.sorted_genome_alignments.bam,26,F39FC113-7955-4DC6-989B-17614C53EA20,ca625067-1c6d-45c7-b752-af40c8327ea5,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F0B9FABC-051B-4FC3-88E0-7BF326B8DA3E,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.88,46.86,RNA,,,,2012.0,Alive
s12114,EFD1FAE6-DF5C-4D7D-9579-296F0077B186,TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted.bam,54,FA63C656-1DD5-4A92-9AE8-36B3408E00C7,398d5c2e-f877-4bbf-a10c-486b8523c9ce,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,B3E6F726-256B-450B-B3F5-A1BB9AAB9C15,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,,44.88,DNA,1CA9AC65-33BA-4A6C-B1C9-BDBDDE0A17D9,Primary Tumor Field,Systemic,2011.0,Alive
s12210,35D2DDD0-7579-4F8E-9037-63BB2891522A,UNCID_1925317.84730d14-88bb-4b77-8b04-16229b83dd9d.sorted_genome_alignments.bam,45,84730D14-88BB-4B77-8B04-16229B83DD9D,778a8f53-53f6-4a03-8ce1-b0928539a444,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,894914E7-7027-482A-8002-307F6ADFDC06,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.9,22.74,RNA,4DE3A06E-8228-4CA5-9725-94F089D4FCA1,Primary Tumor Field,Systemic,2012.0,Alive
s12096,488591C3-7BA4-421A-9FC0-36D0604C8175,TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted.bam,52,8B8B2852-9D53-4654-A37C-2749C0F264ED,866ca8ad-adc9-45d4-ad92-9f8f1a161ddf,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,01EE736B-F907-465B-9142-C50BE0A3461B,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T2,N1b,Stage IVA,Mar-44,C73.9,C73,NO,,Not available,30.0,0.16,1.95,57.81,DNA,,,,2010.0,Alive
s12135,9379A55E-640A-41E6-8B9F-42EF42FA71EF,UNCID_1223428.44ba29fa-b4d1-461b-86b4-fb9730e701f4.sorted_genome_alignments.bam,69,44BA29FA-B4D1-461B-86B4-FB9730E701F4,f2ad720e-579f-4e2c-a3f0-17877ca91067,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,03811796-0ECE-4408-82F7-B449A631D2FB,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.84,49.8,RNA,230D9DE5-DBCE-4CE4-87D0-7818119FF35B,Primary Tumor Field,Systemic,2010.0,Alive
s12168,AA898AD8-26A3-4D49-AE16-D38B1795F5E9,UNCID_1578324.90E7F816-EAD8-413D-A5C4-3BB5B3C48461.sorted_genome_alignments.bam,61,90E7F816-EAD8-413D-A5C4-3BB5B3C48461,63b01b43-a68a-4046-89b0-736ba4d08504,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B48D226E-610A-40DC-B62A-6DB863A7366C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.82,29.4,RNA,,,,2009.0,Alive
s12105,9424534D-10AE-4669-9A13-75AB8E7A7432,TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted.bam,85,417BD826-C151-459E-AAEA-DFA2CB4182DF,c7a2f394-3e3f-4c90-9f1e-f2be3e5b0d6b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8,Alive,Memorial Sloan Kettering,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1b,N0,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,20.0,0.15,,32.87,DNA,,,,2010.0,Alive
s12201,2E592B80-E8E4-4DF8-BA94-D81FCA2D6165,UNCID_1897246.ac3b2403-e941-4b8a-8051-f29055c2428a.sorted_genome_alignments.bam,26,AC3B2403-E941-4B8A-8051-F29055C2428A,c781b49e-d08f-49e6-b774-7cfe4100e92d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,377A0CBF-6A82-43FA-BC95-DADECED8916D,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.98,38.69,RNA,27C874F7-FC72-4555-9473-D7B86F66A600,Primary Tumor Field,RADIOISOTOPES,2002.0,Alive
s12194,BC4B50F1-997C-4983-A5EE-961A1930D384,UNCID_1729730.828c21a3-2e9b-4c2e-b2b5-47ec3ad7c548.sorted_genome_alignments.bam,78,828C21A3-2E9B-4C2E-B2B5-47EC3AD7C548,a1196d5f-8c7d-4d9d-9e46-c5c22a9c2fef,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,62DB8FDB-DCD5-4582-A214-0A9B67F32EAF,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.9,28.2,RNA,ECA72FA1-83FC-42D2-87FA-E3FD696B75CA,Primary Tumor Field,Systemic,2012.0,Alive
s12187,BE281A1F-6873-4E91-8C15-2F7F0D04B1F2,UNCID_1661936.17123AF6-1425-4125-9579-00C6800227C7.sorted_genome_alignments.bam,33,17123AF6-1425-4125-9579-00C6800227C7,97b5017c-2066-4472-ab3f-31cfe64a6762,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,7F540311-430C-46B2-98C8-F314B27ECB0E,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.88,50.06,RNA,,,,2011.0,Alive
s12179,723B29AB-E12A-4BAC-9595-63195472AEEA,UNCID_1655901.DF2975AC-92DC-4A93-8F9C-965E6D4E2CF3.sorted_genome_alignments.bam,60,DF2975AC-92DC-4A93-8F9C-965E6D4E2CF3,04dc8ee3-ec93-4b56-a546-f96746f8122f,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,A1A70A5F-1AC8-49E1-97F2-DE7BAC4C6230,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.89,55.15,RNA,DE2DD5E6-B19C-47F1-AEE6-AE35C0CC912E,Regional site,Systemic,2008.0,Alive
s12169,7821CB90-BB98-4344-B4BE-A4805693CC97,UNCID_1653384.30E48AD0-AF7E-4030-95B2-1C3FD3D96D52.sorted_genome_alignments.bam,50,30E48AD0-AF7E-4030-95B2-1C3FD3D96D52,e48a8fa7-4e2b-44a0-95f5-e2925c60bad3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7EFFB8C1-CDF1-4609-B9AE-0E12EC5066EB,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.37,58.24,RNA,9EDE7A05-6D35-4493-98AF-0C63FCC7B8F9,Primary Tumor Field,Systemic,2008.0,Alive
s12143,C5DEFB66-2733-47AA-9AEF-DDE1F400D3DB,UNCID_1243748.b918679c-600e-4cdb-a2df-40bea373a836.sorted_genome_alignments.bam,51,B918679C-600E-4CDB-A2DF-40BEA373A836,097b9cf1-ec0c-487c-9ade-2bdab12eb4ca,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C29162A3-F162-4D32-AB9A-421BE1FEB13C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,NX,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.86,82.09,RNA,,,,2009.0,Alive
s12183,BFBB73C3-B8A0-4591-8C1E-DD2AC99BF54B,UNCID_1657478.C262A55B-8CF2-4C47-A867-F010361E22AC.sorted_genome_alignments.bam,75,C262A55B-8CF2-4C47-A867-F010361E22AC,ebbd54ad-7b97-4081-ad11-7f7f3ce74eef,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,979CBB75-28D9-4D33-8083-077C25BDDFD6,Alive,Asterand,University of North Carolina,Russia,Thyroid Papillary Carcinoma - Classical/usual,T4a,N0,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.79,56.68,RNA,,,,2011.0,Alive
s12099,2FCAEAF0-3A03-4B60-975A-31AC8AFE58AA,TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted.bam,57,B761F912-BDF6-4F1F-8CD0-0AE9DFC57A59,86f9eca0-d1ea-4375-a6bc-055e44b3198a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,AA8578FE-EDB2-4137-B363-FEB2C27D475A,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.13,2.17,75.83,DNA,,,,2010.0,Alive
s12088,DCBB2120-B24F-4BC5-A07F-706D58345C05,G49537.TCGA-E8-A418-01A-11D-A23M-08.1.bam,75,63EA274B-D42B-4787-9C54-8EE95EA376EC,ebbd54ad-7b97-4081-ad11-7f7f3ce74eef,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,979CBB75-28D9-4D33-8083-077C25BDDFD6,Alive,Asterand,Broad Institute of MIT and Harvard,Russia,Thyroid Papillary Carcinoma - Classical/usual,T4a,N0,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,30.97,DNA,,,,2011.0,Alive
s12149,6A769933-8849-45AC-8BD9-5B530CB6740B,UNCID_1323145.16c0d6f8-cb7a-4fee-a9f8-1b507c4826c7.sorted_genome_alignments.bam,41,16C0D6F8-CB7A-4FEE-A9F8-1B507C4826C7,856893d6-0ed7-422b-ac19-1a5871088805,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F3CC6F9C-3FE1-47C6-9BAE-5C04DAF4C640,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.18,1.79,19.6,RNA,34619A06-B8ED-48A8-8F3D-3A4240A413BB,Regional site,Systemic,2000.0,Alive
s12130,AA4B7F0F-1962-4764-A940-C9464DAC0721,UNCID_1212300.7e9d858a-10ed-4a90-b7da-b13958393555.sorted_genome_alignments.bam,56,7E9D858A-10ED-4A90-B7DA-B13958393555,b07435d4-1341-4b41-9b11-d13a4f1ca0ad,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,2277F3F2-411E-47AB-A2B9-F80FD33540A1,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.82,7.44,RNA,,,,2010.0,Alive
s12137,1083A1E8-C934-4248-8D60-A21564D20F10,UNCID_1233775.a35f9f2f-2378-4825-812e-b55a9f21317f.sorted_genome_alignments.bam,55,A35F9F2F-2378-4825-812E-B55A9F21317F,6675c581-297d-44cd-b80f-ae7e53d48228,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1F945AFF-7BC2-40F5-87DB-92313E541243,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.81,15.04,RNA,,,,2010.0,Alive
s12197,719D4816-04B4-4A68-AEB6-7CB376340CAC,UNCID_1815664.c8f72b88-2a45-47c3-ad3b-b49ec4366345.sorted_genome_alignments.bam,32,C8F72B88-2A45-47C3-AD3B-B49EC4366345,9b1dbd0d-be6d-4a88-881a-faf57ceba81c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,B582505D-7828-4BE4-AE6F-C0A00DE8ADB3,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,2.05,31.85,RNA,,,,2012.0,Alive
s12119,ED0CFF3D-A985-40A9-B0DF-EC57B3BCDD50,TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted.bam,64,C32A9B9D-B381-4492-9BBC-8F25B09D18C1,52203ff5-57b2-4d56-8935-2ff1eb61d7b8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,7AEC7C70-6A5A-48D5-A863-A8DB40D93097,Alive,International Genomics Consortium,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.14,,41.37,DNA,,,,2011.0,Alive
s12189,3FD62CF3-74C0-4211-8790-4977ECC73D0F,UNCID_1660761.AFD66B08-2D7E-4E49-AC27-1AB68DA1D1B9.sorted_genome_alignments.bam,35,AFD66B08-2D7E-4E49-AC27-1AB68DA1D1B9,d61ca744-adc4-44d5-ad15-cc17399e8083,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,FE1F05B6-00E1-43B3-99ED-0168D1478613,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.87,45.85,RNA,,,,2011.0,Alive
s12158,A7125AE6-01BF-427D-B103-C5FA0E64112E,UNCID_1360765.a75c2127-bf78-41c6-b382-71d0d36b741a.sorted_genome_alignments.bam,34,A75C2127-BF78-41C6-B382-71D0D36B741A,9382942c-40dc-404a-ad8a-697612cdb575,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0A6C3AF8-7BC5-4B74-9FD0-202432DEE89C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.17,1.79,28.77,RNA,98AE213A-A328-4A8E-B749-80D3049EF8EF,Primary Tumor Field,Systemic,2008.0,Alive
s12155,93DDC05B-7CDE-4542-BD3F-B10630237F06,UNCID_1347085.7c4c5e6e-2a00-423b-8be0-a647038e9ffa.sorted_genome_alignments.bam,64,7C4C5E6E-2A00-423B-8BE0-A647038E9FFA,424de829-9efd-4689-ac5d-24485a5d5ecf,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,64690DDC-DFA9-46C9-BDE3-8180212236EE,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T2,N1,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.15,1.73,51.14,RNA,979F7AD7-50D6-41B8-B990-FC868A668DDD,Primary Tumor Field,Systemic,2003.0,Alive
s12152,67E9EE70-B7A2-4054-9116-209E72A1F2C8,UNCID_1329330.b3cb1236-9b86-4552-bba1-2e8fd25f30b8.sorted_genome_alignments.bam,20,B3CB1236-9B86-4552-BBA1-2E8FD25F30B8,c8703a65-816b-4f6e-bb15-53dcb3288f66,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,743C45A2-8999-4120-B770-385912E642B6,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.89,36.03,RNA,,,,2011.0,Alive
s12125,E093185B-DAC5-4FA5-9FD0-F904C9945228,UNCID_1033651.5282e6d0-1c77-4189-b17d-4a89847ac143.sorted_genome_alignments.bam,30,5282E6D0-1C77-4189-B17D-4A89847AC143,cbab7a72-11f7-4dfe-80f8-1b1ef1cf0055,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,419983E8-94F8-43B0-803D-0BB811D1FDF7,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.81,22.47,RNA,21544BDE-3733-4E4B-A557-491582664C96,Primary Tumor Field,External,2011.0,Alive
s12147,3B430C5F-9D6F-469C-ACAA-54489BF43EA3,UNCID_1322057.c5fafb87-e6d6-409e-9872-117798b3d4c4.sorted_genome_alignments.bam,64,C5FAFB87-E6D6-409E-9872-117798B3D4C4,55e03ffc-f006-4ec8-8e5d-a738ff091f8a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,1183BCB5-50A7-4CC0-A94C-732636B7EE7D,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.86,20.66,RNA,391735A2-DC97-4581-B41C-B5C1328F0A5B,Primary Tumor Field,Systemic,2011.0,Alive
s12131,1A3BA311-5D91-4932-A46A-413E8E332A5C,UNCID_1214889.1c978cf4-7ec1-4769-843b-1f83449e5918.sorted_genome_alignments.bam,55,1C978CF4-7EC1-4769-843B-1F83449E5918,a175a9a5-ab86-4c68-9814-c30cfcc52662,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,36B3081A-BB1A-4CE8-928D-AEE302F5BACF,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.79,38.4,RNA,,,,2011.0,Alive
s12180,163F9F1A-9A4A-422C-AC7A-5F2286EEC451,UNCID_1656238.AC6623D5-A616-4AE9-87B9-3F3A5C00ABDF.sorted_genome_alignments.bam,30,AC6623D5-A616-4AE9-87B9-3F3A5C00ABDF,a2e2fac3-cca5-4e33-aa6c-1d9d3ac3aeec,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C7B4058E-21B2-4E6B-8FFF-E1981583B9CE,Alive,Asterand,University of North Carolina,Russia,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,55.62,RNA,E102FF6C-BAB8-43E7-8684-EA6E66132DB0,Primary Tumor Field,External,2012.0,Alive
s12186,5922C019-E83F-4744-B4AE-04CC50DC4679,UNCID_1657359.51C0F97A-C059-4688-8E48-7B9975CD4B17.sorted_genome_alignments.bam,42,51C0F97A-C059-4688-8E48-7B9975CD4B17,d4355111-3abb-40f0-bdb7-b9eaa39dc771,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8424B1F6-C75E-4403-B2BF-C670B9E935C9,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.11,28.49,RNA,646364E4-523C-468B-81A7-A8D7B33653F9,Not available,Systemic,2005.0,Alive
s12205,05FD7CD2-A58B-4E5C-8C8E-03288166E1F1,UNCID_1900655.4bdf2f0f-68b6-494f-95ec-659f5a2ab85c.sorted_genome_alignments.bam,32,4BDF2F0F-68B6-494F-95EC-659F5A2AB85C,acb80b76-2394-4250-8687-60e40e16e83b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4D6855A8-076D-4F95-B6CE-2B250CE3087D,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.92,56.29,RNA,,,,2012.0,Alive
s12181,9668568D-1808-407C-9B38-9279CF28C375,UNCID_1654729.29D6F5E8-46CB-4EFC-B230-F213F4B25A8C.sorted_genome_alignments.bam,28,29D6F5E8-46CB-4EFC-B230-F213F4B25A8C,a3b49c90-fa9f-4189-a442-64ec1ad97a01,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,152A2105-2B04-408F-AAAA-3F6EAF58F845,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1b,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.17,1.86,39.38,RNA,AA24B7CA-76D1-4E47-AD7A-9B2A90694281,Primary Tumor Field,Internal,2011.0,Alive
s12101,44C5A52A-3434-4E05-A510-33799F327C93,TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted.bam,80,D030DC18-6E50-4679-8BF9-26A1DAEC8F79,a3810f36-d2b4-4a45-ad08-a4dbfb9d27aa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,3AC025C9-FEC6-4997-8630-085750DC84E0,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.98,37.3,DNA,,,,2010.0,Alive
s12084,3B8DC42D-2715-4480-A0F4-7595B3520131,G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.bam,47,0567D3E6-6278-4D0A-81AE-C084D73C6DD3,a09d0be0-fd41-4b30-b488-9a9f2abef8e7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,11671156-4BBF-4A3C-B074-7D6C27EE4FEE,Alive,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.07,,42.57,DNA,29931907-FF1E-48E5-8ADA-B4D82F2E9E6E,Primary Tumor Field,Systemic,2005.0,Alive
s12129,77E666EF-11D5-444D-9A6B-C8BBDE1561F8,UNCID_1212405.7c372899-4ca8-4f06-9d2c-058f9a859e4a.sorted_genome_alignments.bam,51,7C372899-4CA8-4F06-9D2C-058F9A859E4A,3b3c99ab-5336-4433-b682-e1a590221611,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,AC52BED3-FDD6-4281-89DE-D2F125BA038E,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.13,2.0,13.17,RNA,,,,2010.0,Alive
s12089,2DC0D4BF-C927-40FC-BC8E-FBDC5E1DA355,G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.bam,62,5C02D399-07AF-4573-A568-BC1B256BC8F8,4aed5116-d27b-4911-b310-05c2248b861f,,Thyroid Carcinoma,Not available,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,4548D9EE-668F-495B-845F-8B9FC798EA38,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage IVC,Mar-40,C73.9,C73,NO,,Not available,30.0,0.09,,65.79,DNA,,,,2010.0,Alive
s12212,BD13575C-F550-484D-95AC-891E8587E926,UNCID_2545086.1094851a-de93-4efd-9483-83a36189a0bc.sorted_genome_alignments.bam,34,1094851A-DE93-4EFD-9483-83A36189A0BC,9efd27c7-9893-49fd-886e-e85057dd5d2e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,3681C965-0D71-47C2-AC05-F553BAE0A833,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.85,55.31,RNA,B33100E2-98D8-4912-BC15-58C15B2FEF4B,Primary Tumor Field,Systemic,2012.0,Alive
s12154,FF5A0927-63F0-4DFD-9782-161738D2A5B4,UNCID_1360096.63f7a81e-c404-49fc-bc72-52b2a81ea9a5.sorted_genome_alignments.bam,39,63F7A81E-C404-49FC-BC72-52B2A81EA9A5,4fa53eb7-1fdb-4fe5-b5ad-f3d8069b3eb8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0A16FE83-515B-40BD-A335-352B794C35F3,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,10.0,0.16,1.82,9.4,RNA,,,,2010.0,Alive
s12153,68768F2B-03D2-4A1E-98A7-7ECC991E152E,UNCID_1352894.9893b949-598f-4664-a72c-8495d0047bf0.sorted_genome_alignments.bam,61,9893B949-598F-4664-A72C-8495D0047BF0,acba8d76-999a-4f6d-b3a4-8d7dd0f2bb52,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,7949D5BD-F0F0-4B11-BC49-DADE6C57BCB1,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.78,23.72,RNA,77BAF244-3902-492F-A8D2-86FED622FAD3,Primary Tumor Field,Systemic,2011.0,Alive
s12157,AB2CB2B7-E9EF-4C94-882C-C9815B7974A5,UNCID_1357712.bb6594c5-78de-49b5-996f-b38b3953e37a.sorted_genome_alignments.bam,73,BB6594C5-78DE-49B5-996F-B38B3953E37A,44465a32-8ee9-4575-94b8-0200ba7c5bd4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,8AED91D8-9428-4322-977B-939E9777C817,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.79,25.4,RNA,6CF636A5-1B59-403C-AAB7-178CC848601F,Primary Tumor Field,Systemic,2007.0,Alive
s12170,86D7AD14-9F12-49F7-A7C1-B280326B5EA4,UNCID_1648816.EB3A7004-78FD-466A-A7C4-ACB85BF5CC37.sorted_genome_alignments.bam,37,EB3A7004-78FD-466A-A7C4-ACB85BF5CC37,9348c35a-58ba-4db5-bc4a-e9fc8e07cdf3,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,192AAEDC-108F-4D5E-9FA5-49C6523F0F29,Alive,University of Miami,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.8,54.84,RNA,15F462D9-D6EF-404D-BB5F-C7ECB1B468DD,Regional site,Systemic,2012.0,Alive
s12126,AF4925CC-7637-42CF-99FE-831038ED5E11,UNCID_1212439.87f41e4d-4b34-472f-a776-0a23a99f1c7f.sorted_genome_alignments.bam,23,87F41E4D-4B34-472F-A776-0A23A99F1C7F,169f045f-1739-4b0b-9bdc-028aaca420f8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,2EEB72CD-8A11-4ED1-87B0-3CF0C1BF1FB5,Alive,Medical College of Georgia,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.74,65.4,RNA,9AC0F8F5-023B-4CAE-9764-B53454C7CBCB,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12159,315D47E7-7E6E-4FC5-AE95-1116B90B9016,UNCID_1362574.1cc55d09-ac11-4cd5-a970-879d884ba666.sorted_genome_alignments.bam,40,1CC55D09-AC11-4CD5-A970-879D884BA666,fb83f7d7-2182-4fb7-8e3e-8ad7f1feac72,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7BC433ED-7908-4297-AA5A-E033924BCED1,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.82,11.6,RNA,7B339BD4-768F-4761-9235-D2E46A85A7A6,Primary Tumor Field,Systemic,2005.0,Alive
s12193,6A0C46B0-92A1-49A1-9A6F-64C48CDF6F92,UNCID_1729389.4c1d10e6-c86a-4139-94f6-185a97377550.sorted_genome_alignments.bam,33,4C1D10E6-C86A-4139-94F6-185A97377550,8cfb88f6-7b37-4f1e-882b-3a368b604167,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,29B4816D-4CFB-45F0-BCD2-6B948245F3A4,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,25.87,RNA,,,,2012.0,Alive
s12087,93872277-A7C8-4D30-999D-AFA2DB9D4986,G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.bam,75,13642CF8-9840-4A7D-A26A-95F65B2C70C3,6abc861a-376d-446b-acee-fb0f03a82c09,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,AACF33BD-95CE-40FD-9828-1E78CBBB0E1B,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1a,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.09,1.91,89.61,DNA,02B8F335-A3B6-44AA-8BC6-D454C3A0D1F3,Primary Tumor Field,Systemic,2011.0,Alive
s12097,72CE31C8-5889-450A-AC21-159C97D9B125,TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted.bam,66,EBAA6AE4-66C0-49A7-938C-620E24564846,dc4d8468-6f34-40cb-a826-8d582cd86fde,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,145A474E-D262-468A-8DB7-EE9F1B7CE0A7,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,2.0,79.63,DNA,,,,2010.0,Alive
s12166,A22A8F08-3353-4B70-89E7-3E08200FBB4E,UNCID_1455323.98523760-1ae2-49bc-8106-19247b934cd6.sorted_genome_alignments.bam,57,98523760-1AE2-49BC-8106-19247B934CD6,90750006-fb25-4ccd-90df-9f300cd26a5b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,78FBBE25-11CA-4219-93E4-85D4CA64B41B,Alive,Roswell Park,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.8,23.01,RNA,946C84E7-134D-4FB7-A72F-E2471F59A743,Primary Tumor Field,Systemic,2010.0,Alive
s12161,C3BA4631-C7B4-4F04-B2E4-A7EF42895D59,UNCID_1368399.cd4545b1-1add-488f-80dc-17edaeb7cad6.sorted_genome_alignments.bam,62,CD4545B1-1ADD-488F-80DC-17EDAEB7CAD6,4aed5116-d27b-4911-b310-05c2248b861f,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,4548D9EE-668F-495B-845F-8B9FC798EA38,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage IVC,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.83,24.53,RNA,,,,2010.0,Alive
s12162,7C66A91F-C59B-4637-A7F9-A1BEB0FDC77E,UNCID_1364308.2ba42856-8b82-4fbf-84a9-44eabe27bc62.sorted_genome_alignments.bam,33,2BA42856-8B82-4FBF-84A9-44EABE27BC62,3b5582e4-58af-4a01-b83d-6fe9704f2b43,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,A0224D95-FAAB-4D4A-AE9F-1E5715DBC99A,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.76,21.67,RNA,,,,2009.0,Alive
s12192,F402818A-0CDF-49A9-A1FE-FA1BA98F6F48,UNCID_1664433.54E48C8B-068A-4548-A31D-82EC1128A58E.sorted_genome_alignments.bam,47,54E48C8B-068A-4548-A31D-82EC1128A58E,4e227a7a-b885-4e9b-a4c2-aad9e6c154e5,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,ACD56B0E-D212-43B3-BE6F-BE188781130A,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,21.5,RNA,F292E10C-49EC-43D1-889D-32D07A7E04DC,Primary Tumor Field,Systemic,2009.0,Alive
s12208,CC2B0345-BD62-4E56-8FCF-0E2EA3046BA1,UNCID_1901485.e9eda4da-4b9d-4add-8229-985b27f5ac2c.sorted_genome_alignments.bam,36,E9EDA4DA-4B9D-4ADD-8229-985B27F5AC2C,fffdb1d9-58d1-425c-ac12-1e1e5f443bf7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,A418A2E8-6A8D-4E7D-8C43-F09B521E51D8,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.96,40.12,RNA,,,,2012.0,Alive
s12191,29C6FB5C-0E3C-4957-B59A-AC609386DBA3,UNCID_1660777.2B5A5886-6A1C-4E22-B453-C0715B657249.sorted_genome_alignments.bam,38,2B5A5886-6A1C-4E22-B453-C0715B657249,2610485e-f2b2-45f7-a578-99d6983d5f0e,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,1D5DFCF4-8D9C-4A0A-9B5D-A7060574973A,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.18,1.82,45.5,RNA,A137C92B-0644-46A2-8E83-EB7E49322049,Primary Tumor Field,Systemic,2011.0,Alive
s12203,D9057B2A-E864-43C6-8F40-468C2E3C6FB6,UNCID_1901169.87ad5350-308a-4f86-a205-f4e566f950e2.sorted_genome_alignments.bam,33,87AD5350-308A-4F86-A205-F4E566F950E2,29afb71c-c2ca-499e-b1c7-12758c9b03d6,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,81270A59-8D25-4B67-BD92-5A0616FE9AB2,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.93,31.63,RNA,13940428-0ED6-43B1-BBEE-7325FAFF4AFF,Primary Tumor Field,Systemic,2010.0,Alive
s12184,245C4004-79E5-490B-8663-86A5841311FD,UNCID_1657667.2CC86CC6-6EE2-4006-B019-01F58B75184D.sorted_genome_alignments.bam,18,2CC86CC6-6EE2-4006-B019-01F58B75184D,f2bbb5fa-9997-45de-88d4-8f1e94c18f0d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C46456EC-2238-47AE-A75D-59E35BED91B8,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,38.71,RNA,,,,2010.0,Alive
s12156,374312D2-8199-4633-9CBC-AD5E1DBF8B9E,UNCID_1359261.e72ab00a-512f-40ca-84c6-861456a0976b.sorted_genome_alignments.bam,70,E72AB00A-512F-40CA-84C6-861456A0976B,641ba101-135b-4395-9360-2058fabfed56,963.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,80C2EEF7-E6DC-41AA-B98B-0877EADC5C38,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.77,18.59,RNA,,,,1994.0,Dead
s12138,CBBD89CE-436A-42CD-8045-B4086BCA066E,UNCID_1239500.8b6f7af8-e41f-47d8-8cc3-dad528776ccf.sorted_genome_alignments.bam,28,8B6F7AF8-E41F-47D8-8CC3-DAD528776CCF,ba9dec81-ffc0-453a-9621-94beba45fab1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,28913C64-8637-4537-AF8C-7315097A5AD1,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.13,1.8,11.92,RNA,,,,2010.0,Alive
s12164,6BBA5D67-D354-4B9D-8A47-97ECA8B60044,UNCID_1455162.be3c0583-3b18-4ab5-a87f-9b95b8cdbbad.sorted_genome_alignments.bam,47,BE3C0583-3B18-4AB5-A87F-9B95B8CDBBAD,c9dc11ad-d3f5-4cdf-9c26-7139580b59af,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,9989E65F-210F-4357-AC69-F90B76590EF8,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.86,44.54,RNA,,,,2011.0,Alive
s12104,C717FAC6-B3B3-4335-8EE8-5862D742EA16,TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.bam,60,B80A7146-1AB2-49BD-A3B2-7F6650840195,8c5aef43-341e-4a37-84eb-fd730eb957c7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,CD19D6BB-21A4-409A-A7BA-A4521A03ABD3,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.95,76.6,DNA,,,,2010.0,Alive
s12173,CDD574E7-B6FA-4286-9AF7-05277139C6EE,UNCID_1652851.D82A6D70-CA0E-42DA-94B6-70554643139A.sorted_genome_alignments.bam,28,D82A6D70-CA0E-42DA-94B6-70554643139A,14591ce2-ed02-440d-8004-7ca0ad94d0a7,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,1F6551ED-7984-4809-A3BB-B6B477816062,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.36,30.11,RNA,,,,2011.0,Alive
s12127,679346F3-CCD8-4835-9D6A-1D0BC6EFFDD9,UNCID_1212810.525589a6-6bb6-4736-aa49-4f06deb503d2.sorted_genome_alignments.bam,72,525589A6-6BB6-4736-AA49-4F06DEB503D2,eb15422b-cafd-4af2-973e-8c997a911170,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,BE7674CB-F32E-4B9B-84F4-850B3B8147D8,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.88,41.91,RNA,05A5C9F6-9488-4C27-BFD7-AEDFF74E7149,Primary Tumor Field,Systemic,2010.0,Alive
s12139,03AF7E65-E821-4DE1-BAEF-2A593B0812F7,UNCID_1249760.a60b88ff-4c3b-4da1-b071-b16d13ded954.sorted_genome_alignments.bam,25,A60B88FF-4C3B-4DA1-B071-B16D13DED954,25d8a79e-15fd-4c8a-a7f6-05d78973b757,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,AED3B953-1D76-4C15-92A9-610DFCF13118,Alive,Christiana Healthcare,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.82,44.45,RNA,700073D9-1D7A-4D87-BA52-63B697386ECB,Not available,Systemic,2011.0,Alive
s12198,C42FA575-2E4C-4CE8-80E4-489ABD61AB02,UNCID_1880761.7f6a2c0a-3627-43b0-91f6-9de66c3b1003.sorted_genome_alignments.bam,68,7F6A2C0A-3627-43B0-91F6-9DE66C3B1003,2ae6a00c-bc6e-42fe-a0cb-40339d5fdc73,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7E900EF6-A7BD-40CD-B4EB-AB42FC788DA5,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,49.75,RNA,,,,2012.0,Alive
s12142,C576EA3B-F30E-4132-80F9-4046266BA369,UNCID_1240222.12c5149b-7fd8-4031-9d10-f8efc6247726.sorted_genome_alignments.bam,36,12C5149B-7FD8-4031-9D10-F8EFC6247726,8877b479-b62a-4794-b71e-418de96dff23,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C6D64D80-C8AA-494A-8C0E-8640BEEBDFC9,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.74,27.13,RNA,,,,2010.0,Alive
s12148,A0462D36-9B45-4EC6-A3AD-A5C70A229057,UNCID_1323012.e7927134-7458-42ec-8669-34a201477e9e.sorted_genome_alignments.bam,36,E7927134-7458-42EC-8669-34A201477E9E,6491d025-c061-4180-bfd4-d7c6e6e55f66,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F5B8976B-F31F-42CA-AF42-9DF82165D5B4,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.77,32.71,RNA,A9ED7223-67BB-4CBC-81F5-CE9CBEDB9C9C,Primary Tumor Field,Systemic,2011.0,Alive
s12176,7B110C39-95C6-4691-86EE-6D63AB2CC21C,UNCID_1656742.A8AE9773-3287-43E4-A18A-1ACE7291E83F.sorted_genome_alignments.bam,69,A8AE9773-3287-43E4-A18A-1ACE7291E83F,8a233b01-2959-467f-8950-02be16309156,174.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5297F55C-3A46-47ED-8ACC-03333AC26473,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage IV,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.05,40.16,RNA,,,,2005.0,Dead
s12151,3E74EF23-D844-4A37-BC73-BB1E3425315E,UNCID_1325878.c3499c93-0cff-4d93-b1dc-c795a4d6b48f.sorted_genome_alignments.bam,46,C3499C93-0CFF-4D93-B1DC-C795A4D6B48F,d3e75fb4-fb7c-4ebf-9c75-2be9ffd9f52d,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,966D1C08-73DA-44CD-B6AA-42056D59A7CF,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.87,58.2,RNA,BCC9FFAF-DDC5-4F4B-B4AB-96251FBE2998,Primary Tumor Field,Systemic,2011.0,Alive
s12144,C10CDDE3-73E0-4214-88C1-664F67F68D43,UNCID_1254226.6a279cfe-e09e-4508-95aa-1f2f51a82bf8.sorted_genome_alignments.bam,62,6A279CFE-E09E-4508-95AA-1F2F51A82BF8,cb29e795-7618-4882-a7e0-69d39787b80c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D0A669AF-1A0A-451D-9D6F-9EEE15F7264C,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,2.0,60.16,RNA,,,,2010.0,Alive
s12207,E0D458EE-6DAA-4EAB-8BF8-5D559612BC12,UNCID_1902282.39eb1ae5-70cd-4b7b-94a9-7b070a34f107.sorted_genome_alignments.bam,63,39EB1AE5-70CD-4B7B-94A9-7B070A34F107,1bacebf3-609e-4bb7-bb93-eb217b3a1b5c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B08BCE65-BAFD-42AC-B94E-B1BBEE2E2F75,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.75,59.9,RNA,328D4CA8-8CC5-4824-BE5C-0C0A4CACD4ED,Not available,Systemic,2012.0,Alive
s12199,91E26E26-A4BE-4710-8989-B4B82FD8212D,UNCID_1880882.eeed9479-565a-44d2-8783-458aaae5d51a.sorted_genome_alignments.bam,37,EEED9479-565A-44D2-8783-458AAAE5D51A,38d03e42-db98-43bc-bb3d-2580cf55a681,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,11ED0F3A-3D7F-4B0E-9354-5746D49CC64A,Alive,University of Miami,University of North Carolina,United States,Other  specify,T3,N1b,Stage I,Mar-50,C73.9,C73,NO,NO,Not available,30.0,0.16,1.79,31.58,RNA,AC309FE1-F1D1-4F6B-B34A-67646CBB81CD,Regional site,Systemic,2012.0,Alive
s12206,5B11EB56-B435-454D-840B-48AF1A26E8DC,UNCID_1901989.2d914586-8139-4f9c-be79-99722e36b46a.sorted_genome_alignments.bam,28,2D914586-8139-4F9C-BE79-99722E36B46A,86657a3c-10cf-48b7-9fda-f2df5e2afad5,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5E5829EB-5C1E-4B6B-A37C-EB2F6340F6FB,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.89,32.84,RNA,18ECBF93-6DB3-48AC-BF1A-E3631397E553,Primary Tumor Field,Systemic,2012.0,Alive
s12095,3BCA46E2-DBCE-4B1C-8AEC-37CC8615D471,G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam,26,B8CD6882-BE27-4742-BC63-3227D31BF704,2f59f12d-ca0c-4ac6-9718-98a6d455af46,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,043765F1-FFBD-4AC9-B0AE-733C3643083D,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.07,,53.65,DNA,,,,2011.0,Alive
s12140,9965A38C-27FE-41DA-945F-8C6C70ED7C03,UNCID_1241098.2931c2f4-3095-4eda-be5f-76b6763a590c.sorted_genome_alignments.bam,30,2931C2F4-3095-4EDA-BE5F-76B6763A590C,a1227ffa-2733-4a43-ba82-834755453870,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,DAF2A444-AB89-48D4-9DA7-888AC3099AB7,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.85,84.93,RNA,,,,2010.0,Alive
s12150,9DFF1CFB-0C49-4519-9597-8A79DDF1C5AC,UNCID_1326190.4a51b469-602e-4c5d-8f24-ce26eddde2b5.sorted_genome_alignments.bam,66,4A51B469-602E-4C5D-8F24-CE26EDDDE2B5,1f6be7ca-76fd-4509-99a6-dfa59b0ac51f,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,39085DC6-46FE-4D3B-AE3F-04443DACB7C2,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.86,57.76,RNA,,,,2011.0,Alive
s12167,E05A8C89-C9E9-47BF-BC86-CA55B76EAEC4,UNCID_1455601.39a9dd5b-3cd1-4673-b147-4b789fc04993.sorted_genome_alignments.bam,31,39A9DD5B-3CD1-4673-B147-4B789FC04993,16505d78-90d9-47d0-9b86-c6ef91d23aac,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,71DBAA74-9167-4A01-B02E-8F0D8A6BD391,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.8,23.18,RNA,,,,2011.0,Alive
s12185,2B829D8A-4D4C-4BD5-9293-782DF8F380AC,UNCID_1657332.6F1184E8-EA92-4E59-90CA-0F61A9428F20.sorted_genome_alignments.bam,38,6F1184E8-EA92-4E59-90CA-0F61A9428F20,6befdc6a-27fc-4cde-979b-ffe05cd8603f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6C92A78F-EC4C-4AE6-849A-7ABDD976BBAD,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1b,Stage I,Mar-44,C73.9,C73,NO,YES,Not available,30.0,0.15,1.83,36.01,RNA,7D98B9EF-5674-4170-AD3D-F049EEDA0EF4,Primary Tumor Field,Systemic,2011.0,Alive
s12115,81720382-DB9A-41E3-814E-EE8EC59CE22D,TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted.bam,36,663173D3-A9EE-4E73-8444-52F01727BE6D,2f9ed09d-2626-4c23-ba47-1850d36f812a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,343311B1-D586-4F92-9984-32AF1AFB1F62,Alive,Johns Hopkins,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.0,57.24,DNA,1C5B2B34-804B-467C-B457-46716ED4C490,Not available,Systemic,2009.0,Alive
s12200,B2A271F9-66D4-4F88-8F08-D37C3EA450B0,UNCID_1880569.8f8436ef-f424-4f3e-be6f-bef621ac445b.sorted_genome_alignments.bam,51,8F8436EF-F424-4F3E-BE6F-BEF621AC445B,7cec93da-42c9-495d-8110-9fb43763041b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8745A636-6E9F-4989-A8F7-16F29503266B,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.84,22.63,RNA,B0C69EA6-2308-4660-8EB1-35376C1F3206,Primary Tumor Field,Systemic,2005.0,Alive
s12163,55961739-8846-4ED8-8DE0-855BB537E2D8,UNCID_1375764.cd7add27-efc5-4cc6-83f0-412e14eaaabb.sorted_genome_alignments.bam,62,CD7ADD27-EFC5-4CC6-83F0-412E14EAAABB,8b1987f7-75fd-4e24-be77-891bbd2d40a1,1385.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,CC4521BE-A451-4C9C-99F1-A701A289F690,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N0,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,20.17,RNA,57E15FFF-6FE4-4268-AA7D-C79C75CBD8B8,Primary Tumor Field,External,2004.0,Dead
s12171,10711C06-8976-4B64-A760-EFA836415871,UNCID_1653114.67C6149C-47B1-4A72-BE1C-9CFD6EB66227.sorted_genome_alignments.bam,43,67C6149C-47B1-4A72-BE1C-9CFD6EB66227,fe28f76e-7ead-4d29-8c53-a576ae6021f7,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,3B02EDC2-A41B-4CEB-9EF5-5A2A0A251E11,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.34,56.55,RNA,E80028AF-70BC-4FE2-AC99-A836912EB6A1,Regional site,Systemic,2011.0,Alive
s12123,4920D08D-433E-4371-8DAA-641819A1E53F,TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted.bam,33,A5FA44A2-8101-4A0C-982C-57337853BACA,7deedeba-f05b-453c-9df1-eeb20b0ec72e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D717EECF-11DC-4E15-851A-9EA18332A48B,Alive,ABS - IUPUI,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.8,75.85,DNA,D3271F10-C2B0-4855-8BE9-26B8D2F0F5EA,Primary Tumor Field,Internal,2011.0,Alive
s12160,5743F2E6-67D4-4C86-8994-42BFD1201CBF,UNCID_1361659.e80f8c3a-d7ae-4ea5-b39b-0318c7c0b3bd.sorted_genome_alignments.bam,28,E80F8C3A-D7AE-4EA5-B39B-0318C7C0B3BD,ab17d69e-0078-4206-939e-e4784fdc9a96,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,30955DD6-81C0-48D0-BDA2-BB36B546AC11,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,TX,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.88,31.23,RNA,,,,2000.0,Alive
s12111,52B6FD69-3B74-441B-A40B-77C172DD0979,TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted.bam,83,EEBDC565-A071-4356-8CBF-1560A8BB034D,2a398af1-aea5-4aae-ab00-a2dc152f965a,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,60C1BA59-C04E-4237-A8B9-FA0D894BBAFA,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,,48.3,DNA,86D7F44F-40E6-4B90-ADCE-4C8CC5F2AA48,Primary Tumor Field,Systemic,2011.0,Alive
s12195,31186CAF-4A38-4D86-8682-36AF7AF9B595,UNCID_1815854.6e1468f5-a1f6-4d15-a355-39069bdf9067.sorted_genome_alignments.bam,51,6E1468F5-A1F6-4D15-A355-39069BDF9067,00b62df6-1189-4e38-8601-70416e05550d,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2220B79B-C90B-4747-AD12-9A501BD507DF,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,36.34,RNA,,,,2012.0,Alive
s12196,105BA3FE-CE2F-4BB7-AD10-7159AE323E47,UNCID_1815835.3dbb7586-0e8d-41ff-aa57-ab701b892784.sorted_genome_alignments.bam,51,3DBB7586-0E8D-41FF-AA57-AB701B892784,c5d08be7-b94c-423a-aea8-bbc635787c63,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E6294121-63C4-4736-9A99-9D277D5F3ABD,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,YES,Not available,30.0,0.16,1.84,28.98,RNA,5C4AE84B-EA0B-440B-9F1F-EA78B84D8279,Primary Tumor Field,Systemic,2012.0,Alive
s12178,2D8D8878-44B1-4B1E-87FA-B76F1103750A,UNCID_1655841.D038B388-E5E0-4EE8-AF7C-4D044128E3B8.sorted_genome_alignments.bam,24,D038B388-E5E0-4EE8-AF7C-4D044128E3B8,2513ab46-646c-4750-ab42-de3940890553,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,72322D63-14A4-4AB9-BCB3-3DCA1693A73B,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N1a,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.8,32.58,RNA,D176BA7D-948E-4DF2-B6D4-6BC5F86832DF,Primary Tumor Field,Systemic,2011.0,Alive
s12202,4567533E-8033-490C-9399-9D3E9B0455BE,UNCID_1900747.3e9ed7f0-3324-4c3c-85e2-dadb05025b94.sorted_genome_alignments.bam,38,3E9ED7F0-3324-4C3C-85E2-DADB05025B94,4f340c8c-5912-4257-b57d-c096da254c26,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,67BE946E-8260-40C3-B763-0B43B49C086D,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.88,22.87,RNA,5E0FB7E6-6DB8-45C5-8649-096692B40ABF,Primary Tumor Field,Systemic,2009.0,Alive
s12249,DDF917FF-6B4D-45CA-A503-8D6449F76E72,TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted.bam,55,2604E6C9-A117-49DC-A06E-082E63859DCA,24cf6397-60ef-4635-81f0-78a67157aac0,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,8B048263-6C2F-4BF6-8F37-C69DA9F3839F,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,,47.85,DNA,,,,2011.0,Alive
s12226,102342DA-D9CE-4EB4-8C20-DDA6CE072830,G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam,61,E7335A24-E5FC-4558-9EBA-511C5A802320,b0cb6ed7-3d9f-4d5e-8df5-edcc921c43b4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,08D3CB3B-9A80-4034-B06D-B37DD38C8B9B,Alive,International Genomics Consortium,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Not available,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,,37.07,DNA,,,,2011.0,Alive
s12221,DA7E540D-041B-4D8E-9158-52775A1AAD5F,G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.bam,66,ADD0B0F6-B4A8-4B73-B634-C3600DC567D5,dc4d8468-6f34-40cb-a826-8d582cd86fde,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,145A474E-D262-468A-8DB7-EE9F1B7CE0A7,Alive,University of Pittsburgh,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,2.0,79.63,DNA,,,,2010.0,Alive
s12268,7ACB44F8-D8FE-431E-8A4F-DF306636F38A,UNCID_1253876.e59deb12-6554-4a53-80ee-ebebe64e851c.sorted_genome_alignments.bam,34,E59DEB12-6554-4A53-80EE-EBEBE64E851C,a9d8f797-8a53-4be5-b957-0f1f6d080390,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4CA4149A-E952-4A25-9163-8D4C15B09A62,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.8,31.66,RNA,,,,2011.0,Alive
s12241,AE4A78D9-4C9A-40F7-9612-17D11799EA67,TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.bam,56,EC713290-9998-489B-9D1E-CC9D33CF5428,77d5b246-33ba-4a96-9d73-06aca797653e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,457B11C0-3C36-4907-8C76-60E3861EBABB,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.93,21.24,DNA,,,,2010.0,Alive
s12324,102D227A-5220-41B8-9556-2E36710F1A53,UNCID_1900603.a872e4e0-b63c-4f88-a5c9-ceb9aa751304.sorted_genome_alignments.bam,59,A872E4E0-B63C-4F88-A5C9-CEB9AA751304,12f90efb-c45b-4372-8197-2dfd9ca247ea,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,C9A7A81F-A8C9-41F3-AEE9-002945B55F0D,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.83,50.2,RNA,CE5CA6DE-D67B-4470-B91E-576822DF3B27,Primary Tumor Field,Systemic,2012.0,Alive
s12252,63701F3E-E258-497F-A7B6-1DDDCE3369F2,TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted.bam,33,F125CCA1-271D-4716-9746-9AB9DD2A1C43,97b5017c-2066-4472-ab3f-31cfe64a6762,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,7F540311-430C-46B2-98C8-F314B27ECB0E,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,,55.95,DNA,,,,2011.0,Alive
s12278,4B979416-3C6D-42F2-8B13-8E2D747D4639,UNCID_1324099.84fb7b6d-d38e-41b5-86e4-bb66266da91b.sorted_genome_alignments.bam,45,84FB7B6D-D38E-41B5-86E4-BB66266DA91B,0c50a2c2-1d4c-45ca-9127-f96d4db18daf,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,593736E0-1BED-4EAF-BAC9-E90620554F1D,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.78,15.27,RNA,,,,2011.0,Alive
s12330,3D495AC1-A681-4756-A2D3-88F6C40F0B49,UNCID_1918045.a44ef83c-ef8e-4b10-bba2-86111df19873.sorted_genome_alignments.bam,41,A44EF83C-EF8E-4B10-BBA2-86111DF19873,b4a60a32-2c1b-44fb-92f4-b30f985dc424,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5E93392E-A852-4130-8141-CAD028C40A44,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.86,44.95,RNA,65DEB6AB-33D6-4453-80F3-FD34112C212E,Not available,Systemic,2010.0,Alive
s12243,E98815FD-CD95-4AF1-AF17-129186E4A00A,TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted.bam,42,A070BCA4-DDFA-4BE7-A635-69A2BA97FFE9,3597af5e-65ff-40a7-95fc-dacc26cbca14,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,B4215B1F-3918-43D6-8862-380C35F891EC,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1a,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.86,41.49,DNA,,,,2010.0,Alive
s12215,C13857F7-BB38-4650-9294-AD8287C6C137,G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.bam,85,DBACC1AD-C88A-4BCF-A45F-E9C83C762164,e8f56d0f-eee4-4def-a43a-dec91f4382a1,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,E13C3F11-913D-4371-9A7D-5E4DF15FB42A,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,,59.1,DNA,,,,2011.0,Alive
s12256,2983A837-7D6A-4E9D-A68A-A3AA674FBB8B,TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted.bam,70,056B3922-279A-4869-A933-0C53C1137450,7044dee0-fd6c-4e75-b731-dc60a386a1ab,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,96C298EB-0699-42AE-B2EA-63A192353D69,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,2.16,101.76,DNA,C02D4982-8836-4BDD-BB48-A761B7C0EEDC,Primary Tumor Field,RADIOISOTOPES,2010.0,Alive
s12285,70CE0483-18B9-4423-A940-6BCE4A7E9968,UNCID_1375945.3f428b20-16d5-4139-b8df-307165f37f8c.sorted_genome_alignments.bam,27,3F428B20-16D5-4139-B8DF-307165F37F8C,2ce580e9-4d75-464c-b403-c9f4626d7aa4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,045CB6E7-2029-430F-941D-871C64FCE8F8,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.82,42.35,RNA,,,,2011.0,Alive
s12239,A19C2149-887D-4A36-992F-2A0EBB46072C,TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted.bam,19,3C630C3D-343D-4F9F-8067-43B66466D382,8aa99f35-c644-4f91-9eff-a5d3fae758b0,,Thyroid Carcinoma,HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,17952842-3447-4A38-90F4-D25B90C3233A,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.13,1.97,58.89,DNA,,,,2010.0,Alive
s12234,A9F1F6DE-8F02-48C6-A9E2-6CEF21CD8438,TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted.bam,55,42FE4D84-B54D-42B8-81F8-92191723D057,04fff86a-b6f5-4900-9e37-c1f0b881b160,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,2EB89D79-861E-41C2-BDD5-6F16D2A84B25,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.95,53.09,DNA,FCC5E46D-2F73-4ECB-9DBA-2595EE16F3E6,Not available,Systemic,2010.0,Alive
s12266,9E5D8F43-949F-4234-B195-BDA481F8C1A3,UNCID_1240024.27532782-f61f-466c-9758-d693eeecc86f.sorted_genome_alignments.bam,55,27532782-F61F-466C-9758-D693EEECC86F,72d8dcc3-0709-4fd1-98d4-fb75e9340758,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,51FE3D91-4914-49FC-B69C-990C1DD09E1C,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.82,30.56,RNA,,,,2010.0,Alive
s12326,ABD7B426-49C3-4985-90FD-51A75D48E286,UNCID_1901495.db49acfb-d0a7-4957-82f8-038a1dc5ea9a.sorted_genome_alignments.bam,68,DB49ACFB-D0A7-4957-82F8-038A1DC5EA9A,7851512b-5f44-43de-8b27-99b5e91a8119,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,83FCA567-AC9F-4888-A9AD-E766CA0B322F,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,25.33,RNA,,,,2012.0,Alive
s12218,E27094EC-2670-4EF1-A358-D36554E52DA1,G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.bam,34,1D97BA51-D981-4986-9F71-C2B6CB9961C3,a9d8f797-8a53-4be5-b957-0f1f6d080390,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,4CA4149A-E952-4A25-9163-8D4C15B09A62,Alive,University of Pittsburgh,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,2.0,61.44,DNA,,,,2011.0,Alive
s12303,8694744F-86CC-48E3-9B9B-DE81115EBCB3,UNCID_1654123.B6F2E7D7-CC9C-409B-B4EB-4659C81C721C.sorted_genome_alignments.bam,46,B6F2E7D7-CC9C-409B-B4EB-4659C81C721C,96b95a2c-fb4f-4cba-89e7-a7f0e90db146,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6CE2F367-4F07-444C-9826-6F135C8A5C3B,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.8,46.27,RNA,5D592F60-DD25-41C8-8FF2-A472895E73D6,Regional site,Systemic,2008.0,Alive
s12258,BD320251-720A-4498-A699-419A2544FE75,TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted.bam,57,EFF7FEA8-DF07-4DAD-BD26-7384906844E9,905469d2-4c97-4293-a20c-1b1f0462a25d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,65414BA0-8800-4626-9488-10D79274CF32,Alive,International Genomics Consortium,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,7.0,0.16,,10.85,DNA,,,,2011.0,Alive
s12219,3C0140AE-22A1-4EFF-8981-313AA5DD5315,G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.bam,60,7DFCFE29-3900-4D7B-8067-60C51584B0B1,c31b3adf-3fc6-4a72-83b0-bbc0f295b5e7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,3AE03B86-1473-409C-8118-A91A73A36F60,Alive,University of North Carolina,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1b,Stage IVC,Mar-60,C73.9,C73,NO,,Not available,20.0,0.07,2.03,60.48,DNA,923999C1-45AE-4D19-B055-3C71C2EE7FC2,Not available,Systemic,2008.0,Alive
s12300,FE887008-6E1B-43A0-AB33-100AF29AE0DB,UNCID_1652457.728E9020-E0B9-4816-ADE5-C2C6554E276F.sorted_genome_alignments.bam,42,728E9020-E0B9-4816-ADE5-C2C6554E276F,104b6629-aff4-411b-9704-547c47ada5a1,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,24A47998-87B1-4677-A50F-96A5184C9F5E,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.16,2.09,41.54,RNA,,,,2011.0,Alive
s12316,059004A9-E9F7-4FAC-BC7C-C35D3527D090,UNCID_1661271.C97AD389-99D9-4C27-B19E-CBF454C04E43.sorted_genome_alignments.bam,52,C97AD389-99D9-4C27-B19E-CBF454C04E43,4cccc34b-daf6-41ca-9bf8-f1614525eac9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0BE2571E-3572-4974-95CE-21B9972B24B2,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.17,1.88,51.41,RNA,F4AB91BA-D4DA-43CD-BD9E-18C6887C095A,Primary Tumor Field,Systemic,2011.0,Alive
s12274,1840AB46-C670-4A0A-AB02-87C12C80417D,UNCID_1324100.0ae5650b-0dab-4645-ad7b-854b30bdbf75.sorted_genome_alignments.bam,46,0AE5650B-0DAB-4645-AD7B-854B30BDBF75,b9e6a966-da7c-46f3-825f-8e19c06518c3,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,22FE6D55-2F34-4145-9865-1F62C1F41AA5,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.82,58.41,RNA,78D1533A-D7EB-45F7-BFE3-07182D077A83,Regional site,Systemic,2011.0,Alive
s12332,F72B1303-E453-48C9-B7AE-E3D8F99E8609,UNCID_1918243.deca26c0-d474-4a76-9a60-d49954ce1b68.sorted_genome_alignments.bam,68,DECA26C0-D474-4A76-9A60-D49954CE1B68,aa6e3437-ea1c-4bed-ab7d-8f3f89f8ceeb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,56F93CD9-7925-4804-95E2-5B647ECFF2D1,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.91,22.62,RNA,,,,2010.0,Alive
s12336,076597E2-03CF-443E-B989-730083EBDEB6,UNCID_2223663.27e42af5-cd5b-4028-ac50-e01062a7eeac.sorted_genome_alignments.bam,44,27E42AF5-CD5B-4028-AC50-E01062A7EEAC,5eb0d577-223b-4409-89d1-5c5d196affc3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,213BE6EE-1E61-4FA0-9B73-66B696086397,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.87,45.48,RNA,9CB6DD51-6B74-475E-9CCF-D65EEFFB2F93,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12281,3B932518-6AD2-45CE-BDC5-13A39DC67870,UNCID_1358898.8f6bc2db-4455-4e11-a18b-c98bb1f327bd.sorted_genome_alignments.bam,33,8F6BC2DB-4455-4E11-A18B-C98BB1F327BD,5cdaa0c8-27b8-4552-9dcd-20d67b1eb70f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,53233F47-C7D1-48C8-80E6-91E28EE1D974,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.85,52.63,RNA,,,,2009.0,Alive
s12224,D7F3AEA8-EA8E-4400-B8B3-CC40582E70CD,G49537.TCGA-FE-A233-01A-11D-A33C-08.1.bam,18,473FE833-FCC6-485E-93D2-95E662C3EF53,e70feafd-1390-4f4c-a635-da65c1a7daeb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,76A6F76D-F33E-4B4A-B0EE-FB863345F194,Alive,Ohio State University,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.09,2.05,92.7,DNA,7BE4F3BE-9D1E-40AB-8E97-5440FAE9F4D4,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12334,AC31C8D9-4596-49C1-AD35-78D1F1EFCE5E,UNCID_2214906.8fadca85-e334-4277-9f5f-6f0de8f54cb5.sorted_genome_alignments.bam,47,8FADCA85-E334-4277-9F5F-6F0DE8F54CB5,c14a0460-30b0-453b-ab81-da03ad4ad02e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2E78D231-1272-432B-BA71-20930F970971,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,0.85,49.42,RNA,196E1F8E-1A3E-4116-A3FC-F4A78B970789,Primary Tumor Field,Systemic,2008.0,Alive
s12264,B9C60F62-5416-414F-A249-D4B4C2BFDBD7,UNCID_1227996.8eb57b3e-64eb-408d-ad2d-1ff2c0e69506.sorted_genome_alignments.bam,18,8EB57B3E-64EB-408D-AD2D-1FF2C0E69506,e70feafd-1390-4f4c-a635-da65c1a7daeb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,76A6F76D-F33E-4B4A-B0EE-FB863345F194,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.93,55.91,RNA,7BE4F3BE-9D1E-40AB-8E97-5440FAE9F4D4,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12267,42B78CB5-06DC-43EF-BA86-AA9CBE57B81B,UNCID_1268329.5c437a0d-7e14-4864-8408-98c9028c9d1e.sorted_genome_alignments.bam,71,5C437A0D-7E14-4864-8408-98C9028C9D1E,0ad2a2b3-c1bb-4597-b28e-a6385f93d09c,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,17610B7B-F2EC-4B55-808C-1C2219A0D1BA,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.88,36.79,RNA,7B7BC09E-0D53-40EC-8D9D-44658DB89F7A,Primary Tumor Field,Systemic,2007.0,Alive
s12314,8EDE6AB7-4676-4603-B079-46F16C3B7379,UNCID_1664138.9B57B16A-E4C3-4290-AB1C-7B3FA30F622D.sorted_genome_alignments.bam,46,9B57B16A-E4C3-4290-AB1C-7B3FA30F622D,8a8e05aa-f13a-4142-a335-7aafbee7b664,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4E8151FB-47C7-4994-A494-5740010233B8,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.15,1.79,21.16,RNA,35BACC8A-BA62-409D-B786-9EB94C55E503,Primary Tumor Field,Systemic,2012.0,Alive
s12270,B5B739A9-A53B-428A-8938-D3F4EED7AD7B,UNCID_1268063.e4d13a24-fbba-4167-af93-94c4b0b3bb48.sorted_genome_alignments.bam,70,E4D13A24-FBBA-4167-AF93-94C4B0B3BB48,7044dee0-fd6c-4e75-b731-dc60a386a1ab,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,96C298EB-0699-42AE-B2EA-63A192353D69,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.96,85.71,RNA,C02D4982-8836-4BDD-BB48-A761B7C0EEDC,Primary Tumor Field,RADIOISOTOPES,2010.0,Alive
s12213,304598E8-69DA-48FA-A60C-8F025223E258,G32528.TCGA-DJ-A2Q8-01A-11D-A18F-08.5.bam,47,FA837B4D-55A7-4DCF-9FDF-CF9C13644DF7,f9cf605f-f287-4eba-8e8f-8ba47e14ecc4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,9AF5F9F1-36A3-48EA-A5E1-9B642E609E97,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1a,N0,Stage I,Mar-44,C73.9,C73,NO,,Not available,30.0,0.08,,37.93,DNA,,,,2011.0,Alive
s12323,A5F36CEC-9324-4C2E-AF83-F0051BEF434F,UNCID_1900686.2e4e9b2d-605f-4ce2-ab37-ba8774cbda25.sorted_genome_alignments.bam,68,2E4E9B2D-605F-4CE2-AB37-BA8774CBDA25,89f4a6a5-bf9b-4a0e-bacf-8cd715c2ca93,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2F6E013C-F8BE-4812-9139-6A6FA3213C89,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.83,34.42,RNA,661F4342-CF24-4598-B575-E531E5720DBE,Regional site,Systemic,2009.0,Alive
s12296,A0177E89-DC61-42F7-B02A-9158655CE3A0,UNCID_1598539.9D3DFA06-4C69-49A8-93C2-EE54AAB7B2D8.sorted_genome_alignments.bam,47,9D3DFA06-4C69-49A8-93C2-EE54AAB7B2D8,a09d0be0-fd41-4b30-b488-9a9f2abef8e7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,11671156-4BBF-4A3C-B074-7D6C27EE4FEE,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,22.84,RNA,29931907-FF1E-48E5-8ADA-B4D82F2E9E6E,Primary Tumor Field,Systemic,2005.0,Alive
s12308,3AD63B06-92DB-4A66-B521-C5E4404D44C4,UNCID_1654821.108BCE52-0187-4F9F-9DCD-921450B2E9C3.sorted_genome_alignments.bam,39,108BCE52-0187-4F9F-9DCD-921450B2E9C3,4bd61e82-5168-4222-a8c8-5124ab8fdd44,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F9F2DB6F-7B78-441A-98BF-FE9FD6BBCD97,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.78,55.88,RNA,258F864F-72F4-49DA-AC72-4170195A30AB,Primary Tumor Field,Systemic,2004.0,Alive
s12309,6BC4D6EB-D7C1-43F6-AF29-CDEA45C86735,UNCID_1656360.508E645C-DD4A-4C2B-93D8-864EC3A8080C.sorted_genome_alignments.bam,22,508E645C-DD4A-4C2B-93D8-864EC3A8080C,a253b21e-ba9b-4928-95d1-89b59c868794,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4923B08D-63A2-4143-94C2-C27CAB20FBB2,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,38.23,RNA,4D130297-3164-42BD-A7B4-A85BFAA656D5,Regional site,Systemic,2008.0,Alive
s12321,DBB5903C-EA1A-4F45-8541-441314C0185B,UNCID_1844906.4e1f858e-35c7-4259-b495-dac1d344b4e6.sorted_genome_alignments.bam,42,4E1F858E-35C7-4259-B495-DAC1D344B4E6,541406fa-4443-4094-a303-43913d96f016,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,011C5F57-FA08-46BD-9E48-88C51B118C2D,Alive,University of Miami,University of North Carolina,United States,Other  specify,T3,N1a,Stage I,Mar-50,C73.9,C73,NO,NO,Not available,30.0,0.15,1.8,46.22,RNA,43BDD49B-593A-4328-BE4F-EB9B2994F1AC,Regional site,Systemic,2012.0,Alive
s12298,E5B25DAC-D0CD-4F02-AADF-6E420BB8F864,UNCID_1649992.A57EBF88-F20E-4AE7-83C6-810EF72B99BA.sorted_genome_alignments.bam,37,A57EBF88-F20E-4AE7-83C6-810EF72B99BA,a86ac3b5-b5e9-4420-8de0-a358fcad85b6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7A5628FF-C5C2-4F25-809B-640415323477,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.15,1.93,38.85,RNA,5DA5CF9E-8C18-47FC-8C49-FAC10FE6D715,Primary Tumor Field,Systemic,2006.0,Alive
s12231,B215D9C2-6A64-45CF-8E4B-0E2B87207119,TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted.bam,63,ED0B1C86-A516-422F-92C4-7C535E709989,ab8c9101-adeb-4c43-a8bb-b089ebd711f6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,695C5627-F442-4A86-9702-EF35DEFD8C8C,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,2.03,36.9,DNA,,,,2010.0,Alive
s12331,4B53726F-2104-4B67-A6B4-55199159F79F,UNCID_1925996.e491502d-1c89-4629-83b6-7c00420e8804.sorted_genome_alignments.bam,48,E491502D-1C89-4629-83B6-7C00420E8804,b8cb385a-4e5f-4932-944d-04d6ea1bba5a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,31BA1767-EE52-474D-AE45-A54E9A4E82DF,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N1,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,2.07,18.72,RNA,8C5440BA-D96F-4C25-A6F7-C6F7F04995DE,Primary Tumor Field,Systemic,2012.0,Alive
s12282,DE202FF8-DA3D-422E-9B74-C87BF38A41DA,UNCID_1362960.a5aa7e8e-7a17-4ae0-9bb4-26201e45f914.sorted_genome_alignments.bam,60,A5AA7E8E-7A17-4AE0-9BB4-26201E45F914,d84312e8-999d-49ad-b0aa-e48e87efc462,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,529071A1-30B8-459E-876C-8542CFBD95EE,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T2,N1b,Stage IVA,Mar-44,C73.9,C73,NO,,Not available,20.0,0.17,1.81,27.38,RNA,4D80ED53-5443-4396-94D6-E2588A786357,Primary Tumor Field,Systemic,2007.0,Alive
s12327,F7F2B340-AE53-4585-9011-139D81E343AE,UNCID_1910893.783abefe-0a71-4680-a09b-8152226d909e.sorted_genome_alignments.bam,41,783ABEFE-0A71-4680-A09B-8152226D909E,9c6c44b3-a2ca-456e-a8d1-d375309c1751,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,E7B15591-3E69-40C0-8C6D-A64C0C3C2056,Alive,National Institutes of Health,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,52.48,RNA,615C6467-337E-4FD0-9BB0-C5D943FE86F4,Primary Tumor Field,Systemic,2010.0,Alive
s12276,39F4DFB4-A8AC-420C-A6C3-BEC2D4C3E67F,UNCID_1323846.35b40466-674d-4909-aec0-0067f8f6f00c.sorted_genome_alignments.bam,32,35B40466-674D-4909-AEC0-0067F8F6F00C,3a7c35e0-9ed1-4098-8585-52f5991b2534,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B39D863A-D536-4364-9266-3CA2A9CB5754,Alive,University of Miami,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.74,14.97,RNA,5CC41177-5AB3-4EE7-BDB6-64E9A336A428,Primary Tumor Field,Systemic,2008.0,Alive
s12317,BAB63940-257D-4AF2-A6AD-2F63A84153AB,UNCID_1729798.0fbc9c35-cfb7-40dc-8b00-8322eb00ffc9.sorted_genome_alignments.bam,36,0FBC9C35-CFB7-40DC-8B00-8322EB00FFC9,e7cf1cca-384e-4a00-bb30-bed154ec15c0,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A8250761-DA38-4337-A276-056347C96ED2,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,1.87,22.64,RNA,,,,2012.0,Alive
s12273,8B0AB6A3-D3A2-4B37-83AE-F81AE4B01845,UNCID_1282414.4af17296-dc40-45f6-8bef-0bb5af55406f.sorted_genome_alignments.bam,38,4AF17296-DC40-45F6-8BEF-0BB5AF55406F,524a39ee-8fa3-418e-98a2-a6a90e9c8064,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F4906B86-3971-4ED3-AC3C-69635311FB45,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.73,61.04,RNA,,,,2010.0,Alive
s12335,A79F0C63-CEAD-44F8-BFE9-ABA2481BDC0D,UNCID_2233867.4bcf4c7b-dd71-45dd-9bb3-21a65b4d65ac.sorted_genome_alignments.bam,21,4BCF4C7B-DD71-45DD-9BB3-21A65B4D65AC,c047e741-2b29-45df-a577-351bddc50eb8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,90C331CC-2074-4F10-8DDB-DAEEDDE8BCBF,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.82,21.0,RNA,86F15143-C6BB-4318-BC58-A8A05BB9781A,Primary Tumor Field,Systemic,2009.0,Alive
s12261,FAAB0498-0FE1-4FAD-A43F-2D3064F877DF,UNCID_1212756.e46fd0f4-896f-4a4f-ac4d-b03303e464cb.sorted_genome_alignments.bam,35,E46FD0F4-896F-4A4F-AC4D-B03303E464CB,c30eb9bd-d705-4464-9014-e0aa7cda53c7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4714A896-709E-4A97-B15A-5B9FC145F377,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.87,67.87,RNA,3375BED0-D955-4B95-983C-247793876C3B,Not available,Systemic,2009.0,Alive
s12315,71ECD08A-4DCB-4B65-8CB2-B2970347AF57,UNCID_1661001.3618662D-67B4-4796-9869-3EC651E0AEC9.sorted_genome_alignments.bam,40,3618662D-67B4-4796-9869-3EC651E0AEC9,34b8d361-9c95-4f28-8e45-669defc5c3a7,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,8CCE6685-0688-4923-97AF-AEF08B17CB58,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.87,27.34,RNA,837C7B42-753C-4C53-9FF1-5FCE679E0426,Primary Tumor Field,Systemic,2011.0,Alive
s12333,9F6ACA6D-A8F6-4FA7-ACA2-3E316F483933,UNCID_1926300.aa9d8e32-4e9d-409f-81b0-9c6e2b6af130.sorted_genome_alignments.bam,59,AA9D8E32-4E9D-409F-81B0-9C6E2B6AF130,dd305533-e48c-4fed-9283-5082703c23ff,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,DC208AA4-5D47-4553-B55D-F5C307C24F3D,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,38.27,RNA,001B80D2-5D6D-4A93-81CC-42AFA1418D39,Primary Tumor Field,Systemic,2012.0,Alive
s12284,544D9A63-DBF7-4874-92A7-F98EA35A7212,UNCID_1375515.ce84d560-9f99-4afe-9e54-d9b1f53c591e.sorted_genome_alignments.bam,54,CE84D560-9F99-4AFE-9E54-D9B1F53C591E,d60f6620-575d-47fe-83e8-80a6ad838bed,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,56110C79-55E6-4181-BDD6-C40F29E185C1,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.77,37.98,RNA,,,,2010.0,Alive
s12237,FB73296B-B8EF-4FF9-A954-FAB7D29AB101,TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.bam,49,B3EDF2BC-5E8F-435A-ADA1-F292722EDD9C,2501ee46-8d38-448b-8765-e9c9706cbbe8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,C92FC4E3-7A96-4000-A969-AA894CA58A33,Alive,University of Pittsburgh,Harvard Medical School,United States,Other  specify,T1b,N0,Stage I,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.93,110.16,DNA,6C065D3A-DB37-46BE-9030-694D189B37B8,Not available,Systemic,2010.0,Alive
s12329,8B8DEA0F-1E8F-4F46-9C80-FAB3559434DA,UNCID_1911103.ef3079e2-6eeb-4b6d-b412-1d57219be39c.sorted_genome_alignments.bam,64,EF3079E2-6EEB-4B6D-B412-1D57219BE39C,646d1585-2d12-483c-8425-77d5451b2869,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,1BF49E38-FAFD-40F2-897C-32AFA62EC561,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,35.49,RNA,,,,2011.0,Alive
s12262,DEA16B94-72D8-42B3-B887-F0F0911F6B87,UNCID_1213133.7bf6ccc1-5c04-4ae6-9f92-af14171cdf89.sorted_genome_alignments.bam,42,7BF6CCC1-5C04-4AE6-9F92-AF14171CDF89,1e63d4b3-1b49-4bb9-b64f-001273aae120,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,48171F82-064D-467A-9E04-7B850C5E99C2,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.86,29.32,RNA,,,,2011.0,Alive
s12216,E2561BE5-1C52-4774-A3D5-2A7800D87C6A,G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.bam,31,90883300-D4B6-45D7-AF9A-4E4CE4104500,afb00cd4-e5da-4251-86fb-532c3f65324c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,D3CC158D-413D-49E6-8D23-3ED89FDEA94A,Alive,Johns Hopkins,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,31.42,DNA,932676BE-AE3A-4CBE-9CFC-F1AC1F32EC21,Primary Tumor Field,Systemic,2008.0,Alive
s12263,3031F9FF-65A8-4A77-8293-ED408E0E47C6,UNCID_1220428.0148a96e-972e-4762-9a75-ee2791dc3d95.sorted_genome_alignments.bam,61,0148A96E-972E-4762-9A75-EE2791DC3D95,78d14f86-896a-4f98-9274-b2e8e387add9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D206D300-E0CE-4A40-AF1F-45A685346A6E,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T4a,N1,Stage IVA,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.8,62.28,RNA,DE1ED45F-D7CE-428F-BA0A-27EADF62FD16,Primary Tumor Field,Systemic,2007.0,Alive
s12292,807F9C1E-6B14-427C-970F-7A9CF4108BEA,UNCID_1455462.889cd706-f713-482b-9c49-fe531d5dd4e1.sorted_genome_alignments.bam,31,889CD706-F713-482B-9C49-FE531D5DD4E1,b107b012-335a-4282-a7aa-273b740831f1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,12693F53-FA09-494C-82EB-BF735EA84E98,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.8,26.68,RNA,05726727-A783-4781-A06E-7C5F6A732039,Regional site,Systemic,2004.0,Alive
s12290,E746781F-7834-41D4-AAA8-AAF06D7081F6,UNCID_1455706.be67f169-2a2c-4938-a141-a839b295b87f.sorted_genome_alignments.bam,67,BE67F169-2A2C-4938-A141-A839B295B87F,6a87bbc4-6161-4fc6-b4df-518d7831f4d2,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7C6EBB44-EB6F-4C33-A195-574D00D439B3,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.81,60.48,RNA,,,,2010.0,Alive
s12295,D7C08408-86D7-4CAB-B0AE-08025F0E9808,UNCID_1575798.C2BCC24E-DAE0-4577-9C62-C0DA60C5CC2C.sorted_genome_alignments.bam,55,C2BCC24E-DAE0-4577-9C62-C0DA60C5CC2C,dd1058c5-da32-4f60-9275-5e1a8049d9c5,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,EAA8031B-7895-475C-9851-D3ABB116DBDE,Alive,University of Miami,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1b,N0,Stage I,Mar-44,C73.9,C73,NO,,Not available,30.0,0.16,2.12,61.33,RNA,,,,2012.0,Alive
s12325,E1F55ED0-8ED9-47EC-9BF8-F37090D2629D,UNCID_1901224.b0c0055f-55c8-447a-9590-fd1ae77c7128.sorted_genome_alignments.bam,55,B0C0055F-55C8-447A-9590-FD1AE77C7128,3d952b80-501e-41c6-a3af-0bd6014b81e4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2C11DDB3-F4A6-4EC3-8368-6E89F497C80C,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.81,20.23,RNA,,,,2009.0,Alive
s12305,F92AE99D-C775-4361-BF24-32E04F865558,UNCID_1654634.631E7034-363E-4334-B448-217FB137009E.sorted_genome_alignments.bam,51,631E7034-363E-4334-B448-217FB137009E,744df1f5-a7d5-4675-92ce-6e4713f0d541,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,78CFADF9-CA3A-4909-B629-5654466CFA1B,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.83,44.24,RNA,5321DF26-30AE-491E-AEEF-6D679BAFDC8A,Primary Tumor Field,Systemic,2012.0,Alive
s12297,28EBAABD-CB52-4541-AD7D-D6358F4AF7B5,UNCID_1649367.2D965E21-BFD1-4513-A87C-83F7E570D07F.sorted_genome_alignments.bam,45,2D965E21-BFD1-4513-A87C-83F7E570D07F,23f47401-1bab-4395-970f-4e388aab2542,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,6BD8B6E3-7205-4507-8A32-703E3D127248,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,9.15,RNA,,,,2012.0,Alive
s12287,1FBCA7B7-848F-4F5B-B195-1A008BE695C8,UNCID_1457639.f4649515-f2fa-4ed4-ad69-d9f0a807093b.sorted_genome_alignments.bam,37,F4649515-F2FA-4ED4-AD69-D9F0A807093B,24a968aa-8169-44cb-a8ac-72d7efa1fa7b,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,207970EE-0DC2-459E-B17E-DF1B4A2416DB,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.76,24.87,RNA,BC6311CD-E6B9-4DF1-88CC-7F31C2B3F248,Regional site,Systemic,2007.0,Alive
s12275,93A426D8-FC61-420A-9D7D-42DF188C2188,UNCID_1321946.e2bd971b-d929-4fc0-aec2-1ff9d9827a25.sorted_genome_alignments.bam,19,E2BD971B-D929-4FC0-AEC2-1FF9D9827A25,39d45532-d2f4-49f1-b1c6-880ff0ebe0ed,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3FC6F39F-AF2F-4757-9E38-E08B0DA9D01B,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.77,26.4,RNA,00CB2811-B09C-44DB-ABFB-7CDD9CE04961,Not available,Systemic,2008.0,Alive
s12294,F33102EA-A563-4E62-A3CE-B9CD652D2283,UNCID_1560088.8900F950-C646-4CEC-9D10-F0C2D75FE7CA.sorted_genome_alignments.bam,71,8900F950-C646-4CEC-9D10-F0C2D75FE7CA,c2291b36-7b7f-4c07-a164-6600d9e7929f,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,6C0BF3FD-6F68-4D76-B31B-3375A6741379,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.76,13.7,RNA,,,,2011.0,Alive
s12304,AD669493-C8D8-4E94-96AF-73D9105B6C39,UNCID_1654399.B174413D-E07A-4A7A-8CFE-43833A4890D9.sorted_genome_alignments.bam,34,B174413D-E07A-4A7A-8CFE-43833A4890D9,9dcaa676-10ca-48cb-b245-7cc4bd1fe9bb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,CF4F7C5C-FBB3-4BAD-BC26-01519CC00540,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.8,19.31,RNA,D33D58B7-65BC-459E-A706-70AABD449F63,Primary Tumor Field,Systemic,2008.0,Alive
s12306,F4357F5A-D791-43F4-B0D4-8053278EEAEE,UNCID_1656297.37F1CC69-2CF8-46AE-A052-EA82ACAB9BEF.sorted_genome_alignments.bam,63,37F1CC69-2CF8-46AE-A052-EA82ACAB9BEF,94443df0-7f16-4178-9e66-bee82f6ca33a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F99E9FA1-2E21-4438-94DF-0D03CDEDD443,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.8,61.3,RNA,2E026F72-C8C8-4E30-8023-58CFF25CCE89,Primary Tumor Field,Systemic,2011.0,Alive
s12291,737CFFF7-1677-4ECA-BE21-5A095769AB61,UNCID_1455409.aa0338ae-c4e7-4f20-9be7-347aa5a2d8f2.sorted_genome_alignments.bam,85,AA0338AE-C4E7-4F20-9BE7-347AA5A2D8F2,e8f56d0f-eee4-4def-a43a-dec91f4382a1,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,E13C3F11-913D-4371-9A7D-5E4DF15FB42A,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.76,43.07,RNA,,,,2011.0,Alive
s12251,B6CF1366-A645-4BD9-AC5F-0E8C5D18A4CA,TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted.bam,55,67082C81-DE62-42A4-82B7-CB6BE2C961D3,e92bdb0d-969a-4d98-ada8-5dfec68119b5,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,C1DAF740-06E2-4509-86BE-5BFCC52B508A,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.88,69.84,DNA,,,,2009.0,Alive
s12283,04E1981E-C45C-4B3B-94D1-5A692C88D68A,UNCID_1360943.0cb1e91c-9b3b-4b5b-ba85-2c0e43ca4595.sorted_genome_alignments.bam,28,0CB1E91C-9B3B-4B5B-BA85-2C0E43CA4595,46239f1e-bd85-4d7a-a313-762666599a6d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2E84EA43-6B1B-4A6B-A020-DDC40305D18C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.86,19.19,RNA,,,,2008.0,Alive
s12247,0430ED44-5B5D-4B22-B78A-9B9ECD259736,TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted.bam,55,FEA6D565-EDBC-4FB7-ADB8-090914F4259E,2b84cfbc-7cf6-4cb1-a1e3-ba85dafb89f4,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,319E3498-D5FB-4142-A09F-ABA779DBC094,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,,45.93,DNA,,,,2011.0,Alive
s12301,F3EB0A2F-E38F-4D33-A36D-575C946DA37F,UNCID_1650070.C4E3BE04-2A2C-4ABE-912E-C3D9602E29C4.sorted_genome_alignments.bam,28,C4E3BE04-2A2C-4ABE-912E-C3D9602E29C4,23ad7900-4e99-4abf-82ff-71edeaa8a51c,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2803F075-84C3-4B62-8761-4DE035A9B0D5,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.83,39.12,RNA,BC0A9846-A254-486B-B5F1-2CFCB7D773D6,Primary Tumor Field,Systemic,2000.0,Alive
s12225,477ABD20-1834-4AF2-8091-7566A4D68578,G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.bam,63,1BBB522D-E224-4B3F-9E10-3A47D06B2B05,cfdd2155-57a9-499c-92e1-fb82b577b050,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,56E31332-09FB-4305-8EE8-ADC568B393F3,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,,8.35,DNA,,,,2011.0,Alive
s12286,68C544B1-C978-4BAB-876E-7D9B0FA91EA8,UNCID_1376680.0bbe2604-becb-40aa-8d25-6414467a2bd6.sorted_genome_alignments.bam,33,0BBE2604-BECB-40AA-8D25-6414467A2BD6,0cafefef-911b-46e8-9e6c-19a0e7d555aa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0AE7E75A-9FD4-48FF-A0DE-BD2032543F3E,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.86,81.09,RNA,97304277-6943-4F55-92BC-273306096712,Primary Tumor Field,Systemic,2005.0,Alive
s12235,9218178E-761C-40AC-B3CA-044BF37F8686,TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.bam,54,6D770754-E14D-4E47-AE33-BE0FC9B40CE9,b55375c3-9ef2-4d2f-9c29-224e746931c4,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,582C3030-1F23-4535-9C8B-6B594E656AF4,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage III,Mar-90,C73.9,C73,NO,,Not available,20.0,0.17,2.02,32.81,DNA,,,,2010.0,Alive
s12271,ADD5BC25-7470-4D11-A746-42BCEB4214B6,UNCID_1252638.5edc8af3-4e05-4ef5-933c-6b2c48cc7469.sorted_genome_alignments.bam,57,5EDC8AF3-4E05-4EF5-933C-6B2C48CC7469,86f9eca0-d1ea-4375-a6bc-055e44b3198a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,AA8578FE-EDB2-4137-B363-FEB2C27D475A,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.14,1.81,75.71,RNA,,,,2010.0,Alive
s12240,CD7D52CC-20AC-4FA7-A821-231D15F926FC,TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted.bam,62,EF88FE61-36C4-43CF-BD57-D15F7E264DF0,cb29e795-7618-4882-a7e0-69d39787b80c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D0A669AF-1A0A-451D-9D6F-9EEE15F7264C,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.98,73.27,DNA,,,,2010.0,Alive
s12272,B17594CA-7803-4C4C-8176-74AC3BE7D785,UNCID_1270871.f2675b47-1187-4dad-a53d-60179daa7c88.sorted_genome_alignments.bam,40,F2675B47-1187-4DAD-A53D-60179DAA7C88,7244b7db-8282-43aa-a4b4-ad6af972cf9b,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,C1CDBD62-71BA-4E46-9BD4-0033A75F90FE,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N1a,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.82,15.8,RNA,,,,2011.0,Alive
s12319,2F3E1F2D-C039-4107-B46B-722A91EA1C97,UNCID_1815639.00759cb3-e0d6-47eb-948f-5ed3fc9f944f.sorted_genome_alignments.bam,50,00759CB3-E0D6-47EB-948F-5ED3FC9F944F,a552e8ab-9dec-44ea-9f02-7ca704ee8467,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,A6AA14E9-82FD-4F40-81B8-F55D16EA9065,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.79,47.32,RNA,,,,2012.0,Alive
s12253,9C39283E-3646-4154-8265-D68A2F7DE106,TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted.bam,39,2CC2002C-4F0A-47A6-AA0A-35FE1B545A7A,22eb9f00-6869-4d8f-b657-dfd64f81e9e9,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,7045F3E1-5239-4159-9B38-31E4168853D0,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,2.05,29.55,DNA,,,,2010.0,Alive
s12322,AF2BF26B-B319-49AB-8B1B-29E891798BD5,UNCID_1881140.4c4e1027-4ff7-4fde-98a7-20fd46b5b44e.sorted_genome_alignments.bam,58,4C4E1027-4FF7-4FDE-98A7-20FD46B5B44E,b555b7a4-6324-4d3e-9eed-b140af6c768a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4409E507-19D4-4EED-B54A-FF8DDD7F71D1,Alive,National Institutes of Health,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.15,1.8,39.43,RNA,5C39E7F0-1AD8-40BC-B5B7-F3EA792F8432,Primary Tumor Field,Systemic,2012.0,Alive
s12269,7297B654-1523-4EF7-AB93-4C92162C91EC,UNCID_1266526.05d7b56b-e588-42f8-8bd4-4b966e7258d1.sorted_genome_alignments.bam,28,05D7B56B-E588-42F8-8BD4-4B966E7258D1,75a93f0e-cd41-43c6-a303-ff37e31395e9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,1807CEEE-28E1-4E8D-A1C4-6F6AD60EE310,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.87,21.98,RNA,,,,2010.0,Alive
s12259,24A690E4-62F0-4E09-BBB1-EC78DAFCF3CD,TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted.bam,29,5E15CB1B-B0D3-4FB9-9B30-3AEBE4DFC96B,bf193c4f-fbac-41bc-b1af-19b6ce856f0f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,EAAE1A05-7D7E-406A-A02B-282A8B66F95C,Alive,Christiana Healthcare,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,,58.31,DNA,,,,2011.0,Alive
s12307,1736BFEB-72A8-43BF-B600-E16C17B9F476,UNCID_1655237.8285C4A6-98CC-4277-BBB9-45D38BD3951C.sorted_genome_alignments.bam,55,8285C4A6-98CC-4277-BBB9-45D38BD3951C,3fc062bc-1b0b-4c8f-b79c-770bcaa1ec6e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5710C3E2-2FE5-494C-93C4-EB13E34E4B0A,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.88,48.73,RNA,D7D15298-AF9C-4A9D-8B62-BF3E21944D8F,Primary Tumor Field,Systemic,2012.0,Alive
s12277,D22139D8-182B-4E85-99D3-B4CB24B9C297,UNCID_1323261.4c4f8d6d-77a1-42fd-8671-d2651136d5f6.sorted_genome_alignments.bam,58,4C4F8D6D-77A1-42FD-8671-D2651136D5F6,d2a8035c-a8d3-4038-8a9d-854f2208bc45,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6AC560E0-1D63-4F6B-B0A0-9C81B8150596,Alive,University of Miami,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.71,13.86,RNA,,,,2008.0,Alive
s12320,42993CD5-9764-4028-947C-915CC44DBCB9,UNCID_1817176.64613ae3-9307-49ef-bc90-47a2b08b3d90.sorted_genome_alignments.bam,39,64613AE3-9307-49EF-BC90-47A2B08B3D90,6b85d76d-6098-47ea-9823-586238526cf1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E98DC4DC-30D3-4240-84CC-1118D60D161D,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1a,N1a,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,67.38,RNA,E761321E-06F6-41F8-BF20-4CC2F8E901D4,Primary Tumor Field,Systemic,2012.0,Alive
s12289,9E2BBD41-9609-4272-984C-631F06B89FB4,UNCID_1455107.564410d7-c7e5-4522-b1bf-115772ad7990.sorted_genome_alignments.bam,35,564410D7-C7E5-4522-B1BF-115772AD7990,f9deeda6-8f81-441a-9c47-24c2eefd049a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7A6E571F-7673-4F5E-BBB0-826CD5116A29,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.85,33.42,RNA,,,,2002.0,Alive
s12302,C2EC817B-1C75-4D88-91A9-30FFAACEEDF9,UNCID_1652767.83D04848-BB60-4F0B-8AB4-BAD21D237DED.sorted_genome_alignments.bam,57,83D04848-BB60-4F0B-8AB4-BAD21D237DED,6592a7db-cbc7-4afd-9fdb-5cc16c16eeca,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,7C14E252-52B9-4944-858E-479F29F156B7,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.78,48.61,RNA,,,,2010.0,Alive
s12328,D2E9EDB8-C878-45C9-9708-AD56A47D39DF,UNCID_1901433.2af5af75-e9c3-4297-ad9c-4f65fdaa0c00.sorted_genome_alignments.bam,15,2AF5AF75-E9C3-4297-AD9C-4F65FDAA0C00,256976a4-41ab-445e-ae26-c594ba1fa324,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,800EA1A9-1802-4647-B0AE-62E7F2D8E1FF,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.89,31.78,RNA,E613DFE0-715D-46E3-A5A7-5E5486B23FD4,Primary Tumor Field,Systemic,2012.0,Alive
s12245,52D6A725-E64A-4E5B-88CB-C4845DC97057,TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted.bam,30,7BC99883-45C3-4ADF-8761-40B4836552F2,b7a01148-5bab-4268-986a-a9cf7bca967f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,C25AED9B-A1B7-48A9-8587-8D218F6A9562,Alive,Medical College of Georgia,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.78,80.19,DNA,2DF6C146-0A61-4DE8-9795-1152A9CE0E14,Primary Tumor Field,RADIOISOTOPES,2010.0,Alive
s12217,C90DA8DC-3705-4381-A713-D4A404DD09CE,G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.bam,70,79169C46-7049-4576-9885-63973DB76AB9,e4b08e66-0772-4956-8670-e5c6553eecbe,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.09,1.96,77.76,DNA,,,,2010.0,Alive
s12293,621BD798-46E6-4051-B560-662A3158A194,UNCID_1499502.cc9504fb-b4a6-41af-962f-f3d69653d101.sorted_genome_alignments.bam,30,CC9504FB-B4A6-41AF-962F-F3D69653D101,729fc937-192a-4eb7-b357-b8f0d2da1f08,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,34F73B3B-76B7-4D68-9812-5376810A8F31,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.82,19.08,RNA,,,,2011.0,Alive
s12318,31FA6D04-F312-4C27-BFA1-C311B7D61FAB,UNCID_1815638.f0e775db-aafa-45e0-8428-82d7456b4185.sorted_genome_alignments.bam,62,F0E775DB-AAFA-45E0-8428-82D7456B4185,5c118e15-1e48-42a6-8d29-179e6e71a26c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8CF3F64A-8F09-43FE-B908-8EE1B6243019,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,38.79,RNA,296E8EF9-31DE-440C-BE7A-5A64376371D7,Primary Tumor Field,Systemic,2012.0,Alive
s12232,A470B305-96A5-43A8-B1F4-DB15C7B0B4D5,TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.bam,55,0E4A0528-883D-47A5-B399-57B1B15EC412,6675c581-297d-44cd-b80f-ae7e53d48228,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,1F945AFF-7BC2-40F5-87DB-92313E541243,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.91,26.88,DNA,,,,2010.0,Alive
s12280,3F1D5B5A-17F1-4D28-891F-5EAB4C455615,UNCID_1360480.995d2980-f6c2-4336-8f7f-4e2e4e387cf7.sorted_genome_alignments.bam,61,995D2980-F6C2-4336-8F7F-4E2E4E387CF7,b0cb6ed7-3d9f-4d5e-8df5-edcc921c43b4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,08D3CB3B-9A80-4034-B06D-B37DD38C8B9B,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Not available,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.85,31.59,RNA,,,,2011.0,Alive
s12457,DE327E79-6472-4F4F-8C08-658100601D8D,UNCID_1658952.3DD39419-C444-4D9A-B238-D3A935CDDA1E.sorted_genome_alignments.bam,41,3DD39419-C444-4D9A-B238-D3A935CDDA1E,0314b145-2f3a-4a90-a580-375b5f0a63a4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1A9E811D-1C60-409C-A7D2-1D58AFA473E9,Alive,Christiana Healthcare,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.84,60.64,RNA,88D9F01C-DF4B-4DED-8BAB-76EB446CA357,Not available,Systemic,2011.0,Alive
s12367,DF7BAFB3-C992-479D-BE29-DAE220124025,TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted.bam,20,781162AA-AAFA-4C44-B9AF-727917E8C9F4,da201150-748e-4b74-bb35-10c995e26079,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,A8307181-67CE-4A79-8D23-76CEEE1D2761,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,2.0,61.38,DNA,,,,2010.0,Alive
s12401,9252797E-E6B7-4656-8612-1520DA8EE7AD,UNCID_1233371.c49698bf-315a-4809-b88b-452765b455c6.sorted_genome_alignments.bam,47,C49698BF-315A-4809-B88B-452765B455C6,e632b443-cf6a-4592-96c6-c3493ec86fea,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,A5DE766B-9CCC-4B56-8D9B-25704C1C91D0,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.79,42.37,RNA,,,,2007.0,Alive
s12381,76D6FE1C-FB49-412C-BF6F-43229F7B7DF6,TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted.bam,53,CD27AF7E-F458-49BA-8C82-D18BDE252DB2,8a3659a8-2a85-4bab-8bf3-55795922474c,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,AD5054BB-96D0-47CC-BB8C-F36E58784A31,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.98,41.17,DNA,,,,2007.0,Alive
s12465,964259C2-15DF-432F-8A62-40BF3FE925DE,UNCID_1660221.0F89CE40-61EA-430F-87D1-BE87D9AC924F.sorted_genome_alignments.bam,21,0F89CE40-61EA-430F-87D1-BE87D9AC924F,58ff4366-20a3-40a2-a87a-551e17cdb5d3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E67E2BBE-8C3F-41B1-BE3C-C89555A10AEE,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,48.22,RNA,90610127-78CA-4552-992B-9F378FEE2A78,Primary Tumor Field,Systemic,2011.0,Alive
s12389,5AEAADF5-F228-4383-97CE-9048120F8B41,TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted.bam,30,001C6478-B20D-40D8-AF62-C45C64269129,b1d71782-2443-43f3-bd0e-8b7220515cb6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,12FC3F30-08FB-47C6-92F1-009D961C1E94,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.05,73.25,DNA,AFB0715B-B724-4F23-BE14-48EEF798FE5A,Primary Tumor Field,RADIOISOTOPES,2006.0,Alive
s12458,48E6C139-A2AC-4764-B500-D4473617E785,UNCID_1659187.29092F9C-DFAC-467E-8432-C615B1DA79CE.sorted_genome_alignments.bam,34,29092F9C-DFAC-467E-8432-C615B1DA79CE,90507baa-b716-4bcf-a18e-9d8ae97d809a,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,61367375-8317-4CAE-86CF-2FD65AB8ABC8,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.14,53.45,RNA,1BD81C7D-3066-4A7B-A688-974E0A6B8D59,Primary Tumor Field,Systemic,2003.0,Alive
s12421,EBF34E2D-1CBB-44E2-B30C-C884C6253A00,UNCID_1359580.cc1e4628-b327-4013-a3eb-af114c3faa67.sorted_genome_alignments.bam,70,CC1E4628-B327-4013-A3EB-AF114C3FAA67,745642a0-ddba-495b-bafc-da085552758a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,472D7E5C-8DE9-435D-87A4-7882961AD7F4,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,34.78,RNA,48ABA4C1-0BD8-4CEA-AEB2-3C75D5ABAC24,Regional site,Systemic,2000.0,Alive
s12368,84CF379B-0F45-44D0-B5E3-00A439BAB300,TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted.bam,50,7B0104C8-1264-4580-94D1-C7C39D79C6E6,3e787a0e-b5d2-401e-b1e5-077376090b3a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,27B0FF79-4213-4B57-B6E0-A393B8983D20,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.95,78.88,DNA,0CEEFC3F-1F30-4015-938A-B3B17995CEAC,Primary Tumor Field,Systemic,2010.0,Alive
s12362,C2D55126-05AA-44EF-97C3-AE2AC400C1B9,TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted.bam,28,CE991BB3-A63D-40C1-BFAF-3C4498D2C6EE,75a93f0e-cd41-43c6-a303-ff37e31395e9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,1807CEEE-28E1-4E8D-A1C4-6F6AD60EE310,Alive,ILSbio,Harvard Medical School,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.93,52.72,DNA,,,,2010.0,Alive
s12476,C9CCF65A-789C-4F87-A353-464854753777,UNCID_1815928.46fef818-e07a-46b4-9cd4-de48ab9497ec.sorted_genome_alignments.bam,41,46FEF818-E07A-46B4-9CD4-DE48AB9497EC,2c9e8686-9757-4e05-8d0e-efeaa3045d66,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,ABCE8A03-68A7-45BA-BFAC-EEFE95702C56,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.02,44.82,RNA,,,,2011.0,Alive
s12489,13B92603-646E-45F2-85E5-9A3B0E8BE0B9,UNCID_1918328.d5887688-b311-4ddc-84d4-538750849401.sorted_genome_alignments.bam,75,D5887688-B311-4DDC-84D4-538750849401,4fc8e011-4433-4537-b03f-457a3a70240f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,BB98FF62-4CD8-46D6-9A85-8439265BE40B,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage IV,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.89,33.48,RNA,B917243E-F5D9-44B1-A5B3-DF1BE9879441,Regional site,Systemic,2010.0,Alive
s12417,4B086C56-325C-4F73-92E2-7D2FC3043A5D,UNCID_1323955.8bbcaa0d-d0e4-433c-99be-65a920400ab4.sorted_genome_alignments.bam,37,8BBCAA0D-D0E4-433C-99BE-65A920400AB4,ca65a38e-8b49-4b50-908a-478b95b95c02,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A6E7437B-6707-4FDA-BBC0-3F6EFBC04FC2,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.73,27.23,RNA,C804F78A-B4C6-47E2-AF4E-0AE6DF52C3F3,Regional site,Systemic,2009.0,Alive
s12378,0E5BB14F-1671-4B8A-9A38-E1D389ECD440,TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted.bam,56,EA178797-16FB-41AB-B71F-3B397153CE63,4d9de9a1-7df1-412e-9f16-15dd51b4c5f5,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,225B76AD-DB11-457A-9A77-E1F333895E5C,Alive,Asterand,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.94,17.09,DNA,,,,2011.0,Alive
s12383,C3515173-4E8F-4198-A9DE-0BF2232C3FBD,TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted.bam,46,AF35D79C-4F32-4B6E-8FDE-BDA9D715A542,3a211d5a-085f-4902-86b6-50e4eb36b897,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,362F0CC2-B884-404B-8DF1-2BFC2A75E9C3,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,,34.81,DNA,82A70C8B-9B8D-427C-8ADD-26B23D43EE54,Primary Tumor Field,Systemic,2011.0,Alive
s12395,3E4A866D-5571-4296-AE88-E9BE1FDDF024,UNCID_1207544.90f81e56-e1db-4c5d-9a59-02b765362cd3.sorted_genome_alignments.bam,33,90F81E56-E1DB-4C5D-9A59-02B765362CD3,8023d4c9-b56d-417a-9a52-d45b59c756ed,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0C601625-ED21-47E5-BC3D-A0057D6A148F,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,187.5,34.94,RNA,4889493C-3F2E-49B8-84CE-65998C5B19C8,Primary Tumor Field,Systemic,2010.0,Alive
s12477,6CFED0D3-49A7-495E-AC83-29B56ACAE624,UNCID_1880847.09c1d9fb-fb0f-4cb7-8a02-00e98e478eec.sorted_genome_alignments.bam,59,09C1D9FB-FB0F-4CB7-8A02-00E98E478EEC,fd3315da-c870-4ad0-9d2a-50b1647d3e46,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E094F387-B719-4DE7-B667-30E9F382024B,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,60.37,RNA,7E28865A-137B-475C-90E6-C1344EDE7515,Primary Tumor Field,Systemic,2012.0,Alive
s12358,C8C8646F-54E4-4440-BF91-D2CD90083C44,TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted.bam,69,57FD6BDA-C7B4-4B74-B21A-B7FF5D1C87EE,fd036ec5-3ffb-40b1-8002-943be0e2532e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,E058A8E1-ED00-48A5-A46B-77538D7B73F1,Alive,University of Pittsburgh,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,,45.84,DNA,,,,2011.0,Alive
s12412,7966A691-B07D-4721-8A2E-74D86758775C,UNCID_1279660.22cf19a1-e3a8-4c26-aa7f-76690c0c56f3.sorted_genome_alignments.bam,62,22CF19A1-E3A8-4C26-AA7F-76690C0C56F3,2acb6f29-06d3-48d4-8553-a9f5839afe22,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,B1D8AA5F-C397-47E5-991C-D3E110524546,Alive,University Health Network,University of North Carolina,Canada,Other  specify,T3,N0,Stage III,Mar-10,C73.9,C73,NO,,Not available,30.0,0.17,1.97,44.46,RNA,,,,2010.0,Alive
s12434,ECF15A1C-6513-4C12-9B31-92F095B3ECAD,UNCID_1467692.3169d499-4b3f-4178-ad0e-865cb6a7864d.sorted_genome_alignments.bam,31,3169D499-4B3F-4178-AD0E-865CB6A7864D,105210cc-6fe3-4615-a582-475553e14272,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,840861BF-7F0D-4D08-8E44-770BD71521E9,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,10.0,0.18,1.79,16.02,RNA,,,,2011.0,Alive
s12475,2C7045FA-F7F7-4697-B6B6-2B4F2613ADFF,UNCID_1816105.71dbf432-2bbf-4e76-8625-f863b08b78ce.sorted_genome_alignments.bam,34,71DBF432-2BBF-4E76-8625-F863B08B78CE,80da6e75-b7ad-47a6-9923-1e21a519a968,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,222EAF1F-A7CB-4FB7-B78F-B1C58C4E15D0,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.02,52.3,RNA,,,,2012.0,Alive
s12430,190F8854-4495-4AB1-8572-398AA4A5F58A,UNCID_1455528.3b64c3a6-42e7-434d-9ace-221f68e831f2.sorted_genome_alignments.bam,39,3B64C3A6-42E7-434D-9ACE-221F68E831F2,d8d54c81-7ef5-4b0f-b35b-28fbf8c5198e,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,1316CFD3-0DF0-4D46-8234-C736608AA9F9,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N1a,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.76,51.23,RNA,215FCDF4-4443-44E9-9472-1A8D97FDC91B,Primary Tumor Field,Systemic,2011.0,Alive
s12442,85C2A0B4-15AB-4534-8376-D266CAAED8FB,UNCID_1560238.1F51AFCD-B6B1-490B-A8FF-F538094605F5.sorted_genome_alignments.bam,66,1F51AFCD-B6B1-490B-A8FF-F538094605F5,f82f9ae8-e106-4c61-941c-3614d51b0f41,1597.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5019256B-B0E9-4097-AB4E-88546BD61CDF,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.8,30.59,RNA,2F1CD8DB-BBE9-4465-849B-9D0364A0429C,Primary Tumor Field,External,1998.0,Dead
s12444,B74B9C55-8F95-450E-85D0-09DB56FEA359,UNCID_1565913.39DDCDD4-520A-4039-9838-4C0456CC5223.sorted_genome_alignments.bam,34,39DDCDD4-520A-4039-9838-4C0456CC5223,cd1656d8-55a5-4248-b81d-fed9d5992cbe,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,047A268A-9597-4FA5-A8E6-B0149AFF005E,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.79,19.6,RNA,F197EB5E-12E5-4E19-AB6D-7D46F53FE440,Primary Tumor Field,Systemic,2011.0,Alive
s12407,DEF65F42-5B02-453A-A9D4-FD4B70F63D80,UNCID_1254602.d9296b9a-bdca-49b4-b458-40e0305822b2.sorted_genome_alignments.bam,53,D9296B9A-BDCA-49B4-B458-40E0305822B2,8a3659a8-2a85-4bab-8bf3-55795922474c,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,AD5054BB-96D0-47CC-BB8C-F36E58784A31,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.72,21.92,RNA,,,,2007.0,Alive
s12394,DD0E4C9A-944C-48C1-B5D8-F17B96985216,UNCID_1035689.000b3ce1-5bcf-4dd5-b7e4-e4f9367a939b.sorted_genome_alignments.bam,33,000B3CE1-5BCF-4DD5-B7E4-E4F9367A939B,331cae6e-2868-4c58-9302-709a9ff7d025,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6BF032C1-B7D5-4B1C-BF41-C9BFEAFA5E7A,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.79,20.23,RNA,,,,2010.0,Alive
s12347,6C8370C6-102F-4BDE-84CE-BF930800AC6A,G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam,64,2DFE70FD-2650-49C0-B6EB-67DF585D063B,55e03ffc-f006-4ec8-8e5d-a738ff091f8a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,1183BCB5-50A7-4CC0-A94C-732636B7EE7D,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,,24.95,DNA,391735A2-DC97-4581-B41C-B5C1328F0A5B,Primary Tumor Field,Systemic,2011.0,Alive
s12350,60E1B538-0F36-45EA-892A-A8B64734F42B,G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.bam,44,FC812906-D3B6-4210-A842-96F095280CBF,77bb90f0-e923-4e28-bb88-4d6b420e0b5c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,6CBA95AD-2702-4F50-8B1E-BECDAF014B83,Alive,University of North Carolina,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,,71.37,DNA,57736579-40D4-464A-8A55-C484C7E19271,Primary Tumor Field,Systemic,2011.0,Alive
s12388,F1EEB2EA-CC97-40B1-AC5B-FA027012FFF2,TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted.bam,26,D4A41A96-02D5-455E-BB12-7225EBEA15A5,e4c85bdd-7b7c-414f-9503-647d9b825915,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,8765B072-83E1-40B2-B1C9-15F38D799FC3,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,2.14,101.34,DNA,20037B6C-AC77-436D-9D5D-DCE67644F27B,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12369,6D7B5F3B-5FBA-469E-A651-31A4569D7877,TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.bam,28,8C708D3B-B312-4C27-898B-A0FE87110474,ba9dec81-ffc0-453a-9621-94beba45fab1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,28913C64-8637-4537-AF8C-7315097A5AD1,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.14,1.93,24.89,DNA,,,,2010.0,Alive
s12414,CE991368-78B7-4442-82E8-5ACDAA223C66,UNCID_1321740.92c2186f-ee7b-4297-a876-bc96edc945b4.sorted_genome_alignments.bam,57,92C2186F-EE7B-4297-A876-BC96EDC945B4,40a9c1d3-6629-4e22-a783-12e0d48349d1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9261863A-5C8B-4593-8DC1-38017B26D2EB,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.71,16.79,RNA,EBAA3D2D-C466-4F5D-B458-00D68AA3C96A,Primary Tumor Field,Systemic,2007.0,Alive
s12406,581B6173-652D-4D75-9480-1A2FD09034EE,UNCID_1264355.9499982c-311d-40cd-8353-dd21c6b18d0d.sorted_genome_alignments.bam,42,9499982C-311D-40CD-8353-DD21C6B18D0D,3597af5e-65ff-40a7-95fc-dacc26cbca14,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B4215B1F-3918-43D6-8862-380C35F891EC,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1a,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.87,42.94,RNA,,,,2010.0,Alive
s12484,B587F4A4-E040-4548-9A98-85C81BCA6B9A,UNCID_1902210.a8d45785-d6e2-4c38-9625-ee36e2a1017a.sorted_genome_alignments.bam,49,A8D45785-D6E2-4C38-9625-EE36E2A1017A,f854ce67-c586-4424-a674-2dd67ad0ed7f,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,551D0A51-C755-43EF-ACF7-88B598F06C9B,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.87,49.97,RNA,02AB4A4D-F478-4DFB-AB3B-EE169B719A76,Primary Tumor Field,Systemic,2012.0,Alive
s12379,A03BE55F-C2FB-41D6-88AE-F1063ED587F6,TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted.bam,31,A9886789-6859-4FC9-812A-D9813FD1C20D,4e80f403-0e10-4725-854d-f023c12ee1e2,,Thyroid Carcinoma,Not available,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,C285C3AC-26D7-4481-BAAF-769F49AED55A,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.91,50.69,DNA,,,,2010.0,Alive
s12447,5DF389CD-2A9A-4D7D-97E5-492570D779FF,UNCID_1650162.0FC423CF-3426-4577-BF9D-80400217B500.sorted_genome_alignments.bam,34,0FC423CF-3426-4577-BF9D-80400217B500,e2475d48-628b-4095-b101-865d79a4b0ed,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0804B7AC-D1DE-4AD9-A618-F9228CD0FE3A,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.82,57.42,RNA,B909945B-64F2-4EAD-83D3-1BC9C7D09EC1,Regional site,Systemic,2008.0,Alive
s12344,5C7965A4-3E29-4C83-87E5-2E23F356287C,G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.bam,43,15ABB2A3-10A2-4E04-8EB9-6EADBD976AF0,785803bb-42a8-4afb-b7b4-58c114894408,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,F5EBEFBE-50FA-465A-A355-2C099941039D,Alive,Johns Hopkins,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N1b,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,20.0,0.09,,22.44,DNA,EBEC2900-84A5-4052-8A2E-E3A0C2CE3841,Primary Tumor Field,Systemic,2008.0,Alive
s12404,D75171FE-7E54-43BF-B967-9319CD2689A4,UNCID_1243827.d1883aba-565e-487f-a240-4dac9d5bc50e.sorted_genome_alignments.bam,52,D1883ABA-565E-487F-A240-4DAC9D5BC50E,ef306507-f426-499e-8a1f-3401a522fb6b,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,D5FA6434-5BB5-4114-8D95-3C252E479F64,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.79,48.42,RNA,CD57FD14-B5EC-4080-B611-B0E135BDB8A2,Regional site,Systemic,2011.0,Alive
s12483,35810AD4-8233-4A57-80FF-95B1EEA78063,UNCID_1902381.1fdbc7ad-2c2e-428d-b98d-7a532135eae9.sorted_genome_alignments.bam,28,1FDBC7AD-2C2E-428D-B98D-7A532135EAE9,8dd09d74-0be8-4c58-bf44-de4a2466d044,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,783D1F11-46FA-4E56-B748-1587D26945AB,Alive,University Health Network,University of North Carolina,Canada,Other  specify,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.77,47.21,RNA,2AD00725-C7C9-497E-A8DF-8886F00FE286,Primary Tumor Field,Systemic,2012.0,Alive
s12491,A8A903F5-9178-44C8-99E7-D3225DAE0847,UNCID_2281976.ba21fa26-1b4c-4bb5-a43e-0c455e54f76e.sorted_genome_alignments.bam,52,BA21FA26-1B4C-4BB5-A43E-0C455E54F76E,92e9f5e1-b597-451b-b6d5-fad9a77ba87a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,6F356767-957A-41A7-A581-6F0791D5F06F,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.77,63.32,RNA,,,,2011.0,Alive
s12352,84EC4E2B-C502-4348-B6CE-AE4A912E603C,TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted.bam,58,0AB5F114-C3CC-4DB4-87DF-1B339DDC54C2,0fe3b19a-f5e4-497e-92da-32ff6c77b066,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D17746B4-EDEA-45DB-9AD1-5EE4973F007C,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,2.11,95.63,DNA,,,,2010.0,Alive
s12351,0074A697-0800-4872-9A48-48945F46D18D,TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted.bam,29,56D2A069-7969-40F1-A237-E4FE7E62C84C,acb3b9db-16e9-40f5-87a9-9df9d4ceee54,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,5D1D84D0-9A03-4381-9CF1-E460B3617AAA,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,2.0,77.56,DNA,D8D4F07B-9B20-46FE-A3BC-26CDE7172AC0,Not available,Systemic,2010.0,Alive
s12376,0E84405E-6687-4F5D-89C9-C507D3C0BBA0,TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted.bam,58,31F3AA22-9E90-4FF7-872C-0EED3DB18545,f3c73dc9-6280-4619-a629-b575fdbdb0ca,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,B1775A45-D30D-42C3-91D8-53C662B4A974,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.16,1.61,51.98,DNA,B4432E1A-EF65-404A-92E9-4929D77E0DC8,Primary Tumor Field,Systemic,2010.0,Alive
s12390,66155739-2EB1-4230-8B24-645DCA4E0C0D,TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted.bam,17,3F63EB17-5F71-4EEC-AEF5-1D4FF328043C,39d90499-8549-4da5-b391-c421f18facf1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,A6C23CA9-E6F4-4A2C-BB86-25EF76076381,Alive,Ohio State University,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,,59.24,DNA,8E73AD2A-75CF-48B9-A8F8-474E34029738,Primary Tumor Field,Systemic,2006.0,Alive
s12373,115DF95B-61FB-4FEF-A23F-DF0ADE71C646,TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.bam,70,C5B8FBAE-98B5-437B-A8BD-D695C5E8CB4F,e4b08e66-0772-4956-8670-e5c6553eecbe,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.96,77.76,DNA,,,,2010.0,Alive
s12478,7DB8BB94-DE68-42AB-9A07-11C58E190DBF,UNCID_1880955.d2ced523-6aaf-412e-9b52-b77aad822ba3.sorted_genome_alignments.bam,20,D2CED523-6AAF-412E-9B52-B77AAD822BA3,f0bc4f65-211b-4ae1-8e68-aaef3f3c6db8,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,68DFD2FE-A179-42E4-9662-55C84555A063,Alive,BLN - Baylor,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.85,82.65,RNA,3FFAA238-057F-428F-BE3E-BFB57AFD97D7,Primary Tumor Field,Systemic,2011.0,Alive
s12400,3B6F9090-C81D-4BE3-B750-8C8E85E1DEDE,UNCID_1218467.175e3a6e-b748-4db8-982c-02abb8c23991.sorted_genome_alignments.bam,31,175E3A6E-B748-4DB8-982C-02ABB8C23991,4e80f403-0e10-4725-854d-f023c12ee1e2,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,C285C3AC-26D7-4481-BAAF-769F49AED55A,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.8,46.25,RNA,,,,2010.0,Alive
s12422,5FF7369A-E2A9-4906-8B9F-86BDD691A35E,UNCID_1359674.afc9533e-92be-4971-a2b3-e3ed35c6a464.sorted_genome_alignments.bam,52,AFC9533E-92BE-4971-A2B3-E3ED35C6A464,13577a2b-ee68-45e5-96a8-b1fd71fc62da,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,EFB13C07-156A-434A-8F99-442A0745B8FD,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,20.0,0.15,1.76,13.7,RNA,,,,2011.0,Alive
s12409,44C88C67-5A11-4BED-95F1-B5C7A81E04BA,UNCID_1261418.3b02644e-4b3e-44be-9b5c-f9583559b7c3.sorted_genome_alignments.bam,51,3B02644E-4B3E-44BE-9B5C-F9583559B7C3,7555e736-a9e2-4b96-a633-fb0f7224d62c,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,A6713EDF-42EA-4A4F-BF24-151EE02187BF,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-42,C73.9,C73,NO,,Not available,30.0,0.16,1.84,51.79,RNA,323247D3-5067-444B-B584-129516DB5095,Primary Tumor Field,Systemic,2011.0,Alive
s12418,7AAE0225-BA92-4B5D-B337-EB297C75C114,UNCID_1322940.6f7983d3-c7cc-4696-a53a-747080b79178.sorted_genome_alignments.bam,33,6F7983D3-C7CC-4696-A53A-747080B79178,9b6acc25-447d-4144-b4c0-ef52b8850d96,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,D9EA6BD3-9E2F-4B44-A88B-05179DCE5A18,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.84,53.38,RNA,58234601-1AB2-42A2-B599-DDFE48E88B1F,Primary Tumor Field,Systemic,2011.0,Alive
s12415,D0AAEFE0-EA42-4C27-8485-ABDB39007198,UNCID_1321761.0859cb32-59d7-4127-a9d6-1185fcdb74e3.sorted_genome_alignments.bam,46,0859CB32-59D7-4127-A9D6-1185FCDB74E3,e069dcad-2fd1-464e-a5e9-fe36f05a0446,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4D39B518-BF36-43FF-AF82-FEB4682CDFDE,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.76,21.1,RNA,DFCB932E-80A5-419D-A882-304EC0F9A0AE,Primary Tumor Field,Systemic,2009.0,Alive
s12353,9493C81D-440A-4066-975B-C6265B7641A6,TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted.bam,57,D8B6F131-76CA-45D3-8934-A6CDEA8153AD,f9ceffc0-d544-418d-b4a9-bd3c84e37026,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,B06B7493-F38A-493F-8B47-61E0FA4D111F,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage IVC,Mar-30,C73.9,C73,NO,,Not available,30.0,0.14,1.92,89.84,DNA,,,,2010.0,Alive
s12392,7D0E9D6D-FB33-481E-93F7-84AE9641CE75,TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted.bam,62,3D9D0EC4-8C81-40D9-886F-8813570E732D,c77976b6-35ea-4623-a92a-6d9440a978e6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,BAA64E5A-237E-44AC-8B22-2D86E710F7DB,Alive,International Genomics Consortium,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,,51.96,DNA,38A4E351-4E19-4A69-BAB6-3E8420485702,Primary Tumor Field,Systemic,2012.0,Alive
s12472,54C4681F-7B9D-49FC-9B70-21A125433C71,UNCID_1668829.0E830C7A-984C-4D77-BE7A-78ABB57F2E4E.sorted_genome_alignments.bam,60,0E830C7A-984C-4D77-BE7A-78ABB57F2E4E,35277c30-010c-4d3f-9dfe-754bf72799d7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7EC39A22-ED7C-44B5-97C3-26363239FE91,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.15,1.83,26.8,RNA,691E9580-EE5A-416E-96AD-B7CBF29E84BC,Primary Tumor Field,Systemic,2011.0,Alive
s12411,CE528E5B-F072-401B-B535-AFA8DBDE5B20,UNCID_1280815.70682749-62b2-4516-8e22-4b0b0aac8984.sorted_genome_alignments.bam,62,70682749-62B2-4516-8E22-4B0B0AAC8984,dccba97d-4e81-42fb-93b3-90be68a034fb,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E8BF40C4-8F4D-4032-B18B-D61A87A2DD1A,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.76,32.64,RNA,,,,2003.0,Alive
s12449,A7304A89-FAE2-4AC7-BB08-B2E2454C6E35,UNCID_1652671.D717118D-EBF2-4C3A-9F42-63BA021612C8.sorted_genome_alignments.bam,64,D717118D-EBF2-4C3A-9F42-63BA021612C8,d2cc4d31-38fa-4232-895e-767260f607e9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3DDD5A86-DF91-40B1-BC7E-25A7B307241D,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,61.96,RNA,7BAA8D24-498A-4F12-B1DC-38D5363346D1,Primary Tumor Field,Systemic,2012.0,Alive
s12486,01812BB1-AAC6-4549-8266-7CA31AE2BED2,UNCID_1906503.090c18f2-3ca7-4e56-ac8c-0ac3f93d4e31.sorted_genome_alignments.bam,36,090C18F2-3CA7-4E56-AC8C-0AC3F93D4E31,8492820d-b619-4a74-95d3-eb574067f3f3,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,ADC0DACA-205B-4A88-9C4F-2D191C762989,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.9,36.08,RNA,,,,2011.0,Alive
s12354,A740C90F-9CBC-4FF1-8CAD-C78D4DBB92CF,TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted.bam,58,815C53C3-8ADD-4612-B93C-3ED4BFA530AA,0d497faf-2c1c-4173-a5fe-770cca73323c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,19DEE039-9C98-4D4A-8BAF-EEA1B6DDA8EB,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.98,45.3,DNA,6DC4430D-8AEE-440D-8E8A-6BA596D003B2,Primary Tumor Field,Systemic,2010.0,Alive
s12437,A5C5B08F-AFF6-4175-BC26-E81077FD1A2C,UNCID_1565673.74ce9dad-f088-4a82-9d16-3282124e9b4c.sorted_genome_alignments.bam,63,74CE9DAD-F088-4A82-9D16-3282124E9B4C,3b1e2bd6-3d32-40f7-9b32-0df32dfcbc72,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C58506A1-8C6B-4CE8-99E0-F2D1234F95F5,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.02,63.0,RNA,,,,2010.0,Alive
s12470,87AF5F16-28ED-4571-AB90-F4D827876B0F,UNCID_1664788.40EA4BB8-CD20-4475-B9D2-4A611975AEB8.sorted_genome_alignments.bam,27,40EA4BB8-CD20-4475-B9D2-4A611975AEB8,59681e8f-cf57-47b4-82e1-6be8ead9583e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A7B8C025-BDD4-4FD2-B3FD-47E5C0432F90,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.8,44.28,RNA,09AC1972-785A-404C-AE0C-CDC6361ACEBA,Primary Tumor Field,Systemic,2007.0,Alive
s12464,96C8C949-BE54-4D1E-8D8B-CD9E72964AD4,UNCID_1660396.C61C9218-5597-42F8-AB05-A04D2F56A7F0.sorted_genome_alignments.bam,45,C61C9218-5597-42F8-AB05-A04D2F56A7F0,368689a0-f782-4826-9f08-cf0e0055162e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,92C74118-761E-4FC7-B5DD-7E457254602D,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,20.0,0.17,1.79,24.06,RNA,3A2CD703-A345-4CA3-AA94-34BFEC1E99B2,Primary Tumor Field,Systemic,2011.0,Alive
s12424,1A4C8570-2453-49AF-A9BD-4EA5D506BC5D,UNCID_1359794.4691d3b6-9d7e-4d28-b69f-d13503f24db6.sorted_genome_alignments.bam,53,4691D3B6-9D7E-4D28-B69F-D13503F24DB6,63076bda-61a1-4403-a270-4130b5d003ee,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9A107CB1-D197-4F64-BA64-834A449A5812,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.83,19.12,RNA,,,,2011.0,Alive
s12398,6FC8BADA-04A7-4C67-96A0-F73DF02DC90D,UNCID_1213670.d73edb10-76fc-4bb0-83c4-ac35f73da627.sorted_genome_alignments.bam,37,D73EDB10-76FC-4BB0-83C4-AC35F73DA627,0b170ed4-d919-466b-b765-47878b865aed,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6883BA87-9184-40D7-840B-603B15D73F7A,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.85,30.89,RNA,,,,2009.0,Alive
s12410,BCF86C1B-4686-431B-89C5-C0E0F25A634D,UNCID_1269642.febae3ce-225b-4414-bc02-4538b062d76e.sorted_genome_alignments.bam,61,FEBAE3CE-225B-4414-BC02-4538B062D76E,fca0c7d9-5e6f-4aa7-ba04-5df2eb8ba398,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E4B53CA1-D395-4FEA-A962-DFBD2B373A6B,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,10.0,0.15,1.7,8.21,RNA,,,,2009.0,Alive
s12456,A2E02BD7-CA89-4A7A-B84A-2B359E9A269C,UNCID_1657816.2D1871C3-4AD4-4AF6-8E36-125A385CC899.sorted_genome_alignments.bam,38,2D1871C3-4AD4-4AF6-8E36-125A385CC899,97d0e1bb-1459-4124-b25a-48195f2ad8b5,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,62114ABF-0F25-4521-9CF2-CA591F931B4F,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.12,62.92,RNA,,,,2002.0,Alive
s12384,2D07EF47-3523-49C8-9F8E-64E984C3CEDA,TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.bam,33,F90A631C-4556-43E2-8AA2-1114326B6984,8cfc2589-b0ad-4fe6-8420-8f6fe0178bcc,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,8133FCFE-ECC4-4503-B81E-00FDF6F87426,Alive,University Health Network,MD Anderson - Institute for Applied Cancer Science,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,,51.44,DNA,,,,2011.0,Alive
s12453,11B57861-7610-4E5C-B255-1516F1AF9727,UNCID_1653958.D57A412E-F560-4F06-92D8-06E6F66EBB2A.sorted_genome_alignments.bam,22,D57A412E-F560-4F06-92D8-06E6F66EBB2A,e62adac4-803a-4d94-9ae0-7b1a49041799,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2853C5AE-6D38-43FE-91DF-E7EC755349DC,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Other  specify,T3,N1a,Stage I,Mar-50,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,50.74,RNA,FFF090A3-9E55-49BA-BCC0-2ACC57EFE371,Primary Tumor Field,Systemic,2010.0,Alive
s12487,AB6948DC-AAD5-4BC5-9F82-6E57E9EBA4C5,UNCID_1912018.68d0c316-0488-4f3e-a8de-fd7539f37d10.sorted_genome_alignments.bam,47,68D0C316-0488-4F3E-A8DE-FD7539F37D10,d684399e-46c4-4bad-92e9-3de17c9f9a5f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A17CB817-6489-491B-8C20-A8B1263A9E02,Alive,National Institutes of Health,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.83,26.31,RNA,F701BE45-91D7-4C59-8441-E9011A6E083A,Primary Tumor Field,Systemic,2010.0,Alive
s12429,FCD2942F-8AE8-42EB-986B-15B70E6D6C3B,UNCID_1456237.519c9e61-3b40-4266-b22d-480219ae6263.sorted_genome_alignments.bam,52,519C9E61-3B40-4266-B22D-480219AE6263,866ca8ad-adc9-45d4-ad92-9f8f1a161ddf,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,01EE736B-F907-465B-9142-C50BE0A3461B,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T2,N1b,Stage IVA,Mar-44,C73.9,C73,NO,,Not available,30.0,0.16,1.81,49.67,RNA,,,,2010.0,Alive
s12438,85821610-A9F1-46B9-ABC5-6FA5BEA7C87A,UNCID_1561788.BDF948A0-E974-40D0-B9CA-492E33943F40.sorted_genome_alignments.bam,30,BDF948A0-E974-40D0-B9CA-492E33943F40,0f9b78c8-ee9d-4e60-939c-bdbe040c212d,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F14E9E7A-B4A4-414B-9E71-CAA7E86CC99C,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.74,8.26,RNA,,,,2010.0,Alive
s12443,BB8A4223-FEB3-4598-B7A2-3A8FD68FD4D8,UNCID_1566151.33849BB7-6A8F-49EF-8363-BF36C2F53941.sorted_genome_alignments.bam,57,33849BB7-6A8F-49EF-8363-BF36C2F53941,90473122-7221-491d-8fc2-0c72421d7861,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,DE6423CE-9CF4-4891-BB1E-BFD8DA656E67,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.78,19.69,RNA,,,,2011.0,Alive
s12343,6319FAE0-343D-45E8-A507-CC9F7ACF1B38,G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.bam,68,5DEEAA45-4C1B-4AB2-A487-93C548838F68,b46d88e9-8477-4900-8da9-5e7dbded0653,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,CE24FE0A-5C4D-4FBE-A02C-76345EAA2892,Alive,Johns Hopkins,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,10.0,0.08,,16.24,DNA,C052CDB5-1C84-4CC7-A02C-FC9308706375,Primary Tumor Field,Systemic,2001.0,Alive
s12419,2E4156DB-7AC3-43CB-A3D5-11633AB34896,UNCID_1322541.ff7a84e6-f49c-4832-9e60-7d64cbbf7c2c.sorted_genome_alignments.bam,50,FF7A84E6-F49C-4832-9E60-7D64CBBF7C2C,3585ddab-fe5e-4a5a-92c7-3cbaff52af57,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,309937A5-20BC-459F-B0F7-7A2428005561,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,NX,Not available,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.79,27.11,RNA,BDE3137F-6327-406A-82B7-714479B8A7FD,Regional site,Systemic,1999.0,Alive
s12423,0B02E1BC-FAF5-4B8F-8A80-1AB4F1BEBDB3,UNCID_1358589.2ae16d20-e82e-49de-90fd-cad0c6b900ad.sorted_genome_alignments.bam,35,2AE16D20-E82E-49DE-90FD-CAD0C6B900AD,87858089-1bad-4e5d-80ed-04f846da9ca4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B3CF7E11-9204-4201-BF32-1AFE0233A85E,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.8,29.88,RNA,F721FAF7-09C8-4B08-9368-9F91EA5E0156,Primary Tumor Field,Systemic,2004.0,Alive
s12428,EE72C008-8B4A-42D8-9A51-8008D61A4C1D,UNCID_1425606.c837ff28-0b47-400b-a900-72d0a786e62b.sorted_genome_alignments.bam,33,C837FF28-0B47-400B-A900-72D0A786E62B,aabc7724-71c8-4c1b-a54b-22e88dde148f,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F90925EA-8894-4C74-B48B-FB60E154BC19,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.68,44.19,RNA,,,,2011.0,Alive
s12445,0D8561F9-0F69-4DF3-A4B7-E35EB72CC479,UNCID_1653496.521D8EE8-5906-42E6-8455-2362B884662F.sorted_genome_alignments.bam,36,521D8EE8-5906-42E6-8455-2362B884662F,95dcd0a2-2fcd-4952-9022-d8143ba61fac,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,2A19A202-C53E-44BF-A721-5DFF12E33C7A,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,NX,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.37,62.94,RNA,,,,2011.0,Alive
s12462,2CF9470D-9B3C-46C3-8F8D-990A0108E565,UNCID_1661636.F94F2B3A-4DC6-4FD2-9945-6DDD721B5D30.sorted_genome_alignments.bam,54,F94F2B3A-4DC6-4FD2-9945-6DDD721B5D30,398d5c2e-f877-4bbf-a10c-486b8523c9ce,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,B3E6F726-256B-450B-B3F5-A1BB9AAB9C15,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,37.91,RNA,1CA9AC65-33BA-4A6C-B1C9-BDBDDE0A17D9,Primary Tumor Field,Systemic,2011.0,Alive
s12341,EF836A6F-DD3C-40ED-AF7D-87B77A209877,G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.bam,47,788FBFAA-51BF-42A4-AFA6-5B87ED04C2D5,667eb7f6-1d36-49bb-9d7b-c9d167b64619,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,5F75F169-6835-4B42-AF77-AB64CBFB5EF3,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N1a,Stage III,Mar-40,C73.9,C73,NO,,Not available,20.0,0.08,,27.26,DNA,F1039B47-1122-49F6-B326-82A8E60E4876,Primary Tumor Field,Systemic,2011.0,Alive
s12455,4F753985-2FF3-49E4-B760-727DAF5F9E2A,UNCID_1654855.9B3CC625-CE0D-4C2D-A240-6F8664AF5485.sorted_genome_alignments.bam,31,9B3CC625-CE0D-4C2D-A240-6F8664AF5485,c93c47f4-88f3-405a-85f4-ba9450b74522,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E16F6015-39C9-4080-8114-6788CAB77F2D,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.79,8.79,RNA,C68354B1-AEF6-428D-A09D-664C73F946D9,Primary Tumor Field,Systemic,2010.0,Alive
s12492,F88B5EF3-8777-4AF5-B1A3-9034BCEA90CC,UNCID_2490126.1e9c7167-da62-4ba3-960d-240c8445bb76.sorted_genome_alignments.bam,50,1E9C7167-DA62-4BA3-960D-240C8445BB76,c35e4390-2809-4d88-86f3-208de05b338a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,32383CFD-9CBE-4CA7-9D94-FB215AA863EE,Alive,Emory University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.72,26.54,RNA,,,,2013.0,Alive
s12408,20722F16-8607-4110-8F24-E2D381D7A59D,UNCID_1265718.04821584-22a4-4717-98f4-328d953719ef.sorted_genome_alignments.bam,65,04821584-22A4-4717-98F4-328D953719EF,3e9fda23-676d-4e78-8948-0c9df3d10064,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8281953B-47A1-439D-BED5-8803DB42FA92,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.88,63.58,RNA,12A823BE-2508-46B0-AF62-6D1A8A460F65,Primary Tumor Field,Systemic,2009.0,Alive
s12480,47419A7D-7FDF-4827-9D26-E0CD16FC1EEB,UNCID_1901152.d2f6cb89-6c39-4265-9164-679614214514.sorted_genome_alignments.bam,48,D2F6CB89-6C39-4265-9164-679614214514,b78c953f-f1bb-4295-85f1-23c4000ce9d3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,AC862772-C5C7-4308-AFE1-4D5D6C171FEF,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1a,N0,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.17,1.92,24.18,RNA,,,,2012.0,Alive
s12473,05B902D7-3FAC-40C8-BE0F-3A467D1528A5,UNCID_1815729.f94fcd81-0c2b-4221-844b-9eafdadbbd6b.sorted_genome_alignments.bam,57,F94FCD81-0C2B-4221-844B-9EAFDADBBD6B,1da4ab7d-4353-4565-a522-d2fecadd4a85,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,14ED4892-124B-44DA-8072-A25076300FAB,Alive,Asterand,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,TX,NX,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,31.47,RNA,,,,2011.0,Alive
s12469,063993B4-EBA1-4FED-821E-5A23AC844A49,UNCID_1664343.BF8240F0-9780-49B9-90FD-DD008629ECEA.sorted_genome_alignments.bam,50,BF8240F0-9780-49B9-90FD-DD008629ECEA,b983a678-b0ae-42c2-8f37-d6ecaf07413b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E85B6BC8-C182-4483-8F53-F312D5A545CB,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,19.0,0.15,1.83,7.05,RNA,,,,2012.0,Alive
s12454,907044E5-8C95-4B0C-98F9-0314764CFB1A,UNCID_1656060.7A455C8A-E7D5-4C52-BE07-C75DC51C2EB6.sorted_genome_alignments.bam,40,7A455C8A-E7D5-4C52-BE07-C75DC51C2EB6,c042a639-63c6-471b-a7c5-3fb4e12c4d12,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,14C89F9B-F35F-4410-BF1E-CB91091EC7D0,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,20.0,0.17,1.81,39.48,RNA,,,,2010.0,Alive
s12439,2DE290C4-EB71-49D7-8094-91B8CAB8AB57,UNCID_1560145.393DEC41-BD0A-40FD-836D-57F5090AC82A.sorted_genome_alignments.bam,52,393DEC41-BD0A-40FD-836D-57F5090AC82A,430ad51d-f68c-40b2-bfa2-9da68370b7fa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,54F379D7-C7F2-424B-A78E-5FE37691EA07,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.71,59.05,RNA,5F74ABA4-3820-4DF0-9436-C31BC83CCCFC,Primary Tumor Field,Systemic,2011.0,Alive
s12416,83E289C6-A879-4A5F-9CD5-3630A013C0F3,UNCID_1321775.3b52da51-036d-4ae5-9ddf-99b67495a1cc.sorted_genome_alignments.bam,88,3B52DA51-036D-4AE5-9DDF-99B67495A1CC,fd661b1b-fe0b-4ab0-ae82-76324e2f6a81,2973.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,349FD52B-A358-464C-B37E-5BA8DF33CED0,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.79,8.88,RNA,5CFA50CC-6A55-4712-83AE-E058C0D3CDED,Regional site,Systemic,1999.0,Dead
s12446,46D2375F-5966-46A2-9075-76E840587E3D,UNCID_1649490.42250872-9CAE-4D81-97EF-1A21EC1F977A.sorted_genome_alignments.bam,39,42250872-9CAE-4D81-97EF-1A21EC1F977A,a09b20b5-c187-4632-b996-0d5314a9885c,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,EFDAD0C2-A44D-48F8-A908-E8C9747E78B8,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.8,56.7,RNA,F2BAB745-CD60-4D3D-BB22-67026F70E63F,Primary Tumor Field,Systemic,2012.0,Alive
s12468,1B681211-23DD-4BC8-BFA9-3AEF3344FC2B,UNCID_1665029.A8B74A73-DB40-4A71-A922-2A6943122F97.sorted_genome_alignments.bam,60,A8B74A73-DB40-4A71-A922-2A6943122F97,a7030d2b-2cc0-46be-9721-dc210954bee0,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,54552917-03BD-4DD2-831B-CC15D02FF3CC,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1b,Stage IVA,Mar-44,C73.9,C73,NO,NO,Not available,20.0,0.16,1.8,34.29,RNA,705E8432-F0AF-4CEA-B54B-BD1CEB4F1311,Primary Tumor Field,Systemic,2011.0,Alive
s12482,A804AB38-8262-4A61-8D63-EEFC562C0B5B,UNCID_1906020.e0da883a-782b-4dd1-944f-b0b79ae11fa8.sorted_genome_alignments.bam,49,E0DA883A-782B-4DD1-944F-B0B79AE11FA8,dc2bece1-1fcd-467a-8476-da171d56488c,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,5B3977D1-818E-4F61-9B09-0DC5085A183B,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.78,24.55,RNA,,,,2010.0,Alive
s12377,A349224E-F179-4A21-AE6F-5807917A484D,TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted.bam,23,C69C86EC-D4E4-422B-88F8-AF3CE8B14148,169f045f-1739-4b0b-9bdc-028aaca420f8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,2EEB72CD-8A11-4ED1-87B0-3CF0C1BF1FB5,Alive,Medical College of Georgia,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.77,91.81,DNA,9AC0F8F5-023B-4CAE-9764-B53454C7CBCB,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12420,08FB2EE5-EBA3-4168-A03C-9572B9831CD3,UNCID_1323107.cd342b71-4d9c-42bc-95e6-e9ef31124811.sorted_genome_alignments.bam,72,CD342B71-4D9C-42BC-95E6-E9EF31124811,4e959d61-4f7f-4933-bada-d33a621d9c03,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,754D6B39-7412-402D-996D-54EEA27DF08A,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,16.25,RNA,,,,2010.0,Alive
s12452,9EEF292A-32CF-4E3E-BB0F-00E24A47E790,UNCID_1656884.6434CAA0-3816-472B-9A2A-6238C10131F7.sorted_genome_alignments.bam,36,6434CAA0-3816-472B-9A2A-6238C10131F7,989e9202-c08e-4bbf-85b3-1e278a475cb7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,6961DFA4-A986-4ED0-96DD-675177A4FEE2,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,2.12,20.1,RNA,CF5A5C06-D107-4725-B4CE-BEC90DCDF4CF,Not available,Systemic,2005.0,Alive
s12426,43883C55-9FB0-4CC1-825D-AB9764943428,UNCID_1359082.955f7278-0d9c-4a27-8ca2-f05714e4bf48.sorted_genome_alignments.bam,57,955F7278-0D9C-4A27-8CA2-F05714E4BF48,a00da907-e527-45f9-9afb-2fad2c7b0940,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A2E3CA88-9FF0-44AD-8C5A-CA4C7B404DE6,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.77,28.72,RNA,,,,2011.0,Alive
s12425,A8CC5C16-8E9B-4F3F-9611-B6C419B1329D,UNCID_1358386.4f87793c-9697-46ac-80b5-079c7db1f12b.sorted_genome_alignments.bam,37,4F87793C-9697-46AC-80B5-079C7DB1F12B,c951b786-7de3-4195-85b9-c4c19e95f546,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F5446CF5-5FEE-4ABC-8CC5-B68A25185B66,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,27.51,RNA,9F5404B2-DA87-4114-A0D5-58577751638C,Regional site,Systemic,2007.0,Alive
s12337,7466949F-795D-4B2C-99E4-92D507C8772E,G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam,22,D0A33FD2-085C-488B-B843-2CA97C85A5CB,934a58af-0ffc-487e-9e95-fa7643b7d5cb,,Thyroid Carcinoma,HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,C65B5941-3E1D-41C6-9458-CDE70425E7C7,Alive,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,46.65,DNA,,,,2005.0,Alive
s12431,79E7CACF-566C-45CE-A285-9A2792F9C08C,UNCID_1457522.a73f836e-fa7b-4e38-8075-adb2dc4322fb.sorted_genome_alignments.bam,34,A73F836E-FA7B-4E38-8075-ADB2DC4322FB,5be6c0d9-6ad7-482f-bd00-0432702df495,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,48095E3F-E658-4100-B2F4-069461BF0693,Alive,Roswell Park,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.83,25.92,RNA,,,,2006.0,Alive
s12361,42209B7E-0B20-42C9-AA80-993445DE4B03,TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted.bam,52,C290C4E6-11FF-49B6-89A1-0332A8D8DD6B,4cccc34b-daf6-41ca-9bf8-f1614525eac9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,0BE2571E-3572-4974-95CE-21B9972B24B2,Alive,University of Pittsburgh,MD Anderson - RPPA Core Facility (Proteomics),United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.15,,52.74,DNA,F4AB91BA-D4DA-43CD-BD9E-18C6887C095A,Primary Tumor Field,Systemic,2011.0,Alive
s12396,8A98329C-6A4C-4870-8E67-64F671C4BE82,UNCID_1212432.1a07f820-bac6-445d-a2ae-e07f7a87e47e.sorted_genome_alignments.bam,28,1A07F820-BAC6-445D-A2AE-E07F7A87E47E,ebccfb5f-c0a8-4263-aaff-b5dd83585191,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0CD93B1F-1CBB-4C1E-A4F6-940F95C41683,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.81,17.47,RNA,FEC020ED-7460-4310-A172-A799B97AAB21,Not available,Systemic,2009.0,Alive
s12405,D2237632-02F2-4D0B-B2CB-8C7E3FE24269,UNCID_1243711.9434a419-0eeb-4952-a60c-a8afe98a0347.sorted_genome_alignments.bam,30,9434A419-0EEB-4952-A60C-A8AFE98A0347,6ad260ad-769a-4f3c-bd07-927adf6b2338,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,EB4FEEBB-293E-43E3-A2ED-344B17D180B3,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.86,63.77,RNA,0A404AB4-7AD5-47FB-85B0-DC771E77C3A0,Not available,Systemic,2010.0,Alive
s12471,5B39D68F-E123-48E3-921D-0A4DFF0F91A0,UNCID_1664923.C578FB16-0105-4E86-B582-440DFEE16791.sorted_genome_alignments.bam,50,C578FB16-0105-4E86-B582-440DFEE16791,e071c940-60fa-4c73-bb65-1ad670021854,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,644177C4-983D-4EB7-8328-209695F47744,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.79,23.03,RNA,,,,2011.0,Alive
s12427,E2E886FD-F8BE-4E8B-932F-5F07C42BEA59,UNCID_1374459.cfd4785f-1844-4274-8892-e2e558cb112a.sorted_genome_alignments.bam,22,CFD4785F-1844-4274-8892-E2E558CB112A,934a58af-0ffc-487e-9e95-fa7643b7d5cb,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C65B5941-3E1D-41C6-9458-CDE70425E7C7,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.83,64.8,RNA,,,,2005.0,Alive
s12481,A6EE1EB2-DB9C-47C3-BA37-C9873776EAF4,UNCID_1900929.899e71cc-c363-4842-a4c7-b3e13cfd0f70.sorted_genome_alignments.bam,41,899E71CC-C363-4842-A4C7-B3E13CFD0F70,6f77fc81-1bf4-47c8-b1d8-78bb17cb13f8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,FD18F650-4F93-4888-9683-C9160AF94BAF,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,47.7,RNA,D1FCBE88-BBF7-4035-BDE8-22C8E3A7CF27,Regional site,Systemic,2009.0,Alive
s12402,A59EE3B7-B681-46B5-962A-CE23F8BEB3FE,UNCID_1246481.d217afe9-268f-4b7b-9e93-a31e3b4221c1.sorted_genome_alignments.bam,30,D217AFE9-268F-4B7B-9E93-A31E3B4221C1,b7a01148-5bab-4268-986a-a9cf7bca967f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C25AED9B-A1B7-48A9-8587-8D218F6A9562,Alive,Medical College of Georgia,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.79,53.76,RNA,2DF6C146-0A61-4DE8-9795-1152A9CE0E14,Primary Tumor Field,RADIOISOTOPES,2010.0,Alive
s12397,2C225F0F-8A29-45BE-B708-F53A0DD64191,UNCID_1212572.8143b9c8-6ab2-48c4-88ab-a4aea81ad8fe.sorted_genome_alignments.bam,40,8143B9C8-6AB2-48C4-88AB-A4AEA81AD8FE,9f31deb9-b9f4-439b-aea4-f87c71406c79,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,750EE423-6F57-4C61-8E06-9188D0DC4F28,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.79,34.44,RNA,6B9EB2D7-4BFB-476C-AEBF-B6BFAD1151B7,Primary Tumor Field,Systemic,2011.0,Alive
s12490,FE09115D-C382-4CE5-B88C-8B71CE6EE7FE,UNCID_1984967.640a5950-2e39-4c64-808c-b40f71decc62.sorted_genome_alignments.bam,39,640A5950-2E39-4C64-808C-B40F71DECC62,bcd63672-8a22-4a30-9045-a43def5b4d6f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,A0FF2BA4-1A57-452F-8706-8A47C13A4739,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.76,16.31,RNA,1DC57D8F-A0D6-4961-93BC-0A1A637A1AD9,Primary Tumor Field,Systemic,2006.0,Alive
s12441,23E4540E-9359-406B-91F6-ED9F49E31402,UNCID_1559990.ED6DFCED-49E3-47C5-9EF3-86CB52CC8CF5.sorted_genome_alignments.bam,40,ED6DFCED-49E3-47C5-9EF3-86CB52CC8CF5,b2e6933f-50e1-48e3-ae1f-173e1bc889ff,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,CB5BDA84-01A5-498E-8DF7-DEB78D9D9B35,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.8,26.26,RNA,,,,2011.0,Alive
s12459,DC7DCBCC-E964-472B-B8E5-A9EFA9BC542E,UNCID_1657927.92E44AF9-1DF7-4346-9FD1-23ED1B7DF109.sorted_genome_alignments.bam,45,92E44AF9-1DF7-4346-9FD1-23ED1B7DF109,d579370b-8aa7-4472-9e28-43c761be3eda,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,3722C788-ED16-4ABB-8E0F-8FC7D3416CA4,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.9,27.61,RNA,,,,2010.0,Alive
s12436,8630FB4A-1187-4A23-BED6-A0E99791B796,UNCID_1560058.39BC85C4-E9AC-40E3-8932-7AA4AFB27B84.sorted_genome_alignments.bam,81,39BC85C4-E9AC-40E3-8932-7AA4AFB27B84,7746be87-7ad0-48a7-84fb-08a81b220bdb,533.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E1C4D037-D70F-4AB1-BB34-554538C934CD,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,NX,Stage IVC,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.79,30.93,RNA,675B6EE0-EFB4-431B-9957-8A246635A078,Regional site,Systemic,2004.0,Dead
s12339,AFCDAE7E-5422-4F04-A64D-6BBDF39605AA,G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.bam,17,5BDCA282-C671-48FF-B32B-2380996016C0,39d90499-8549-4da5-b391-c421f18facf1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,A6C23CA9-E6F4-4A2C-BB86-25EF76076381,Alive,Ohio State University,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,,59.24,DNA,8E73AD2A-75CF-48B9-A8F8-474E34029738,Primary Tumor Field,Systemic,2006.0,Alive
s12372,1AC10023-1615-4727-AC8D-23B842C19D3C,TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted.bam,69,9E0C97ED-7482-4400-B66A-72AB48BA11A2,f2ad720e-579f-4e2c-a3f0-17877ca91067,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,03811796-0ECE-4408-82F7-B449A631D2FB,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,,Not available,30.0,0.18,1.8,43.74,DNA,230D9DE5-DBCE-4CE4-87D0-7818119FF35B,Primary Tumor Field,Systemic,2010.0,Alive
s12474,74FC247F-D841-4CEE-9DB3-8752C7DCAFFA,UNCID_1815786.5141d525-ef8b-4cdb-b69e-5292017bf190.sorted_genome_alignments.bam,53,5141D525-EF8B-4CDB-B69E-5292017BF190,dff3c4f1-9009-4111-9fc2-3834f8f7dbdd,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,265746F6-D199-4A3F-B553-E22208C87AAD,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.04,17.39,RNA,,,,2012.0,Alive
s12709,1F21558E-77F0-4002-BC71-0A9C2E3DB033,UNCID_1669196.5A2EBAB3-98A8-4226-987C-3009B2E0D062.sorted_genome_alignments.bam,68,5A2EBAB3-98A8-4226-987C-3009B2E0D062,1ebd5834-56b8-498a-8f34-c0031fcfd856,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,20D9CA9B-DEDC-428A-A0F0-9332E4BB68AA,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,6.22,RNA,C4C54421-F0D1-4EA1-BE0C-74AAF79CA46A,Primary Tumor Field,Systemic,2011.0,Alive
s12723,6B422295-2BD7-4379-8631-3B47975DC61E,UNCID_2281305.31a1cf5c-f1ba-400f-8722-081c9cf7f013.sorted_genome_alignments.bam,32,31A1CF5C-F1BA-400F-8722-081C9CF7F013,a6d37f61-beca-46ea-a59a-62257475ac77,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,32AEF736-82A4-4813-A272-86EF160E7D56,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.9,36.74,RNA,,,,2011.0,Alive
s12683,3DAD7EC1-845B-4EB0-8D35-7DE39D6BB07A,UNCID_1457781.7a68c24f-b332-4746-b032-2a0322d02e9b.sorted_genome_alignments.bam,46,7A68C24F-B332-4746-B032-2A0322D02E9B,884ad3b9-5350-4580-85f6-80ac05a6dcea,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E2F01234-2C93-44A1-BA33-2A058CD78D53,Alive,Roswell Park,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.15,1.66,14.01,RNA,,,,2007.0,Alive
s12706,09632A97-5C8F-4580-98CD-74061C0EEF84,UNCID_1665371.70DD0D77-092F-4770-82C6-E6B37B800AD2.sorted_genome_alignments.bam,35,70DD0D77-092F-4770-82C6-E6B37B800AD2,64de42bd-d134-4f44-82fa-d6614709bf01,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E31A612A-014E-4B1A-8AE7-EF09C3F05F56,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.81,51.13,RNA,366AD837-F4CF-4862-ADDD-47FE8639F9CC,Regional site,Systemic,2008.0,Alive
s12722,93AA4F98-CB86-47FA-A0F7-8100C6E739CB,UNCID_2223476.b2f92878-065c-460d-95a2-a96a95a4b629.sorted_genome_alignments.bam,62,B2F92878-065C-460D-95A2-A96A95A4B629,5d0cc336-26f2-4cb0-aa9e-58491dda102f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,45CD4775-799B-4894-82D5-2B887FDC7262,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.78,10.19,RNA,0D000579-3BA9-4902-B10E-CEC5973350A4,Regional site,Systemic,2008.0,Alive
s12710,4300624D-FE49-4ACF-8C93-168858FF7A8E,UNCID_1829938.842A5261-5E7F-4AD7-A426-0CE48E937919.sorted_genome_alignments.bam,31,842A5261-5E7F-4AD7-A426-0CE48E937919,afb00cd4-e5da-4251-86fb-532c3f65324c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,D3CC158D-413D-49E6-8D23-3ED89FDEA94A,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.35,25.41,RNA,932676BE-AE3A-4CBE-9CFC-F1AC1F32EC21,Primary Tumor Field,Systemic,2008.0,Alive
s12617,68B5668A-A719-42B2-99BB-D26C59C19B2F,G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.bam,80,19233FD1-5229-466E-ACF3-5882165758E0,bed1fb3c-4459-460e-8190-29211857fa73,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,4862B699-580D-4F2E-97A0-BD8918537067,Alive,University of Pittsburgh,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,2.0,78.4,DNA,,,,2011.0,Alive
s12679,CBE600B2-EDA4-40E5-89CE-383A7EA1AB18,UNCID_1455250.4996ab99-52ad-42b7-9f5f-aa2ac978cab8.sorted_genome_alignments.bam,51,4996AB99-52AD-42B7-9F5F-AA2AC978CAB8,dec7a0a2-c26e-4a89-a4d5-74bd1409ff91,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,928F7462-C492-4E30-B17E-D4F9CB203035,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.8,38.87,RNA,,,,2011.0,Alive
s12713,65A2A9F8-1BEC-40D4-81D8-4BCF1C0C29DE,UNCID_1880805.9f492497-0039-460c-b408-192cc194baf6.sorted_genome_alignments.bam,45,9F492497-0039-460C-B408-192CC194BAF6,4d30606f-3ab6-4ef0-9991-8897cdb9960b,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,88AD3801-2464-4327-A72E-291794FDA877,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,15.96,RNA,5C18B86F-5B31-401A-8599-111484FE5196,Primary Tumor Field,Systemic,2011.0,Alive
s12673,00E29B4B-795C-4A39-9B63-D7194B21B69B,UNCID_1456115.a5e6c3d1-f729-4393-864b-f153863aec46.sorted_genome_alignments.bam,50,A5E6C3D1-F729-4393-864B-F153863AEC46,3e787a0e-b5d2-401e-b1e5-077376090b3a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,27B0FF79-4213-4B57-B6E0-A393B8983D20,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.88,55.45,RNA,0CEEFC3F-1F30-4015-938A-B3B17995CEAC,Primary Tumor Field,Systemic,2010.0,Alive
s12618,B84E6415-1014-4D91-A469-879B108FA3BB,G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.bam,57,2DD5EEA1-42A1-4E8B-99AC-20399CC7E15C,f9ceffc0-d544-418d-b4a9-bd3c84e37026,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,B06B7493-F38A-493F-8B47-61E0FA4D111F,Alive,University of Pittsburgh,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage IVC,Mar-30,C73.9,C73,NO,,Not available,30.0,0.07,1.92,89.84,DNA,,,,2010.0,Alive
s12613,6AD47953-E067-450E-9C68-69B531CABA51,G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.bam,45,248FD0ED-F14C-40B8-9F14-E9C7ADF16E22,0c50a2c2-1d4c-45ca-9127-f96d4db18daf,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,593736E0-1BED-4EAF-BAC9-E90620554F1D,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,,56.44,DNA,,,,2011.0,Alive
s12687,41AD2B97-5B2A-4097-9C8D-4D10FE395647,UNCID_1652976.4C657A84-F794-4324-B1C7-D118AD2E90A8.sorted_genome_alignments.bam,21,4C657A84-F794-4324-B1C7-D118AD2E90A8,8446bcba-0dcd-42eb-96a1-00f5470c9f65,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9583A87A-FEDF-49CE-A2F1-506B97716062,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.15,1.35,29.11,RNA,,,,2008.0,Alive
s12647,7072B927-397F-4821-A834-0B1E21EC3434,TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted.bam,37,8B0BF4B5-9846-473B-A2DB-8390B0DB90A7,a86ac3b5-b5e9-4420-8de0-a358fcad85b6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,7A5628FF-C5C2-4F25-809B-640415323477,Alive,Ohio State University,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.15,,48.5,DNA,5DA5CF9E-8C18-47FC-8C49-FAC10FE6D715,Primary Tumor Field,Systemic,2006.0,Alive
s12634,A3620988-3968-488B-88E7-9AE555459DC7,TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted.bam,21,DB0AC00C-ABED-4D02-B05B-A3CD87DCA75F,99ac4f2e-2e63-4f1e-af0f-8f23a2caf999,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,A870F5CA-F049-48C1-AFAC-B788A3111086,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.14,1.94,80.38,DNA,A00859AB-D428-4EE5-ACB6-DB9BF1032399,Primary Tumor Field,Systemic,2010.0,Alive
s12684,1A6FC135-2040-4501-8502-3DE6E6B8BD75,UNCID_1559817.853DE7E0-6FE3-40AF-B243-E1BECA83E6BD.sorted_genome_alignments.bam,42,853DE7E0-6FE3-40AF-B243-E1BECA83E6BD,59cd0969-a798-4d19-95ed-a311f39d2f38,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,63130E8F-11DE-44BC-8B2C-A8EA2613C3A5,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.76,13.7,RNA,,,,2011.0,Alive
s12700,EB22E80B-FACA-4391-8D06-75CDA0871132,UNCID_1659765.2BC6743C-DC3D-4693-B5D2-F55381712D7F.sorted_genome_alignments.bam,17,2BC6743C-DC3D-4693-B5D2-F55381712D7F,39d90499-8549-4da5-b391-c421f18facf1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A6C23CA9-E6F4-4A2C-BB86-25EF76076381,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.85,48.27,RNA,8E73AD2A-75CF-48B9-A8F8-474E34029738,Primary Tumor Field,Systemic,2006.0,Alive
s12670,5ED0A2D7-04C7-4A60-BF41-05643DF5B069,UNCID_1367642.4d2831b9-a52b-48a7-8541-7e23917a3b2f.sorted_genome_alignments.bam,77,4D2831B9-A52B-48A7-8541-7E23917A3B2F,04ae6b65-8514-47fa-b573-ec1e067ff116,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,8C3C215E-DA32-4E42-96D3-A2C6D246A7EE,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.86,25.45,RNA,,,,2011.0,Alive
s12694,EA8550EC-A1B4-4FDD-86B7-7FF1BF8A7C8B,UNCID_1656005.910DDC69-2AD3-4C0D-8B2D-D5D09B6BD2E6.sorted_genome_alignments.bam,41,910DDC69-2AD3-4C0D-8B2D-D5D09B6BD2E6,3d8b7654-b403-4360-80dc-8273ca90c2dc,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,B64CA6E7-ADF3-4B32-9A33-A20BECA40B9E,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.79,32.05,RNA,012CE56E-1D5F-4586-B7D9-96927371FDFB,Regional site,Systemic,2007.0,Alive
s12719,759526FC-51CB-49A0-9211-702D480A443A,UNCID_1902351.1adb31d9-b06e-4820-8ccc-958298f59395.sorted_genome_alignments.bam,43,1ADB31D9-B06E-4820-8CCC-958298F59395,85def63a-39ab-4c83-ab8c-02c6f702f05d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,AMERICAN INDIAN OR ALASKA NATIVE,HG19,Primary Tumor,C7BB4564-AF84-460D-BA07-78292DF59C97,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.15,1.89,63.64,RNA,58BBE6FC-367C-4927-96BB-6D4575DF5E73,Primary Tumor Field,Systemic,2011.0,Alive
s12701,211A79DC-8E94-4DD2-A75A-76809B811A39,UNCID_1660125.88E25F76-1B1F-4AFB-AB08-215D4F7F08B5.sorted_genome_alignments.bam,85,88E25F76-1B1F-4AFB-AB08-215D4F7F08B5,c7a2f394-3e3f-4c90-9f1e-f2be3e5b0d6b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T1b,N0,Stage I,Mar-44,C73.9,C73,NO,NO,Not available,20.0,0.16,1.82,34.51,RNA,,,,2010.0,Alive
s12628,DDAE4F5A-AED4-4466-9434-23F6ED312D19,TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted.bam,33,3D0982B1-944E-4C03-AAA4-F8FD4602D4C9,331cae6e-2868-4c58-9302-709a9ff7d025,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,6BF032C1-B7D5-4B1C-BF41-C9BFEAFA5E7A,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.98,64.48,DNA,,,,2010.0,Alive
s12718,2B575061-DD69-4E3D-9BAA-EC0D5E4F5E4C,UNCID_1902424.47855530-fdf4-4ab1-8387-f77db6b19e78.sorted_genome_alignments.bam,69,47855530-FDF4-4AB1-8387-F77DB6B19E78,4729410a-7240-4ed0-b478-78cc6c7a4810,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,A11056F6-D3D4-45DA-9832-7B0EA5141612,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,NX,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.15,1.83,45.12,RNA,2E8681EA-8728-45F0-B272-20B9E0739701,Primary Tumor Field,Systemic,2011.0,Alive
s12675,53385C8A-D89C-406F-A315-112BF7A7E189,UNCID_1457457.a38ddef7-d9a7-47b2-9567-a7fdc77f2180.sorted_genome_alignments.bam,58,A38DDEF7-D9A7-47B2-9567-A7FDC77F2180,77200abe-4a09-4a4a-bb45-60d9b96d4998,1019.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,64E11D42-FEC9-47E4-A6A6-8DF2A6BFD79B,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,36.59,RNA,2B8F6B58-3274-443C-9CE9-2412F0B976C4,Regional site,Systemic,2002.0,Dead
s12714,FBB62EB5-7B60-4E07-A15A-40EB83C7F6C6,UNCID_1889523.40ec3184-5b50-47b0-95eb-865fe3df4513.sorted_genome_alignments.bam,37,40EC3184-5B50-47B0-95EB-865FE3DF4513,6ff5c8bd-9929-43ee-b53c-3c7c0b23f97b,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,99808BB5-E6E3-4E21-A4D1-080C71F26C52,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.81,78.39,RNA,53122B3C-FE17-4B5F-A7C6-852D2732DA84,Primary Tumor Field,Systemic,2012.0,Alive
s12672,3FA02419-56F0-46D8-93AA-64D2FC1B3606,UNCID_1385185.7a4056de-e2d5-4c28-ad1e-25569a212650.sorted_genome_alignments.bam,55,7A4056DE-E2D5-4C28-AD1E-25569A212650,04fff86a-b6f5-4900-9e37-c1f0b881b160,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2EB89D79-861E-41C2-BDD5-6F16D2A84B25,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.86,36.22,RNA,FCC5E46D-2F73-4ECB-9DBA-2595EE16F3E6,Not available,Systemic,2010.0,Alive
s12664,4AC79F36-0E31-4268-9CA4-97A47A75FBE9,UNCID_1320936.7aa5ec16-e882-4627-9a15-1bb19a421576.sorted_genome_alignments.bam,78,7AA5EC16-E882-4627-9A15-1BB19A421576,4c0b29e6-8530-43d5-8e8a-efb754e83ecd,1854.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,26A8BE9F-DD2F-474B-A06B-1E9558617A56,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1a,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,10.0,0.18,1.82,25.9,RNA,,,,2004.0,Dead
s12702,0EF58DE4-677D-483E-AFD4-6EE96B3EBB46,UNCID_1661040.DBFB44E2-A785-4E49-A02B-FBE06573689D.sorted_genome_alignments.bam,69,DBFB44E2-A785-4E49-A02B-FBE06573689D,fd036ec5-3ffb-40b1-8002-943be0e2532e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E058A8E1-ED00-48A5-A46B-77538D7B73F1,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.87,28.85,RNA,,,,2011.0,Alive
s12656,F2F1C764-73DA-4425-998C-59D795DE7E35,UNCID_1211610.b8876a0e-9937-41d5-b01e-273b038031d5.sorted_genome_alignments.bam,63,B8876A0E-9937-41D5-B01E-273B038031D5,5dcbdfcf-8a4d-4da5-9049-f2b970fe8ca8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,400009E4-A0F0-465F-B4A6-60D730FF3E38,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.8,27.34,RNA,,,,2011.0,Alive
s12632,7F979498-38E3-4B28-B84A-C3EEDE43FA06,TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted.bam,30,7CEF35A1-E530-47C9-9A86-3EA2C970FCD3,a1227ffa-2733-4a43-ba82-834755453870,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,DAF2A444-AB89-48D4-9DA7-888AC3099AB7,Alive,ILSbio,Harvard Medical School,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.02,88.59,DNA,,,,2010.0,Alive
s12640,5CFA9EA5-2E72-4F40-96BE-D6ACCC8482A8,TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted.bam,42,F5D0FC17-824D-42F7-931B-E23CD68B9E2F,2012869d-c169-4cea-aa09-c892fb79bbaa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,884C1978-00CF-4E48-BEF8-F03CA67D6C02,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.91,94.75,DNA,,,,2010.0,Alive
s12717,B4038587-FE6B-4CDF-97A7-99CD9F473EE7,UNCID_1902568.016536b0-a6c4-4b7c-81c5-9fca8315c94f.sorted_genome_alignments.bam,36,016536B0-A6C4-4B7C-81C5-9FCA8315C94F,64131b0b-9f36-44be-8bec-92c71ec36343,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,72328827-DF43-4DDC-BB11-730A229FD7EC,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.74,22.01,RNA,2DE6EBC1-4CF6-4CF1-86DC-6D69BA28EFED,Not available,Systemic,2012.0,Alive
s12623,D49DE1AF-8DD9-4FDB-8A60-87BD8894395B,G49537.TCGA-E8-A416-01A-11D-A23M-08.2.bam,51,C8381701-31CB-465A-BDF2-1B8132BE7A14,86b82345-6f4d-44fd-a9db-6f107de62f53,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,AF7B5868-2C11-4C74-8033-E914C987ECE6,Alive,Asterand,Broad Institute of MIT and Harvard,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,16.01,DNA,,,,2012.0,Alive
s12716,80B71B3F-1744-4F30-A083-DF27FF658CAA,UNCID_1901125.b127c23e-b16b-4402-8a0c-764867fc6b52.sorted_genome_alignments.bam,55,B127C23E-B16B-4402-8A0C-764867FC6B52,86d5865e-6a1c-467c-97c9-47460b77f5a4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8D1C5CF2-C21B-4EF6-921D-096DC6B00144,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.96,44.03,RNA,2F66C346-0201-4EE1-84E1-9838ADE41C2B,Primary Tumor Field,Systemic,2011.0,Alive
s12657,80CE3B59-9211-4B42-8D22-6A04F4A590BC,UNCID_1211980.619741f2-4f5e-41ab-9033-bfc0dd525750.sorted_genome_alignments.bam,26,619741F2-4F5E-41AB-9033-BFC0DD525750,edb90376-0ef9-47dd-be6f-a6e8a0380a9c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2EB05E94-554E-402F-B319-1BE9DE36C66E,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.79,39.92,RNA,A98AD64E-5B3E-4C0A-8F03-38FDF0BD0973,Primary Tumor Field,Systemic,2010.0,Alive
s12663,EA4F9617-3FDD-4C16-BAC4-DDB6E57CF08D,UNCID_1270864.14f1d95e-473a-4b72-9ba2-8a1e3e3a0d5e.sorted_genome_alignments.bam,37,14F1D95E-473A-4B72-9BA2-8A1E3E3A0D5E,1005ccb2-10ef-4e37-950e-ad72393db03c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,92A3F4B8-63F8-496C-8CB6-05D43A433D5B,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.84,39.82,RNA,0033B28E-016F-41BC-A7AC-1D2E3C4B52C0,Not available,Systemic,2008.0,Alive
s12641,E0052E53-2D8C-45BA-8D2C-DB4EAB61A141,TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted.bam,63,3C049586-BD3C-490D-93DB-E344BD6A1AE8,3b1e2bd6-3d32-40f7-9b32-0df32dfcbc72,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,C58506A1-8C6B-4CE8-99E0-F2D1234F95F5,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.98,97.61,DNA,,,,2010.0,Alive
s12711,C04B2A23-D4AA-4FBD-A565-6152B9E419B7,UNCID_1880678.639dfa00-695c-48a6-be06-8557aea24cfe.sorted_genome_alignments.bam,41,639DFA00-695C-48A6-BE06-8557AEA24CFE,d3d9ccdd-4789-43b0-8e73-b2c42cb7d83d,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,AC04A279-0FB7-453D-9FA6-CEE17ACE1206,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.98,65.63,RNA,D2A6F1E9-3900-41E4-892D-A2BECE9A4A7B,Primary Tumor Field,Systemic,2007.0,Alive
s12681,004A80A5-F9FD-43DF-9668-64CD6C86D3DD,UNCID_1455100.594a61ec-d2f1-4bc3-a16f-6f33cb1012c5.sorted_genome_alignments.bam,44,594A61EC-D2F1-4BC3-A16F-6F33CB1012C5,e9ccf355-e68a-489c-a914-31b766bd0aef,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,FDA77112-5C61-4D6B-AB2B-13EF7F567D18,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,10.0,0.15,1.79,5.55,RNA,42F2A734-8B4B-4CB8-95B3-887A170DB1F3,Primary Tumor Field,Systemic,2010.0,Alive
s12724,084D21B3-C12C-4908-B6CB-05717D845E5A,UNCID_2545180.faddc64d-e125-4a53-a37c-b4e615ae9df9.sorted_genome_alignments.bam,74,FADDC64D-E125-4A53-A37C-B4E615AE9DF9,e1c8af06-9ea4-4062-9264-aa916e0025d1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,A5B168E1-A5E3-48D3-9C7B-006750C34D97,Alive,Mary Bird Perkins Cancer Center - Our Lady of the Lake,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1b,Stage IVA,Mar-50,C73.9,C73,NO,NO,Not available,30.0,0.18,1.92,37.8,RNA,,,,2013.0,Alive
s12678,BFD56847-FFD6-426F-A0ED-DACF8E326EB9,UNCID_1455312.6044cdaf-212b-477f-a967-fc44911ab337.sorted_genome_alignments.bam,41,6044CDAF-212B-477F-A967-FC44911AB337,707312fe-1d92-413e-a891-1ea3f496c343,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F970F195-179D-4050-8111-4D78339D8829,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.17,1.88,8.4,RNA,9A33D717-ABB6-4474-B56B-1BC11305498B,Primary Tumor Field,Systemic,2011.0,Alive
s12650,CC57E94A-0D41-4543-A4D8-3B42FC1AFD8C,TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted.bam,33,F89BA6FD-2785-49F3-8611-5147D09C6AC0,05a8268a-6b33-429b-8638-8c9bb366ef28,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,955243D6-118F-41B7-BC8A-D3DDF7AD00B6,Alive,Ohio State University,MD Anderson - RPPA Core Facility (Proteomics),United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,,45.08,DNA,B922582E-4870-41F5-B3DB-099C8693CB7C,Primary Tumor Field,Systemic,2004.0,Alive
s12651,A7A005EC-F27F-4C17-8BB6-879C800BB0AE,TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted.bam,21,40CA310C-DB41-44D5-A76C-72938CF4AED0,58ff4366-20a3-40a2-a87a-551e17cdb5d3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,E67E2BBE-8C3F-41B1-BE3C-C89555A10AEE,Alive,International Genomics Consortium,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,,38.77,DNA,90610127-78CA-4552-992B-9F378FEE2A78,Primary Tumor Field,Systemic,2011.0,Alive
s12688,DC4A8434-951B-4DF1-BED8-9ED10EE353FD,UNCID_1653445.7EF03172-68BE-438A-85CD-B9DB97FFD5B9.sorted_genome_alignments.bam,45,7EF03172-68BE-438A-85CD-B9DB97FFD5B9,63c20d30-3bc9-4dca-8a8d-09fdea41f288,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E2732FE9-7198-4F5A-8126-D1C5929BB385,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.77,7.88,RNA,,,,2012.0,Alive
s12660,E1AA6385-D2F4-4D67-B496-C764FE86AD4A,UNCID_1237767.c3a60103-efb6-4553-bb36-917fcb21d811.sorted_genome_alignments.bam,33,C3A60103-EFB6-4553-BB36-917FCB21D811,300720c8-68e5-4a3b-a873-3ad36ad0f953,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,6E2AABB1-2418-49AC-80AC-60BB8FD5E13B,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.9,35.48,RNA,F83CEC89-894F-4F5E-A70D-9E558981F31C,Primary Tumor Field,RADIOISOTOPES,2004.0,Alive
s12685,96E36FE4-3BC4-4E08-85AB-728FDFB8C8D5,UNCID_1560211.D0B96C1F-FFAE-4503-9864-AADE8173B4E7.sorted_genome_alignments.bam,38,D0B96C1F-FFAE-4503-9864-AADE8173B4E7,5832c002-e5a4-45bc-b8f9-dbb841fd22f3,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,BDD239BA-DBC5-4F30-AD5D-8159C67E7597,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.75,27.11,RNA,,,,2009.0,Alive
s12655,4CD0CA9C-C490-4B6C-B4F6-79129A75333A,UNCID_1212558.26490a5f-6d48-4864-a1ab-7caa14924c73.sorted_genome_alignments.bam,60,26490A5F-6D48-4864-A1AB-7CAA14924C73,c31b3adf-3fc6-4a72-83b0-bbc0f295b5e7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,3AE03B86-1473-409C-8118-A91A73A36F60,Alive,University of North Carolina,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1b,Stage IVC,Mar-60,C73.9,C73,NO,,Not available,20.0,0.17,1.93,47.49,RNA,923999C1-45AE-4D19-B055-3C71C2EE7FC2,Not available,Systemic,2008.0,Alive
s12703,5BB10AB0-D111-412B-8EB1-E59EE6C0399B,UNCID_1662014.F4B77689-800D-4A80-BEEE-AFC74877A4EC.sorted_genome_alignments.bam,29,F4B77689-800D-4A80-BEEE-AFC74877A4EC,bf193c4f-fbac-41bc-b1af-19b6ce856f0f,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,EAAE1A05-7D7E-406A-A02B-282A8B66F95C,Alive,Christiana Healthcare,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.85,54.6,RNA,,,,2011.0,Alive
s12669,52969FE7-3BF3-4CEF-B65A-5A968B776A47,UNCID_1359171.21d475d7-7f65-4961-8244-e43822cf6954.sorted_genome_alignments.bam,64,21D475D7-7F65-4961-8244-E43822CF6954,1a4164d9-4484-452d-9382-8cbf896a870e,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,775F1197-AC0C-47E1-B63E-CC1D3C63151D,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.83,18.49,RNA,70C15161-0076-4252-8373-EA87682BB916,Primary Tumor Field,Systemic,2011.0,Alive
s12658,0AA12407-4C7B-42D8-8E88-ACCBA53F397F,UNCID_1214387.c438f605-641a-4e89-937e-7f63c176f20c.sorted_genome_alignments.bam,52,C438F605-641A-4E89-937E-7F63C176F20C,ca95a11c-b54c-409e-b9a0-da850945033d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,EFAD8B07-B295-468F-A836-F94029AEC777,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.86,61.57,RNA,,,,1999.0,Alive
s12682,AEF6EA52-23A8-4711-8C74-C43B60671D9C,UNCID_1457687.c8c2f184-1d51-4364-99f5-5d78cb89ecf3.sorted_genome_alignments.bam,55,C8C2F184-1D51-4364-99F5-5D78CB89ECF3,59e47734-96de-4328-aca7-e9423dda9c52,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,CC1213A0-BC99-4505-9B20-42FEA416F6AB,Alive,Roswell Park,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.15,1.72,13.77,RNA,A3C1D8CD-6CDD-4BE1-92CB-FF26D3447C05,Primary Tumor Field,Systemic,2010.0,Alive
s12712,E5657161-C7E1-4FF7-895B-88F81FFBACDC,UNCID_1880865.50cf3cc2-9fc8-4b5c-a3ad-051cd27a2030.sorted_genome_alignments.bam,41,50CF3CC2-9FC8-4B5C-A3AD-051CD27A2030,25184e51-1464-438a-80ff-cfc9a443cd36,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F85BC000-0E95-45B9-8614-EDC42E777A90,Alive,BLN - Baylor,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.74,34.19,RNA,931EA901-3D39-4E11-BB5E-622621C6C827,Primary Tumor Field,Systemic,2011.0,Alive
s12674,71A66D18-3FF6-4007-85F1-BB36B7AACA1B,UNCID_1456250.bff2f4fe-4522-4627-b432-bb7cee8755c7.sorted_genome_alignments.bam,32,BFF2F4FE-4522-4627-B432-BB7CEE8755C7,762eddb5-1b47-4b79-b20a-1edfb07c0705,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,95D077B1-E4F3-48EA-84BC-F663FD438693,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.81,68.71,RNA,,,,2010.0,Alive
s12619,82A795DA-F726-45AF-A15F-A778695D466A,G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.bam,51,178D0486-CB0D-4979-8BDF-BB3FE99149BD,7629f864-a009-4aa9-bf7e-2d99e00d294e,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,E01D507C-8E8E-45C6-B4EF-193177A382C4,Alive,Johns Hopkins,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.07,,32.52,DNA,9FAB3533-B192-46A3-B1C2-CF2A20B7D306,Primary Tumor Field,Systemic,2012.0,Alive
s12689,68B3FC12-EAD1-44F2-B1E6-F9094167BD65,UNCID_1653734.D38A7386-1ACE-4EDD-A42C-D3D93C8ACE02.sorted_genome_alignments.bam,66,D38A7386-1ACE-4EDD-A42C-D3D93C8ACE02,7ef22138-ac76-4846-b3bb-ddf1efb96531,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3E9A8137-7AD9-42EC-B94B-DE6F43852EAC,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.79,31.1,RNA,,,,2012.0,Alive
s12621,961C7C05-824F-48C1-AED0-956B03C74C9F,G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.bam,81,A9C29EDD-2EF1-46EF-93C6-796CF0332A2B,7746be87-7ad0-48a7-84fb-08a81b220bdb,533.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,E1C4D037-D70F-4AB1-BB34-554538C934CD,Dead,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,NX,Stage IVC,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,37.42,DNA,675B6EE0-EFB4-431B-9957-8A246635A078,Regional site,Systemic,2004.0,Dead
s12615,9A38B46C-3B59-40AD-9D22-D0D153C211A1,G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.bam,33,77EBE6D2-6537-49D3-849D-FE93E2CF52AF,8cfb88f6-7b37-4f1e-882b-3a368b604167,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,29B4816D-4CFB-45F0-BCD2-6B948245F3A4,Alive,University of Pittsburgh,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.08,,27.47,DNA,,,,2012.0,Alive
s12653,A202435E-452E-42AE-ADF3-5E36030425AD,UNCID_1034562.2fc29812-f419-4a62-959f-c2e3da708a45.sorted_genome_alignments.bam,53,2FC29812-F419-4A62-959F-C2E3DA708A45,f00fd40a-1254-4300-baf9-88528c453a2e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,595129DE-C08C-4220-9FF2-53E034A8BFFB,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.75,37.8,RNA,,,,2011.0,Alive
s12662,7783E632-0024-4718-9E77-6B84F2FBB88D,UNCID_1262804.8a91ad45-592a-4539-90ed-2dddf33b10a4.sorted_genome_alignments.bam,74,8A91AD45-592A-4539-90ED-2DDDF33B10A4,567e4d90-5c5a-44f0-a462-90c831f3c096,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,D0880877-36CF-4DED-87B2-898C3446F90D,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.87,29.95,RNA,2FA4C8BE-6A3C-4EA7-B69B-28DEAA7C71AF,Primary Tumor Field,Systemic,2010.0,Alive
s12692,10A2D148-9E9C-4E39-AED1-E071069FB06C,UNCID_1653891.7E2BFC91-ACAB-4170-81E1-A8E37D09A112.sorted_genome_alignments.bam,28,7E2BFC91-ACAB-4170-81E1-A8E37D09A112,1f3915cb-718c-42ae-ab0a-ce62b8664995,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1EF9DA2A-0E06-4A28-B9F5-5D900A9FC55E,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.74,23.02,RNA,,,,2008.0,Alive
s12697,DD0706E9-0325-464F-9169-9E1BB867F29A,UNCID_1659271.67107614-9A9D-4D62-9C2E-3B8E242AC92D.sorted_genome_alignments.bam,46,67107614-9A9D-4D62-9C2E-3B8E242AC92D,3a211d5a-085f-4902-86b6-50e4eb36b897,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,362F0CC2-B884-404B-8DF1-2BFC2A75E9C3,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.79,23.8,RNA,82A70C8B-9B8D-427C-8ADD-26B23D43EE54,Primary Tumor Field,Systemic,2011.0,Alive
s12665,78D4D3B4-5A36-4C76-ACAB-4132637BEEC0,UNCID_1328506.524de4bb-5432-4a0b-bee2-4c5bf58ba449.sorted_genome_alignments.bam,43,524DE4BB-5432-4A0B-BEE2-4C5BF58BA449,f9217c58-11ef-4c4b-99cf-0e134a718552,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3C8B7DBA-CF05-461B-908F-56FBB0DDD64B,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.82,9.8,RNA,,,,2008.0,Alive
s12668,3EB2F98C-ADA0-493F-8FF9-3973011AD57F,UNCID_1328260.c1cb3897-c384-41ec-9fea-051e7a612de9.sorted_genome_alignments.bam,24,C1CB3897-C384-41EC-9FEA-051E7A612DE9,9a19f08b-386a-40b1-b694-78e8556a6caa,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4508BAF5-EC75-4C7A-8F69-FBD7F6B43A6C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.76,48.73,RNA,,,,2007.0,Alive
s12661,3F47C155-080D-401C-B8A9-1E132E24DCF4,UNCID_1241222.1ba7877e-fd4e-452d-8eed-20fc9fb39698.sorted_genome_alignments.bam,65,1BA7877E-FD4E-452D-8EED-20FC9FB39698,f3ee888e-5116-4313-a2f6-3b1dcc3e4bc1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F07142D5-F504-4760-B5CC-F58C6D93EF0A,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.78,48.22,RNA,,,,2009.0,Alive
s12720,953C44E5-4010-4316-A091-6B741DE48E7B,UNCID_1901820.72b416c6-968b-46aa-b172-664472feee85.sorted_genome_alignments.bam,60,72B416C6-968B-46AA-B172-664472FEEE85,274225cf-a0f4-4635-848b-819f479001de,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,B5010A3F-F634-4094-A0ED-75C543C9DA0F,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Other  specify,T3,N1b,Stage IVA,Mar-50,C73.9,C73,NO,NO,Not available,30.0,0.17,1.9,32.93,RNA,CF51337A-59DF-43BD-BD99-F6669424C4E4,Primary Tumor Field,Systemic,2012.0,Alive
s12677,945E1454-0F11-45B3-83BE-7ABAA209E834,UNCID_1455443.5e035459-b8ce-4de1-bef6-ba12d618a711.sorted_genome_alignments.bam,80,5E035459-B8CE-4DE1-BEF6-BA12D618A711,a3810f36-d2b4-4a45-ad08-a4dbfb9d27aa,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3AC025C9-FEC6-4997-8630-085750DC84E0,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.83,18.85,RNA,,,,2010.0,Alive
s12708,A120F662-225C-475A-AE4B-15F143D8653C,UNCID_1668828.477B8DD7-F662-471A-962D-E4E06742AE71.sorted_genome_alignments.bam,70,477B8DD7-F662-471A-962D-E4E06742AE71,ab0a98ae-98f1-425e-9418-550df6ac24cd,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5146BB48-50BE-4D3C-815B-B05708CE3064,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,20.12,RNA,,,,2011.0,Alive
s12696,0BFDC42A-74E9-410D-BB32-0B3E471FD5F3,UNCID_1657560.5199A3B8-6C4D-485F-963E-7131EB539CC6.sorted_genome_alignments.bam,51,5199A3B8-6C4D-485F-963E-7131EB539CC6,c5fd200b-ce02-4d7d-a240-78f147e483be,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9201C13A-4DBE-48B2-9324-95A4B667F198,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N1a,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,10.0,0.15,1.74,20.26,RNA,,,,2010.0,Alive
s12625,F2CF3084-F780-42F8-B97C-C1D5483A1DD9,G49537.TCGA-ET-A2N1-01A-11D-A18F-08.2.bam,47,7ED3E66E-F784-483F-AC37-1300736584A4,e74b8474-f74a-498d-8848-6aa97d38d2d8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,1EFC40AF-FEDF-4BC3-BE59-1E31A87BAA15,Alive,Johns Hopkins,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,,49.49,DNA,0ECFE2C9-B459-462A-AF2E-1B58715440F7,Primary Tumor Field,Systemic,2010.0,Alive
s12639,091BB28F-4FE0-41E6-B7C5-B952DC370506,TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted.bam,43,DDE34A05-A208-4F86-9803-0FB1EB858947,99ef2fec-5a3c-4e42-8f78-7eaf9877e26d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,64D1F58A-986F-4D4B-962E-DA59A48C988B,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.91,48.48,DNA,,,,2010.0,Alive
s12654,2D95E0FF-7B2B-4176-B2AF-F352ED45DF1D,UNCID_1207583.fa7ae96d-aa85-4328-8806-abed43d7d561.sorted_genome_alignments.bam,52,FA7AE96D-AA85-4328-8806-ABED43D7D561,4481d84d-109e-44a0-bcb4-e6e61bdce796,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7D90939F-BAB7-4A39-8D57-79540142BB63,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1b,Stage IVA,Mar-44,C73.9,C73,NO,,Not available,30.0,0.17,1.83,44.24,RNA,56A0A56D-15DE-446B-AFC6-27E2AD480D39,Primary Tumor Field,Systemic,2010.0,Alive
s12705,AD4A2B17-3EF2-44A1-B61E-ABE9C4C4E6AC,UNCID_1665394.32583958-4AE0-4BBB-9518-19E24AC77A17.sorted_genome_alignments.bam,32,32583958-4AE0-4BBB-9518-19E24AC77A17,dc659941-8d12-4095-8d8a-1769878c363c,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,FC559D77-47B2-4166-90E1-599C451C282F,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,47.29,RNA,1A90F84B-F18B-4A2E-8022-813B7316DC61,Primary Tumor Field,Systemic,2011.0,Alive
s12648,AE24AB9D-6983-466A-A7F4-50DA56438303,TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted.bam,61,B7A31BAC-FD92-47AF-8C9C-E78E3FC1609A,78d14f86-896a-4f98-9274-b2e8e387add9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D206D300-E0CE-4A40-AF1F-45A685346A6E,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T4a,N1,Stage IVA,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,2.03,78.59,DNA,DE1ED45F-D7CE-428F-BA0A-27EADF62FD16,Primary Tumor Field,Systemic,2007.0,Alive
s12695,1E3E0381-A1B4-429B-BD17-62F82E23BC84,UNCID_1657825.49FCB2C7-64FB-47F5-9FE9-7C197F442397.sorted_genome_alignments.bam,43,49FCB2C7-64FB-47F5-9FE9-7C197F442397,9d3f6163-f586-4974-babc-67b5163b706b,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,68764CCE-82CA-4A2C-833A-2EDD79ABF5FF,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1a,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.8,31.07,RNA,,,,2010.0,Alive
s12715,C48D8487-BCBC-4008-AAFB-68F673CA26DA,UNCID_1900765.4ab212b1-2a55-4850-8610-8a3c96ed0c1b.sorted_genome_alignments.bam,51,4AB212B1-2A55-4850-8610-8A3C96ED0C1B,7629f864-a009-4aa9-bf7e-2d99e00d294e,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E01D507C-8E8E-45C6-B4EF-193177A382C4,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,42.85,RNA,9FAB3533-B192-46A3-B1C2-CF2A20B7D306,Primary Tumor Field,Systemic,2012.0,Alive
s12629,649E17CB-1ADF-40A9-A837-4980ACC1A108,TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted.bam,36,D54FCA2A-0B8E-4A33-8B52-3FBF0E47D799,8877b479-b62a-4794-b71e-418de96dff23,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,C6D64D80-C8AA-494A-8C0E-8640BEEBDFC9,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.9,59.26,DNA,,,,2010.0,Alive
s12635,B2380599-45DD-48D5-840C-F6E358DB7169,TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted.bam,62,FB93D33F-510B-45BD-8E70-8FD3A0EA5DBE,dccba97d-4e81-42fb-93b3-90be68a034fb,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,E8BF40C4-8F4D-4032-B18B-D61A87A2DD1A,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.05,36.64,DNA,,,,2003.0,Alive
s12680,A446486B-021D-4576-8260-BCBBF657DDA6,UNCID_1455191.d22c6856-ea5b-4ce7-bf68-ebab9fd5ae23.sorted_genome_alignments.bam,46,D22C6856-EA5B-4CE7-BF68-EBAB9FD5AE23,98a08015-9040-4e0b-bcfa-2c6db7d0f888,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,C332CE53-F002-4824-9718-5065C2C1AF29,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.82,47.13,RNA,47249AF7-BF3C-4A03-B57B-C70738B685CF,Primary Tumor Field,Systemic,2011.0,Alive
s12667,A4B42AC7-28E3-4344-BEA6-1A29B9285041,UNCID_1328134.dcbfdc62-310c-48e0-bb03-f32a657b210a.sorted_genome_alignments.bam,24,DCBFDC62-310C-48E0-BB03-F32A657B210A,8a02f305-6fd8-4908-bc19-06babf028b5b,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,7A756CE5-C46A-47E9-B18B-3B0FC471366C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.81,74.7,RNA,,,,2010.0,Alive
s12666,65409595-9FDE-4F53-A119-66CBE7BE4619,UNCID_1325588.4b7f688f-453c-4f80-b6a5-e7486454e550.sorted_genome_alignments.bam,78,4B7F688F-453C-4F80-B6A5-E7486454E550,258dccee-a3ce-4d4b-a60c-64f45ebfb7ad,233.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,BBD33641-B868-49F3-A424-AA321F29E5CD,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,31.76,RNA,,,,2002.0,Dead
s12721,69BA30D8-29EF-44BB-995D-D6581E9B671E,UNCID_1902140.1826da69-3d45-4607-820b-47fb71d60812.sorted_genome_alignments.bam,72,1826DA69-3D45-4607-820B-47FB71D60812,e0ab95ef-5c96-4d00-8950-04e26e3b4672,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,FDC8D5C5-A5B7-4199-B535-9A1E8685FB22,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.85,26.54,RNA,C1B9CA94-FB1B-4C62-B567-2F22F8AFC11E,Primary Tumor Field,Systemic,2012.0,Alive
s12693,0861F2E8-9A6B-45BE-8639-E570CBD4A98E,UNCID_1656249.C131A5EF-4BCE-419E-9BD2-4FF4D348BE12.sorted_genome_alignments.bam,39,C131A5EF-4BCE-419E-9BD2-4FF4D348BE12,c438c562-a2b6-4ceb-b91a-7e77eb2ec962,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,F24DA390-205C-482F-99DE-8F8AE4EDBC86,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1a,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.87,28.8,RNA,,,,2012.0,Alive
s12704,B4209B46-F882-4181-B644-18481C8491FE,UNCID_1660347.3B8BD89B-9D4E-49A9-BC74-8D6C712D5DD8.sorted_genome_alignments.bam,62,3B8BD89B-9D4E-49A9-BC74-8D6C712D5DD8,c77976b6-35ea-4623-a92a-6d9440a978e6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,BAA64E5A-237E-44AC-8B22-2D86E710F7DB,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.81,54.94,RNA,38A4E351-4E19-4A69-BAB6-3E8420485702,Primary Tumor Field,Systemic,2012.0,Alive
s12831,DF9E8A12-3FC1-4BA0-B997-5081355A7A49,UNCID_1815783.34f062f8-e5c5-4bb3-9778-d2cf440a4178.sorted_genome_alignments.bam,52,34F062F8-E5C5-4BB3-9778-D2CF440A4178,980d1c65-b675-4568-9ce8-c0278686ae8d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,DC79E975-13A4-4EBD-A5FE-F6EB20CAE943,Alive,Asterand,University of North Carolina,Russia,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.86,35.82,RNA,,,,2011.0,Alive
s12817,24FFFF4B-7307-400C-B2CE-1B1494628882,UNCID_1657602.03A8D214-2F94-4EDE-B6BC-E5E7D6D6515D.sorted_genome_alignments.bam,50,03A8D214-2F94-4EDE-B6BC-E5E7D6D6515D,5e085199-152a-40f5-a8f8-3a3a0f31c2e0,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8985644D-C4A6-475D-B090-0148B5C4CDF9,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.82,41.67,RNA,,,,2007.0,Alive
s12737,D881881C-7108-46EA-92A8-1B1D9C915D5B,G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.bam,61,8845FCE6-E2B4-4929-942B-57096B0BBAFC,78d14f86-896a-4f98-9274-b2e8e387add9,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D206D300-E0CE-4A40-AF1F-45A685346A6E,Alive,Ohio State University,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T4a,N1,Stage IVA,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,2.03,78.59,DNA,DE1ED45F-D7CE-428F-BA0A-27EADF62FD16,Primary Tumor Field,Systemic,2007.0,Alive
s12727,BD9E1DA9-58F5-49D6-B838-2ACFFB8EE860,G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.bam,40,B1753E9C-29D0-4955-89D2-949CDABD1211,fb83f7d7-2182-4fb7-8e3e-8ad7f1feac72,,Thyroid Carcinoma,HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,7BC433ED-7908-4297-AA5A-E033924BCED1,Alive,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,15.76,DNA,7B339BD4-768F-4761-9235-D2E46A85A7A6,Primary Tumor Field,Systemic,2005.0,Alive
s12733,9CC1B2F2-01F5-4ED3-873B-152726B61E55,G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.bam,66,62FCEB56-8C6E-4D20-9D2F-5B7042854D23,8d54a2ed-03f1-4a23-bdd2-f3395f5d3716,1500.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,9ED0332E-C846-4091-BF6E-0C5BF55B9F1A,Dead,MD Anderson,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,31.88,DNA,04D5950E-C8F6-4616-BB4C-9994E98B3CBE,Not available,Systemic,1993.0,Dead
s12751,13ADD68C-DF0C-4F19-8032-D084A8CEDCAB,TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted.bam,73,59B09269-9CB6-4AD9-874D-5237896747A1,b43a4f92-7a13-4558-a97e-7b3feb2d70c9,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,13C7182D-EF93-48A7-9569-EED7714CEC40,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.93,31.49,DNA,0F65B1EA-D43B-46D3-8ACE-17EA38027B23,Primary Tumor Field,Systemic,2010.0,Alive
s12771,8216B553-0244-48E1-9604-58F58DD3021C,UNCID_1237439.84ba6854-4027-4301-ad03-95444ccc0ff7.sorted_genome_alignments.bam,52,84BA6854-4027-4301-AD03-95444CCC0FF7,7a9b57c9-6f80-4aea-bf9c-76407c8084be,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,0CE47762-53D3-4D94-B895-90391FF02D7C,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.79,21.62,RNA,,,,2011.0,Alive
s12769,1DE5CFBB-B5BE-4A20-B98F-261CEFF3986C,UNCID_1233392.d4c152fe-3931-47d0-8ed2-df40c8cd4cd0.sorted_genome_alignments.bam,63,D4C152FE-3931-47D0-8ED2-DF40C8CD4CD0,ab8c9101-adeb-4c43-a8bb-b089ebd711f6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,695C5627-F442-4A86-9702-EF35DEFD8C8C,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.89,42.34,RNA,,,,2010.0,Alive
s12762,91B791C7-9AC1-4A55-BB8A-110046B81A61,TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted.bam,54,79850C4D-71D0-4905-946A-F309DCDDA59F,e61fb24b-613a-4b6d-bb2b-00ccedbd3dbc,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,A4240AB1-970E-4A99-989E-8968903E3A25,Alive,Christiana Healthcare,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.91,65.58,DNA,817A7C16-DEAB-45CE-B991-1122E20CCDC3,Not available,Systemic,2011.0,Alive
s12846,403BC9ED-A771-4791-9EE5-3175ECB12AB1,UNCID_2494105.a6592f20-f26d-4690-88c0-22df42a0052a.sorted_genome_alignments.bam,74,A6592F20-F26D-4690-88C0-22DF42A0052A,227dac7d-6bc3-4d8b-ac9c-ea4cab9a602c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,139F6657-166F-4A2F-828F-60CE3579CD09,Alive,BLN - Baylor,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,NX,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.18,1.79,39.09,RNA,729747FA-91E7-4EC5-A408-AC9FC6EC4717,Primary Tumor Field,Systemic,2013.0,Alive
s12781,D40BAB0D-4E89-4D49-AB31-8D81B6D9352A,UNCID_1327446.f837995e-48a9-46b4-bf57-0dd6f3086046.sorted_genome_alignments.bam,79,F837995E-48A9-46B4-BF57-0DD6F3086046,59e91fe5-c80f-4915-be0f-1a7cd3f31f3e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,59E396CB-65B0-4DB8-822E-918231F69234,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,2.0,65.47,RNA,,,,2010.0,Alive
s12819,1D37EC93-878D-4651-B175-EC2C4F80B335,UNCID_1660291.2B0BABA1-90EF-47AD-9910-44B522F7182D.sorted_genome_alignments.bam,37,2B0BABA1-90EF-47AD-9910-44B522F7182D,6ee95dc8-2bac-4691-afa2-8222e07506ad,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,9F63C13D-6008-416E-9E6B-D4ED4210E569,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,46.62,RNA,,,,2010.0,Alive
s12841,A4B9D689-AD21-426C-861C-24C26B69C884,UNCID_1911923.11b81a6e-be33-4bc8-8b91-1034c67a3ed8.sorted_genome_alignments.bam,47,11B81A6E-BE33-4BC8-8B91-1034C67A3ED8,667eb7f6-1d36-49bb-9d7b-c9d167b64619,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,5F75F169-6835-4B42-AF77-AB64CBFB5EF3,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N1a,Stage III,Mar-40,C73.9,C73,NO,,Not available,20.0,0.17,1.83,26.32,RNA,F1039B47-1122-49F6-B326-82A8E60E4876,Primary Tumor Field,Systemic,2011.0,Alive
s12804,0A124BEC-CDD1-4775-9F55-5A965B9C8CCC,UNCID_1653137.62EAA394-4B8C-4719-B483-C450D223597B.sorted_genome_alignments.bam,62,62EAA394-4B8C-4719-B483-C450D223597B,d5932dd7-b777-427f-8b55-3ec369fd76a3,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F410EFAF-80DD-4C07-9AE6-FB7969761F00,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.36,58.4,RNA,AEE86024-88E0-40DB-A95E-CED95307537A,Primary Tumor Field,Systemic,2011.0,Alive
s12808,D3ABA24E-1624-4184-B1D9-E1367AB90FEC,UNCID_1655758.3781742A-0468-41DB-9D54-112FFB35AD92.sorted_genome_alignments.bam,54,3781742A-0468-41DB-9D54-112FFB35AD92,9aa61ab5-f675-43dd-8a99-077164b41f30,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F87AD974-9699-4545-B402-913508BA63A5,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,16.45,RNA,59BB7EA3-D218-42D0-AD85-9A2C833D4BCF,Primary Tumor Field,Systemic,2010.0,Alive
s12811,5A83DEE9-05DC-4163-A837-1D28BD66ED02,UNCID_1653821.8F45A24A-220D-4F37-99C3-D5F584CF3B64.sorted_genome_alignments.bam,39,8F45A24A-220D-4F37-99C3-D5F584CF3B64,039bfc94-fadd-440a-aade-a1595128583e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,ABA9A48D-CD5B-4031-A517-6F4B9619B490,Alive,Mayo Clinic,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.77,20.07,RNA,7B05373B-66AC-4A97-B864-8A21558B61B1,Primary Tumor Field,Systemic,2011.0,Alive
s12754,69CBA75E-7BE6-4707-B524-255288547622,TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted.bam,74,D1BD818E-62BF-4375-A171-ED388341014F,567e4d90-5c5a-44f0-a462-90c831f3c096,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,D0880877-36CF-4DED-87B2-898C3446F90D,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.18,1.87,45.94,DNA,2FA4C8BE-6A3C-4EA7-B69B-28DEAA7C71AF,Primary Tumor Field,Systemic,2010.0,Alive
s12752,256CEE86-6DD3-4D12-BB0B-E3AB680044AA,TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.bam,71,3D02FB7F-EB7D-49F9-BD40-20E9BDA1FBAB,0ad2a2b3-c1bb-4597-b28e-a6385f93d09c,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,17610B7B-F2EC-4B55-808C-1C2219A0D1BA,Alive,University Health Network,Harvard Medical School,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.93,43.33,DNA,7B7BC09E-0D53-40EC-8D9D-44658DB89F7A,Primary Tumor Field,Systemic,2007.0,Alive
s12844,92DF6D1A-FEF6-4003-BBDE-999329BBA04F,UNCID_1918282.0d43a86d-9356-426a-94dc-4448bd6820b8.sorted_genome_alignments.bam,46,0D43A86D-9356-426A-94DC-4448BD6820B8,212b2002-1ebf-47dd-82f8-6c0b904cf909,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,6E1CBA50-1B4C-40F3-B847-C88FB1F64C2A,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.83,45.89,RNA,,,,2011.0,Alive
s12807,9539D800-E093-4A57-8E59-D0F54C03CEC1,UNCID_1654373.F60D7FBE-225A-48F6-879D-7F342DCF3057.sorted_genome_alignments.bam,32,F60D7FBE-225A-48F6-879D-7F342DCF3057,7b49f263-fa0d-4f1b-9c00-1ff7a8c9ac79,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,25FF2EA2-7CED-4865-9DF7-6E3E8830D55C,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.18,1.8,26.21,RNA,,,,2011.0,Alive
s12777,FE73D148-B81B-4F54-BC7D-2F3CBD10B200,UNCID_1281327.7c03a305-f07b-4bbc-937f-8ec0dfdb2731.sorted_genome_alignments.bam,73,7C03A305-F07B-4BBC-937F-8EC0DFDB2731,b43a4f92-7a13-4558-a97e-7b3feb2d70c9,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,13C7182D-EF93-48A7-9569-EED7714CEC40,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.75,26.03,RNA,0F65B1EA-D43B-46D3-8ACE-17EA38027B23,Primary Tumor Field,Systemic,2010.0,Alive
s12748,A3B0754A-92CA-4EF2-B612-4E5BF2F74048,TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted.bam,51,3E92A45C-FFFB-4C07-BD81-DB3EBF41841F,3b3c99ab-5336-4433-b682-e1a590221611,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,AC52BED3-FDD6-4281-89DE-D2F125BA038E,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.95,52.8,DNA,,,,2010.0,Alive
s12744,787AED3E-08D4-4FA8-93E1-C04216A9875F,TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted.bam,67,F3A353BB-07C3-49D1-BED2-2F8F5A328E1C,4c513413-263e-4c7b-b997-7b688c47b698,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,A61A9EC7-B893-44A5-AB6F-A390C168BE88,Alive,University of Pittsburgh,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.95,34.66,DNA,,,,2010.0,Alive
s12780,215A4642-1DDC-48A3-A87C-61C179200C1B,UNCID_1326303.433015bc-0391-4556-9cb3-7aa2b660acb2.sorted_genome_alignments.bam,29,433015BC-0391-4556-9CB3-7AA2B660ACB2,c6f08366-f30d-45bd-b949-b59d2493995d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2429F318-BD68-4483-A762-ED697CBF14B6,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.81,66.13,RNA,,,,2011.0,Alive
s12809,017A6246-DB7E-46E5-9836-259A40174579,UNCID_1656577.BB5BE7FF-D74C-41F6-B3C7-9F79F494C024.sorted_genome_alignments.bam,79,BB5BE7FF-D74C-41F6-B3C7-9F79F494C024,3bfa52af-cb40-45d8-9bdc-591985aae7fb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0C13351C-EA7C-44B1-A9EE-ED7E383B7924,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.8,35.6,RNA,,,,2008.0,Alive
s12764,E479B09B-6A95-492C-B1D2-834C5D06EB88,UNCID_1209266.102d50cb-a421-42d3-b417-be1e96a85ec8.sorted_genome_alignments.bam,28,102D50CB-A421-42D3-B417-BE1E96A85EC8,7802140a-e518-4ae6-9bd1-c26d80b14ab1,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,53B4B1BF-2C13-4530-8E58-9629B20C658E,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N1b,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.87,30.58,RNA,,,,2010.0,Alive
s12801,8F8DB9B7-9D56-4892-BAC2-79AA9B61FCF4,UNCID_1565627.F88AF011-238B-465B-B83C-F4C4CE1FA296.sorted_genome_alignments.bam,69,F88AF011-238B-465B-B83C-F4C4CE1FA296,029da211-9b52-45ad-b0dc-2322da783c9c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,8120ECC1-BBDA-4747-AA57-4E8CF9095084,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,11.0,0.15,2.0,13.7,RNA,C8D7897E-0CF6-45E1-B7AF-D2A16A85483D,Primary Tumor Field,Systemic,2011.0,Alive
s12760,0D67CDED-FF5A-4B7C-BC1E-2BDA8EE44700,TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted.bam,16,DBD2621E-9F39-45C6-B9AE-67873AECA03D,10bdafbb-831d-48b5-b9a3-ad374fc50235,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D37BED2A-BF63-43E0-91D0-6C95E4CA2D45,Alive,Ohio State University,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T4,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,10.0,0.15,,44.72,DNA,5BDAD2FF-EDC0-4CDE-A92F-117A81CB2DFC,Distant site,Systemic,2002.0,Alive
s12818,BF32C4CC-55C4-468A-BA01-94E18F72B94F,UNCID_1660368.1B4E42C0-C100-404F-843D-A27EA314858A.sorted_genome_alignments.bam,32,1B4E42C0-C100-404F-843D-A27EA314858A,02a8e937-c747-4ba1-911c-0860e62b8f83,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1BCBD492-986E-41D1-BCFF-0BFB7DD74AE9,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.81,18.62,RNA,,,,2011.0,Alive
s12825,C01C94C5-A1DF-4BFA-B583-0A4B8586E9AC,UNCID_1668682.DBC6D549-CAB2-4A9B-A85B-2E9B09BD016D.sorted_genome_alignments.bam,76,DBC6D549-CAB2-4A9B-A85B-2E9B09BD016D,7b82e2d2-47f9-41a1-9eca-40904c92039c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,FB1E4845-7B30-44C0-8799-FB2C9C619F34,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N0,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.15,1.76,33.42,RNA,0F6AA9B5-7037-4596-977C-1626FFA36F17,Primary Tumor Field,Systemic,2011.0,Alive
s12788,BC6AFADC-AF71-450D-B071-B8F1F82BE5E1,UNCID_1375060.3c93d676-52b4-4c4e-a19f-08b77ba1fd32.sorted_genome_alignments.bam,64,3C93D676-52B4-4C4E-A19F-08B77BA1FD32,229004af-14eb-442e-905e-61c842b3efa0,813.0,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,3FDB3D6D-E8FF-4B5B-83C5-63265A4C915E,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.76,19.02,RNA,AFF2AF90-F49D-431B-996A-2E7303D9D372,Regional site,Systemic,1996.0,Dead
s12795,6C5BD2CC-E13A-4522-9F28-52182C3F3D51,UNCID_1560084.CD987AFF-9F7D-47BB-AD56-555D863855A5.sorted_genome_alignments.bam,66,CD987AFF-9F7D-47BB-AD56-555D863855A5,ea2c873a-ea52-4920-8d20-554d5fa8ddc1,1753.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,41B0039F-00C0-4B3A-B90D-80F8FA394625,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T4,N1,Stage IVC,Mar-60,C73.9,C73,NO,YES,Not available,30.0,0.15,1.78,62.44,RNA,5E47F282-E0EB-47AC-BCD0-B84419028A27,Regional site,Systemic,2004.0,Dead
s12835,E6AE462E-FE72-45A0-9BB5-A5B930D05481,UNCID_1900755.9bea59ee-e522-41c7-ba60-4cb0cb6b266a.sorted_genome_alignments.bam,74,9BEA59EE-E522-41C7-BA60-4CB0CB6B266A,dc392a57-2028-4eca-8bf3-760ec99703ee,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,27BC60C8-C2CB-4DDC-92F2-E5A437002B11,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.78,58.62,RNA,,,,2009.0,Alive
s12778,32417913-8CD8-4E5A-ABDB-356B76471383,UNCID_1328196.a1d090b6-22e9-44df-919d-0f5754851945.sorted_genome_alignments.bam,42,A1D090B6-22E9-44DF-919D-0F5754851945,a061976d-ba2c-4a18-a51e-952f198eb4d5,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2CECA350-0D77-47D5-9D5A-12C3B71704EF,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.84,31.8,RNA,,,,2008.0,Alive
s12775,47080508-C392-489D-B86A-3ED872976104,UNCID_1265174.8854ee68-24a7-4ff1-b411-50e9141404d9.sorted_genome_alignments.bam,46,8854EE68-24A7-4FF1-B411-50E9141404D9,de9315b3-b3df-45f0-adc2-69aa6b8ff717,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,8494EA4B-C009-4318-BFF6-FBE9449F64BA,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1b,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.92,62.51,RNA,B9D41CB6-897E-4DBD-815E-B5E2768D2EB1,Primary Tumor Field,Systemic,2011.0,Alive
s12829,958130BB-8F85-439D-AAF8-6063DBB46C78,UNCID_1815961.b544247b-a6dd-4a10-b9dc-a9437ccbded2.sorted_genome_alignments.bam,23,B544247B-A6DD-4A10-B9DC-A9437CCBDED2,2d633ced-ae85-462c-90e7-c1b109e084cf,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,6296EFE7-08BB-45FC-AE3F-CC07B5042033,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.77,46.43,RNA,,,,2012.0,Alive
s12822,21935182-39F8-4732-B045-2F72E778C6A8,UNCID_1660587.AEA3BB66-7279-4352-9CEF-5459CBDFE183.sorted_genome_alignments.bam,63,AEA3BB66-7279-4352-9CEF-5459CBDFE183,d78012b6-24f9-48f5-9409-9845d0be2b3c,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,AC509941-28B2-4257-A8CD-918F8572F64D,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1b,Stage IVA,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.87,43.47,RNA,02D87E67-2F33-4968-8653-B50D92FF3E0D,Primary Tumor Field,Systemic,2010.0,Alive
s12776,41C86756-D4BC-45B8-8AE8-8AE5EBBDDEEC,UNCID_1273510.f92e4800-911b-4603-aff1-8af07649763d.sorted_genome_alignments.bam,31,F92E4800-911B-4603-AFF1-8AF07649763D,286de8cd-7222-4f85-a370-79a7903edf45,,Thyroid Carcinoma,Not available,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,ED984F05-7FD9-4231-9D5C-002ABC29CB64,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.86,31.28,RNA,,,,2010.0,Alive
s12812,778EB881-1453-4380-99DF-30DE2852456E,UNCID_1656782.A6D66740-E560-42DC-9AAC-4AD00649E361.sorted_genome_alignments.bam,52,A6D66740-E560-42DC-9AAC-4AD00649E361,b305b716-5ae5-421b-b3c9-0824d37b08a8,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,E3325E6D-C54E-47C2-A50C-E4071312DFC9,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1a,Stage III,Mar-44,C73.9,C73,NO,NO,Not available,30.0,0.17,1.83,33.9,RNA,45ADD2B0-16C7-44FE-940D-47901D41E481,Primary Tumor Field,Systemic,2011.0,Alive
s12840,9D7CA0F1-C53F-4F6E-8E25-B9855ED11E00,UNCID_1902405.865c259f-80d6-4f88-b5d1-14d8d6e7f2e6.sorted_genome_alignments.bam,45,865C259F-80D6-4F88-B5D1-14D8D6E7F2E6,29963391-3926-4b7c-8066-185f0f2d5bfc,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F76F10F8-BCE1-4BAB-8B70-FFAA560D45DC,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,NX,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,20.0,0.17,1.85,16.8,RNA,,,,2012.0,Alive
s12773,11DCF049-38D7-4446-AF5E-80E99AC4734F,UNCID_1237046.e7b0528c-6ca5-45ae-9b9e-4bdf472ef15a.sorted_genome_alignments.bam,36,E7B0528C-6CA5-45AE-9B9E-4BDF472EF15A,dffc4f7a-c67a-4ac5-a338-717dffde686d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D68C3B99-CB82-48BD-A1F8-BEE0A9A9E8C3,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,2.0,59.89,RNA,2A0BA6DD-DE0D-4EF4-9DE9-52FFD3BFE727,Primary Tumor Field,RADIOISOTOPES,2005.0,Alive
s12826,0F0B8CF6-2EC4-4E3A-A252-6F36F56BCD7D,UNCID_1665614.D0B1F7B1-C604-46A9-B2E3-FD4285E56C8C.sorted_genome_alignments.bam,78,D0B1F7B1-C604-46A9-B2E3-FD4285E56C8C,315cbbe8-62c8-488b-92c5-e2046321efb7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,39A70BF2-437C-4CBC-8667-E7DCECF1AE57,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.82,73.02,RNA,14A1B41C-0B7F-4029-94C7-68F2F1BBC069,Regional site,Systemic,2008.0,Alive
s12782,A9CF0D8A-A404-42D2-8267-4325FC227C96,UNCID_1346092.18dd389b-b0b7-43f7-877f-0fb8e3471af0.sorted_genome_alignments.bam,80,18DD389B-B0B7-43F7-877F-0FB8E3471AF0,bed1fb3c-4459-460e-8190-29211857fa73,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,4862B699-580D-4F2E-97A0-BD8918537067,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.04,42.27,RNA,,,,2011.0,Alive
s12836,AF33860A-C6B2-4D79-B615-9C27C9F60A26,UNCID_1900704.e84aa302-bced-477d-a3ff-d462a2530616.sorted_genome_alignments.bam,36,E84AA302-BCED-477D-A3FF-D462A2530616,c53c4bfe-d9d2-4882-a46b-fa487d95b8ba,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,EE7BBEE7-B6F5-49CB-8A25-B7B6CCF2710B,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N1b,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.17,1.9,43.08,RNA,3EB4D866-1D9B-44C7-A23A-2B1FE4BB3232,Primary Tumor Field,Systemic,2012.0,Alive
s12827,5330FA17-9818-48B7-A876-5B278170C779,UNCID_1677050.D4111037-F2AC-4B83-8E8C-87ABF68EC189.sorted_genome_alignments.bam,47,D4111037-F2AC-4B83-8E8C-87ABF68EC189,b1640709-8b2f-4cca-a2c0-55a1b4a1884b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,76E3D9F4-513F-4A44-8918-4C29CE5FB305,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.0,42.28,RNA,,,,2004.0,Alive
s12830,693C7248-09DA-4542-B745-66B0AA3CC7FE,UNCID_1815522.bde8a6f0-44cd-4627-adab-5a040bee35c4.sorted_genome_alignments.bam,46,BDE8A6F0-44CD-4627-ADAB-5A040BEE35C4,7d818f01-49a6-4ba8-9f1c-c77398adbdd0,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,9632923B-6540-4F0F-918B-EC1926EB1A98,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,NX,Stage III,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.88,38.0,RNA,F41B8DEF-EE74-445D-A241-2F7988ED6917,Primary Tumor Field,Systemic,2008.0,Alive
s12743,1E492402-4405-430B-A336-E8043EF159C8,G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.bam,49,546B97B0-AB82-42A1-BBD2-241523278EC3,e1ff7694-64e1-47ed-b0d8-34acfb4ffef1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,D6183BCA-9A4D-41AC-940D-0EAA23DECF56,Alive,National Institutes of Health,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,NX,Stage IVC,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.08,,42.4,DNA,064FC312-27D3-4A19-B264-30416C37E478,Primary Tumor Field,Systemic,2011.0,Alive
s12794,C2258D69-3A81-403C-9AD0-8A595E74D05C,UNCID_1560220.96E0E370-4DB3-4DB4-8123-7026ECC1E320.sorted_genome_alignments.bam,65,96E0E370-4DB3-4DB4-8123-7026ECC1E320,e95c7f24-89ab-4d56-aae6-d2268888c549,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A7D31C23-C222-48AF-A389-AB1A99449610,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.71,23.69,RNA,564557EB-24E0-48EA-8CD4-2AF3B214BB2B,Regional site,Systemic,2008.0,Alive
s12803,83C14813-F1E3-43BB-8DCE-916D2C47A48C,UNCID_1578399.389D9804-EA66-4E27-8808-295A9EB16697.sorted_genome_alignments.bam,89,389D9804-EA66-4E27-8808-295A9EB16697,8392edea-82b3-4610-87a0-f545f673e922,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,09808DCB-1011-43FF-8782-5A367DF02A3C,Alive,University of Miami,University of North Carolina,United States,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),T3,N1b,Stage IVA,Mar-44,C73.9,C73,NO,,Not available,20.0,0.18,1.79,17.15,RNA,,,,2012.0,Alive
s12785,1C21C483-7E70-41BE-BB30-ECAB1DBEF7F0,UNCID_1347548.79e2e047-5d06-4e11-99f3-b22441bb70d1.sorted_genome_alignments.bam,70,79E2E047-5D06-4E11-99F3-B22441BB70D1,fb39f29a-5d1e-4f96-8adb-e18cc87fad2e,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D156E12D-4D39-4E10-B1D7-C3B664BBFC7E,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.76,17.49,RNA,,,,2010.0,Alive
s12834,A885505D-E609-4653-9B5C-C045C5A8E3EE,UNCID_1897708.cf19f287-ebc8-4be0-a619-cb26e7d5a671.sorted_genome_alignments.bam,48,CF19F287-EBC8-4BE0-A619-CB26E7D5A671,6e1c9ac8-eead-4db9-8f30-ef3591daf78b,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2669313A-0641-42E4-B284-964E426B9C9D,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.76,47.39,RNA,A316E91E-4CF7-4BDA-A220-025D08F23AE2,Primary Tumor Field,Systemic,2006.0,Alive
s12784,91DCD81D-A5FD-466D-8E08-956C30766C12,UNCID_1357911.7473f4ae-a2b7-4be3-99ca-560d93fc793d.sorted_genome_alignments.bam,87,7473F4AE-A2B7-4BE3-99CA-560D93FC793D,011ae7b8-5003-4fcd-9f20-906a723f2c66,1734.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,590C3292-1DDD-4204-B6B7-956C5467D1E3,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,32.89,RNA,,,,2000.0,Dead
s12766,044D2D85-E024-4E66-A0DF-3B256160C228,UNCID_1211507.ec025dfd-0c20-478f-babb-51c16aab8cf2.sorted_genome_alignments.bam,70,EC025DFD-0C20-478F-BABB-51C16AAB8CF2,1f094db9-f8cc-4066-adff-609682936172,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,392C23AD-B249-4432-BA8F-5AD501206E2D,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.83,24.01,RNA,,,,2010.0,Alive
s12772,95E8AA08-1A3B-498B-9D64-65C5C7E911FF,UNCID_1235450.7f385a18-a567-4386-99b8-4f54f13d325e.sorted_genome_alignments.bam,54,7F385A18-A567-4386-99B8-4F54F13D325E,e61fb24b-613a-4b6d-bb2b-00ccedbd3dbc,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A4240AB1-970E-4A99-989E-8968903E3A25,Alive,Christiana Healthcare,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.88,24.86,RNA,817A7C16-DEAB-45CE-B991-1122E20CCDC3,Not available,Systemic,2011.0,Alive
s12832,1AF20675-8BEB-4165-89E4-31622FED516A,UNCID_1856814.0931e34f-0ec0-41a7-bd0c-e1c4824c92ad.sorted_genome_alignments.bam,51,0931E34F-0EC0-41A7-BD0C-E1C4824C92AD,cc84500c-0196-450d-87a1-ca394cc227b5,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,72A05186-7575-4D52-A81A-5B036A71611D,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.75,24.15,RNA,,,,2012.0,Alive
s12787,C29D3EB5-FD8D-415D-95A6-5D8173CCACF9,UNCID_1360947.39d90ab6-7625-41b2-b6d9-28e2347a7529.sorted_genome_alignments.bam,47,39D90AB6-7625-41B2-B6D9-28E2347A7529,05350770-2b5b-4c58-84ce-0917665ccb90,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,F6DE8D5D-FDEF-4B72-9C0F-184FD79FF3E5,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,30.0,0.16,1.81,61.36,RNA,,,,2011.0,Alive
s12789,7258EC5B-08DB-4515-9CE2-6FFDCBB62A50,UNCID_1375758.7168b8b4-be72-48aa-942c-0e72ca68926c.sorted_genome_alignments.bam,65,7168B8B4-BE72-48AA-942C-0E72CA68926C,d487536f-0521-4d42-9150-6a806ae00241,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D9EC9029-BE41-43D5-A134-6A0416B01AB7,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.84,31.55,RNA,31163575-E375-4603-9858-F552C341D251,Primary Tumor Field,Systemic,2011.0,Alive
s12758,3609A0F8-B027-4392-ADEA-96EAB2E1D78F,TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted.bam,18,4336BC49-7D28-4EB6-8B41-F43127ED8EC1,e70feafd-1390-4f4c-a635-da65c1a7daeb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,76A6F76D-F33E-4B4A-B0EE-FB863345F194,Alive,Ohio State University,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,2.05,92.7,DNA,7BE4F3BE-9D1E-40AB-8E97-5440FAE9F4D4,Primary Tumor Field,RADIOISOTOPES,2007.0,Alive
s12774,25566B08-22C0-499B-BDC6-370E321961C1,UNCID_1248483.ad4a6ae8-63bb-4890-9b31-314a2fa81d1b.sorted_genome_alignments.bam,27,AD4A6AE8-63BB-4890-9B31-314A2FA81D1B,fd8c4ff3-e759-495f-96e7-1f406bb70190,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,829DB78C-AB3C-41CC-89D6-9C38519F7989,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.85,62.24,RNA,66CE2ADC-B01C-41CD-BFF2-92A5C2D7AF0F,Primary Tumor Field,RADIOISOTOPES,2006.0,Alive
s12791,2FE4801C-ACA7-4FE0-B841-AAB0249EAC6C,UNCID_1457485.0bf79d69-9960-4881-a7a7-2eabe048f81f.sorted_genome_alignments.bam,53,0BF79D69-9960-4881-A7A7-2EABE048F81F,00a02e62-e1ab-467a-91b3-5f526dd2251a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,CB3E83EF-1C8E-4F7D-8A92-B355DEF240CC,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,NX,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.86,54.05,RNA,B399B5D4-F6BD-494C-8BF3-F0C6799BC4E0,Primary Tumor Field,Systemic,2000.0,Alive
s12814,4EF54932-6B08-404F-9530-6298A759C66C,UNCID_1658802.78F4DE91-9CB5-40C4-AF0D-F295468716FD.sorted_genome_alignments.bam,20,78F4DE91-9CB5-40C4-AF0D-F295468716FD,4d1aec67-c345-4721-8ee8-356b0dff009b,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,1392A49C-87BC-45E7-B7D2-ACD53E921467,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.86,34.03,RNA,16C8FBA0-9EAC-47B8-A864-C42F887F2892,Primary Tumor Field,Systemic,2011.0,Alive
s12839,60B0A862-701B-4E10-AE46-0EAD611AFEA4,UNCID_1902614.8f581126-cf99-41bb-84ce-c9533f2db53a.sorted_genome_alignments.bam,54,8F581126-CF99-41BB-84CE-C9533F2DB53A,08293bf4-727d-45c2-abbf-1aec3ba1c8a4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2F9B1634-04B5-44AD-8EC2-A23EF4FFB0DD,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.85,26.6,RNA,,,,2010.0,Alive
s12770,413D673E-4FAA-47F5-90B5-FAC36E5C52BB,UNCID_1234040.0a664c34-94cf-490a-8f3e-e735a75af74c.sorted_genome_alignments.bam,43,0A664C34-94CF-490A-8F3E-E735A75AF74C,99ef2fec-5a3c-4e42-8f78-7eaf9877e26d,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,64D1F58A-986F-4D4B-962E-DA59A48C988B,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.18,1.83,42.24,RNA,,,,2010.0,Alive
s12757,970A6DAB-C1E4-4446-968A-4B37D1506EEB,TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.bam,36,663173D3-A9EE-4E73-8444-52F01727BE6D,2f9ed09d-2626-4c23-ba47-1850d36f812a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,343311B1-D586-4F92-9984-32AF1AFB1F62,Alive,Johns Hopkins,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,2.0,57.24,DNA,1C5B2B34-804B-467C-B457-46716ED4C490,Not available,Systemic,2009.0,Alive
s12731,DBBAB09C-382C-48F0-AECA-E5EC1CC0C948,G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.bam,19,79133E29-BA0B-4E2F-A6D9-BF294C5144F0,fef9c64f-5959-4da0-aaa2-66b56fc7b4c3,,Thyroid Carcinoma,Not available,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19_Broad_variant,Primary Tumor,4F88157A-572E-4236-B956-206A9E227DEB,Alive,University Health Network,Broad Institute of MIT and Harvard,Canada,Other  specify,T3,N1b,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.08,,10.98,DNA,,,,2011.0,Alive
s12767,1B33D998-3AC3-4CBB-88E1-1B4E12434399,UNCID_1218532.2bad2998-4066-4796-8569-1de516cb0d36.sorted_genome_alignments.bam,55,2BAD2998-4066-4796-8569-1DE516CB0D36,e92bdb0d-969a-4d98-ada8-5dfec68119b5,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,C1DAF740-06E2-4509-86BE-5BFCC52B508A,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.79,33.44,RNA,,,,2009.0,Alive
s12763,AAD24755-049E-4F93-849F-A4AA9264E9C0,UNCID_1209597.47039a8f-de54-4ff9-84e2-6c1cdcd97dc0.sorted_genome_alignments.bam,26,47039A8F-DE54-4FF9-84E2-6C1CDCD97DC0,2f59f12d-ca0c-4ac6-9718-98a6d455af46,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,043765F1-FFBD-4AC9-B0AE-733C3643083D,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T2,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.84,35.35,RNA,,,,2011.0,Alive
s12730,DBBFCD8F-5283-4BF9-98F1-9211808BFED9,G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.bam,37,AD874249-9964-4E48-AA3F-7E828EA28F3F,6ee95dc8-2bac-4691-afa2-8222e07506ad,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,9F63C13D-6008-416E-9E6B-D4ED4210E569,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.08,,47.65,DNA,,,,2010.0,Alive
s12820,DED6120E-D3A3-4E35-8C3E-993331ACAFC9,UNCID_1661355.3EDD1965-26F0-4223-9840-9FDBE2CA531E.sorted_genome_alignments.bam,37,3EDD1965-26F0-4223-9840-9FDBE2CA531E,8e274b77-c05e-4a8c-a106-c552df1f2d11,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,637267D7-9AFF-494E-9D51-C2651EF0681F,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,41.13,RNA,9BB1DA72-D722-4793-A96A-03B6E03622AF,Primary Tumor Field,Systemic,2002.0,Alive
s12815,7C2AABF0-F424-4BBA-9237-94935C59A400,UNCID_1659801.CDECDCED-115E-4775-BE8A-614FD1A3414F.sorted_genome_alignments.bam,83,CDECDCED-115E-4775-BE8A-614FD1A3414F,2a398af1-aea5-4aae-ab00-a2dc152f965a,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,60C1BA59-C04E-4237-A8B9-FA0D894BBAFA,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.04,39.81,RNA,86D7F44F-40E6-4B90-ADCE-4C8CC5F2AA48,Primary Tumor Field,Systemic,2011.0,Alive
s12833,4ED74768-EF59-49F6-996E-DBF6B4E8BB56,UNCID_1880732.237aa00b-7c17-45ef-a95e-396565c7b581.sorted_genome_alignments.bam,46,237AA00B-7C17-45EF-A95E-396565C7B581,52bc133b-8a10-4c9b-adc3-22910a191e6b,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,AA007E4C-E9AF-490B-9CD8-45D6C3C8AA99,Alive,University of Michigan,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.88,54.52,RNA,01DA8F4A-BB44-4C06-A9A7-EE5B37CA1CB1,Primary Tumor Field,Systemic,2007.0,Alive
s12806,FB360583-16BD-490F-87F3-4640379B1F8B,UNCID_1653306.D8C91DE0-3257-4C49-8EAE-DFC381A81481.sorted_genome_alignments.bam,55,D8C91DE0-3257-4C49-8EAE-DFC381A81481,44c2da7c-6975-4d09-b65c-4b30afd019bb,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,DC7A88BE-6521-4457-A2CA-3C71701E382E,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1a,N0,Stage I,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.18,1.86,27.15,RNA,,,,2012.0,Alive
s12838,1906843F-AECC-412F-A6E6-0472BB8503EC,UNCID_1905121.34dda809-a7af-411f-ab80-b021b077eaf9.sorted_genome_alignments.bam,75,34DDA809-A7AF-411F-AB80-B021B077EAF9,6abc861a-376d-446b-acee-fb0f03a82c09,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,AACF33BD-95CE-40FD-9828-1E78CBBB0E1B,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1a,Stage IVA,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.76,71.05,RNA,02B8F335-A3B6-44AA-8BC6-D454C3A0D1F3,Primary Tumor Field,Systemic,2011.0,Alive
s12790,63CEA3D1-2122-4C51-9F3B-925D744E9A46,UNCID_1374941.bf2e2e27-73f7-439a-aeb5-7dce828d8903.sorted_genome_alignments.bam,23,BF2E2E27-73F7-439A-AEB5-7DCE828D8903,1757c89f-8795-4c3b-bbad-1e6f617f2472,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,F1A60CA8-A19E-4802-BCA8-D7286A3F4A77,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,20.0,0.18,1.75,25.9,RNA,ACA9B7FD-5078-4704-A3FC-600230F38A2D,Primary Tumor Field,Systemic,2006.0,Alive
s12786,A6A433DB-B772-4717-A658-3BC99AA8BA68,UNCID_1361852.c03f59b1-2550-4a6c-aad1-b1dec3e3ecd3.sorted_genome_alignments.bam,83,C03F59B1-2550-4A6C-AAD1-B1DEC3E3ECD3,369a07a5-f835-4886-a204-d5584c67f253,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,2F2DDF50-99C0-42A3-9CA1-0440B9AF3072,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1,NX,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.78,30.58,RNA,,,,2007.0,Alive
s12768,F232384E-789F-4C4D-B2E1-BBDE22344484,UNCID_1218815.7cb4c793-df92-4168-86f3-b0a89f4ae248.sorted_genome_alignments.bam,39,7CB4C793-DF92-4168-86F3-B0A89F4AE248,22eb9f00-6869-4d8f-b657-dfd64f81e9e9,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,7045F3E1-5239-4159-9B38-31E4168853D0,Alive,University Health Network,University of North Carolina,Canada,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.17,1.93,15.72,RNA,,,,2010.0,Alive
s12805,D1F33440-B1FA-4D6C-AC72-262F4BA40CBB,UNCID_1649868.E5E28111-9541-4A74-A2EC-9B60637C76E8.sorted_genome_alignments.bam,56,E5E28111-9541-4A74-A2EC-9B60637C76E8,efc46db7-f9df-494e-acca-357cb64c019a,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,CB3EFC94-0F31-44E0-BA69-4EB7CBEDEBB3,Alive,Asterand,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,1.77,16.85,RNA,,,,2012.0,Alive
s12845,576CB87B-1B1D-412D-838F-432DEDB3DE33,UNCID_2281975.77212876-e70b-4697-bf83-240e2a0a4c56.sorted_genome_alignments.bam,46,77212876-E70B-4697-BF83-240E2A0A4C56,3b088cb4-6fd4-45ac-a708-dffd873546dc,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,C4D60838-3EA2-492A-85DA-45A80FD20146,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1a,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,20.0,0.18,1.84,38.17,RNA,,,,2012.0,Alive
s12792,DB7ADE86-8200-47CF-9EEE-E2F39591141B,UNCID_1457735.a672af36-469b-4ec9-8f47-69dbdf2a6242.sorted_genome_alignments.bam,47,A672AF36-469B-4EC9-8F47-69DBDF2A6242,471636d5-9eca-49df-872a-c2a2cac61838,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,CD834FE0-00D5-431C-B8A4-CDC1EC3E1387,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.84,30.49,RNA,058CBEFC-FFF2-4F41-ACB7-863790778232,Regional site,Systemic,1999.0,Alive
s12837,81E85710-E846-4C8F-9910-15454A617ECC,UNCID_1900716.eab55e05-a92f-471a-88d4-7663d70d940b.sorted_genome_alignments.bam,31,EAB55E05-A92F-471A-88D4-7663D70D940B,6a63961e-6ca4-45fa-93ee-65f7c392fcf0,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,52750F76-8519-4267-917F-253231038CF0,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.88,23.18,RNA,,,,2009.0,Alive
s12796,92B8D338-9A99-4D6E-B6A9-834C3875F95E,UNCID_1560276.A2642F34-BADA-4983-A1A9-93B62AE1CC8F.sorted_genome_alignments.bam,48,A2642F34-BADA-4983-A1A9-93B62AE1CC8F,f7f6e9f4-1aa8-48a0-bea9-efaa9379f6f6,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,851B3D3D-BED1-4865-8163-F39A6CAF0710,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,,Not available,30.0,0.16,1.8,35.74,RNA,,,,2011.0,Alive
s12739,F713E001-9C18-4A72-A093-90BD147D414F,G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.bam,61,29578759-9CCB-4A24-B5B8-C45EBD4339D9,63b01b43-a68a-4046-89b0-736ba4d08504,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,B48D226E-610A-40DC-B62A-6DB863A7366C,Alive,Johns Hopkins,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.07,,32.19,DNA,,,,2009.0,Alive
s12843,96B418E5-62ED-4673-987C-34FC13AF9083,UNCID_1911052.4fe8f85b-b46a-4e29-b152-8f46cfbd09ae.sorted_genome_alignments.bam,49,4FE8F85B-B46A-4E29-B152-8F46CFBD09AE,e1ff7694-64e1-47ed-b0d8-34acfb4ffef1,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D6183BCA-9A4D-41AC-940D-0EAA23DECF56,Alive,National Institutes of Health,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T3,NX,Stage IVC,Mar-40,C73.9,C73,NO,NO,Not available,30.0,0.16,1.82,32.18,RNA,064FC312-27D3-4A19-B264-30416C37E478,Primary Tumor Field,Systemic,2011.0,Alive
s12813,CDDE4F95-68BF-41E3-852B-067F18C72914,UNCID_1659429.0E538879-75BE-4F5B-8EC1-A513546AF04B.sorted_genome_alignments.bam,63,0E538879-75BE-4F5B-8EC1-A513546AF04B,6435ea21-7214-40c5-9ccb-a1f22685a728,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,5187A6C7-C87F-4198-BC78-9C95586C2575,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,2.13,33.2,RNA,F462FB98-2493-41E4-84CD-7AEE3FD8D2FA,Primary Tumor Field,Systemic,2002.0,Alive
s12793,8FB61FEF-F0A4-4DCA-878E-7FD40552116D,UNCID_1560175.BEDFA47C-8383-4AAF-A609-F96850B414A2.sorted_genome_alignments.bam,66,BEDFA47C-8383-4AAF-A609-F96850B414A2,8d54a2ed-03f1-4a23-bdd2-f3395f5d3716,1500.0,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,9ED0332E-C846-4091-BF6E-0C5BF55B9F1A,Dead,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.18,1.76,23.56,RNA,04D5950E-C8F6-4616-BB4C-9994E98B3CBE,Not available,Systemic,1993.0,Dead
s12736,2A8CAA63-CA28-490F-8B5C-13DB08AFD1C8,G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.bam,45,0C18A8B7-BAD1-4AA4-A6DF-472F89D9761C,3b48cc5e-3396-4dd5-893d-54b75b98b016,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,4DCA97A5-B0E5-4383-8CC5-B6FF07741647,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T1b,N0,Stage I,Mar-40,C73.9,C73,NO,,Not available,30.0,0.08,1.95,50.62,DNA,,,,2010.0,Alive
s12802,22F8B650-FB8C-433B-908A-16FD674CCA00,UNCID_1565705.D84C9CCD-897B-436D-8CBE-165CD8A0D42B.sorted_genome_alignments.bam,43,D84C9CCD-897B-436D-8CBE-165CD8A0D42B,18a58e3e-f18e-45cf-86bc-1851abb9b3de,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,3A1B36A7-177D-4529-BC94-91A7C6063BCE,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,NX,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.17,1.83,21.86,RNA,,,,2007.0,Alive
s12747,0D7263BD-8FFA-4BA1-93C4-0444AFD9B56E,TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted.bam,51,EC6A8D75-A25A-4179-BAF4-53607841AC09,29c4319c-3ead-42b1-810d-418da8d515c4,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19_Broad_variant,Primary Tumor,8C112A5F-AE83-4B13-8E00-802382729344,Alive,University of Pittsburgh,MD Anderson - Institute for Applied Cancer Science,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage III,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.15,,17.47,DNA,FE74EC84-EEA7-4254-AE6F-E44A6A759759,Primary Tumor Field,Systemic,2011.0,Alive
s12779,6CD0874B-55FB-4259-93DA-88F016DDE257,UNCID_1325496.13b585a4-2072-49c1-87fa-ad55d5447b6e.sorted_genome_alignments.bam,27,13B585A4-2072-49C1-87FA-AD55D5447B6E,dfe086e6-71a5-4131-9602-f20977bf7454,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,902ADB27-13EF-4C87-845C-9A79944A1644,Alive,Johns Hopkins,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1,N0,Stage I,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.75,10.66,RNA,,,,2007.0,Alive
s12828,144C4C18-F286-4928-9B2A-A12654279AD7,UNCID_1815905.c801b113-11ce-4edd-bc44-48dd19d00791.sorted_genome_alignments.bam,37,C801B113-11CE-4EDD-BC44-48DD19D00791,e62a728d-390f-428a-bea1-fc8c9814fb11,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19,Primary Tumor,5C575FFB-C093-408F-8CBA-BF3C7E6E4609,Alive,ILSbio,University of North Carolina,Vietnam,Thyroid Papillary Carcinoma - Classical/usual,T2,N1,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,2.02,36.59,RNA,,,,2012.0,Alive
s12765,C6D174B3-BC45-4E3D-94BC-2FB6921E98B7,UNCID_1212016.3d39fcd3-b37d-47be-8693-d9afbb6a3648.sorted_genome_alignments.bam,67,3D39FCD3-B37D-47BE-8693-D9AFBB6A3648,4c513413-263e-4c7b-b997-7b688c47b698,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,A61A9EC7-B893-44A5-AB6F-A390C168BE88,Alive,University of Pittsburgh,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N0,Stage II,Mar-60,C73.9,C73,NO,,Not available,30.0,0.15,1.78,23.89,RNA,,,,2010.0,Alive
s12823,3B5F1450-EDBB-42BE-9020-597CF0540855,UNCID_1665087.6366C684-E20D-4E51-916B-9CA2FBBBA85F.sorted_genome_alignments.bam,16,6366C684-E20D-4E51-916B-9CA2FBBBA85F,10bdafbb-831d-48b5-b9a3-ad374fc50235,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,D37BED2A-BF63-43E0-91D0-6C95E4CA2D45,Alive,Ohio State University,University of North Carolina,United States,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),T4,N0,Stage II,Mar-40,C73.9,C73,NO,,Not available,10.0,0.17,1.88,30.24,RNA,5BDAD2FF-EDC0-4CDE-A92F-117A81CB2DFC,Distant site,Systemic,2002.0,Alive
s12842,6907568E-1DAB-4A9A-860A-F071AB5DED1E,UNCID_1918160.fce125fa-4f67-46cf-bdc9-988e081ae777.sorted_genome_alignments.bam,35,FCE125FA-4F67-46CF-BDC9-988E081AE777,dc5c1a76-30de-4b30-b397-3ad691c92a86,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,0F2AD5D1-FE8F-4555-80D9-F4155CF9B653,Alive,MD Anderson,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T3,N0,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.17,1.81,10.58,RNA,,,,2012.0,Alive
s12797,650FF935-077F-4B4E-82D9-F08C4C7AF2CF,UNCID_1565638.E40F49F2-C949-4260-AE96-5913AB2FB0A9.sorted_genome_alignments.bam,48,E40F49F2-C949-4260-AE96-5913AB2FB0A9,b3b7d701-ec84-4018-a3ce-f59198b35767,,Thyroid Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,Not available,HG19,Primary Tumor,D60A60D0-3DBB-435D-9CE6-E5F35F2A465F,Alive,International Genomics Consortium,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T1b,N1a,Stage III,Mar-60,C73.9,C73,NO,,Not available,13.0,0.18,2.0,5.88,RNA,,,,2011.0,Alive
s12848,E17F6C8D-D069-4561-8371-8138731E3DD2,TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.bam,60,F3099D9B-DBBE-46CB-BA22-DAD7F9428C4F,c31b3adf-3fc6-4a72-83b0-bbc0f295b5e7,,Thyroid Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,ASIAN,HG19_Broad_variant,Primary Tumor,3AE03B86-1473-409C-8118-A91A73A36F60,Alive,University of North Carolina,Harvard Medical School,United States,Thyroid Papillary Carcinoma - Classical/usual,T4a,N1b,Stage IVC,Mar-60,C73.9,C73,NO,,Not available,20.0,0.14,2.03,60.48,DNA,923999C1-45AE-4D19-B055-3C71C2EE7FC2,Not available,Systemic,2008.0,Alive
s12850,541EDCD7-8CF8-42C1-8CB5-57AB2E76C1A1,UNCID_1664922.DA1A8538-F647-463B-B927-F375F6A5B82F.sorted_genome_alignments.bam,39,DA1A8538-F647-463B-B927-F375F6A5B82F,e28e35b1-eb58-45bb-b19a-958187227500,,Thyroid Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THCA,Illumina HiSeq,Thyroid,WHITE,HG19,Primary Tumor,E1B11D66-3258-402F-AE1D-A7DEDD46A3FA,Alive,University of Miami,University of North Carolina,United States,Thyroid Papillary Carcinoma - Classical/usual,T2,N1a,Stage I,Mar-60,C73.9,C73,NO,NO,Not available,30.0,0.16,1.84,59.1,RNA,,,,2012.0,Alive
s10302,F79EC4CC-8BDC-4966-8886-F4AD14E43ABF,UNCID_1076823.8c547100-3fac-4519-91e9-7976a49ec9c3.sorted_genome_alignments.bam,63,8C547100-3FAC-4519-91E9-7976A49EC9C3,df7cfd84-a36a-44a0-b39f-a9ea1e0fd500,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,1F963F26-4EE8-42CB-BDCE-1F375829D3CB,Alive,Indivumed,University of North Carolina,Germany,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-70,C34.1,C34.1,NO,,Not available,143.0,0.13,1.8,486.0,RNA,,,,2007.0,Alive
s15289,80E1978C-BF78-4D25-951B-8B01B24D0034,_1_TCGA-D7-8576-01A-11R-2343-13_rnaseq.bam,54,A9A69F94-128A-453F-819E-20C6A7E43091,ec8268c7-943d-451a-9036-f0196078b6c5,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,28BD43CF-A80C-495D-A4FF-E4F57B6D4970,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N3a,Stage IIIB,Mar-11,C16.3,C16.3,NO,NO,Complete Remission/Response,36.0,0.13,,281.7,RNA,FA44E53B-C4D3-4326-9339-CFF8275DE044,Not available,External,2012.0,Alive
s17619,6059C54F-84FE-4716-94E0-34042ACDE9E8,TCGA-24-1425-01A-02R-1566-13_rnaseq.bam,45,F580E84B-B405-43DC-9DAE-4588CEDF435F,b120b701-c194-43d7-a491-3206fac38ec1,,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,7D0D7E28-9530-4D03-9041-AECA61ECF42C,Alive,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,112.0,0.14,1.8,135.0,RNA,,,,2008.0,Alive
s3974,91B58182-30C5-4B45-BF21-EE32128E4AD0,TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted.bam,55,B9FAA261-1FA4-4870-B98F-60153ED7AD8C,c46022f8-b122-4367-836b-ec1ae641a87d,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,30558AEB-76B7-4D27-99C0-E3EE21A00BD1,Alive,Roswell Park,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,47.0,0.15,1.9,156.4,DNA,,,,2005.0,Alive
s8846,A9FB7D5C-D750-4FD0-87EA-6BD807E54711,UNCID_1089368.07e52141-d5c6-456f-bad7-cedec6a93ea0.sorted_genome_alignments.bam,75,07E52141-D5C6-456F-BAD7-CEDEC6A93EA0,c499b3be-9db0-4809-b7c0-f5d81208d7ec,54.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,50ED062D-64CD-4C93-B51B-C179EF7AF6C7,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.14,1.8,31.3,RNA,,,,2004.0,Dead
s1079,CCDAF97F-1F76-43E9-957B-D1354B1CB67E,UNCID_2380797.c2850229-e8a6-436a-9ed9-b8c6b101a0c9.sorted_genome_alignments.bam,36,C2850229-E8A6-436A-9ED9-B8C6B101A0C9,faf91ee3-3281-4f8e-8bdf-2fda22261010,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,6A21F1F0-BE6E-46A1-ACAD-32C1F9EEEC00,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.18,1.79,38.85,RNA,,,,,Alive
s14794,1FBB278B-A62C-4021-9DA1-ED4578961F49,_1_TCGA-CG-4301-01A-01R-1157-13_rnaseq.bam,75,7AF442FB-3C5B-456A-BCFC-9C6C4FBC4053,7e13fe2a-3d6e-487f-900d-f5891d986aa2,,Stomach Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-STAD,Illumina GA,Stomach,Not available,GRCh37-lite,Primary Tumor,F8CCC777-65A2-41FA-95AC-AB33C3E9AD9A,Alive,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T4,N1,Stage IV,Mar-40,C16.0,C16.0,NO,,Not available,34.0,0.15,1.8,199.3,RNA,,,,2006.0,Alive
s11345,FB1682CF-0FCA-4BF1-963D-67A3A177FE98,TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted.bam,71,61ADB041-60CE-4263-BEB3-33A4DBBA217B,f17d3463-af6c-42c2-a8e9-fae45f69286f,,Lung Adenocarcinoma,Not available,WGS,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,EA75499C-7BF0-47BE-9B09-3C12AAA22F12,Alive,International Genomics Consortium,Harvard Medical School,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2a,N1,Stage IIA,Mar-40,C34.1,C34.1,NO,,Not available,33.0,0.15,1.9,218.7,DNA,,,,2010.0,Alive
s715,8DA8240E-3357-4C59-8C6D-A5E5824EAB3F,UNCID_2610671.275b0baf-883e-4b17-ae92-143d65f6b57f.sorted_genome_alignments.bam,33,275B0BAF-883E-4B17-AE92-143D65F6B57F,f02b66f4-3f20-443e-80c4-70139252959a,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,WHITE,HG19,Primary Tumor,D957621C-2FD6-4D63-8068-2104B8F11E1E,Alive,Cleveland Clinic Foundation,University of North Carolina,United States,Not available,T1,N0,Stage IS,Mar-85,C62.9,C62.90,NO,NO,Not available,30.0,0.16,1.84,23.31,RNA,,,,,Alive
s4145,FE462CBB-5D52-4A0E-8CB8-A7E6C0F39C7C,TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted.bam,61,0FC53595-F61A-4171-B982-335AEE13CC85,e90ab72a-4bbb-4c37-b48a-8a1a85d79d04,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,992415EF-53DE-4C52-A538-07931E68182B,Alive,University of Pittsburgh,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,,0.14,,261.3,DNA,,,,2011.0,Alive
s3323,2A13274C-4E40-40EC-97F9-63F68F428F05,UNCID_1343202.e33ab42a-bfb3-4923-a305-a6babcee61f4.sorted_genome_alignments.bam,62,E33AB42A-BFB3-4923-A305-A6BABCEE61F4,58520c66-7688-435a-b09f-653b18768c41,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,6B48DAE5-B757-450A-8248-65C2434A7AFC,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3,N0,Stage III,Mar-20,C67.2,C67.2,NO,,Not available,30.0,0.17,1.83,24.95,RNA,,,,2011.0,Alive
s9692,E8A03663-38B1-4647-8876-AFFF602A969C,UNCID_368783.TCGA-BP-4345-01A-01R-1289-07.110429_SN851_0035_AB0AKJABXX.4.trimmed.annotated.translated_to_genomic.bam,62,AD98CE63-0A5D-46CC-B1CC-EE2AEBE8AE59,8958c2bf-b986-4c07-98d2-09dfe2375a14,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,8485819F-DB44-43B9-B330-1AA55F1B8FC7,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,32.0,0.17,1.8,33.3,RNA,,,,2006.0,Alive
s10711,CF62A364-D5CC-4E7C-8286-DE112AD61AEF,UNCID_1208084.bfad522f-6130-424d-8497-99cac9714966.sorted_genome_alignments.bam,43,BFAD522F-6130-424D-8497-99CAC9714966,e16ca88f-488b-40f0-9169-e5a62482a2ff,97.0,Lung Adenocarcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,27A64F32-69C5-4C49-86B4-C8FC923CAE08,Dead,Christiana Healthcare,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-40,C34.1,C34.1,NO,,Not available,143.0,0.13,1.8,641.3,RNA,,,,2009.0,Dead
s701,07CD80A2-D598-426E-98D7-47C630692FD6,UNCID_2612661.f6333470-40af-4870-b743-2aaaf64bc983.sorted_genome_alignments.bam,28,F6333470-40AF-4870-B743-2AAAF64BC983,a1fe45e4-587e-43fc-b53d-85b5a7c4959b,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,WHITE,HG19,Primary Tumor,5DAC55AF-755C-45AE-BA7D-FD3918BF1C0E,Alive,Not available,University of North Carolina,United States,Not available,T1,NX,Stage I,Mar-61,C62.9,C62.9,NO,NO,Not available,30.0,0.16,1.8,39.06,RNA,,,,,Alive
s17989,A01A565D-5D1A-4826-A2B0-31FAE8A152FE,TCGA-23-2081-01A-01R-1568-13_rnaseq.bam,49,4C8DD391-5A1C-490E-A7D7-FDE372C3EC47,41178cbc-db73-4007-b5d8-febebf7f578d,2342.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,48B84B42-0A80-4429-9D6F-1A51B8AAAE2E,Dead,Cedars Sinai,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,124.0,0.17,1.8,514.0,RNA,,,,2000.0,Dead
s16160,127B054F-6C0D-45C8-80E2-B7B5C3D03B0F,UNCID_2523480.2e585fad-30bf-4670-a83f-f782647d0cfb.sorted_genome_alignments.bam,52,2E585FAD-30BF-4670-A83F-F782647D0CFB,dbdeb4ca-f67c-4d89-af60-88b425ebe461,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,D22843CB-8A14-4592-B339-A04CF1514205,Alive,Molecular Response,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T4a,N2c,Stage IVA,Mar-70,C32.9,C32.9,NO,,Not available,30.0,0.17,1.87,97.69,RNA,,,,2013.0,Alive
s3338,15153EE5-A111-46CF-BB79-B95C357BE691,UNCID_1781269.221bd562-e77d-4374-9491-efb5c3b026c3.sorted_genome_alignments.bam,75,221BD562-E77D-4374-9491-EFB5C3B026C3,aa6142af-bad7-493c-98a0-fd070de39073,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,FE1B2BE2-296A-4B78-A009-CFB676357323,Alive,BLN - Cleveland Clinic,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,NX,Stage II,Mar-20,C67.9,C67.9,NO,NO,Stable Disease,30.0,0.15,1.83,50.27,RNA,FDFBAFA6-64C9-48FD-9D23-2B6CE33514F3,Distant site,External,2012.0,Alive
s5352,0F85C9B6-B4B5-471D-8742-E97DB3132788,UNCID_364282.TCGA-AP-A1DM-01A-21R-A137-07.110628_UNC6-RDR300211_00110_FC_70K9TAAXX.2.trimmed.annotated.translated_to_genomic.bam,60,631C96E1-7E11-4C0F-A6EA-49CD942F4390,ca7f9d8b-2abc-4606-bf95-4c42791b38bd,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,7F4344CF-A5D7-4623-ABE8-9F046723EA0A,Alive,MSKCC,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.18,1.93,108.06,RNA,E79143F0-2BB8-4F39-9F9C-13364502C953,Primary Tumor Field,OTHER: SPECIFY IN NOTES,2007.0,Alive
s11193,B2FFD044-28C1-4D88-BAF8-94A11FA0E1C0,UNCID_2063783.da2c0992-74c0-4380-8c6c-c9ffa73767f6.sorted_genome_alignments.bam,54,DA2C0992-74C0-4380-8C6C-C9FFA73767F6,70081320-540f-41d2-8687-ee6d011f8eb0,1265.0,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,CCA5449D-6645-4588-A0B5-C1F0B57E5C3B,Dead,Washington University - Mayo Clinic,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N2,Stage IIIA,Mar-40,C34.1,C34.1,NO,YES,Complete Remission/Response,30.0,0.18,1.91,9.55,RNA,8CE9F14D-8BF0-438D-94D0-89396D078E74,Primary Tumor Field,External,2006.0,Dead
s13922,0FBA7CA4-20E6-489C-B54F-006499B57915,G17473.TCGA-14-1034-01A-01R-1849-01.2.bam,60,28239A0E-9990-49EF-A159-BA63FB078C77,0078b0c4-68a9-483b-9aab-61156d263213,485.0,Glioblastoma Multiforme,Not available,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,Not available,HG19_Broad_variant,Primary Tumor,F2FFA9FF-86D6-41EF-92E7-7F87E981985B,Dead,Emory University,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,,0.14,1.8,126.7,RNA,C89EC5A7-544E-49E0-9CD1-C0D2C31EA305,Primary Tumor Field,EXTERNAL BEAM,1999.0,Dead
s1582,5F093496-6D3B-40B3-9404-72645CA74CB9,UNCID_2253553.c9e3d4c7-862b-4ef2-9a08-216fc44e0bdc.sorted_genome_alignments.bam,50,C9E3D4C7-862B-4EF2-9A08-216FC44E0BDC,7c93642d-7e05-40f8-b1ef-a014edcfba42,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,Not available,HG19,Primary Tumor,4C1108C0-ED8A-4CAF-9417-DDFB6352C61E,Alive,Ontario Institute for Cancer Research,University of North Carolina,Canada,Cervical Squamous Cell Carcinoma,T1b,N1,Not available,Mar-72,C53.9,C53.9,NO,,Not available,30.0,0.15,1.8,37.88,RNA,14667F7F-D488-4C55-8BDE-A25444E95973,Regional site,External,2006.0,Alive
s14660,828B2A91-758C-422D-96DD-CCC6A3529AC8,_1_TCGA-BR-4362-01A-01R-1157-13_rnaseq.bam,74,99D614E6-E492-45D2-97B9-4D6A1373DD51,b1f261e9-c896-46d2-93c7-0290970196f8,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina GA,Stomach,WHITE,GRCh37-lite,Primary Tumor,0B832116-6BDA-4023-8792-297A2B65713F,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),TX,N1,Not available,Mar-40,C16.9,C16.9,NO,,Not available,36.0,0.15,1.8,405.3,RNA,,,,2008.0,Alive
s9384,F175378C-877D-4229-9BE6-196D592E9509,UNCID_2215409.461bd90d-3db2-44a1-853e-6bbe4e8c3139.sorted_genome_alignments.bam,67,461BD90D-3DB2-44A1-853E-6BBE4E8C3139,5722df9f-5631-476d-a11b-b3c1e9a40fbf,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,Not available,HG19,Primary Tumor,694CA445-7BAC-4216-ACF5-E227650AE973,Alive,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,35.0,0.16,1.8,66.8,RNA,,,,2007.0,Alive
s17053,2FFB31F9-A63F-4F47-B91F-025E56E0CC29,UNCID_2641156.392aa482-9a49-403c-817e-7b429e1d82f9.sorted_genome_alignments.bam,66,392AA482-9A49-403C-817E-7B429E1D82F9,e50edba1-8ec4-47e7-a01e-9f1b2cd75fd7,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,3065D32F-2852-4478-A6E7-C8129A2ACF0B,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.16,1.84,70.68,RNA,,,,2011.0,Alive
s6367,2A8E9B59-515D-4927-9B3B-19765F5E3DC3,UNCID_1154560.67e019fc-65c4-4274-a0f7-5a92f0f87bba.sorted_genome_alignments.bam,52,67E019FC-65C4-4274-A0F7-5A92F0F87BBA,68177e92-4784-45d9-af14-4ce0c00eae74,1127.0,Breast Invasive Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,Not available,HG19,Primary Tumor,4C54A99B-A820-4602-9B39-DEACA98034A5,Dead,Indivumed,University of North Carolina,Germany,Infiltrating Ductal Carcinoma,T4b,N3,Stage IV,Mar-41,C50.9,C50.9,NO,,Not available,30.0,0.15,1.79,33.06,RNA,,,,2005.0,Dead
s9025,78D72049-EA26-4265-9568-493E43CF4070,UNCID_1176215.29739602-d94f-4341-849e-a5b8a4c342eb.sorted_genome_alignments.bam,61,29739602-D94F-4341-849E-A5B8A4C342EB,bbdaa931-e922-49be-bfbf-fa0c2ae27d7a,41.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,B4F9B73B-94DB-4E0F-AF55-CF0583318A4A,Dead,Mayo Clinic - Rochester,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T3a,N1,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,27.0,0.15,1.8,41.8,RNA,,,,2003.0,Dead
s178,79F1A873-EAC7-4C9E-B649-96F5808B9A50,UNCID_2158583.744e863c-e24e-4eee-b0ee-ee24f2ef7401.sorted_genome_alignments.bam,54,744E863C-E24E-4EEE-B0EE-EE24F2EF7401,fc83ab27-929e-4ad4-ba18-abb0694f1e43,1105.0,Adrenocortical Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-ACC,Illumina HiSeq,Adrenal Gland,WHITE,HG19,Primary Tumor,6DD9DD3B-F1FF-4ADE-B7B0-2FF7ACA52CA8,Dead,University of Michigan,University of North Carolina,Germany,Not available,T2,N1,Stage IV,Mar-70,C74.0,C74.0,NO,YES,Progressive Disease,30.0,0.18,1.91,72.33,RNA,,,,,Dead
s997,60E04830-8D0D-420E-BD3A-0DA166CFA546,UNCID_2370172.ed44bcc4-99b7-4308-8673-64797735fb5a.sorted_genome_alignments.bam,74,ED44BCC4-99B7-4308-8673-64797735FB5A,cc95f915-33e7-4c57-9e6b-4c0e2ba598b2,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1A0DDA9D-8DAD-4692-A9D5-75AC6E268D97,Alive,University Hospital Motol,University of North Carolina,Czech Republic,Not available,Not available,Not available,Not available,Mar-00,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.81,28.22,RNA,,,,,Alive
s9385,C730DD6D-FA4B-4EB9-9259-BA5CF985A5F6,UNCID_2279025.7ee68b4e-e81d-438d-97b2-d89fe7405a74.sorted_genome_alignments.bam,73,7EE68B4E-E81D-438D-97B2-D89FE7405A74,424e5c99-3693-4b10-bbf0-fc43e851610c,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,77E32689-497B-4F52-A6F6-A8112F435D40,Alive,Christiana Healthcare,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,YES,,Not available,400.0,0.17,1.85,19.32,RNA,,,,2010.0,Alive
s15415,7F65DC05-3359-40D0-90D7-11FE7FEE75E5,TCGA-RD-A8N0-01A-12R-A36D-31_rnaseq.bam,53,8205B289-5207-4D9A-AE3B-F12F4019FDE4,2360c1e2-90f5-4737-9486-3f4590c37322,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,D74E6F28-5B07-446A-85C1-5D45293A63A7,Alive,Peter MacCallum Cancer Center,Canada's Michael Smith Genome Sciences Centre,Australia,Stomach  Adenocarcinoma  Diffuse Type,T3,N2,Stage IIIB,Mar-45,C16.1,C16.1,NO,NO,Complete Remission/Response,20.0,0.17,1.89,9.43,RNA,1B6497A4-D9F0-42AC-9AE6-546FF2429255,Primary Tumor Field,External,2006.0,Alive
s11060,6050C9AB-E965-4737-825F-1B694B7C1832,UNCID_1500743.d4f590d7-626c-4c70-b170-1ad19d2ff6eb.sorted_genome_alignments.bam,52,D4F590D7-626C-4C70-B170-1AD19D2FF6EB,dbd5b0de-94c9-45dd-afb3-6820a7ecaca2,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632,Alive,St Joseph's Medical Center (MD),University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-40,C34.3,C34.3,NO,,Not available,36.0,0.14,1.8,162.2,RNA,,,,2010.0,Alive
s17834,9B826F34-4DB0-48D0-90BE-64DE6C788D8D,TCGA-24-2020-01A-01R-1567-13_GRCh37-lite_rnaseq.bam,67,19765B4F-458E-4F02-BF96-01498D80AC83,e20ea417-7296-4da8-9fdb-71cd1f45153a,4624.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,871FC478-CF3F-43C2-8AEA-0DB7C777ABE1,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,134.0,0.17,1.8,611.0,RNA,,,,1994.0,Dead
s14199,A0D363F2-2D9D-469B-95CE-39D562751396,440a2f2ecb7e515f50cbe3008fb3e1e5.bam,50,B73CFD2E-044F-4B41-B404-080D9D18E61D,12824b2b-9c0a-4dcf-8941-34593a4e93da,701.0,Glioblastoma Multiforme,Not available,WGS,FEMALE,TCGA-GBM,Illumina GA,Brain,WHITE,GRCh37-lite,Primary Tumor,597CAEAF-8957-43FE-99DC-43E136881A55,Dead,Emory University,Washington University School of Medicine,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,142.0,0.14,1.9,234.3,DNA,023F5226-0F15-4F4A-A5C1-BD2787EFFAEB,Primary Tumor Field,EXTERNAL BEAM,1998.0,Dead
s10605,9F42DCE3-A017-400F-91D1-B1D5D69A1228,UNCID_1073110.fca05afb-d892-431c-a19a-e0c8c6e283eb.sorted_genome_alignments.bam,61,FCA05AFB-D892-431C-A19A-E0C8C6E283EB,0e2ee54a-51c9-4868-842d-a2a1c1cfb016,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,F091C76E-5D01-4F4B-8F6F-463C9F302930,Alive,Fox Chase Cancer Center,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-70,C34.3,C34.3,NO,,Not available,,0.16,1.8,165.0,RNA,,,,1997.0,Alive
s3223,F8715F70-B572-4D80-AFEB-8BE36C91142B,UNCID_2503633.0cb1b6e8-1a05-472d-9651-126f92d17e73.sorted_genome_alignments.bam,74,0CB1B6E8-1A05-472D-9651-126F92D17E73,42bcf1a7-2f3a-4ed8-a41d-cdd67e65b928,182.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,ABE273CD-9F0D-45CA-B72B-A154685708C1,Dead,University of Southern California,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3b,N1,Stage IV,Mar-30,C67.9,C67.9,NO,YES,Progressive Disease,30.0,0.17,1.86,38.75,RNA,9F92B734-3E4F-4FB7-B8C8-D292B2B6F755,Distant site,External,2006.0,Dead
s369,9D983337-E9DF-45A1-ABAE-7E7EA6EC1781,UNCID_2325857.7713e075-01d5-466b-ae5b-aa019a9f4db8.sorted_genome_alignments.bam,58,7713E075-01D5-466B-AE5B-AA019A9F4DB8,dc6720dd-5028-49d3-8508-a7936e7b3faa,78.0,Mesothelioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-MESO,Illumina HiSeq,Mesothelium,WHITE,HG19,Primary Tumor,D467175B-F8E5-4579-A0E1-1F85238C5A93,Dead,Memorial Sloan Kettering,University of North Carolina,United States,Not available,T2,N0,Stage II,Mar-53,C38.4,C45.0,NO,NO,Not available,30.0,0.17,1.89,52.31,RNA,,,,,Dead
s5628,456682BF-18D1-4383-96BA-6E06FE7DD669,4042a719096f3096b3cbb539a45e6492.bam,40,AACABA97-ECDE-440B-AAE0-0E9C608C4B24,44bec761-b603-49c0-8634-f6bfe0319bb1,,Breast Invasive Carcinoma,HISPANIC OR LATINO,WGS,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,Not available,GRCh37-lite,Primary Tumor,7EC2C455-D90F-4CD5-9BBB-AEDBF21ECA00,Alive,MSKCC,Washington University School of Medicine,,Infiltrating Ductal Carcinoma,T2,N1,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.07,2.0,47.52,DNA,7E8CCC49-DEFA-4A33-BD6A-EDB852153291,Regional site,EXTERNAL BEAM,2005.0,Alive
s16397,AF92BFA8-A70F-4436-B545-46899487C859,TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina.bam,56,4ECBFD89-393F-4126-AA1C-951A2C23EF89,9680b5ff-1882-434f-9981-e8ac33764b93,,Kidney Chromophobe,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-KICH,Illumina HiSeq,Kidney,WHITE,GRCh37-lite,Primary Tumor,50DA0237-8E9D-4C08-AE44-F32103E8F095,Alive,NCI Urologic Oncology Branch,Baylor College of Medicine,United States,Kidney Chromophobe,T1a,NX,Stage I,Mar-17,C64.9,C64.9,NO,NO,Complete Remission/Response,34.0,0.05,,26.3,DNA,,,,2005.0,Alive
s6801,CAE83C24-1E46-4759-B6A0-A6439F03BBD9,UNCID_1124417.dde1d3ab-ad71-4526-bc98-058b6049edcf.sorted_genome_alignments.bam,60,DDE1D3AB-AD71-4526-BC98-058B6049EDCF,f43d622f-eed5-4933-adc6-ae9ad1e33028,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,24153FE0-2C47-456A-B344-874A0E28DE4D,Alive,Roswell Park,University of North Carolina,,Infiltrating Ductal Carcinoma,T1c,N0,Stage I,Mar-00,C50.9,C50.9,NO,,Not available,10.0,0.16,1.79,15.68,RNA,EF81F606-FAFB-46F1-82DB-B3285D7A9803,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s4783,2C99D5D5-1F92-452E-9370-59486A6D7BCE,TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted.bam,63,7132C5C6-9DC5-42A8-863F-D82280266427,233e947a-d5e2-48e5-a8ce-5da1abb20681,,Uterine Corpus Endometrial Carcinoma,Not available,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,42199E5A-9F4F-4445-9E6E-114D47BA67FA,Alive,Duke,Harvard Medical School,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.92,90.33,DNA,18494A76-FF86-479E-83CD-787AAD3F37D0,Primary Tumor Field,OTHER: SPECIFY IN NOTES,2007.0,Alive
s2573,556C6EA8-D587-4BDB-B415-84FCBA4BDBCF,UNCID_2457256.bfa5f94d-8017-4548-8fc1-40d3613a4daa.sorted_genome_alignments.bam,57,BFA5F94D-8017-4548-8FC1-40D3613A4DAA,07a6bbce-012b-48fe-8c62-e79a1b200eb6,1845.0,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,07A15D4D-8902-4A54-A053-2FD306E44456,Dead,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-11,C48.0,C48.0,NO,YES,Not available,30.0,0.16,1.88,7.88,RNA,7AB8E5CB-4E37-41F2-87F1-ADAFFBDF142D,Primary Tumor Field,External,,Dead
s10432,2054A56D-73A2-4D73-878D-949D6157839B,UNCID_1093142.b9db5c2a-c5dd-4e58-905f-fefccd469f1f.sorted_genome_alignments.bam,83,B9DB5C2A-C5DD-4E58-905F-FEFCCD469F1F,7abb4883-60b7-4882-b946-1a4665889257,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,0109063D-7BC6-4973-8C67-98E48A2A2E4E,Alive,University of Pittsburgh,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IIB,Mar-70,C34.3,C34.3,NO,,Not available,27.0,0.15,1.7,99.2,RNA,,,,2010.0,Alive
s6130,755F6799-1954-4455-B9BC-4A488F795928,UNCID_1115045.50808f98-d10b-4190-aff7-428f56abb0f9.sorted_genome_alignments.bam,36,50808F98-D10B-4190-AFF7-428F56ABB0F9,d5be2ab3-f748-480d-954b-385cf01b4c81,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,4F69C5F3-4E8C-4B71-A5FE-3179412C17E6,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Infiltrating Ductal Carcinoma,T2,N2a,Stage IIIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.17,1.83,27.3,RNA,,,,2011.0,Alive
s3503,44E418FA-14AE-47AC-821E-ECA7EFEB0A1A,UNCID_1896609.3d626bcf-fa11-443c-ac02-b2a099494189.sorted_genome_alignments.bam,55,3D626BCF-FA11-443C-AC02-B2A099494189,e0ff90e5-e6c3-4fb5-9512-6f09a891378b,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19,Primary Tumor,23078E16-3D54-4FCA-A09F-E9A4838A2A89,Alive,Roswell Park,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,27.0,0.16,1.7,30.2,RNA,,,,2009.0,Alive
s6099,72408057-2F24-40C3-A30A-7EC6D22307F6,UNCID_2611118.c2df60f6-40d5-4fe0-88f8-d168feb0d921.sorted_genome_alignments.bam,73,C2DF60F6-40D5-4FE0-88F8-D168FEB0D921,95c53ecf-d8f1-4bcb-9b1a-c9a0542939f0,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,D91EC6E8-CDEA-41B8-A88E-252586D3B9AE,Alive,Hartford Hospital,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T1c,N0,Stage IA,Mar-00,C50.9,C50.9,NO,,Not available,60.0,0.15,1.8,15.4,RNA,,,,2013.0,Alive
s758,648F2A11-5319-4853-95F4-2821785E74D1,UNCID_1677675.aaf4883f-911b-4a55-a271-e197b2ca6ab6.sorted_genome_alignments.bam,62,AAF4883F-911B-4A55-A271-E197B2CA6AB6,fe699c36-82ef-45dd-b636-8c18a9ef6c76,110.0,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,FDB06325-7545-495A-84C8-DFC5C3C209FB,Dead,Alberta Health Services,University of North Carolina,Canada,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.9,C25.9,NO,,Not available,31.0,0.15,,162.2,RNA,,,,2009.0,Dead
s13674,3A88F23B-5740-4937-BE5D-A5AED2C4E962,TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam,89,F1E05BF6-0B98-45F8-9F97-10ABE5957C99,bc42fe2d-1a33-428d-a601-b1871f4c8d9b,,Colon Adenocarcinoma,Not available,WGS,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,Not available,HG18,Primary Tumor,8C5799BF-DB65-40F6-9A67-ABD4DA4025F2,Alive,Indivumed,Harvard Medical School,Germany,Colon Mucinous Adenocarcinoma,T3,N0,Stage IIA,Mar-80,C18.9,C18.9,NO,,Not available,134.0,0.15,1.9,526.89,DNA,,,,2009.0,Alive
s14053,6A3B2F16-7241-47C5-9EA1-B44E6D3BD45B,G17816.TCGA-28-5215-01A-01R-1850-01.4.bam,62,05A2EEA8-F366-4AE7-80F3-03324FB6E66E,c9e4f0bf-48fc-4600-9e03-314bc575273f,335.0,Glioblastoma Multiforme,Not available,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,5739BCD5-23B4-4A94-94E0-0CA261179F85,Dead,Cedars Sinai,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,57.0,0.15,1.8,45.7,RNA,5F1016A4-2667-4E53-BCE3-99F6EE9B0F78,Not available,Not available,2010.0,Dead
s956,AF11028C-0401-4151-AB3D-A4719E276ADE,UNCID_2363802.c9bd38a7-823d-4019-8016-1e5bd8cd8ee1.sorted_genome_alignments.bam,35,C9BD38A7-823D-4019-8016-1E5BD8CD8EE1,f8d78495-c000-461f-a311-3467fb1178aa,,Pheochromocytoma and Paraganglioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,1961FD02-1596-4F4C-B480-F48DAEA382BA,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.85,44.18,RNA,,,,,Alive
s10640,61BB72A1-5C87-411D-AF04-3E058C2BEAB2,TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.bam,76,1F0C98A3-3EED-45E0-BF81-78632C02D375,9f81c602-8afa-4588-b0b6-6e5a1a128d5a,303.0,Lung Adenocarcinoma,Not available,WGS,MALE,TCGA-LUAD,Illumina HiSeq,Lung,Not available,HG19_Broad_variant,Primary Tumor,4D85772B-287E-4790-B1E8-CD1C0E88AD48,Dead,Indivumed,Harvard Medical School,Germany,Lung Adenocarcinoma Mixed Subtype,T4,N1,Stage IIIB,Mar-55,C34.3,C34.3,NO,,Not available,37.0,0.16,1.9,301.7,DNA,,,,2006.0,Dead
s12984,705DB422-812C-46D0-A122-9687589A71E0,UNCID_269266.TCGA-AA-3950-01A-02R-1022-07.100723_UNC2-RDR300275_0016_62330AAXX.3.trimmed.annotated.translated_to_genomic.bam,79,CB1E7865-B10C-4DCB-95DB-537F3C53FFB5,cc53bf9e-5e27-4305-a08b-552120c10aa5,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,6F6820C0-BEED-4944-A241-D65F58BDDF9A,Alive,Indivumed,University of North Carolina,Germany,Colon Mucinous Adenocarcinoma,T3,N0,Stage IIA,Mar-80,C18.2,C18.2,NO,,Not available,81.0,0.15,1.8,165.3,RNA,,,,2010.0,Alive
s15097,6BBB2709-A3CA-451A-82C8-996E619878B9,G39020.TCGA-D7-6822-01A-11D-1882-08.3.bam,77,1021B60D-F7B2-43B0-B2CC-F282D619D533,e2aaabd9-f4ba-4763-a28a-c14d46a4bc5d,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,HG19_Broad_variant,Primary Tumor,C30AFDA8-FC63-4228-A9A9-42BCDB562ACE,Alive,Greater Poland Cancer Center,Broad Institute of MIT and Harvard,Poland,Stomach  Intestinal Adenocarcinoma  Tubular Type,T2,N0,Stage IB,Mar-11,C16.2,C16.2,NO,,Not available,32.0,0.05,1.9,442.7,DNA,,,,2011.0,Alive
s10009,8A3CFE07-1EF9-46CF-B9AA-A6733E711E34,UNCID_1067477.f31fd0a1-b600-42bc-a6fa-689c05a581ce.sorted_genome_alignments.bam,68,F31FD0A1-B600-42BC-A6FA-689C05A581CE,44b1d457-3a50-404e-b54c-ca619262bc2f,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,0D7C693E-B6F6-4EE0-8F13-D1CE1033BFAE,Alive,Johns Hopkins,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-70,C34.1,C34.1,NO,,Not available,113.0,0.14,1.8,343.0,RNA,,,,2007.0,Alive
s9585,A8C88A68-DB74-43CB-9687-2468CCE1AE8D,UNCID_1168530.7d3f4aeb-243c-4379-b9d5-1c8a312d475f.sorted_genome_alignments.bam,61,7D3F4AEB-243C-4379-B9D5-1C8A312D475F,a8db1341-a7fc-4306-91ad-5caaca5c8a6e,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,45FF8C0E-F7A1-4F97-B8B6-5692937CC5B1,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T2,NX,Stage II,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.16,1.8,66.3,RNA,,,,2006.0,Alive
s2799,25E408E7-B8EE-4D7D-8825-32EDB39E0A04,UNCID_2306023.ed8b8326-fa77-4e72-b146-49c0543a5792.sorted_genome_alignments.bam,87,ED8B8326-FA77-4E72-B146-49C0543A5792,cc8602bb-78e2-4732-9784-83c3388b999e,,Bladder Urothelial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,546E9EC3-7745-4A94-BB1D-B5F40203669A,Alive,Cornell Medical College,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4a,NX,Stage III,Mar-20,C67.4,C67.4,NO,NO,Complete Remission/Response,30.0,0.16,1.77,32.67,RNA,,,,2011.0,Alive
s5176,ED6EB61C-8B0F-403D-B4BE-F56691CE03AC,UNCID_617353.03141105-bc66-4e89-ad97-c54fcf189468.111103_UNC2-RDR300275_00093_FC_62DLAAAXX.2.trimmed.annotated.translated_to_genomic.bam,69,03141105-BC66-4E89-AD97-C54FCF189468,a8def1a0-a136-47f4-9ad9-60ebcf9b726b,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C,Alive,Gynecologic Oncology Group,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.85,103.7,RNA,,,,2008.0,Alive
s2115,F5825CD5-FB87-4D18-8802-EAEE85AFFB6C,UNCID_271366.TCGA-AG-4008-01A-01R-1119-07.100816_UNC6-RDR300211_00023_FC_629FTAAXX.6.trimmed.annotated.translated_to_genomic.bam,63,424F0F4A-48D0-4DFB-BEE6-B45298D0B75D,72802851-9340-4c5f-a90b-23b7afd7577a,,Rectum Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,D803F092-3340-485D-9964-D6554D210E2E,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.9,C18.9,NO,,Not available,126.0,0.14,1.8,600.3,RNA,,,,2008.0,Alive
s8661,7B1C155E-0372-4F54-81E2-4B7D65E79399,UNCID_2054781.10b6c170-88d1-4cea-87c7-b23d6810ea6a.sorted_genome_alignments.bam,49,10B6C170-88D1-4CEA-87C7-B23D6810EA6A,cfcd3835-bb09-400e-b7eb-55ac139d01f8,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,B434838F-2EB4-4D42-8D15-D35E62F15D3C,Alive,University of Florida,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.0,C71.0,NO,NO,Complete Remission/Response,30.0,0.16,1.88,23.79,RNA,,,,2012.0,Alive
s10840,54FDF3C0-01D9-4574-96A8-84EEC2627A92,UNCID_1215498.8835ae28-831e-49da-a046-a1a43b626a4e.sorted_genome_alignments.bam,47,8835AE28-831E-49DA-A046-A1A43B626A4E,31c96e35-5e2f-429c-b12a-7bc5a497a300,,Lung Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,DA010683-C537-478F-8F95-E606B05DBC5C,Alive,Indivumed,University of North Carolina,Germany,Lung Adenocarcinoma Mixed Subtype,T4,N3,Stage IIIB,Mar-55,C34.1,C34.1,NO,,Not available,141.0,0.15,1.8,464.3,RNA,,,,2006.0,Alive
s8774,1271FA90-5FEF-45CF-800A-35D94FFF8F05,UNCID_1568684.e752561a-f5e2-4390-93f1-a487447b6557.sorted_genome_alignments.bam,54,E752561A-F5E2-4390-93F1-A487447B6557,f4a1fc14-0d32-4e77-a8a3-fd8fea82188a,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,B16C0429-9B18-4852-ABB4-1EF16D5E310F,Alive,Case Western - St Joes,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.9,C71.9,NO,,Not available,28.0,0.16,,0.0,RNA,,,,2011.0,Alive
s17572,021F03F0-43D7-48DB-BFBD-A8452E9EF361,TCGA-24-2033-01A-01R-1568-13_rnaseq.bam,87,B03B75E2-D1D0-4FD7-B66E-891F7B0ACB76,872d2922-7292-4681-adb7-d3b267eccbe7,562.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,88152AB3-4BBC-4D80-9E1E-34C96DE3D604,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,131.0,0.16,1.8,652.0,RNA,,,,1995.0,Dead
s9081,1B3E20C3-9F61-4C3E-A7DA-AE6B48AF37E6,UNCID_2442518.31b392f4-0d9c-49f4-a82a-71589813f0ed.sorted_genome_alignments.bam,68,31B392F4-0D9C-49F4-A82A-71589813F0ED,d3b47e53-6f40-4fc8-b5a4-cbe548a770a9,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,775EA8FB-DB72-4941-8B70-A0191DBF71B7,Alive,University of Oklahoma HSC,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,NO,Not available,30.0,0.18,1.73,15.71,RNA,,,,2013.0,Alive
s15831,7AF212E4-F6F6-4D2F-96BA-45FF687C0210,UNCID_1499121.3b470500-2427-4540-bc8e-df91e42c3d26.sorted_genome_alignments.bam,74,3B470500-2427-4540-BC8E-DF91E42C3D26,8b574abc-646b-4252-8eb7-b9c737d034d9,602.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,56C942D2-D77C-48C3-81FF-1C7BD64AC7CF,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,NX,Stage III,Mar-70,C01.9,C01,NO,,Not available,27.0,0.15,1.7,97.2,RNA,,,,1999.0,Dead
s17559,CAB12315-D576-4525-A538-838C5B709F09,TCGA-13-1404-01A-01R-1565-13_GRCh37-lite_rnaseq.bam,48,5A24A912-7E38-4D60-A1B9-56023D2A321A,8e107f4b-1912-4d3e-814a-b863e2d65ed7,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,F3CEA00C-BC4A-450F-AE7B-CD97AB7369BE,Alive,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,122.0,0.17,1.8,655.0,RNA,,,,2008.0,Alive
s10444,03540944-83E6-4903-86D8-640AAE99FBAE,UNCID_1841074.2afa4dfe-6d9b-46b1-89bd-235c7b5cbebf.sorted_genome_alignments.bam,68,2AFA4DFE-6D9B-46B1-89BD-235C7B5CBEBF,81b7cbc1-c037-426f-95b0-d729a30697da,835.0,Lung Squamous Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,75384E41-370E-4972-870C-2845FB4DED2F,Dead,University of Miami,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N2,Stage IIA,Mar-70,C34.9,C34.9,NO,,Not available,39.0,0.16,,108.2,RNA,7EEFFFC4-B83E-400B-98B4-01A55EB1E76C,Primary Tumor Field,External,2009.0,Dead
s14491,3BC07391-1EF5-4BBF-9614-E3F31B8448C9,TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted.bam,66,E09E88E6-7697-4A1F-BF79-6DE9BE6E0960,e62d5f3c-0a99-4932-a589-bff4fa02b1d3,,Stomach Adenocarcinoma,Not available,WGS,MALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,HG19_Broad_variant,Primary Tumor,5295412B-3D28-4774-85D8-3D38C682C343,Alive,Indivumed,Harvard Medical School,Germany,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T2,N3,Stage IV,Mar-44,C16.0,C16.0,NO,,Not available,40.0,0.16,1.9,180.0,DNA,,,,2003.0,Alive
s13606,19FC13A2-198C-4A0D-B45F-A874E4165F8C,UNCID_1874362.b16349cb-2b41-4235-b20f-116b8c71604f.sorted_genome_alignments.bam,77,B16349CB-2B41-4235-B20F-116B8C71604F,56d5b0b9-9093-4286-a2c6-7faa9a1680f5,899.0,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,5321BCC9-A2A0-4671-875A-B1153FF47E13,Dead,University of Pittsburgh,University of North Carolina,United States,Colon Adenocarcinoma,T2,N1,Not available,Mar-40,C18.7,C18.7,NO,,Not available,32.0,0.15,1.7,82.2,RNA,,,,2002.0,Dead
s9347,7ABDD02B-E4BB-4058-8F74-98788EB7E7FB,UNCID_1188406.0a6270b6-a8a3-4a36-9f40-82f4196987ec.sorted_genome_alignments.bam,62,0A6270B6-A8A3-4A36-9F40-82F4196987EC,822cf6c1-dd65-4814-94b1-0c335208ad9b,574.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,3F90DD96-9414-4E74-B2C8-C829EB33E1EC,Dead,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T2b,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,37.0,0.14,1.7,60.8,RNA,,,,2003.0,Dead
s16399,171AF111-4E87-4E89-AF1B-EE3FBED93DB6,TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina.bam,45,148536CE-EE2A-4952-A19D-10D6F44146B9,23656226-2d99-4548-959f-5c2eed803e33,,Kidney Chromophobe,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-KICH,Illumina HiSeq,Kidney,WHITE,GRCh37-lite,Primary Tumor,3CBDEE56-19F7-4A7A-850E-A7664E67C919,Alive,NCI Urologic Oncology Branch,Baylor College of Medicine,United States,Kidney Chromophobe,T2,N0,Stage II,Mar-17,C64.9,C64.9,NO,YES,Complete Remission/Response,30.0,0.05,,40.3,DNA,,,,2000.0,Alive
s13967,1017E67A-6F30-47E0-ACAA-D7D9567F9BF6,G17482.TCGA-06-2570-01A-01R-1849-01.2.bam,21,48724EA4-25F1-463C-883A-69897E7D9A41,b37d944c-c65c-46d6-bb8b-3eb37cb85b68,,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,42200DBC-8248-461D-BF90-5386360213A9,Alive,Henry Ford Hospital,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,144.0,0.13,1.8,167.7,RNA,248CEE0E-D1EC-4F25-969C-F63E6AA87EA3,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s48,8123952B-F03D-4D3E-B43B-75DD52BE5E24,UNCID_2113930.90f0894e-91d4-49d8-b9c3-4bd5a73aaab6.sorted_genome_alignments.bam,59,90F0894E-91D4-49D8-B9C3-4BD5A73AAAB6,75a43851-8fa0-4259-b843-88dc6fbce270,,Uterine Carcinosarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCS,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,BBD9612E-1C20-4F85-9CD9-E610F6200D6E,Alive,University of Pittsburgh,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-50,C54.1,C54.1,NO,NO,Complete Remission/Response,30.0,0.16,1.84,32.76,RNA,8299965E-771C-4DDA-8CAA-785FC91B98BD,Primary Tumor Field,External,,Alive
s9681,4587A3FD-5439-43E7-83C1-59F1F422D3BB,UNCID_360427.TCGA-BP-4352-01A-01R-1289-07.110511_UNC11-SN627_0085_BC01AFABXX.7.trimmed.annotated.translated_to_genomic.bam,74,C8397E86-4001-496A-A06C-80F835428B89,037c691e-6320-451b-9276-78459f1b705c,344.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,4FA249ED-2767-4EDA-BC68-798D47B94725,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,36.0,0.16,1.8,365.3,RNA,43E257BC-4F33-49AB-8A78-AD148B65904F,Distant site,OTHER: SPECIFY IN NOTES,2007.0,Dead
s653,2ECEB6E5-A68A-4DEF-BCCA-0781884DBE3D,UNCID_2597950.bba87ce6-0c45-49f8-872a-057a63ab4930.sorted_genome_alignments.bam,20,BBA87CE6-0C45-49F8-872A-057A63AB4930,dfdd5d0a-b87a-4b07-8e66-8ff396e86efd,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,WHITE,HG19,Primary Tumor,590EE86A-D158-4EC3-90D0-EA1B1A9B9894,Alive,Not available,University of North Carolina,United States,Not available,T1,NX,Stage I,Mar-61,C62.9,C62.9,NO,NO,Not available,30.0,0.16,1.78,38.64,RNA,,,,,Alive
s6405,4E3FD27D-B2E5-4627-994E-9520D9557C93,UNCID_1674395.fa1917b0-c3e1-412d-b063-e74b5cafb8dc.sorted_genome_alignments.bam,53,FA1917B0-C3E1-412D-B063-E74B5CAFB8DC,0e1d0d46-7a7b-4538-95dd-b9fc20a15aec,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,1DDC4C86-029F-49B5-893C-A218240D3FA4,Alive,Roswell Park,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N0,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.8,24.24,RNA,9FC62023-6140-4514-B9DE-74BCC48157A0,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s14537,7A8B4F0B-CEF7-47DD-97E8-72B8842273DF,TCGA-BR-7704-01A-11R-2055-13_rnaseq.bam,69,3796ED18-1911-4D81-8D69-40BBA4542703,9ef7582b-d4c1-4036-a1ed-ef65aa46fc60,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,933A3086-2E72-476A-8318-00EBD910A830,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T3,N0,Stage II,Mar-44,C16.2,C16.2,NO,,Not available,37.0,0.17,,467.2,RNA,,,,2011.0,Alive
s14413,67CBAA1A-7B2E-4AC2-95A2-C7B256F17BF3,TCGA-CG-4441-01A-01R-1802-13_rnaseq.bam,83,484434A5-5522-43EC-A43D-46B426D89DC4,37e22429-efd7-4d6a-b79a-9d8c7be2170c,426.0,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,GRCh37-lite,Primary Tumor,60937697-57BA-4D03-9545-B0E321215448,Dead,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T2,N2,Stage IIIA,Mar-44,C16.2,C16.2,NO,,Not available,36.0,0.15,1.8,212.7,RNA,,,,2006.0,Dead
s17839,AD217AFC-4839-43AF-AEB6-48FD1592E799,TCGA-25-1312-01A-01R-1565-13_rnaseq.bam,69,0D7561DC-7069-41DF-BA49-8FCD4DF52EFB,66face4a-f35c-4364-90e5-8f28e6372606,31.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,CE884866-7563-44B2-A7B0-849512C66ABF,Dead,Mayo Clinic - Rochester,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,132.0,0.15,1.8,499.0,RNA,,,,2001.0,Dead
s2814,9A041EB5-DF2D-469F-ACCA-A4C672144D2C,UNCID_2495402.f18b7d09-aace-4a7e-839a-6f6eeb189f63.sorted_genome_alignments.bam,70,F18B7D09-AACE-4A7E-839A-6F6EEB189F63,6c5f09f0-2019-4440-8554-e8912bce5e98,1077.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,1B16D49D-4DB7-472C-86BE-4BE3A1C68624,Dead,University of Sheffield,University of North Carolina,United Kingdom,Muscle invasive urothelial carcinoma (pT2 or above),T3a,NX,Stage III,Mar-20,C67.4,C67.4,NO,,Partial Remission/Response,30.0,0.16,1.86,37.12,RNA,,,,2009.0,Dead
s3273,6559C325-D368-4F95-A2C0-DF5EFA895E3D,TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.bam,62,86D4A4FB-47BB-4CD4-B481-CE9F815D38E6,f1ebf96b-8df9-4e59-acef-7ad433e40214,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,ASIAN,HG19_Broad_variant,Primary Tumor,A373568A-BBD3-4D67-92D6-96E8378065CF,Alive,ILSbio,MD Anderson - Institute for Applied Cancer Science,Vietnam,Muscle invasive urothelial carcinoma (pT2 or above),T2,N0,Stage II,Mar-30,C67.9,C67.9,NO,,Not available,30.0,0.14,,46.48,DNA,,,,2011.0,Alive
s2524,4C5BCAF4-5BA0-4686-B34B-3EEA6357C02D,UNCID_2423462.d0e72bd9-4233-4c76-8582-fe42733b5087.sorted_genome_alignments.bam,84,D0E72BD9-4233-4C76-8582-FE42733B5087,1a319d92-d5d4-41f7-8a10-2afb52513d83,456.0,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,D6DD84FA-2295-4B22-8A12-13E8DA9CF3A9,Dead,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-90,C48.0,C48.0,NO,YES,Not available,30.0,0.18,1.82,15.75,RNA,,,,,Dead
s4390,0AEE8865-90E5-4676-8FAA-719431E3DB4E,UNCID_596876.c9bdd9d8-f0f6-4abb-aca8-11d274f90995.111018_UNC2-RDR300275_00092_FC_634BHAAXX.3.trimmed.annotated.translated_to_genomic.bam,66,C9BDD9D8-F0F6-4ABB-ACA8-11D274F90995,4cb4dd07-0ce5-4de7-a0bd-546183949efe,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,1576C6C1-B9F0-4ACD-9A75-E5F2D5A4ECC1,Alive,Cureline,University of North Carolina,Russia,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.92,40.47,RNA,,,,2010.0,Alive
s6744,42EEDFCC-119E-4931-B863-A058164EF75E,UNCID_2635274.24ef9702-a1e5-4276-abb2-87088861d471.sorted_genome_alignments.bam,63,24EF9702-A1E5-4276-ABB2-87088861D471,45013972-2dfd-4f82-a076-e3e4af1b43b8,116.0,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,0692591C-B717-4D4E-B3CE-EA1620EB127E,Dead,Mary Bird Perkins Cancer Center - Our Lady of the Lake,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T4d,N3b,Stage IV,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.83,36.51,RNA,,,,2013.0,Dead
s2788,3AC39FEA-195C-4DE0-BD50-08D18DBBBE64,UNCID_2116237.a83e6d94-8bef-4ffe-889a-2eecc4b97cae.sorted_genome_alignments.bam,69,A83E6D94-8BEF-4FFE-889A-2EECC4B97CAE,eeca58fe-b5cb-4d13-a93f-a5a2ca00b6e2,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,A4ACAB2E-D8F9-41AB-8E03-D3580221D2AF,Alive,ABS - Lahey Clinic,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3a,N0,Stage III,Mar-20,C67.0,C67.0,NO,YES,Progressive Disease,30.0,0.17,1.94,33.43,RNA,5259EFAF-6965-4AD2-A397-34428738CC4E,Regional site,External,2012.0,Alive
s10099,BABF415E-BCF3-486D-8D5F-B7393AE2F309,UNCID_1065899.2c6ccb67-23b3-4e1c-9136-30f373c7e40c.sorted_genome_alignments.bam,65,2C6CCB67-23B3-4E1C-9136-30F373C7E40C,5d3d3918-7da8-4147-90a3-dc015be1dfbe,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,BC1B8610-9E9D-4FBF-9698-82CECA1E935F,Alive,Cureline,University of North Carolina,Russia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1b,N0,Stage IA,Mar-70,C34.1,C34.1,NO,,Not available,114.0,0.15,1.8,146.0,RNA,,,,2010.0,Alive
s3595,8BD51D54-E1BE-4A0A-BAD5-3B8013692B90,TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted.bam,69,ADB6611D-7A44-4FFE-A48B-FF8E24696B38,c039014f-821c-43d6-9d3c-914f9c8d98fa,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,144E0265-C04E-4538-A721-94DEF2570486,Alive,Indivumed,Harvard Medical School,Germany,Prostate Adenocarcinoma Acinar Type,T3b,N1,Not available,Mar-50,C61.9,C61,NO,,Not available,36.0,0.16,1.9,257.7,DNA,,,,2007.0,Alive
s4496,19152F82-679B-49FA-8B49-CFAE5F5BDDA6,UNCID_1636549.414c904a-29d0-44d0-bceb-ce7d024f1a58.sorted_genome_alignments.bam,81,414C904A-29D0-44D0-BCEB-CE7D024F1A58,06d16b6b-9ca6-4cec-a785-f27aa4323cec,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,5B5CC2BA-6A10-4279-A0AA-8DDAE94D56EA,Alive,Cedars Sinai,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.13,1.82,46.29,RNA,233DBDB3-7F2B-4C9D-BE39-7ED1D07BC9A9,Primary Tumor Field,IMPLANTS,2010.0,Alive
s3717,6F422D32-BE96-4CC9-AAE9-608C50B31616,UNCID_2394061.02fea7d7-d604-41c2-9506-a62824140df4.sorted_genome_alignments.bam,65,02FEA7D7-D604-41C2-9506-A62824140DF4,88705b03-aa27-45c5-bef0-bb697799f9df,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,2CC1817C-7EE6-4A0D-ABD4-DC8712F88CF1,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-40,C61.9,C61,NO,,Not available,30.0,0.17,1.76,53.83,RNA,,,,2012.0,Alive
s11665,D2AD0A1D-2B2F-4164-A9F6-DD8BCA8D3961,UNCID_1194301.176143e0-adb3-4791-8075-2cbc16601cd5.sorted_genome_alignments.bam,75,176143E0-ADB3-4791-8075-2CBC16601CD5,e15a108e-0b32-426f-926a-3fb1af0a82d3,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,BB0EFB98-DB70-499D-BC72-56AF138C419C,Alive,Christiana Healthcare,University of North Carolina,,Kidney Papillary Renal Cell Carcinoma,T2,NX,Stage II,Mar-60,C64.9,C64.1,NO,,Not available,70.0,0.15,1.8,264.3,RNA,,,,2010.0,Alive
s10338,876B04B2-685F-4F12-A83B-A25908B19DC7,UNCID_2059416.f68d990e-ed0b-46d2-8658-bf5e686e79c1.sorted_genome_alignments.bam,47,F68D990E-ED0B-46D2-8658-BF5E686E79C1,6d991de7-8bfb-40a6-9070-edea041bd782,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,ASIAN,HG19,Primary Tumor,660D639D-CC7C-4FE6-897A-6C06CC3E5BEC,Alive,Asterand,University of North Carolina,Vietnam,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2b,N0,Stage IIA,Mar-70,C34.1,C34.1,NO,NO,Not available,30.0,0.17,1.9,19.12,RNA,,,,2012.0,Alive
s17762,F11B7ED8-05AA-4B4D-AA97-CFDCFAA8928D,TCGA-04-1337-01A-01R-1564-13_rnaseq.bam,78,42FAAF19-95DD-426C-96D5-F3363C2E12AB,d1e974e7-dd68-40cc-ad06-2b57d964e5a1,61.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,D8AB03A2-3DC9-433F-B9F3-644F0FB7313F,Dead,Gynecologic Oncology Group,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,69.0,0.16,1.8,233.0,RNA,,,,2005.0,Dead
s4489,568BEC22-5F76-457D-B2BA-1C2DC5AD3D13,UNCID_1626727.2ede539e-5856-4781-bb6f-b1c6efbdf23d.sorted_genome_alignments.bam,67,2EDE539E-5856-4781-BB6F-B1C6EFBDF23D,efa4c675-e35e-4f48-8d12-a40f30b63ddb,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,179BDB8C-C4FD-4949-8ACA-ECA735A5320F,Alive,Mayo Clinic,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.84,135.75,RNA,,,,2010.0,Alive
s14402,6CA1644F-6A3E-4F0B-92CC-B536BE113AB0,TCGA-BR-8365-01A-21R-2343-13_rnaseq.bam,70,C73F497B-E0E6-4022-847C-574D38C30BCD,55a2c884-49a7-4d1a-9e0e-42f6a8b720fa,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,03BE8FE5-AA79-4C4A-826E-2052D470C33B,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Ukraine,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N0,Stage IIA,Mar-40,C16.1,C16.1,NO,,Not available,30.0,0.14,,46.5,RNA,,,,2011.0,Alive
s2011,E00D5548-A577-4019-9F7C-5BAD23811D4E,TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina.bam,33,8853CBEE-7931-49A6-B063-A806943A10AD,0cb21fb0-520f-4105-99ec-697a335115b5,,Rectum Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-READ,Illumina HiSeq,Colorectal,WHITE,GRCh37-lite,Primary Tumor,37BB8CE7-6C55-4237-A7AD-ADC42E6FF6A8,Alive,Greater Poland Cancer Center,Baylor College of Medicine,Poland,Rectal Adenocarcinoma,T3,N1,Stage IIIA,Mar-55,C20.9,C20,NO,,Not available,36.0,0.05,1.9,325.0,DNA,,,,2010.0,Alive
s7693,40A52169-D476-4650-A043-D5FDA21A4213,TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted.bam,77,411370DC-4C66-484F-AC7E-42A19E486DFC,2bbf00f4-7798-4dad-9894-96202c9132be,1354.0,Skin Cutaneous Melanoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-SKCM,Illumina HiSeq,Skin,WHITE,HG19_Broad_variant,Primary Tumor,EA15A5B0-8BA7-4114-853F-E3396E81CCEB,Dead,University of Pittsburgh,Harvard Medical School,United States,Not available,Not available,N0,Not available,Mar-20,C49.1,C49.1,NO,NO,Not available,30.0,0.17,,30.36,DNA,,,,2005.0,Dead
s2750,4C0758F2-1016-4CCB-8083-7DC82219979F,UNCID_1177675.958520af-f270-49ab-8fb6-57e1ae8ae68f.sorted_genome_alignments.bam,60,958520AF-F270-49AB-8FB6-57E1AE8AE68F,40398c03-a9cc-476b-9ee9-aecf161be43f,,Bladder Urothelial Carcinoma,Not available,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,Not available,HG19,Primary Tumor,54234A11-8674-4B01-B2EF-A4C6D772AA43,Alive,Indivumed,University of North Carolina,Germany,Muscle invasive urothelial carcinoma (pT2 or above),T2b,N0,Stage II,Mar-20,C67.9,C67.9,NO,,Not available,10.0,0.08,1.89,7.34,RNA,,,,2007.0,Alive
s15662,C4CF2BA3-FC8D-4C6A-A6B2-7BE05930F0F7,UNCID_1483039.7aad25fb-ebf1-4540-946a-9bc25b3b3c41.sorted_genome_alignments.bam,65,7AAD25FB-EBF1-4540-946A-9BC25B3B3C41,f3a626e4-2d93-4d13-a34c-de0e0c6118ac,3059.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,ED42E6F5-9894-49F5-A2A9-E12A9F342CE5,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,NX,Stage II,Mar-70,C14.8,C14.8,NO,,Not available,31.0,0.15,,237.2,RNA,,,,1997.0,Dead
s1249,C50F9D32-97FB-405C-B829-4D957338A470,UNCID_1712116.76e090d4-d2c2-4918-97d8-4dd1dbea5452.sorted_genome_alignments.bam,64,76E090D4-D2C2-4918-97D8-4DD1DBEA5452,d7f07485-522a-49d9-b105-5a9a51aca8f7,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,5686F844-BE97-472D-8564-A35C3A3EBAC2,Alive,Gynecologic Oncology Group,University of North Carolina,United States,Cervical Squamous Cell Carcinoma,Not available,Not available,Not available,Mar-70,C53.9,C53.9,NO,,Not available,30.0,0.15,2.04,6.62,RNA,,,,2008.0,Alive
s588,EAECAA19-60F6-49F5-88FC-E36D3AFC958F,UNCID_2567966.cbb214e1-ea22-4231-815b-d27d585e61c3.sorted_genome_alignments.bam,28,CBB214E1-EA22-4231-815B-D27D585E61C3,1b6f6269-64a6-408b-9103-58128615117c,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,ASIAN,HG19,Primary Tumor,C695A4C1-4580-43D5-9F81-DBE48E246B40,Alive,Erasmus MC,University of North Carolina,Netherlands,Not available,T1,N0,Stage IS,Mar-61,C62.9,C62.9,NO,NO,Not available,30.0,0.18,1.82,44.1,RNA,,,,,Alive
s1547,2C584444-242A-48ED-82EE-7D111D7132AE,UNCID_1664628.1a6ee24e-975c-4ba8-8cc3-666555fb89d6.sorted_genome_alignments.bam,40,1A6EE24E-975C-4BA8-8CC3-666555FB89D6,c13215d9-26a8-4c8b-b4fe-5da6aa3222af,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,F0CA60FB-BD45-4F15-A791-0C5B1218D8EF,Alive,Gynecologic Oncology Group,University of North Carolina,United States,Cervical Squamous Cell Carcinoma,Not available,Not available,Not available,Mar-70,C53.9,C53.9,NO,,Not available,30.0,0.17,1.82,64.83,RNA,,,,2009.0,Alive
s6584,01C69C8E-2F6B-45D8-8441-ED535BD4BE81,UNCID_1879333.254c611f-7808-4745-9155-f2d578b29df2.sorted_genome_alignments.bam,54,254C611F-7808-4745-9155-F2D578B29DF2,eff2360e-399a-4167-ab2b-798e27bef739,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,22848A4A-ED0D-4EFB-850F-A49F11CD77EC,Alive,Roswell Park,University of North Carolina,,Infiltrating Lobular Carcinoma,T3,N2a,Stage IIIA,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.16,1.82,14.11,RNA,1241840C-6ACC-43D3-8CA1-58BE8ECB2824,Regional site,EXTERNAL BEAM,2008.0,Alive
s11728,2CA554C3-04D2-4D25-85B0-413478249BC0,UNCID_2344439.1aded3d8-d927-4a8b-af9d-e4e00b7480b4.sorted_genome_alignments.bam,62,1ADED3D8-D927-4A8B-AF9D-E4E00B7480B4,cf059d8a-6c7a-48f4-a545-1160177d208d,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRP,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,F8B793D2-0B40-4E9C-A446-A2F22EF9736E,Alive,BLN - Baylor,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1b,NX,Stage I,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.16,1.9,30.28,RNA,,,,2013.0,Alive
s2733,EC0A1F1D-C6E7-4B4A-A296-02087E0B6586,TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.bam,45,8B23B777-2BF2-422A-8AB3-1DF94EE61690,74cbb078-9aae-422a-a7af-dd29ebca949e,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19_Broad_variant,Primary Tumor,DB9442F6-38F2-4092-9E85-F5EC0C924025,Alive,International Genomics Consortium,MD Anderson - Institute for Applied Cancer Science,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3a,N0,Stage III,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.16,,65.0,DNA,,,,2011.0,Alive
s4517,F9A2F245-EE99-4C4E-864C-0E40CDDD22BE,UNCID_2032239.0ed2207e-47d3-47aa-804f-abffb6f42e64.sorted_genome_alignments.bam,72,0ED2207E-47D3-47AA-804F-ABFFB6F42E64,c9ebaeff-6a27-4a6c-a34c-5337a3508a52,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,Not available,HG19,Primary Tumor,570BB596-BAD8-4A83-A7D7-E9FA8C9E16AA,Alive,British Columbia Cancer Agency,University of North Carolina,Canada,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,NO,Complete Remission/Response,30.0,0.17,1.85,52.65,RNA,,,,2011.0,Alive
s6480,20E645AB-D087-4D74-872F-00EBE42454A3,UNCID_1118167.554df3b0-e305-4dab-a268-47ad7c1dcffc.sorted_genome_alignments.bam,49,554DF3B0-E305-4DAB-A268-47AD7C1DCFFC,82ec33dd-e783-4c74-9a87-797a699e11df,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,09191482-34DE-4130-AFBE-DD47D481D539,Alive,Not available,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N3a,Stage IIIC,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.18,1.78,15.23,RNA,A77D9CB5-BE36-4F5B-A97C-A8A048732921,Regional site,EXTERNAL BEAM,2010.0,Alive
s15993,35678F7B-7640-488C-9509-E882745C7F16,UNCID_2199227.aceec37c-273e-44da-8f26-78769d4ad0a2.sorted_genome_alignments.bam,51,ACEEC37C-273E-44DA-8F26-78769D4AD0A2,8f6c64c9-7799-436d-bff0-b166e56532a8,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,ASIAN,HG19,Primary Tumor,0629EF87-AFB1-432C-86BE-995192C7ED81,Alive,Asterand,University of North Carolina,Vietnam,Head and Neck Squamous Cell Carcinoma,T2,N2b,Stage IVA,Mar-71,C02.9,C02.9,NO,NO,Not available,30.0,0.16,1.82,57.19,RNA,,,,2012.0,Alive
s6361,D9280BEE-70C2-44F1-8BE7-BB8F906D1B20,UNCID_1154631.a5405b3a-e351-4e9e-b3fa-07c33e3318d3.sorted_genome_alignments.bam,35,A5405B3A-E351-4E9E-B3FA-07C33E3318D3,316625b8-a217-4829-90d1-dfd9cb7e4bc3,,Breast Invasive Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,Not available,HG19,Primary Tumor,E7008896-7348-4B14-A443-D9DA1352C80E,Alive,Indivumed,University of North Carolina,Germany,Infiltrating Ductal Carcinoma,T2,N1a,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,20.0,0.14,1.81,6.5,RNA,D420AEC4-2B57-4231-822E-611BDD49C141,Primary Tumor Field,External,2009.0,Alive
s9435,5130AD44-D433-47BA-ABF8-3530B950220D,UNCID_602139.abb072fe-25c3-49f2-83ca-b738e90850a6.111007_UNC9-SN296_0249_BB03KMABXX.1.trimmed.annotated.translated_to_genomic.bam,60,ABB072FE-25C3-49F2-83CA-B738E90850A6,e33dff22-5bf1-4dd8-bed7-063cb555677c,1980.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,D67BE8E3-41E9-4948-94CF-ADC5EDDD294B,Dead,University of Pittsburgh,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T4,NX,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.14,1.7,25.8,RNA,,,,2004.0,Dead
s844,58A1868E-F443-4A76-8D85-DB9B07B59BC8,UNCID_2487183.ecd432eb-db83-4987-b252-4765d83c3b55.sorted_genome_alignments.bam,65,ECD432EB-DB83-4987-B252-4765D83C3B55,cd9dc5c5-1161-43ea-a617-1356a3b23e16,458.0,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,4D3509FE-B8A7-4A45-A32A-82BA4D5FBF95,Dead,Moffitt Cancer Center,University of North Carolina,United States,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,YES,Not available,30.0,0.18,1.89,34.22,RNA,,,,2011.0,Dead
s6886,7B0B327F-3300-47F4-9F2D-B16EADA4EDC2,UNCID_2028077.6bbb74ed-93be-4cbe-a854-4ea6aaec0615.sorted_genome_alignments.bam,62,6BBB74ED-93BE-4CBE-A854-4EA6AAEC0615,9c895825-d6f6-4d14-a662-23212200f6e5,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,CEC6AD5E-A8D3-43CD-8A74-2199899F2422,Alive,Mayo,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T2,N0,Stage IIA,Mar-20,C50.9,C50.9,NO,YES,Not available,30.0,0.17,1.87,18.0,RNA,5B7461B2-C13C-47B1-B736-33437677102C,Primary Tumor Field,External,2008.0,Alive
s10012,728EF74B-584B-4F98-81E5-C5447E5F39A4,UNCID_1075871.1190c768-24c0-4762-8701-dea5d35e8fe1.sorted_genome_alignments.bam,68,1190C768-24C0-4762-8701-DEA5D35E8FE1,a9d7adec-3849-40e2-a2a2-f43443ec43bb,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,290BBFA2-1028-46A3-B8A4-CA7848590BBF,Alive,Indivumed,University of North Carolina,Germany,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-70,C34.1,C34.1,NO,,Not available,147.0,0.15,1.8,612.0,RNA,,,,2008.0,Alive
s17834,9B826F34-4DB0-48D0-90BE-64DE6C788D8D,TCGA-24-2020-01A-01R-1567-13_GRCh37-lite_rnaseq.bam,67,19765B4F-458E-4F02-BF96-01498D80AC83,e20ea417-7296-4da8-9fdb-71cd1f45153a,4624.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,871FC478-CF3F-43C2-8AEA-0DB7C777ABE1,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,134.0,0.17,1.8,611.0,RNA,,,,1994.0,Dead
s17621,2FFA0129-60F6-47BB-98AD-C51440C87293,TCGA-24-2024-01A-02R-1568-13_rnaseq.bam,72,BDD5AFB1-A251-4541-BBBE-0FCD1126A3CE,0a48873a-092a-4b25-822b-b0b3c18c08a8,1769.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,BLACK OR AFRICAN AMERICAN,NCBI36_BCCAGSC_variant,Primary Tumor,A3F8DCAD-C42A-4070-80C4-782627BBACA2,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,150.0,0.16,1.8,847.0,RNA,,,,1994.0,Dead
s6066,FBFB82F9-0EDD-4CE5-A7ED-9F478EB8375E,UNCID_1378654.79a14838-69d2-4c73-83a7-b57ff6ecdd79.sorted_genome_alignments.bam,87,79A14838-69D2-4C73-83A7-B57FF6ECDD79,e37ae674-a107-4eb3-94d8-b86b0035a9f7,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,96E71B7B-D32B-48BC-858D-20F7C8B7812D,Alive,International Genomics Consortium,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T2,N1a,Stage IIB,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.17,1.76,10.81,RNA,,,,2011.0,Alive
s1103,649FF853-287A-4F0D-94DB-0842347BF98C,TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina.bam,42,A29278AF-7ECF-403E-B6A9-623EA7879D05,c8cde9ea-89e9-4ee8-8a46-417a48f6d3ab,,Lymphoid Neoplasm Diffuse Large B-cell Lymphoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-DLBC,Illumina HiSeq,Lymph Nodes,ASIAN,GRCh37-lite,Primary Tumor,047CAECB-6829-4943-BBC5-F45EED3979B6,Alive,SingHealth,Baylor College of Medicine,Singapore,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),Not available,Not available,Not available,Mar-80,C17.9,C83.3,NO,,Not available,37.0,0.05,,443.7,DNA,,,,2010.0,Alive
s1071,366BDF96-E166-4F4B-A4E3-5071BC58364D,UNCID_2375628.4d01a3d8-d9b7-45e7-82d6-420c5d786de2.sorted_genome_alignments.bam,55,4D01A3D8-D9B7-45E7-82D6-420C5D786DE2,065f7b7a-05ee-4728-bcfc-6095357512a6,95.0,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,07938EED-25A4-4F64-B80C-63E5A9DCA148,Dead,Tufts Medical Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-80,C72.9,C72.9,NO,NO,Progressive Disease,30.0,0.18,1.88,18.93,RNA,,,,,Dead
s1522,684E83C6-0894-4BFD-A2EE-6B1877C74F82,TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted.bam,35,E87CC37B-FD44-4DD9-9D14-455B89C6D4C2,753ee373-fbcf-4349-b9b2-5a41936e27e9,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19_Broad_variant,Primary Tumor,0835FA38-9870-472E-B9A0-2A2652807BC5,Alive,Asterand,MD Anderson - Institute for Applied Cancer Science,Russia,Cervical Squamous Cell Carcinoma,T1b,N0,Not available,Mar-70,C53.9,C53.9,NO,,Not available,30.0,0.16,,76.91,DNA,,,,2011.0,Alive
s13487,612AFDCB-A8A6-4E28-83FE-7C83481BBC97,UNCID_2635811.fa58821e-b6a7-4d83-be93-b1ae5a382824.sorted_genome_alignments.bam,76,FA58821E-B6A7-4D83-BE93-B1AE5A382824,a54b322b-80d3-435c-8d14-25841b741f6c,,Colon Adenocarcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,02981F5D-786D-4BC8-9449-CEDE512502BC,Alive,University of Sao Paulo,University of North Carolina,Brazil,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.2,C18.2,NO,YES,Progressive Disease,30.0,0.17,1.83,18.79,RNA,,,,2011.0,Alive
s8647,0C2CDB73-6DD4-4863-9E19-42962B21D353,UNCID_1845326.83071fd2-bdb5-4135-97cd-dc6d68120a02.sorted_genome_alignments.bam,39,83071FD2-BDB5-4135-97CD-DC6D68120A02,6105c037-90f1-42d9-ac38-6e2252999a64,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,A434EA0F-8E75-4EC7-991C-1F029955A159,Alive,MSKCC,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.0,C71.0,NO,NO,Stable Disease,36.0,0.14,,12.2,RNA,,,,2012.0,Alive
s9517,4F5CE0B7-ED8A-4556-96C1-9C54461C2184,UNCID_2191714.52f0c611-1545-4796-8ea9-4578a988dcad.sorted_genome_alignments.bam,74,52F0C611-1545-4796-8EA9-4578A988DCAD,9cdda9fa-d492-4902-afc1-eb2244e70c1b,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,D3E3821A-8D26-4B15-B928-E98EEE5FB537,Alive,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T2,N0,Stage II,Mar-10,C64.9,C64.9,NO,,Not available,37.0,0.16,1.7,31.8,RNA,,,,2006.0,Alive
s1165,F860DA6F-1CEC-4913-AA35-B32670A1734F,6e5cc39dc99c646350c2188f42625edd.bam,21,945E6808-2887-4F32-AC32-8F9E00353BF6,14c65927-b9dd-4ef6-9917-db7bc431ff2f,348.0,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,59B0B757-7D08-4B3E-9974-FD02747D3665,Dead,Medical College of Wisconsin,Washington University School of Medicine,United States,Cervical Squamous Cell Carcinoma,T1b,N1,Not available,Mar-71,C53.9,C53.9,NO,,Not available,20.0,0.08,1.95,59.06,DNA,1FD559E6-464D-4A77-81D6-3F572F0C29F2,Local Recurrence,EXTERNAL BEAM,1997.0,Dead
s9111,3955D310-9BAF-4C5C-AF8C-575627049400,UNCID_372674.TCGA-BP-4974-01A-01R-1334-07.110620_UNC14-SN744_0132_AD0CP3ABXX.5.trimmed.annotated.translated_to_genomic.bam,58,627E1C9B-194B-4BD8-AA60-57400A2682A6,d6625c4d-cd1c-4c62-8100-e8b2a49ce3ad,220.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,A75C92B2-C67B-42B5-A8C2-7EEA1B567ED0,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.16,1.8,38.3,RNA,,,,2006.0,Dead
s4165,B66AA3D3-55FB-4CC4-B76A-B536AD26DF76,UNCID_1233771.bb36bff9-44fd-4f93-a82f-8c23658c335c.sorted_genome_alignments.bam,60,BB36BFF9-44FD-4F93-A82F-8C23658C335C,d4ffafdc-ee83-43df-aa3b-7326503c6438,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19,Primary Tumor,6D1A2D44-72F3-4333-8506-E53CDC4E5185,Alive,Indivumed,University of North Carolina,Germany,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,29.0,0.14,1.8,122.8,RNA,,,,2005.0,Alive
s4068,260ED59A-F972-4D56-A1C0-85ED88AF01EB,UNCID_2253874.dbde3775-bbbc-4492-8449-6f04c4edc65d.sorted_genome_alignments.bam,53,DBDE3775-BBBC-4492-8449-6F04C4EDC65D,93d10d8b-5f98-4d2c-8af3-11471385d4d4,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,5FAF8EC8-F94C-4B0C-9D91-70942F15F3C8,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.17,1.81,16.97,RNA,,,,2012.0,Alive
s667,86A13844-A2D7-4DA7-A7EE-BDA88E2C365E,UNCID_2598702.7d273a8f-7967-4ad8-8cdc-13be7eee126e.sorted_genome_alignments.bam,29,7D273A8F-7967-4AD8-8CDC-13BE7EEE126E,3713865f-b6d5-44f4-809b-8b17b696ace3,,Testicular Germ Cell Tumors,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,Not available,HG19,Primary Tumor,3DCC6FBC-597F-4DBE-AFBA-CFB26CEDDBAE,Alive,University of Southern California,University of North Carolina,United States,Not available,T1,NX,Stage IS,Mar-61,C62.9,C62.9,NO,NO,Not available,30.0,0.18,1.89,75.34,RNA,9E633FC2-560D-45FC-AAC1-E4AA748033CD,Regional site,External,,Alive
s17608,301450B4-4C25-41BD-9DF9-05E043AF91B5,TCGA-13-1488-01A-01R-1565-13_GRCh37-lite_rnaseq.bam,59,FBD513D6-46E8-48F7-9DC3-F7369AD0F3C7,a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61,2154.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,22461884-5FDB-4188-A469-5DFA55A2823E,Dead,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,134.0,0.14,1.8,351.0,RNA,,,,2002.0,Dead
s680,249C0C99-7BAC-4781-B3D6-474CDC27C957,UNCID_2603986.43833af2-f61d-45d1-bf14-24ae5ef4c755.sorted_genome_alignments.bam,33,43833AF2-F61D-45D1-BF14-24AE5EF4C755,59f1f860-2f84-4668-ae62-8ca8fa38e47a,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,ASIAN,HG19,Primary Tumor,B254EAA1-215C-4244-BA6F-FD345B455E6F,Alive,University of Southern California,University of North Carolina,United States,Not available,T2,NX,Stage I,Mar-61,C62.9,C62.9,NO,NO,Not available,30.0,0.16,1.74,56.19,RNA,,,,,Alive
s15880,C1887D1C-970A-4E8D-80DF-A16844DAEF9F,TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.bam,61,1CB41C9B-FB04-438D-A9FB-89D6186E0D37,dedd71b4-8537-4947-839e-90aceddd0893,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19_Broad_variant,Primary Tumor,A1FD1C9D-C763-488A-8649-FF069F56D2BE,Alive,University of Pittsburgh,Harvard Medical School,,Head and Neck Squamous Cell Carcinoma,T1,N1,Stage III,Mar-70,C02.9,C02.9,NO,,Not available,28.0,0.14,1.9,7.7,DNA,,,,2010.0,Alive
s5409,7724D61B-1076-4B97-8CC7-E408C8E559BF,UNCID_1610850.dbe07c69-fd67-4dcd-b69d-6bdc4a85110c.sorted_genome_alignments.bam,66,DBE07C69-FD67-4DCD-B69D-6BDC4A85110C,38f9fe64-de79-498c-b3ca-1c83af0ed72a,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,203C6ED3-2E18-400D-83EE-69A8FD9BB386,Alive,MSKCC,University of North Carolina,,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.17,1.76,31.07,RNA,D08CA9CD-8E66-4213-AB44-5352B1E76258,Primary Tumor Field,OTHER: SPECIFY IN NOTES,2008.0,Alive
s13635,DE68CCD1-8105-4BD5-BA92-D5264567E002,UNCID_270877.TCGA-AA-3856-01A-01R-0905-07.100909_UNC4-RDR3001561_00023_FC_62ELHAAXX.3.trimmed.annotated.translated_to_genomic.bam,59,106517BE-43B1-471D-8162-00AD40675603,0b8de222-119a-40f3-8beb-12b9d933225b,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,67D6E183-9565-4E35-BE64-30CFB74B2B65,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.9,C18.9,NO,,Not available,138.0,0.15,1.8,280.3,RNA,,,,2009.0,Alive
s1796,1ED4199F-0A58-4F13-B9B6-EF6C4062C8FA,TCGA-Z6-A8JE-01A-11R-A37I-31_rnaseq.bam,57,9AF58C98-1B09-4560-891D-7BDFA1F2C680,1116ddae-76b0-48d6-869c-be65d8b09d35,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,F72009C2-7E17-4595-B691-105764FBEE12,Alive,Cureline,Canada's Michael Smith Genome Sciences Centre,Russia,Not available,T3,N1,Stage IIIA,Mar-70,C15.3,C15.3,NO,NO,Not available,30.0,0.18,1.89,72.0,RNA,,,,,Alive
s16823,48A8337D-0965-419B-A982-38F355AF4E35,UNCID_2388647.932e8866-4903-4541-a239-8318abbca064.sorted_genome_alignments.bam,53,932E8866-4903-4541-A239-8318ABBCA064,cca827ca-0066-497d-83dc-477f3b08ea6d,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,CBDAAC78-7866-47B0-BBDE-62E1B84B96D7,Alive,Asterand,University of North Carolina,Vietnam,Hepatocellular Carcinoma,T2,N0,Stage II,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.17,1.83,81.82,RNA,,,,2013.0,Alive
s6264,77D3443D-1BF9-4867-89A2-65CC8E10141B,63caf3c72c859d6a05579c2a05cead25.bam,49,B27D75BA-5989-4200-BFE9-F1B7D7CF8008,65cac997-4d39-4501-85ec-4fcb328a8eb5,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,FED3A891-21BE-4196-B9EF-0BF7C8F976AA,Alive,MD Anderson,Washington University School of Medicine,United States,Infiltrating Ductal Carcinoma,T2,N0 (i-),Stage IIA,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.08,,32.95,DNA,5579FB1C-390D-4919-A4B9-138CA5AF97BB,Primary Tumor Field,External,2007.0,Alive
s16990,73F69200-3B5D-4858-BA49-5E5AD6CD9CA5,UNCID_1201223.d6cb14d4-1ee1-4d83-ad3f-efa19969c00f.sorted_genome_alignments.bam,66,D6CB14D4-1EE1-4D83-AD3F-EFA19969C00F,0bf5bbd4-d9e8-42a6-9ab5-f2c174dec12c,308.0,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,995180F2-5AA7-47B9-BB3F-585F94B2457A,Dead,UNC,University of North Carolina,United States,Hepatocellular Carcinoma,T3,NX,Not available,Mar-70,C22.0,C22.0,NO,,Not available,30.0,0.15,1.78,85.09,RNA,,,,1999.0,Dead
s17856,35FBB64D-533B-4101-A39A-102CFB956B37,TCGA-59-2354-01A-01R-1569-13_GRCh37-lite_rnaseq.bam,63,33367EB6-4CA9-4DAF-9E47-30A47A78E144,d7925dfc-18ce-46ab-a47b-9d06eacc96d0,1046.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,7CE668A0-DA92-4201-9F07-2C5B02DF2C88,Dead,Roswell Park,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,144.0,0.14,1.8,719.0,RNA,,,,2005.0,Dead
s16572,F1DAFC21-D5B0-48E6-AB3E-2FFFA2D599E4,TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.bam,67,0B811C6A-8F05-44BD-AC33-FB720D189E71,2ea84e23-6a0a-4c5d-9c70-d5355a85df35,,Kidney Chromophobe,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-KICH,Illumina HiSeq,Kidney,WHITE,GRCh37-lite,Primary Tumor,E1D3EE37-402B-4727-8E27-B797D42F46BA,Alive,NCI Urologic Oncology Branch,Baylor College of Medicine,United States,Kidney Chromophobe,T1a,NX,Stage I,Mar-17,C64.9,C64.9,NO,NO,Complete Remission/Response,38.0,0.05,,157.0,DNA,,,,2005.0,Alive
s13597,758821A8-2141-4C3D-BF3F-68D183F10056,UNCID_1803822.9043031b-caea-441e-8187-34f63ab36978.sorted_genome_alignments.bam,71,9043031B-CAEA-441E-8187-34F63AB36978,38d65618-4857-490e-86b3-0a3f772a9f60,643.0,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,A0D03ED1-358A-45CE-A26A-F16D6FFA6050,Dead,Harvard,University of North Carolina,United States,Colon Adenocarcinoma,T1,N0,Stage I,Mar-40,C18.2,C18.2,NO,,Not available,28.0,0.15,1.8,66.8,RNA,,,,2003.0,Dead
s9486,0EED3ECD-7217-49FD-B8EE-406743327718,UNCID_1187077.84b85f9f-2496-4539-aa1d-1053b98476d3.sorted_genome_alignments.bam,68,84B85F9F-2496-4539-AA1D-1053B98476D3,9245a557-01ea-4446-b9e9-313f6ab18834,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,5CD539B8-90BF-4465-826F-73269EA2E802,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,34.0,0.17,1.7,39.3,RNA,,,,2007.0,Alive
s17873,5D97901C-EBC3-4010-A553-FA6676B63443,TCGA-24-0982-01A-01D-0516-08_IlluminaGA-DNASeq_whole.bam,77,1BE8FA2C-8FEA-4E8C-90DB-C04D9FCDBF49,206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18,679.0,Ovarian Serous Cystadenocarcinoma,Not available,WGS,FEMALE,TCGA-OV,Illumina GA,Ovary,WHITE,HG18_Broad_variant,Primary Tumor,7FEC33CD-6F46-44C7-8204-E0F42B543ABE,Dead,Washington University,Broad Institute of MIT and Harvard,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,127.0,0.16,1.9,418.87,DNA,,,,2003.0,Dead
s5052,C283F5C4-3806-41AE-9AC0-71FF0FC211BB,UNCID_1613927.e8736e4d-6e9b-49b0-a321-0e42740a11c1.sorted_genome_alignments.bam,55,E8736E4D-6E9B-49B0-A321-0E42740A11C1,1b35d083-f7c9-47d2-9a9e-718788f9e39a,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,A2D2A29A-5ABC-48C3-AC17-76B8B9EE1717,Alive,Washington University,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.18,1.92,80.72,RNA,,,,2008.0,Alive
s15854,565C10D0-7AD9-4BD4-8B7D-EF3934511B43,UNCID_2488420.5dece5bd-86aa-4309-b150-5d44b1b377f0.sorted_genome_alignments.bam,79,5DECE5BD-86AA-4309-B150-5D44B1B377F0,9205dc07-93f5-4b5e-924e-8e097616160f,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,A623A7B2-FEE2-4080-8E17-118BCBB7FEBF,Alive,International Genomics Consortium,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,N1,Stage III,Mar-70,C02.9,C02.9,NO,NO,Not available,20.0,0.17,1.88,43.68,RNA,,,,2012.0,Alive
s11157,B3610696-E8EB-4030-940A-8F4977D99478,UNCID_1202652.d41fd6e3-f45d-40df-86bc-7fb9d2e3cdd3.sorted_genome_alignments.bam,61,D41FD6E3-F45D-40DF-86BC-7FB9D2E3CDD3,c1a01e8c-1f7e-4e24-bfad-90b73f88e992,,Lung Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,D0090140-E835-484E-BEF0-E83011931B66,Alive,Prince Charles Hospital,University of North Carolina,Australia,Lung Adenocarcinoma Mixed Subtype,T4,N2,Stage IV,Mar-55,C34.3,C34.3,NO,,Not available,35.0,0.15,1.7,65.2,RNA,,,,2008.0,Alive
s17282,D8AED7B8-8C2D-432E-8946-4E405BA8A3FE,TCGA-04-1348-01A-01R-1565-13_GRCh37-lite_rnaseq.bam,44,1465139E-D1B2-4026-A532-08513FE0AD4D,f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4,1483.0,Ovarian Serous Cystadenocarcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,CDAA3A57-C3E7-4858-A048-8F75B882DDE7,Dead,Gynecologic Oncology Group,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,105.0,0.15,1.8,491.0,RNA,,,,2004.0,Dead
s3552,7D7F6AE1-8448-46E9-AE60-FDAA778A3DE1,UNCID_2478437.f4024393-b3f0-43b4-916e-4e92cb95c084.sorted_genome_alignments.bam,63,F4024393-B3F0-43B4-916E-4E92CB95C084,5a4d8694-947d-45e9-9a21-6de0f63837f0,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,36DA3689-5B86-480D-8763-FEFB7A73AD42,Alive,University of Kansas,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,Not available,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.18,1.83,14.92,RNA,,,,2007.0,Alive
s10435,6F6DA353-3A24-4EEE-8ABA-BB3C304C1C40,UNCID_1341686.318d06a1-77ea-4a5a-a886-d8b470713451.sorted_genome_alignments.bam,73,318D06A1-77EA-4A5A-A886-D8B470713451,ea741488-5475-4a3d-b9fe-81722f129974,5.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,B70ABA76-CC36-48B0-BF1A-D83E5CF1CD54,Dead,Washington University - Emory,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-70,C34.1,C34.1,NO,,Not available,28.0,0.16,,85.7,RNA,,,,2011.0,Dead
s17540,990927FF-00F7-4D91-9353-111BB36CC4DD,TCGA-30-1862-01A-02R-1568-13_GRCh37-lite_rnaseq.bam,65,AB0701BC-0BC5-4008-A75B-5F665EF9C14A,58f5a54e-de50-4cca-afa1-cc331d8b3479,186.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,6211110A-552C-492F-B066-C3B41DB7FBAD,Dead,Harvard,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,124.0,0.15,1.8,330.0,RNA,,,,2003.0,Dead
s2803,D20AB198-798F-4512-8498-9FC303E3A4CD,UNCID_2315815.842484b0-6661-4dc2-bf70-b1216ab05475.sorted_genome_alignments.bam,60,842484B0-6661-4DC2-BF70-B1216AB05475,65295450-36cd-45a7-a4a6-2d52ee11378f,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,290DCC7F-5957-4FE7-9E6A-32DAEB18FE69,Alive,BLN - University Of Chicago,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3a,N0,Stage III,Mar-20,C67.3,C67.3,NO,NO,Complete Remission/Response,30.0,0.17,1.9,30.43,RNA,,,,2013.0,Alive
s11918,3815E1D5-396F-40A6-B631-B922214DB35C,UNCID_2099825.3865d65b-930c-4979-91c5-497b72d1b7a8.sorted_genome_alignments.bam,43,3865D65B-930C-4979-91C5-497B72D1B7A8,60df8616-8189-4d5c-8ebc-a05488cd9083,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,C27551A9-E0BD-4D67-803B-1074C12A8DEF,Alive,NCI Urologic Oncology Branch,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1b,N0,Stage I,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.17,1.85,30.58,RNA,,,,2010.0,Alive
s17860,A5A38B79-004D-49DE-860D-9425560503BB,TCGA-61-2101-01A-01R-1568-13_GRCh37-lite_rnaseq.bam,55,95970BDB-E1F2-49DC-903B-C30088CEF71D,5d1a54fe-e0df-4c17-b623-b649a136dc82,1688.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,46D32513-DC68-4261-8E1B-26D407B6546A,Dead,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,141.0,0.15,1.8,378.0,RNA,2E12C990-CD4B-46FC-A84C-C6F3478884E1,Local Recurrence,EXTERNAL BEAM,1999.0,Dead
s16592,34884FF9-C16B-4800-9B84-DD3EC001B261,TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.bam,52,D02597F8-3AC7-4165-A65F-0E134E5D215B,65e430e1-0c9a-4045-83a9-653b7cff811d,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,GRCh37-lite,Primary Tumor,56DAAD30-A336-4311-9FEB-26CF3E48C734,Alive,International Genomics Consortium,Baylor College of Medicine,United States,Hepatocellular Carcinoma,T1,NX,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.08,,41.34,DNA,,,,2012.0,Alive
s4055,0E36854B-7618-4D25-85C4-714573F1CAB8,UNCID_2136555.3be6c54c-f606-4eba-8242-8dff705fa2d0.sorted_genome_alignments.bam,62,3BE6C54C-F606-4EBA-8242-8DFF705FA2D0,89c150cf-f60c-4f11-8f3e-384b0e0902f9,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,B0A9A48B-6053-469E-9812-2815BDD9AA22,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.16,1.88,28.34,RNA,,,,2012.0,Alive
s99,5C7B96FC-CA8A-469F-B49A-F76F38495F74,UNCID_2136979.29f9f4c4-da13-4e12-926a-d3b111a7599e.sorted_genome_alignments.bam,62,29F9F4C4-DA13-4E12-926A-D3B111A7599E,ce2b2c41-7d28-4d8b-a037-af842a8fe20f,114.0,Uterine Carcinosarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCS,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,4C789412-2F7B-4CC1-A9BC-F87D5B457B38,Dead,Duke University,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-51,C55.9,C55,NO,NO,Not available,30.0,0.18,1.89,37.68,RNA,,,,,Dead
s10783,3CB48D09-95AC-452F-9C92-19D7F966AEC0,TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam,77,8DF0AEB4-1455-4760-A230-54FE1551D08C,c6d78e27-e510-4f57-abae-19efa6105a8d,1081.0,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,GRCh37,Primary Tumor,7CA68089-C61F-4D31-8CC8-FB11AE70910A,Dead,Johns Hopkins,Harvard Medical School,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T3,N2,Stage IIIA,Mar-40,C34.1,C34.1,NO,,Not available,110.0,0.16,1.9,245.2,DNA,,,,1995.0,Dead
s9243,6571042B-8C71-4107-8E3C-A9EE66693A07,UNCID_2306250.c59fa3d3-ce24-4d46-8d3e-e4b247768671.sorted_genome_alignments.bam,60,C59FA3D3-CE24-4D46-8D3E-E4B247768671,09d7ce7a-774e-4784-9c9a-32b766fdb173,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,8B849E83-CF60-44F4-A955-EACAD7F50E8A,Alive,UNC,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T2a,NX,Stage II,Mar-12,C64.9,C64.9,NO,NO,Complete Remission/Response,30.0,0.17,1.9,29.35,RNA,,,,2012.0,Alive
s6387,33F0A300-A5D8-4265-87BB-09E0F547C950,UNCID_1167437.b1ecc303-eb55-436f-9629-cdac63bde297.sorted_genome_alignments.bam,52,B1ECC303-EB55-436F-9629-CDAC63BDE297,c744fc13-3aca-4245-9e24-abd368cc8bef,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,D3C85F76-56ED-4F64-9EDB-9CDF80526E33,Alive,Walter Reed,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N0 (i-),Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,1.79,40.37,RNA,69E31EE3-A4BA-40BF-B722-F1A229006582,Not available,Not available,2006.0,Alive
s6447,F0967810-7B67-40B6-9995-A392153F2FBA,f059a2333e0663ef4831e98db4f4c9e5.bam,52,F6114C69-71A1-47D5-9B28-B0227B1872F7,d8d7a6c2-6427-4f47-968c-6c3affba4617,,Breast Invasive Carcinoma,Not available,WGS,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,Not available,GRCh37-lite,Primary Tumor,1964ADDF-C524-4C72-B596-009235BAD133,Alive,Indivumed,Washington University School of Medicine,Germany,Infiltrating Ductal Carcinoma,T2,N0,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.08,1.86,69.64,DNA,05C8AF27-7A23-4CF3-8294-437ABD8EE4C1,Primary Tumor Field,External,2008.0,Alive
s9568,AD992CD4-C4D5-4F87-B721-A2CBDF70F57D,TCGA-CJ-4899-01A-01D-2100-10_Illumina.bam,42,9C181313-5B4C-41C5-9AD5-A5A86FE609AA,900b5f21-e8fb-4a3f-b8e3-ef098716e508,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,ASIAN,GRCh37-lite,Primary Tumor,E2D40747-F751-4CCB-A45C-A60B06046DB1,Alive,MD Anderson Cancer Center,Baylor College of Medicine,,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.16,1.9,109.4,DNA,,,,2006.0,Alive
s9306,FF078C8B-F861-46F7-AC62-EB5FF21A805C,TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina.bam,51,3FEAC02A-C99F-4DD9-9EFF-E4F5E87F7DC5,0487fc41-386c-4d76-9084-daf959bf5e98,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,GRCh37-lite,Primary Tumor,B5040DA2-0D96-422A-9760-98A95C136FE8,Alive,Mayo Clinic - Rochester,Baylor College of Medicine,United States,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,29.0,0.15,1.88,288.4,DNA,,,,2003.0,Alive
s4924,6986A10A-2BCE-4988-9E93-F53CC202D071,UNCID_257309.TCGA-BG-A0MI-01A-11R-A040-07.101014_UNC2-RDR300275_00039_FC_706C1AAXX.8.trimmed.annotated.translated_to_genomic.bam,83,C199BAB3-C6E3-4123-811C-2C50E8D44FAE,b8588e0f-aad6-4ded-845e-3cff67a48d8f,714.0,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,F030DAE4-BD6F-4D0D-96E0-12B299057338,Dead,University of Pittsburgh,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.13,2.05,81.57,RNA,,,,2007.0,Dead
s513,BA483FEE-1324-4EF2-9C51-9523BD30691A,UNCID_2584705.659185ac-707a-4695-be80-a718cc34e8bc.sorted_genome_alignments.bam,78,659185AC-707A-4695-BE80-A718CC34E8BC,2b794eae-814c-4b5c-b276-be9096b94f94,379.0,Thymoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THYM,Illumina HiSeq,Thymus,WHITE,HG19,Primary Tumor,0C4C53AE-6C18-4207-B932-C2E58CDAFC20,Dead,Thoraxklinik,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-86,C37.9,C37,NO,YES,Not available,30.0,0.17,1.88,102.93,RNA,14361D2E-A3C1-43E7-8964-8D00BC6A0CAE,Primary Tumor Field,External,,Dead
s10408,A03B759A-2030-4FB1-9126-4B6894C5E8FC,UNCID_1068045.43672213-eb65-4206-bc57-56587b08259f.sorted_genome_alignments.bam,77,43672213-EB65-4206-BC57-56587B08259F,d4bc755a-2585-4529-ae36-7e1d88bdecfe,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,EEFFADF9-2CCB-4937-AE1E-1D50ABA41C4D,Alive,Princess Margaret Hospital (Canada),University of North Carolina,Canada,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-70,C34.3,C34.3,NO,,Not available,96.0,0.15,1.8,170.6,RNA,,,,2004.0,Alive
s13612,7BEF7E61-D3AE-48AD-8569-4573E4C8FE4E,UNCID_1931089.ab5e0fde-c76b-4f9a-ae15-fa17e8695dbd.sorted_genome_alignments.bam,55,AB5E0FDE-C76B-4F9A-AE15-FA17E8695DBD,326c1637-ea91-4006-b440-d38420af1ae5,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,32FC9332-A9FD-47F6-9DEE-6413E58E8CCE,Alive,Christiana Healthcare,University of North Carolina,United States,Colon Adenocarcinoma,T3,N1c,Stage IIIB,Mar-40,C18.2,C18.2,NO,,Not available,36.0,0.15,1.7,119.2,RNA,,,,2010.0,Alive
s13411,245C7742-8C4B-4437-94DB-2488DB8A4A0D,UNCID_1592854.1b7c1662-b8ee-4e22-92f8-1e9eaff7b3ad.sorted_genome_alignments.bam,72,1B7C1662-B8EE-4E22-92F8-1E9EAFF7B3AD,b4c3cf95-a27c-4bcf-9321-38723473e83b,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,2104463B-9421-47F3-9974-A00080C6E937,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T2,N0,Stage I,Mar-40,C18.9,C18.9,NO,,Not available,146.0,0.15,1.8,409.3,RNA,,,,2009.0,Alive
s15509,E7FCC1C5-E66D-4024-ADB8-45DEF5252F1A,TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.bam,59,7EBDEF16-0A0E-4DB2-AB6A-7B6115A7B739,1f6167d9-c99d-4873-8d6e-e62a1c964135,406.0,Head and Neck Squamous Cell Carcinoma,HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19_Broad_variant,Primary Tumor,4DF92618-5E63-46D7-8526-846932BCE3C2,Dead,MD Anderson Cancer Center,Harvard Medical School,,Head and Neck Squamous Cell Carcinoma,T4a,N2b,Stage IVA,Mar-70,C02.9,C02.9,NO,,Not available,29.0,0.15,1.9,115.0,DNA,,,,2009.0,Dead
s422,B0C2A695-A4C2-400C-AFBE-855DE1A90221,UNCID_2548123.f0b52bcf-d7b4-4daa-82bb-e13e2d753be9.sorted_genome_alignments.bam,53,F0B52BCF-D7B4-4DAA-82BB-E13E2D753BE9,ebe927e6-0a7e-4c97-ad73-f3c302cca7bc,885.0,Mesothelioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-MESO,Illumina HiSeq,Mesothelium,WHITE,HG19,Primary Tumor,B71B1FB6-3C73-46C8-AB3B-BDFAA4B66B67,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Not available,T3,N2,Stage III,Mar-52,C38.4,C45.0,NO,YES,Not available,30.0,0.17,1.88,53.76,RNA,,,,,Dead
s13155,3696330A-D701-4A03-9C5A-05B70EC0873C,UNCID_270337.TCGA-AA-3552-01A-01R-0821-07.100908_UNC6-RDR300211_00030_FC_62EL4AAXX.8.trimmed.annotated.translated_to_genomic.bam,85,C229D778-B9E2-430E-A9B7-789174C347A2,265d7b06-65fe-42c5-ad21-e6b160e94718,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,4E728ECB-3169-48FD-9F80-2A5DFF2DB506,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N2,Stage IIIC,Mar-40,C18.0,C18.0,NO,,Not available,114.0,0.16,1.8,620.3,RNA,,,,2008.0,Alive
s3245,EC1F611E-8F53-4EC3-A8D9-139F96BA6283,UNCID_2649318.debf57c3-f5e0-418a-ad1c-40a8ccc93692.sorted_genome_alignments.bam,67,DEBF57C3-F5E0-418A-AD1C-40A8CCC93692,73db40ce-2ba7-4a56-aef2-b78d2c744be1,615.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,34A093D9-85BD-4E22-814C-60E74B97998B,Dead,University of Sheffield,University of North Carolina,United Kingdom,Muscle invasive urothelial carcinoma (pT2 or above),T3b,NX,Stage III,Mar-20,C67.4,C67.4,NO,YES,Partial Remission/Response,30.0,0.17,1.9,83.71,RNA,,,,2010.0,Dead
s5976,EFED1BB1-6F43-4F06-842B-E07A82611653,UNCID_1114219.07c52f68-8ece-4702-8573-9b21f32df787.sorted_genome_alignments.bam,62,07C52F68-8ECE-4702-8573-9B21F32DF787,e663954c-05a8-479a-a623-400c1eb5efc6,2712.0,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,5CD62B0E-902E-492C-843D-5D8AA6964DC5,Dead,University of Pittsburgh,University of North Carolina,,Infiltrating Ductal Carcinoma,T1c,N1a,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.79,29.16,RNA,,,,2002.0,Dead
s110,64E5F2EF-3542-4006-8EF0-C3DF0902CB66,UNCID_2135065.d979c964-68e1-4ea4-a473-69b69cba8e5c.sorted_genome_alignments.bam,53,D979C964-68E1-4EA4-A473-69B69CBA8E5C,48402d61-3a6b-4603-bfa0-b1a38a47d34d,922.0,Adrenocortical Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-ACC,Illumina HiSeq,Adrenal Gland,WHITE,HG19,Primary Tumor,292BCBE1-2FB7-4781-89DA-C33F4589E71B,Dead,University of Michigan,University of North Carolina,Australia,Not available,T4,N0,Stage IV,Mar-70,C74.0,C74.0,NO,NO,Not available,30.0,0.17,1.86,46.4,RNA,,,,,Dead
s4665,C64B5338-96A7-43E6-94FE-9D45E6235A81,UNCID_1631885.714254dd-834a-4b70-8f88-c48bc7b4fdb8.sorted_genome_alignments.bam,74,714254DD-834A-4B70-8F88-C48BC7B4FDB8,0b672aa4-fc13-476f-b61e-5f2c3a615c23,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,52265B60-6F79-4E28-92A9-F4F5BEE5A95E,Alive,Duke,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.86,34.44,RNA,16380B85-2A23-46EC-BC67-3F5E6D5ECBBE,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s4364,A17342E2-6694-46D1-9484-82A4B6F09938,UNCID_294267.TCGA-D1-A16B-01A-11R-A12I-07.110509_UNC6-RDR300211_00102_FC_634VYAAXX.5.trimmed.annotated.translated_to_genomic.bam,64,90250B43-5A36-42C0-886F-32A0ED39BEA6,bca1057a-1e96-404d-8a37-5a8dc1944ee7,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,6A59FF6E-7CC6-4D46-8983-7D9E6A48CC19,Alive,Mayo Clinic,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.84,97.61,RNA,,,,2008.0,Alive
s16258,F542F82A-0B5B-4F70-9454-3DDA5F16A429,UNCID_1496826.5a057036-4674-47df-96d4-ed7cd581d49b.sorted_genome_alignments.bam,41,5A057036-4674-47DF-96D4-ED7CD581D49B,15714e69-e075-4688-8f51-c7102fe4ca07,366.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,55849997-67DE-4FC6-B7BF-9D02D15920C9,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T4a,N2,Stage IVA,Mar-70,C02.9,C02.9,NO,,Not available,33.0,0.15,1.8,215.2,RNA,,,,1993.0,Dead
s3332,F68C5D84-5564-49D4-85F3-EB963A63C254,UNCID_1474521.3BEA01E7-E5BC-484B-91F4-A143CAED0AED.sorted_genome_alignments.bam,80,3BEA01E7-E5BC-484B-91F4-A143CAED0AED,db52c68a-ed44-4ec4-9381-d75f9bcbc29a,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,24F9D01B-1210-4716-9466-8FE9F3612B8B,Alive,International Genomics Consortium,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3,N0,Stage III,Mar-20,C67.9,C67.9,NO,NO,Not available,30.0,0.16,1.81,20.69,RNA,,,,2011.0,Alive
s4134,C9A43591-8317-4FF5-A2E9-33C98C6A6012,TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted.bam,63,83248990-416D-48F0-B6F4-59C4C7CEEBD8,d44d4bcb-beb1-4464-acd2-9972751f5018,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,9EEBD2EC-AF9D-493C-A006-A436C28D4CD3,Alive,University of Pittsburgh,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,24.0,0.14,1.9,72.7,DNA,,,,2008.0,Alive
s3102,0E78DEC3-7B8B-425E-9CC5-489BF825E0EA,TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.bam,60,DC0A234A-9177-4E2A-B218-212F1278B4A1,c5b20ccc-523d-491c-8536-008e05c57212,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19_Broad_variant,Primary Tumor,954E46BA-514F-4708-AD3C-ECBF8CEF005A,Alive,Memorial Sloan Kettering,Harvard Medical School,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3,N2,Stage IV,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.17,1.91,16.46,DNA,,,,2010.0,Alive
s2210,762A7523-1B77-439D-9DD4-42C58C31D6B7,UNCID_1582031.03d8df12-70ee-48bc-bf3e-1debfe385eb9.sorted_genome_alignments.bam,59,03D8DF12-70EE-48BC-BF3E-1DEBFE385EB9,a18acb1d-403a-4802-8efb-9085e006f4c5,,Rectum Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,A7AFFAA9-37F8-4D9B-80E8-72FEA71BE2A6,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C20.9,C20,NO,,Not available,100.0,0.15,1.67,94.1,RNA,,,,2009.0,Alive
s11404,42416BAD-DF50-4818-8101-56490B4869F3,UNCID_1905554.e776b3c7-2afe-4f44-8596-4c0de62fd46d.sorted_genome_alignments.bam,41,E776B3C7-2AFE-4F44-8596-4C0DE62FD46D,202e5df9-69f2-432c-a59d-cc5aa176e973,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,727BAF6E-E991-426E-A823-07908AA85202,Alive,International Genomics Consortium,University of North Carolina,United States,Lung Bronchioloalveolar Carcinoma Nonmucinous,T1a,N1,Stage IV,Mar-52,C34.3,C34.3,NO,NO,Not available,39.0,0.13,,56.2,RNA,,,,2012.0,Alive
s1018,C3E2A1DD-29D4-4FA7-ABC2-A6E14D1C96F5,UNCID_2366962.e9566249-b898-4da6-ae19-360b3c71aa20.sorted_genome_alignments.bam,66,E9566249-B898-4DA6-AE19-360B3C71AA20,9d6e8692-ab14-414f-a5fd-556b9d62fe34,,Pheochromocytoma and Paraganglioma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PCPG,Illumina HiSeq,Nervous System,Not available,HG19,Primary Tumor,7E143858-0F6A-4B52-B5DA-E366ABF2E91C,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.86,34.01,RNA,,,,,Alive
s1555,FEB675A4-6414-4A3A-8F62-CD2DCD4CF580,UNCID_1669578.7feffd22-85c5-4bf9-9a41-28a1f4e0586d.sorted_genome_alignments.bam,57,7FEFFD22-85C5-4BF9-9A41-28A1F4E0586D,638035f6-2909-4a44-980f-468ac5d74e18,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,1FBFA952-F272-4531-9F9D-1B8BD1DD0845,Alive,Asterand,University of North Carolina,Russia,Cervical Squamous Cell Carcinoma,T2a,N0,Not available,Mar-70,C53.9,C53.9,NO,,Not available,30.0,0.18,1.87,29.13,RNA,,,,2011.0,Alive
s17841,1828508E-16EF-4742-B065-E9C67BE5EAF4,TCGA-25-2042-01A-01R-1568-13_rnaseq.bam,60,AE1E5F8D-CDD9-41F5-B56C-80DFE27E1B6C,818dc159-aba4-46bc-a4ed-68ee0f8c4461,396.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,AMERICAN INDIAN OR ALASKA NATIVE,NCBI36_BCCAGSC_variant,Primary Tumor,71484ED8-3496-48B2-81B8-888D04F10F0A,Dead,Mayo Clinic - Rochester,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,111.0,0.15,1.8,181.0,RNA,,,,2006.0,Dead
s17041,B2DC07C6-2155-4D8D-9BE7-1ECF5850BB4D,UNCID_2534071.8f0b105f-e2de-4433-bd6a-dd81cb6c0c93.sorted_genome_alignments.bam,64,8F0B105F-E2DE-4433-BD6A-DD81CB6C0C93,5436fafb-bc16-4450-ac8b-568e1e5ee5fe,,Liver Hepatocellular Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,FAF5DE3B-B8B2-43D9-89C4-1A6B2EE207A5,Alive,Yale University,University of North Carolina,United States,Hepatocellular Carcinoma,T1,NX,Stage I,Mar-70,C22.0,C22.0,NO,YES,Not available,30.0,0.17,1.83,61.52,RNA,23145CED-9A16-4516-9724-23CFB2C8E2A9,Primary Tumor Field,Internal,2011.0,Alive
s3399,8C5D03AF-DB90-44D4-BCF7-2EA1DD0FDDE6,UNCID_2434322.a77cf51f-45de-4a5b-a6ca-6773f8e236d2.sorted_genome_alignments.bam,59,A77CF51F-45DE-4A5B-A6CA-6773F8E236D2,854e5236-f2d6-4681-be62-0bead955c926,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,ASIAN,HG19,Primary Tumor,C867C28D-635D-4074-A148-04C4B29FC410,Alive,Asterand,University of North Carolina,Vietnam,Muscle invasive urothelial carcinoma (pT2 or above),T2,N0,Stage II,Mar-20,C67.9,C67.9,NO,NO,Complete Remission/Response,30.0,0.18,1.86,86.39,RNA,,,,2013.0,Alive
s8234,66B6E0BD-93B0-4040-A18C-765836966240,UNCID_2054732.b8ee7519-8052-4ac2-b331-7196e3f0d30f.sorted_genome_alignments.bam,65,B8EE7519-8052-4AC2-B331-7196E3F0D30F,df22bc30-96e2-42de-9a39-2954db49841d,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,3193B9C5-0768-4D3D-A909-785CA78C3BF9,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,NO,Stable Disease,30.0,0.16,1.85,18.23,RNA,649811CF-0CB8-40D3-91D6-E2B58EADD1AA,Primary Tumor Field,External,2012.0,Alive
s4061,74349BBF-FD0E-446A-AAEE-375ED1EBC87D,UNCID_2173071.14b3c94a-781d-4df9-9ee6-a3236d099dc6.sorted_genome_alignments.bam,61,14B3C94A-781D-4DF9-9EE6-A3236D099DC6,ead15a1b-726a-46aa-9005-a22f4b89d011,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,19E1137B-FBBB-4BBD-B5B3-A6892D91BF4E,Alive,International Genomics Consortium,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,Not available,Not available,Mar-40,C61.9,C61,NO,NO,Not available,30.0,0.18,1.94,28.13,RNA,,,,2012.0,Alive
s4297,91A0F673-6F46-493C-A18C-4C0F866D7533,UNCID_1630781.88e9cdc4-bcf1-49e9-8965-7dc6b3688585.sorted_genome_alignments.bam,76,88E9CDC4-BCF1-49E9-8965-7DC6B3688585,a8614c49-c7f1-4de9-bd2f-4764b094d604,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,B5B941E3-F828-4091-B9B1-6B38D1493847,Alive,Cedars Sinai,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.81,32.34,RNA,59DDEB88-4276-4E39-BD90-1B7A7E9DBB52,Primary Tumor Field,IMPLANTS,2003.0,Alive
s14333,FD965E54-2471-4D2A-AC56-D3DC36386A40,G17505.TCGA-06-2564-01A-01R-1849-01.2.bam,50,6245A56E-EEC6-4E7B-B9EF-BF0D1A3DCF36,8ff9f921-f9e9-41c1-a5d4-891fd4cfe979,,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,E09161B9-D935-4BB4-A725-0384B6DEDD06,Alive,Henry Ford Hospital,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,121.0,0.15,1.8,370.7,RNA,B15E3C5E-1003-41A0-B9C2-D1D4EFA4E032,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s8783,431025F1-2003-49FE-B95B-C3585E30C901,UNCID_1658461.6ff35e89-30b4-447e-9ef5-b67210b7859d.sorted_genome_alignments.bam,43,6FF35E89-30B4-447E-9EF5-B67210B7859D,f86fa219-34e9-4812-8edf-2b66d7219779,639.0,Brain Lower Grade Glioma,Not available,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,CB40F8BB-879E-496D-AE52-5535B277A952,Dead,Thomas Jefferson University,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-82,C71.9,C71.9,NO,,Not available,42.0,0.14,1.8,32.3,RNA,3900F1F9-EF6D-47D9-868B-8D5633AC1BC0,Primary Tumor Field,EXTERNAL BEAM,2007.0,Dead
s17921,6D2C26C8-083A-461A-B516-C5A1A48D47BD,TCGA-13-1510-01A-02R-1565-13_rnaseq.bam,62,B75DB551-4254-4736-A089-0A38890E7778,dac96910-0cb2-44ea-b108-2d6d51b07112,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,557F7CAB-8204-4295-831E-9A8CACF72231,Alive,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,157.0,0.17,1.8,403.0,RNA,,,,2008.0,Alive
s15739,5808DC25-6C19-4BD5-A740-044515D6009D,UNCID_2350584.acf05ba0-17f2-4952-a7e4-696c7a2219ee.sorted_genome_alignments.bam,58,ACF05BA0-17F2-4952-A7E4-696C7A2219EE,5436b002-4e4f-4d0f-9566-c0ef4d2d1854,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,1CE08042-34C7-450E-B1F5-8CDF9BFC5A77,Alive,Memorial Sloan Kettering Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,N0,Stage II,Mar-72,C09.9,C09.9,NO,NO,Complete Remission/Response,10.0,0.17,1.92,33.77,RNA,,,,2013.0,Alive
s5591,1EFB664C-3EB3-420D-8D65-ED75BF63F14C,UNCID_1806528.90d04601-4a15-44fc-bf1b-e0859310e644.sorted_genome_alignments.bam,78,90D04601-4A15-44FC-BF1B-E0859310E644,f0de67ff-8967-4fce-9c12-0e07193285cd,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,CD8AC496-CD1B-426F-8E17-8F15BA8E94D1,Alive,Roswell Park,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T2,N3,Stage IIIC,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.16,1.8,24.12,RNA,9D9DEECE-7130-4B3B-890A-CCBD6A3A989F,Regional site,External,2011.0,Alive
s14442,ED4C5D42-9F27-4B95-A00A-F08096DB52DA,_1_TCGA-BR-A44T-01A-32R-A24K-31_rnaseq.bam,53,74B657CE-3A01-4A24-9E45-79D36921F221,98bf4652-0088-4ecc-9dfa-376438cb063c,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,A7FD8028-FFB5-41C0-84F5-960920995F00,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Ukraine,Stomach  Adenocarcinoma  Diffuse Type,T3,N0,Stage IIA,Mar-45,C16.0,C16.0,NO,NO,Not available,10.0,0.16,1.86,6.37,RNA,,,,2012.0,Alive
s8184,2BAD247D-812A-45A1-9A9E-57570D56D848,UNCID_1572462.dbd2c9f3-4a21-4f9f-8346-62551d1c609b.sorted_genome_alignments.bam,39,DBD2C9F3-4A21-4F9F-8346-62551D1C609B,1b43ff0c-cf13-4620-b5c7-7abd9129612f,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,7CA0AD96-427A-4F12-A4A5-8A950061B273,Alive,Henry Ford Hospital,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,,Not available,38.0,0.16,1.8,50.2,RNA,86A85CD1-84AD-45DF-AF9F-C080D128A56E,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s1696,57EBBF3C-B2DA-458E-9F43-2C4D2780D800,TCGA-V5-AASX-01A-11R-A38D-31_rnaseq.bam,74,C4DEB7B2-CB61-4832-94B2-3DBB88BA60D9,6c7d464e-09f1-4478-837d-bfbf6addf062,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,24B9FAF3-A1A4-4345-A0E4-E842930E2E30,Alive,Duke University,Canada's Michael Smith Genome Sciences Centre,United States,Not available,Not available,Not available,Not available,Mar-40,C15.5,C15.5,NO,NO,Not available,5.0,0.15,1.85,8.83,RNA,,,,,Alive
s8354,0F660D53-1DAE-499D-8A76-F591E1110ACB,TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.bam,34,036EF90A-EACA-4105-9B7B-74C20BFA0BB9,a0bc5147-d9b4-41fd-8df3-a241d23722e8,2433.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,1B3185BF-9DEF-4B13-93F8-02CF3171464A,Dead,Duke,Harvard Medical School,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.9,C71.9,NO,,Not available,32.0,0.14,1.9,57.7,DNA,,,,2000.0,Dead
s9007,EFBC4F4F-BA4F-401B-A7FD-A56C6B416D00,UNCID_1088563.33dbf062-5980-4b6b-affa-0157eaa3016a.sorted_genome_alignments.bam,45,33DBF062-5980-4B6B-AFFA-0157EAA3016A,028d32fc-1b9f-49c6-9cb2-2d69671943cd,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,6A3A3238-EB9A-43B4-8BC5-11203C0AB827,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,31.0,0.15,1.8,66.3,RNA,,,,2004.0,Alive
s4175,AC2CA082-31A4-4BDA-83FD-F8BECB1D91F4,UNCID_1325265.731721fa-4ced-445d-855f-e4ded85f9726.sorted_genome_alignments.bam,63,731721FA-4CED-445D-855F-E4DED85F9726,4bc71292-60bb-4b63-86c1-0fe021083804,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19,Primary Tumor,0D3EC78C-3DA8-443F-BAA6-93CAED5B065C,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,34.0,0.15,,255.2,RNA,,,,2011.0,Alive
s3122,15128DAE-4500-4372-9676-D23D4C116527,TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.bam,77,D850DDCD-6E04-4EB4-887C-E1AE410C301C,30c7445e-d0c4-4a0f-96a4-27e4259ee10b,819.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19_Broad_variant,Primary Tumor,90F1D206-3E97-4C88-922C-FE4773C37CAA,Dead,MD Anderson,Harvard Medical School,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,N0,Stage II,Mar-20,C67.2,C67.2,NO,,Not available,10.0,0.16,,27.96,DNA,62DC3FF1-598F-4719-A951-F396EB3FC72A,Distant site,External,2009.0,Dead
s16499,5E6B081E-A592-483C-BE56-B04487F90355,UNCID_1706888.1573fde6-2abe-4ef8-b2f3-3c33507aca0c.sorted_genome_alignments.bam,38,1573FDE6-2ABE-4EF8-B2F3-3C33507ACA0C,366219b9-fde3-4d2d-82d3-15fe6245aa98,,Kidney Chromophobe,Not available,RNA-Seq,FEMALE,TCGA-KICH,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,B802658C-4715-4878-97CA-99576F08AF6A,Alive,Harvard,University of North Carolina,United States,Kidney Chromophobe,T3a,N0,Stage III,Mar-17,C64.9,C64.9,NO,YES,Complete Remission/Response,30.0,0.16,,56.2,RNA,,,,2006.0,Alive
s17297,9FDA313B-D2C9-417A-B4A4-FAAD1DCEA416,TCGA-23-1109-01A-01R-1564-13_rnaseq.bam,62,D47E074A-F78E-40C5-8AF4-F737CE010041,7c466a5f-a6b4-4d1a-a0f5-ddcd7ef90ff1,1562.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,146F9463-DE59-4418-9099-2425A6F86A0F,Dead,Cedars Sinai,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,105.0,0.15,1.8,218.0,RNA,9294A1C2-8B3A-40E0-8112-1DD01671610E,Local Recurrence,EXTERNAL BEAM,1999.0,Dead
s14732,2CDBDD02-66A0-41EB-9C53-07387BB7CCB7,_1_TCGA-CG-5721-01A-11R-1602-13_rnaseq.bam,58,143BD716-EDB6-4F17-8BC8-9272BEAED4F2,588abaea-ab16-42f4-9457-5901ee791b5f,,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,GRCh37-lite,Primary Tumor,B79123B9-5094-426D-8267-FD4A1C9F2778,Alive,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T4,N1,Stage IV,Mar-44,C16.3,C16.3,NO,,Not available,34.0,0.15,1.7,168.8,RNA,,,,2005.0,Alive
s10498,541BD2EB-5C99-4A8C-A9D3-C05C470D15F8,G47088.TCGA-85-8052-01A-11D-2244-08.3.bam,53,43AA4123-0FE2-4071-8A81-CBDD0410B917,395babb3-3f5d-4e71-a675-af4443f23028,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,9248B38E-EC7B-4C7C-BCB0-E942CE3C4847,Alive,Asterand,Broad Institute of MIT and Harvard,Russia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T3,N0,Stage IIB,Mar-70,C34.1,C34.1,NO,NO,Complete Remission/Response,,0.05,,56.03,DNA,,,,2011.0,Alive
s11579,0FD919C5-B847-49F4-B928-4DD15A94C3A0,TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina.bam,54,B4F515CE-5BEE-4E40-A66A-01F41E92181E,b06cdf61-61c9-4035-a55d-1ef21dc21069,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,GRCh37-lite,Primary Tumor,BD6B7CBE-57B6-45B9-96F6-4D39B8303407,Alive,Fox Chase,Baylor College of Medicine,United States,Kidney Papillary Renal Cell Carcinoma,T3a,NX,Stage III,Mar-60,C64.9,C64.1,NO,NO,Not available,30.0,0.07,,26.68,DNA,,,,2009.0,Alive
s11917,C051E69B-0F65-4A76-9900-02B8A8C582CF,UNCID_2100288.e2a9aab4-6aa4-4609-a659-18de75283081.sorted_genome_alignments.bam,50,E2A9AAB4-6AA4-4609-A659-18DE75283081,fcb7ed90-6c6b-4420-8d5b-4fc6f763adaa,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,494BDCD5-52F4-471B-9D69-A7B106D0BE84,Alive,UNC,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T2b,NX,Stage II,Mar-60,C64.9,C64.1,NO,,Complete Remission/Response,30.0,0.18,2.02,38.41,RNA,,,,2012.0,Alive
s4563,AF3B1140-0E76-4EF3-8978-7B2104555405,UNCID_559541.1857cddd-76d1-403b-a14e-f14d0781f68b.110928_UNC6-RDR300211_00126_FC_6348UAAXX.1.trimmed.annotated.translated_to_genomic.bam,63,1857CDDD-76D1-403B-A14E-F14D0781F68B,944a102f-3475-45aa-9e30-4b92d1449f00,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,5FABCE9C-0DFB-4B0D-8478-599FD181A84F,Alive,MD Anderson,University of North Carolina,United States,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.16,1.62,122.13,RNA,,,,2008.0,Alive
s2127,DF3192F9-1041-4EF9-80AA-2F3E263FA968,TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam,64,8F233F73-550A-4708-9C2C-BEA9347969F7,fdeeff8e-1328-42a4-aca0-a03b97421f1e,,Rectum Adenocarcinoma,Not available,WGS,MALE,TCGA-READ,Illumina HiSeq,Colorectal,Not available,HG18,Primary Tumor,D2F28259-87A7-4BD8-84BC-832E551C1ACE,Alive,Indivumed,Harvard Medical School,Germany,Rectal Adenocarcinoma,T2,N0,Stage I,Mar-40,C20.9,C20,NO,,Not available,55.0,0.15,1.9,360.61,DNA,,,,2007.0,Alive
s2600,4F0C1108-D61C-4D45-BBCE-01C1572BCD6D,UNCID_2532275.c8e08e13-b873-437d-94ac-fca3e6cb2e1e.sorted_genome_alignments.bam,83,C8E08E13-B873-437D-94AC-FCA3E6CB2E1E,31397970-59d8-4ee8-83cf-901cd8ba17b3,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,3E8C0319-B011-4030-B0D4-3EA2F48FE7D8,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-11,C49.2,C49.2,NO,YES,Not available,80.0,0.16,1.8,6.14,RNA,C4DB227D-D563-4053-9FFC-CB5041725BFF,Primary Tumor Field,External,,Alive
s8067,876F6E8A-5895-4808-A1E0-C3F21D1C8541,UNCID_1560061.207051F1-5725-4C9B-9AC8-E4DF261B4C94.sorted_genome_alignments.bam,69,207051F1-5725-4C9B-9AC8-E4DF261B4C94,68567581-0be3-48f1-8dcd-487bc0c1e6f6,,Skin Cutaneous Melanoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SKCM,Illumina HiSeq,Skin,WHITE,HG19,Primary Tumor,DA13FEB1-2122-4711-B2CB-8CED093D7162,Alive,University of North Carolina,University of North Carolina,United States,Not available,T4b,N0,Stage IIC,Mar-21,C44.6,C44.6,NO,NO,Not available,30.0,0.15,1.79,5.29,RNA,,,,2011.0,Alive
s4722,29BD6D0C-B51B-4B39-A07D-C7683C4B39A9,UNCID_2191871.4da7543e-f58a-46f1-bf94-834d4ce4cbff.sorted_genome_alignments.bam,65,4DA7543E-F58A-46F1-BF94-834D4CE4CBFF,71ed2681-79bb-4ffb-985c-6d3cf18e9168,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,Not available,HG19,Primary Tumor,C27F13AB-69DD-403C-B81E-FC4BC4BFA329,Alive,University Health Network,University of North Carolina,Canada,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.71,87.51,RNA,1372A0A7-6B53-46D2-BB13-53047695D68B,Primary Tumor Field,Not available,2010.0,Alive
s1333,906B7106-01EF-4357-913F-669CA4120F68,UNCID_2649397.57955c20-b0c4-4d4c-aea6-cee9179a4118.sorted_genome_alignments.bam,32,57955C20-B0C4-4D4C-AEA6-CEE9179A4118,2c600a58-98ed-4572-9b6f-edba2719790c,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,Not available,HG19,Primary Tumor,4B9DFE4E-B74C-4EB8-82A6-1CF044BAFA1F,Alive,Barretos Cancer Hospital,University of North Carolina,Brazil,Mucinous Adenocarcinoma of Endocervical Type,T1b,N0,Not available,Mar-82,C53.9,C53.9,NO,YES,Complete Remission/Response,30.0,0.18,1.87,46.47,RNA,F695D9CA-26D0-4A3F-8A03-B38756A05CBC,Regional site,External,2011.0,Alive
s15404,033D6940-9D77-42D1-895D-9CF0D8B2A4A6,TCGA-D7-A4Z0-01A-22R-A251-31_rnaseq.bam,60,F7C95993-E8CA-4E6D-A820-25ED2C4C3CEF,dce21359-004f-4e8b-89e4-9e1a30faffdf,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,17FE8CF0-FC98-4478-AB5E-58EAEAFF7AFF,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach Intestinal Adenocarcinoma Mucinous Type,T2,N2,Stage IIB,Mar-80,C16.3,C16.3,NO,NO,Not available,20.0,0.17,1.88,20.82,RNA,2947DA76-E9BE-40E3-B99A-2F69DA35A9B6,Primary Tumor Field,External,2012.0,Alive
s8425,C3659252-0627-4EA1-9B57-C7F42BE888A8,UNCID_1676690.f09a51df-011a-419e-b90a-7cd2037c5690.sorted_genome_alignments.bam,58,F09A51DF-011A-419E-B90A-7CD2037C5690,9ee6e821-3af2-42d7-9d14-f0ca455f338c,538.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,5F73FA4E-FC7D-4FC0-8436-2241E57B9B69,Dead,Thomas Jefferson University,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.9,C71.9,NO,,Not available,28.0,0.15,1.8,100.2,RNA,A5BBA276-A594-4020-8EB1-6EFE3FE4AFBD,Primary Tumor Field,EXTERNAL BEAM,2009.0,Dead
s11423,B4C629BF-0564-4B24-A817-7881879762BF,UNCID_2636363.b58ffa95-5a94-4b18-b149-8a0095c53bb8.sorted_genome_alignments.bam,56,B58FFA95-5A94-4B18-B149-8A0095C53BB8,98ef41fa-3015-445a-bbdc-984361c911f7,1135.0,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,CEA128CA-4E69-4BF4-BE47-E0481A809727,Dead,Johns Hopkins,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-40,C34.3,C34.3,NO,,Complete Remission/Response,30.0,0.18,1.8,26.52,RNA,,,,2000.0,Dead
s11572,AF0FC653-DF0F-4FB5-B32C-B7D4A736B2A1,UNCID_1990250.39408ce7-3fca-4e7e-8016-e8586b7bafad.sorted_genome_alignments.bam,45,39408CE7-3FCA-4E7E-8016-E8586B7BAFAD,31ff69b5-9e58-44da-8326-bdfc7ee495c4,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,4B24BB00-ACF5-4CF4-A84A-020BAA60782D,Alive,Washington University - NYU,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T1a,N0,Stage IA,Mar-55,C34.3,C34.3,NO,NO,Complete Remission/Response,30.0,0.18,1.96,17.15,RNA,,,,2012.0,Alive
s14447,A2F774BD-E038-4DB6-AC34-AD50320E37A0,_1_TCGA-CD-A4MI-01A-21R-A251-31_rnaseq.bam,62,8BEBC13D-FAAA-4F8B-A871-1E589F3D27D2,cda6d95c-be6a-485e-ba9a-c57f3eb3f99a,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,39E514BE-9A47-4229-8728-80E1BF0AC00D,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N1,Stage IIIA,Mar-40,C16.3,C16.3,NO,NO,Complete Remission/Response,30.0,0.17,1.87,36.48,RNA,,,,2011.0,Alive
s14292,505DB837-697E-4049-8505-486D0669CC66,G17663.TCGA-19-2619-01A-01R-1850-01.2.bam,55,ADAFA15C-5834-427E-BC93-24D3C4F775A9,f2de4316-026c-4c2d-b091-47bc0ec8612a,,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,BC1FA4FB-9B73-460F-9C4D-D1180C3ABBA8,Alive,Case Western,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,130.0,0.15,1.8,243.7,RNA,2021D4E4-D721-4366-9CFB-37E1089E5FA2,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s13864,9A9F5E2C-F398-4055-B03E-9BB9F263CAC2,UNCID_269290.TCGA-AA-3846-01A-01R-1022-07.100708_UNC8-RDR3001640_0010_62333AAXX.7.trimmed.annotated.translated_to_genomic.bam,74,1AF1B06F-81EF-48AB-BB79-6EFEC1FDA91F,f2ef5afa-6191-43a1-a023-d53c0d985139,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,0881378B-2103-4D63-8173-430B34267EAC,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.7,C18.7,NO,,Not available,148.0,0.17,1.8,231.3,RNA,,,,2009.0,Alive
s2758,05FF61D5-8993-42F6-A5BE-9E90685AEC1B,UNCID_1224366.eb5b988d-308e-4afb-b21b-8bdd45010c72.sorted_genome_alignments.bam,53,EB5B988D-308E-4AFB-B21B-8BDD45010C72,86d1e388-b30f-48fd-9647-3848eb6134f1,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,708501D2-B376-49EA-94ED-3E0AB73AF619,Alive,Medical College of Georgia,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4a,N0,Stage III,Mar-30,C67.9,C67.9,NO,,Not available,30.0,0.17,1.94,35.83,RNA,,,,2010.0,Alive
s8215,1ADC7CF9-B84D-4C34-A98A-60C15CA2B447,UNCID_1857382.b74282a3-9f58-4342-8ae5-2fc1cbb4933c.sorted_genome_alignments.bam,31,B74282A3-9F58-4342-8AE5-2FC1CBB4933C,c916b9a4-008e-4d79-a50c-f15c3549fcf6,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,5C724D2B-CC13-4FEF-AE5B-15DA6EDEF521,Alive,Case Western - St Joes,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,,Not available,30.0,0.14,,13.2,RNA,92476855-3269-42F5-91D8-3834B9D3CE2F,Primary Tumor Field,EXTERNAL BEAM,2011.0,Alive
s11100,CA52B233-0134-446F-A729-797DB25D3066,UNCID_2501051.717093f1-916b-4d01-a74c-18af938563c0.sorted_genome_alignments.bam,75,717093F1-916B-4D01-A74C-18AF938563C0,a815619f-dbba-469f-a1f7-dfbd51cd86c5,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,B08432A7-891A-41EE-A2C0-10A994D01E00,Alive,Candler,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T1b,N1,Stage IIA,Mar-55,C34.3,C34.3,NO,NO,Complete Remission/Response,20.0,0.17,1.86,10.81,RNA,,,,2012.0,Alive
s14179,37834E28-0806-43CC-B497-0E9BAEF51BA7,UNCID_1530992.ff4d089b-8f65-46f1-b3bc-dab1271725fb.sorted_genome_alignments.bam,72,FF4D089B-8F65-46F1-B3BC-DAB1271725FB,7338e476-10ff-444a-a16f-429d28355f65,,Glioblastoma Multiforme,Not available,RNA-Seq,MALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,B6CA6325-97DF-4790-BE83-71E3579F78DA,Alive,Cedars Sinai,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,142.0,0.15,1.8,117.7,RNA,D70DA875-5DDC-4D39-9859-956F960048F1,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s8985,D20D9FD2-7AB5-4C1A-B862-8F83D9D54F24,UNCID_408203.3097579d-f791-4677-a115-0fb1389b0274.110503_UNC10-SN254_0215_BBOB7MABXX.4.trimmed.annotated.translated_to_genomic.bam,65,3097579D-F791-4677-A115-0FB1389B0274,ed97aeee-2a5b-4361-ab4f-f53c3fc5f532,461.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,1C0F9575-9895-4068-9134-211CAEB6E80E,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,33.0,0.14,1.8,83.3,RNA,B8B11E18-C531-4E89-896B-701C9612E83E,Distant site,OTHER: SPECIFY IN NOTES,2003.0,Dead
s5033,898921BD-E501-439F-80DF-5C1B43D18BDD,UNCID_1607427.06c39fc6-9167-4913-bf84-4fde036869a2.sorted_genome_alignments.bam,78,06C39FC6-9167-4913-BF84-4FDE036869A2,a7329910-b1c7-4a18-b28e-8fad79121339,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,F0AF3F30-3D64-4BD8-9A8F-7FF7AB9BB7B0,Alive,University of Pittsburgh,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.78,66.07,RNA,96E2402E-E29C-4D23-A164-9992184A4C7C,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s8901,E92695A1-DD8C-477C-ABFE-671B46D8AAD2,UNCID_1194335.fe66d7a7-c591-4dbb-9e05-12c5fa3fa814.sorted_genome_alignments.bam,40,FE66D7A7-C591-4DBB-9E05-12C5FA3FA814,d9208e7b-0b47-43ff-a4e8-d4e591e286c4,1034.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,D161861C-6E70-48C7-9A1D-87969D7FF473,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T4,N1,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,36.0,0.16,1.8,96.3,RNA,F14E509C-DC56-4415-A65B-36F0D7AB111B,Distant site,EXTERNAL BEAM,2006.0,Dead
s5715,765374B4-CF28-4A2F-929D-D72AE07AE5B0,UNCID_1161356.3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b.sorted_genome_alignments.bam,39,3FC1C7A8-E5AD-4A4E-89AB-DDF12AA11A3B,eadf8482-e60e-4307-adb7-d5c3b9fa6cae,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,2C619641-7849-4837-AB92-0DA80342B3E9,Alive,Walter Reed,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N1,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.17,1.95,63.86,RNA,45D50414-CE7E-456B-BB0F-D49E70BB491D,Not available,Not available,2010.0,Alive
s9854,D0D4BEDB-83C7-4005-87F3-37BA34F1556D,UNCID_338080.TCGA-B8-4154-01A-01R-1188-07.110418_UNC15-SN850_0062_AB07THABXX.1.trimmed.annotated.translated_to_genomic.bam,73,AD99E8C5-A7A3-4558-99FD-2DD1E3B2A17D,8c6720ef-4f85-4d22-b9bc-6745b55bf6d8,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,C912F33A-B4B4-4E5D-B1A6-D5A43A5B472B,Alive,UNC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,128.0,0.12,1.8,24.63,RNA,,,,2010.0,Alive
s1784,E82E4A8C-C859-4C66-834B-8F4FA46DF1C1,TCGA-LN-A9FO-01A-11R-A38D-31_rnaseq.bam,42,027AF223-8A23-46C0-A4B7-687CDFACD606,cad8bd3a-ffd8-4baf-9de6-3ac3a1eb19e1,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,ASIAN,GRCh37-lite,Primary Tumor,6F3196CD-2C3F-4B81-8E7F-8CB84F383837,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Not available,T2,N0,Stage IIA,Mar-70,C15.5,C15.5,NO,NO,Not available,30.0,0.18,1.94,88.17,RNA,,,,,Alive
s4710,940A1E62-BB09-4473-8304-4F4CD71345E0,UNCID_2035670.8b8048b4-fe60-45f4-97c5-662c45169334.sorted_genome_alignments.bam,62,8B8048B4-FE60-45F4-97C5-662C45169334,a31554af-d77a-4862-8aed-4581fb2bd877,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,BE387236-F691-4303-AA47-BE1D67CBDD5E,Alive,University of Pittsburgh,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.82,61.52,RNA,7F0F89F9-6731-4068-92B8-4F66E05F20B7,Primary Tumor Field,External,2011.0,Alive
s7572,177AB7D2-E8C9-4094-95D5-63CFBB790757,UNCID_1233878.a57841bb-fa68-4d84-85e0-2d5e4f3ce828.sorted_genome_alignments.bam,74,A57841BB-FA68-4D84-85E0-2D5E4F3CE828,eff78af6-0f68-49b9-866b-0d511606f2b1,,Skin Cutaneous Melanoma,Not available,RNA-Seq,FEMALE,TCGA-SKCM,Illumina HiSeq,Skin,WHITE,HG19,Primary Tumor,090DEBB2-290D-49DD-B642-7F01C99A795C,Alive,Cureline,University of North Carolina,Russia,Not available,T4b,N0,Stage IIC,Mar-20,C44.9,C44.9,NO,NO,Not available,30.0,0.18,1.85,7.18,RNA,,,,2010.0,Alive
s16968,BA7FB93A-0ED1-4054-B11E-EB2FE9EC2397,UNCID_2657639.b05b2c69-27f3-46db-891a-9d2f8b0d8b97.sorted_genome_alignments.bam,63,B05B2C69-27F3-46DB-891A-9D2F8B0D8B97,460a3cbd-c63c-4e6f-b670-2619687ac5a0,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,31A1ACBE-DF1C-42B1-817A-DA0E805C7FB3,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,20.0,0.18,1.84,69.84,RNA,,,,2013.0,Alive
s9978,365DEF90-A1FD-45B6-A3AB-749E13D4833D,G47088.TCGA-21-1083-01A-01D-1521-08.3.bam,75,FB0C6353-A90C-45E2-9355-7CD16CF756FF,0398eae1-7216-4595-80a5-6b117d96e070,1315.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,300CB22F-ACB4-4ACD-8D64-FE8DCDF64801,Dead,Fox Chase Cancer Center,Broad Institute of MIT and Harvard,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-70,C34.1,C34.1,NO,,Not available,119.0,0.05,1.9,532.0,DNA,,,,1997.0,Dead
s11217,9D582E65-3AD6-4679-A554-5713CC921076,G7165.TCGA-44-2666-01A-01D-0969-08.12.bam,43,251C7CF7-EABB-4349-8E25-FC156D84314A,e16ca88f-488b-40f0-9169-e5a62482a2ff,97.0,Lung Adenocarcinoma,HISPANIC OR LATINO,WGS,MALE,TCGA-LUAD,Illumina GA,Lung,WHITE,HG19_Broad_variant,Primary Tumor,27A64F32-69C5-4C49-86B4-C8FC923CAE08,Dead,Christiana Healthcare,Broad Institute of MIT and Harvard,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-40,C34.1,C34.1,NO,,Not available,143.0,0.15,1.9,569.9,DNA,,,,2009.0,Dead
s16459,83FB5121-26C9-4526-BB7D-1D9D0E936CEF,UNCID_1709487.d5965538-4255-4877-88a8-9a71b5cea58c.sorted_genome_alignments.bam,28,D5965538-4255-4877-88A8-9A71B5CEA58C,4a88bc85-4c6e-4fac-8dbb-d3fc5f36b35e,,Kidney Chromophobe,Not available,RNA-Seq,FEMALE,TCGA-KICH,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,8AC713B0-3781-4964-92F1-DEA763B046DE,Alive,Harvard,University of North Carolina,United States,Kidney Chromophobe,T1a,N0,Stage I,Mar-17,C64.9,C64.9,NO,NO,Complete Remission/Response,37.0,0.16,,207.2,RNA,,,,2005.0,Alive
s14850,8BE21ACB-A394-4C70-8711-B5539E48CD8E,TCGA-VQ-A91Z-01A-11R-A414-31_rnaseq.bam,67,72C76D91-905B-4131-A116-1A990BD54797,cafbae18-12a5-40fb-9dbe-c1d0598b9091,,Stomach Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,EC6ED61A-1D7E-4057-9AC2-DD1ED2ACCFB0,Alive,Barretos Cancer Hospital,Canada's Michael Smith Genome Sciences Centre,Brazil,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N1,Stage IIIA,Mar-11,C16.3,C16.3,NO,YES,Complete Remission/Response,30.0,0.17,1.87,97.05,RNA,,,,2010.0,Alive
s6128,29989DD0-CFFF-4372-8CD6-94309715EE3C,UNCID_1099674.50c720f4-dbcb-4b8b-9808-d130f5197d27.sorted_genome_alignments.bam,44,50C720F4-DBCB-4B8B-9808-D130F5197D27,aaea5f9c-b35b-47f8-93cb-bdc7b81844ff,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,57E65074-4DC7-4F55-9638-8D123702305C,Alive,Walter Reed,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T2,N0 (i-),Stage IIA,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.16,1.94,9.98,RNA,E691C50B-1796-4283-817C-0F5231B1908D,Not available,EXTERNAL BEAM,2003.0,Alive
s15501,083DAA5F-0E79-4402-94B2-48A892A5A4F1,TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.bam,64,180BC055-9C10-4B84-80C4-3DF00742719D,45a10908-19e6-421a-8903-1440bfa57c9d,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,63535469-D402-4BA2-9AB5-986E6ED80F55,Alive,University of Pittsburgh,Harvard Medical School,,Head and Neck Squamous Cell Carcinoma,T4a,N0,Stage IVA,Mar-70,C32.9,C32.9,NO,,Not available,30.0,0.16,1.9,322.7,DNA,,,,2010.0,Alive
s16769,D6F1CCBD-D6F3-43D8-877F-6F921CAC148D,UNCID_2639333.c623f952-e487-4d8d-a5c3-eef8bac53a05.sorted_genome_alignments.bam,59,C623F952-E487-4D8D-A5C3-EEF8BAC53A05,485d283a-552c-485a-84fb-3abdb98dc797,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,B2060A24-43D9-48F2-8A45-1DB926042938,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T2,N0,Stage II,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.18,1.87,77.62,RNA,,,,2013.0,Alive
s10848,12FD48BB-AD44-4DCC-B4E5-F161BAB22EA4,UNCID_1323857.22366c3f-bf63-421e-b086-0ffb87945bf9.sorted_genome_alignments.bam,67,22366C3F-BF63-421E-B086-0FFB87945BF9,36470b30-a3b3-4d28-851b-918a7ff88011,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,A5D9BE94-1204-49CB-8758-1505D853564C,Alive,International Genomics Consortium,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-40,C34.1,C34.1,NO,NO,Not available,39.0,0.14,,89.2,RNA,3F231937-362D-43AA-8744-F5FA20BA913D,Distant Recurrence,External,2011.0,Alive
s17218,4BF15F90-C50C-4990-AB70-B0DF9971E49A,TCGA-13-0795-01A-01R-1564-13_GRCh37-lite_rnaseq.bam,66,5345EEF4-EE81-4128-96FB-85C29750CC96,b1e11e94-646b-4c44-9d33-1ca67d8356fb,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,61EF4D54-BFA5-4D62-89BC-2717EABC741B,Alive,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,135.0,0.19,1.8,70.0,RNA,,,,2007.0,Alive
s3529,FDCA76C8-2BE8-4D46-BA44-201FDC2AF7AD,UNCID_2314384.94399af6-33b3-4622-a5b1-d2e446061980.sorted_genome_alignments.bam,73,94399AF6-33B3-4622-A5B1-D2E446061980,5f69ca7d-f8e0-4f5b-9987-1e5c234eb759,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,67C95255-97F0-41EE-99A3-CEC801512829,Alive,International Genomics Consortium,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-40,C61.9,C61,NO,NO,Not available,30.0,0.17,1.85,20.16,RNA,,,,2012.0,Alive
s17505,70290B7D-725E-44E1-B64A-6064E3297B93,TCGA-24-0979-01A-01R-1565-13_GRCh37-lite_rnaseq.bam,53,639429A9-C1D3-410D-828A-C3B44D648609,9a30dee8-962a-49db-a85a-c39515c91b68,1264.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,9B072344-31CF-471A-AF4F-23AE73A98C93,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,99.0,0.15,1.8,265.3,RNA,FAED94C3-B6AF-485D-BE70-907D82F81D1E,Distant Recurrence,EXTERNAL BEAM,2003.0,Dead
s15648,B66083B7-E0AE-4F6E-AB6A-76CAF55A13BC,TCGA-CV-7180-01A-11D-2266-10_Illumina.bam,34,1727E88B-DF0A-4AF2-9191-8C6061D98AD0,d2ca9a4d-c14c-40c0-871c-88794a02e4aa,327.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,GRCh37-lite,Primary Tumor,551B5AC7-41E8-42BC-B64D-20E7E156DBBC,Dead,MD Anderson Cancer Center,Baylor College of Medicine,United States,Head and Neck Squamous Cell Carcinoma,T2,NX,Stage II,Mar-70,C02.9,C02.9,NO,,Not available,27.0,0.05,,52.7,DNA,,,,1996.0,Dead
s15406,D3081D33-B267-4A25-B7B0-93815A01C3FE,TCGA-D7-A74A-01A-11R-A32D-31_rnaseq.bam,61,6733749A-5C43-44EE-B672-BBE616A6255A,40837a4d-7931-497c-a6bf-6a661813c443,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,9C0D48A6-99F0-4084-8A9B-4D82E3E4ED26,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N2,Stage IIIA,Mar-44,C16.0,C16.0,NO,NO,Complete Remission/Response,30.0,0.18,1.89,50.87,RNA,,,,2013.0,Alive
s8767,2D992886-8E0E-4080-A5DB-F130CCF54286,UNCID_1509151.927d20e2-da09-42ca-a70c-2b203a8297a6.sorted_genome_alignments.bam,48,927D20E2-DA09-42CA-A70C-2B203A8297A6,84569c1a-6baa-4380-ae3c-707df1be4618,2907.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,1EE9478B-84A5-4FFD-8499-F2E02A3A21D7,Dead,Duke,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.9,C71.9,NO,,Not available,38.0,0.14,1.7,21.7,RNA,C6470616-FB03-4678-BF8C-3A3183E301F5,Primary Tumor Field,EXTERNAL BEAM,1998.0,Dead
s3381,9A5EF459-1465-4FCA-B008-79F0DFC911EA,UNCID_2507402.97226f81-8074-4b17-bcc7-c74e51216706.sorted_genome_alignments.bam,82,97226F81-8074-4B17-BCC7-C74E51216706,423b7fc5-3970-4c96-990d-96ad0842f1eb,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,14E1CB71-07E9-46AF-84DA-E35A360A2BBC,Alive,Mayo Clinic Arizona,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4,N1,Stage IV,Mar-20,C67.4,C67.4,NO,NO,Complete Remission/Response,10.0,0.18,1.85,17.5,RNA,,,,2011.0,Alive
s4051,AFE7E3DF-57D5-4514-869C-1D1811D2F65F,UNCID_2136426.3479eef9-e120-4723-b333-cd4623de6499.sorted_genome_alignments.bam,59,3479EEF9-E120-4723-B333-CD4623DE6499,8631bb5e-6d08-4c20-a85e-cb84f5dac290,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,AF0C6ECC-502D-46FF-B5AA-4A34D9928A6E,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma  Other Subtype,T3b,N0,Not available,Mar-55,C61.9,C61,NO,YES,Progressive Disease,30.0,0.15,1.83,13.67,RNA,9EA118D9-8D02-43D6-80CC-7290D0A81173,Primary Tumor Field,External,2012.0,Alive
s1247,5EB1EEF3-A790-4726-A111-5B633C02BE55,UNCID_1674963.A5793D2B-3DEC-477F-B29B-163D235431AC.sorted_genome_alignments.bam,25,A5793D2B-3DEC-477F-B29B-163D235431AC,6248f2a3-0da9-419f-ab77-c3f6f4353eb5,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,Not available,HG19,Primary Tumor,6F0C0187-4FC7-492C-BB0D-535E0F9976C4,Alive,Ontario Institute for Cancer Research,University of North Carolina,Canada,Adenosquamous,T1b1,N0,Not available,Mar-40,C53.9,C53.9,NO,,Not available,30.0,0.15,1.83,98.87,RNA,,,,,Alive
s14921,DEEF20A4-4E7B-4495-BBD8-1809876BA354,TCGA-KB-A93J-01A-11R-A39E-31_rnaseq.bam,78,3219C73D-8163-41ED-B1A3-82C8963F81AC,5f263b2c-3385-4d07-99c2-d7b613c4a470,,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,888711A8-8FFD-49BB-AA85-7455C07F1AD5,Alive,"University Health Network, Toronto",Canada's Michael Smith Genome Sciences Centre,Canada,Stomach  Adenocarcinoma  Diffuse Type,T2b,N1,Stage II,Mar-45,C16.0,C16.0,NO,,Complete Remission/Response,30.0,0.15,1.87,62.37,RNA,9A901BA8-3D16-4686-8007-51676C3E30A7,Primary Tumor Field,External,2008.0,Alive
s4843,74596841-FEF3-4FDF-B259-C3797F98D9F1,UNCID_1626038.cadf8449-cd8e-4581-ad35-37a0aa2f7a9b.sorted_genome_alignments.bam,70,CADF8449-CD8E-4581-AD35-37A0AA2F7A9B,3ede5dff-8cf5-43e8-bf4b-e8ad75bf68ee,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,B627E715-006F-45AC-A168-85D37E9DC6E1,Alive,Gynecologic Oncology Group,University of North Carolina,,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.18,1.85,63.58,RNA,,,,2009.0,Alive
s17326,49D9B64B-DC27-4530-98BC-9781DDCD7C8A,TCGA-04-1361-01A-01R-1565-13_rnaseq.bam,57,746BA0B0-F7A4-4F43-9961-97DCCC756E71,a6aad7f9-8444-4c2f-8e4b-b19fd453544f,,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,702CC8D9-38F6-474A-BD7E-E56820C5A5B0,Alive,Gynecologic Oncology Group,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,93.0,0.16,1.8,244.0,RNA,,,,2005.0,Alive
s8858,D9C440CD-D8F2-4F5F-843E-48A39A725D80,UNCID_1168980.a72c1d4e-1be3-4a21-b2cf-d7b5f8e78df1.sorted_genome_alignments.bam,85,A72C1D4E-1BE3-4A21-B2CF-D7B5F8E78DF1,53dede5a-4423-4da5-bc1e-e5e98b011e36,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,9433D0EC-47C9-48DF-B7D0-1F57ACB09C38,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,35.0,0.15,1.8,79.3,RNA,,,,2004.0,Alive
s4158,8574FF22-8D08-4125-B6B5-7B58E3A6E452,UNCID_1209270.9caa440e-a8a6-4851-b62e-4ebb09412fad.sorted_genome_alignments.bam,69,9CAA440E-A8A6-4851-B62E-4EBB09412FAD,c039014f-821c-43d6-9d3c-914f9c8d98fa,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19,Primary Tumor,144E0265-C04E-4538-A721-94DEF2570486,Alive,Indivumed,University of North Carolina,Germany,Prostate Adenocarcinoma Acinar Type,T3b,N1,Not available,Mar-50,C61.9,C61,NO,,Not available,36.0,0.15,1.8,379.8,RNA,,,,2007.0,Alive
s16293,63302117-7180-413B-BD79-7C6DF5CA2917,UNCID_2310173.090f0891-7991-4b5c-8dc7-e591c0d65faf.sorted_genome_alignments.bam,50,090F0891-7991-4B5C-8DC7-E591C0D65FAF,22233a31-023f-412f-9b42-73b58c51dee8,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,812B8EE1-096A-40FF-914D-9957644B7D11,Alive,University of Pittsburgh,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,N2b,Stage IVA,Mar-70,C32.9,C32.9,NO,NO,Complete Remission/Response,30.0,0.18,1.91,42.58,RNA,15433769-FF48-4ADE-BF2B-DBA090CDE30E,Primary Tumor Field,External,2011.0,Alive
s4622,08674646-1CAC-4739-B4D5-3DB16E8CD28C,UNCID_1011520.eb32a70b-8e73-4c44-8a44-c623158e87b1.120306_UNC6-RDR300211_00136_FC_650PFAAXX.5.trimmed.annotated.translated_to_genomic.bam,58,EB32A70B-8E73-4C44-8A44-C623158E87B1,3405c549-7da5-48ee-ba48-177a67bbcc5d,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,698A5085-0137-4BD8-A8C0-F749D03FBD95,Alive,University of Hawaii,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.82,53.35,RNA,,,,2006.0,Alive
s9816,74072AE8-5E09-4DB9-9593-675E62D71953,UNCID_1196932.d77d4850-de1b-4cff-93a1-3accc6a0cb46.sorted_genome_alignments.bam,59,D77D4850-DE1B-4CFF-93A1-3ACCC6A0CB46,62f5ceb7-bb0b-4248-850b-cc1cf012f570,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,A15BE7AB-B030-420F-90E1-2B7DDDF72B16,Alive,University of Pittsburgh,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,32.0,0.15,1.4,36.8,RNA,,,,2008.0,Alive
s1265,C3BDB29E-5689-4DA4-AAE2-126D47A49A3B,UNCID_2054892.0ec8f213-1b87-4c8e-86b8-90362601df4a.sorted_genome_alignments.bam,54,0EC8F213-1B87-4C8E-86B8-90362601DF4A,5e39485a-ac6b-496d-9984-2ea8075f6a9b,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,ASIAN,HG19,Primary Tumor,9BAA2C92-0111-4399-AD08-8F6169081AE8,Alive,Asterand,University of North Carolina,Vietnam,Cervical Squamous Cell Carcinoma,T1b1,N0,Not available,Mar-70,C53.9,C53.9,NO,NO,Complete Remission/Response,30.0,0.17,1.87,31.07,RNA,,,,2012.0,Alive
s2431,DD8511E8-6CAA-4939-863B-91F63736ABF1,UNCID_2478245.ce2398b9-d222-4688-97c4-06da3b0c129a.sorted_genome_alignments.bam,56,CE2398B9-D222-4688-97C4-06DA3B0C129A,90bc0f31-0ec2-4ceb-ad99-6be8f8b19180,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,40BBDDF9-5D42-4D41-991B-60EA008E5E37,Alive,University of Iowa,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-05,C49.2,C49.2,NO,YES,Not available,30.0,0.18,1.89,48.41,RNA,79F566D8-83AE-42ED-80E3-392673D03657,Primary Tumor Field,External,,Alive
s16843,19DA5E8F-C857-448E-A046-68F0762C1EB1,UNCID_2657123.078cb900-3686-4894-9e1f-cc4bb1e39eae.sorted_genome_alignments.bam,39,078CB900-3686-4894-9E1F-CC4BB1E39EAE,82d6268a-de59-4a14-abd2-7492178fa5bd,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,87BAC135-BC68-4CED-BC5F-F36699C593C9,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,20.0,0.17,1.9,80.99,RNA,,,,2009.0,Alive
s2907,B9214AC8-956D-471D-8CAD-A44DDC8825E8,TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.bam,69,BA548041-624F-4357-A9F9-3BE29A3FF4FD,a658becf-3934-49f2-9e74-291dca61d4bb,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,66559B5F-AB2F-406B-9EDB-0F5085EEC7C5,Alive,BLN - University Of Chicago,MD Anderson - Institute for Applied Cancer Science,United States,Muscle invasive urothelial carcinoma (pT2 or above),T2b,N0,Stage II,Mar-20,C67.4,C67.4,NO,,Not available,30.0,0.15,,30.45,DNA,,,,2011.0,Alive
s4618,3574ADE8-F6BC-44DC-94CE-8EA657978707,TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted.bam,39,93FEF054-0782-4A27-A27B-22176874E805,40f43483-b504-4ea7-ad24-40682b10caac,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19_Broad_variant,Primary Tumor,F57EB4ED-4393-4DC3-9362-A4757EF8B21D,Alive,Mayo Clinic,Harvard Medical School,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.39,93.33,DNA,,,,2010.0,Alive
s1776,F1A50812-CBDE-4171-B87E-F1B420E565AB,TCGA-LN-A4A3-01A-11R-A260-31_rnaseq.bam,61,5274A9C2-5C4C-4EC0-8028-1C6E2D0E1079,3c0bb5e2-ad33-4d91-a31e-2a18f1c94d2d,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,ASIAN,GRCh37-lite,Primary Tumor,3C85B0AB-C83E-4371-9F53-6A71D3763F3F,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Not available,T3,N1,Stage III,Mar-70,C15.4,C15.4,NO,NO,Not available,20.0,0.16,1.84,29.84,RNA,320C3F55-937B-4D8D-B02E-14E3F59171B0,Local Recurrence,External,,Alive
s15716,D900C65C-9B26-4BB7-8738-565865448881,UNCID_2207559.1c56c507-a52a-4d92-9c99-45d4fca1227d.sorted_genome_alignments.bam,61,1C56C507-A52A-4D92-9C99-45D4FCA1227D,b843df7e-db06-4d29-b00d-6a93effd9191,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,E5D8F8C3-A08D-4B63-BD8F-33E3C8E6406B,Alive,International Genomics Consortium,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T1,N1,Stage III,Mar-70,C02.9,C02.9,NO,NO,Not available,30.0,0.14,,94.2,RNA,,,,2012.0,Alive
s5729,9856D481-3AAF-429A-AA23-3010AA4249B6,UNCID_1281052.461cbf67-a11d-4411-95b5-cf83ecf05d02.sorted_genome_alignments.bam,49,461CBF67-A11D-4411-95B5-CF83ECF05D02,0bf6e772-1aa1-4f54-9a50-c1414e2f22f3,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,9EBE5223-7566-4026-83AE-812283A8AAEB,Alive,Mayo,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T1,N1,Stage II,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.17,1.83,22.82,RNA,,,,2007.0,Alive
s13285,990456DC-A5EE-4815-B3B9-86611857D05C,UNCID_1950456.f7fb5192-be86-40e7-b7dc-19896b0058b6.sorted_genome_alignments.bam,49,F7FB5192-BE86-40E7-B7DC-19896B0058B6,39aec099-a33e-47a4-a602-cbf65ddd3830,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,46F8F339-748F-4FCD-AEEE-6EAD28BC5010,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.5,C18.5,NO,,Not available,37.0,0.16,1.7,78.8,RNA,,,,2010.0,Alive
s9875,3768DC68-36E6-4608-92F2-39E9C23DA3ED,UNCID_370306.TCGA-A3-3382-01A-02R-1325-07.110427_UNC15-SN850_0065_BB09BPABXX.8.trimmed.annotated.translated_to_genomic.bam,69,BFE2A633-8C76-4B72-A807-FE986C35944F,e1663694-17dd-4b01-b613-2516e022dfb7,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,3DE5B87E-B12F-446C-AA04-6C20370DE727,Alive,International Genomics Consortium,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.16,1.8,44.0,RNA,,,,2007.0,Alive
s6004,8C81153B-11B8-49B4-90E9-605128D6076A,UNCID_1132393.d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32.sorted_genome_alignments.bam,37,D0F11931-DDCC-4CD5-8DFC-8EF984AA8A32,058dcb78-bed1-40c3-a6c2-a0cc40065531,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,78F8B01E-292F-4131-A3EF-4F9FAEC7913A,Alive,Walter Reed,University of North Carolina,,Infiltrating Ductal Carcinoma,T1c,N1mi,Stage IB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.17,1.8,51.39,RNA,F00904BF-C888-403A-A5D4-2D76FCBC5378,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s4811,B3D78C31-9D49-4B3F-A766-ACDB650D1519,UNCID_1606383.174acfe1-d3ab-4912-9d05-7aa598ae1add.sorted_genome_alignments.bam,60,174ACFE1-D3AB-4912-9D05-7AA598AE1ADD,73e5310d-ba8c-4cbc-aa4f-e06206f898f4,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,E6E7E411-45CF-47A1-BCF0-7AE800A61A8D,Alive,University of Pittsburgh,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.88,77.82,RNA,,,,2008.0,Alive
s7799,6E557487-7C24-4F63-8FB4-5785B93854DF,UNCID_2506396.99106f6c-2f6f-4b14-8d47-df22b7862153.sorted_genome_alignments.bam,90,99106F6C-2F6F-4B14-8D47-DF22B7862153,4a2135bd-31ff-4564-9e87-1164b3422f61,,Skin Cutaneous Melanoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SKCM,Illumina HiSeq,Skin,WHITE,HG19,Primary Tumor,B10C679B-B9C9-49DF-BC56-ADDA81E16955,Alive,Not available,University of North Carolina,Russia,Not available,T4,N0,Stage II,Mar-20,C44.7,C44.7,NO,,Not available,30.0,0.17,1.88,7.9,RNA,,,,2013.0,Alive
s6792,0B1C8308-8E5C-48C9-9495-77322B4DEDDA,UNCID_1121369.4795628e-50d8-41e0-b3c6-00fe4600dc5d.sorted_genome_alignments.bam,56,4795628E-50D8-41E0-B3C6-00FE4600DC5D,86a18ae0-dfb1-49c3-b5c4-67ec331d6e40,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,ASIAN,HG19,Primary Tumor,FC3FE505-F138-426F-87D3-C7AE138BE02D,Alive,ILSbio,University of North Carolina,Vietnam,Infiltrating Ductal Carcinoma,T2,N0,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.17,1.76,40.1,RNA,,,,2010.0,Alive
s1608,3ACD6540-876A-4A51-AF45-749C70987037,UNCID_2651003.1f431436-f6bd-4f64-81ad-820e11385e94.sorted_genome_alignments.bam,58,1F431436-F6BD-4F64-81AD-820E11385E94,b5f0e361-d67d-4fa9-9916-43623dafb10f,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,Not available,HG19,Primary Tumor,A6024A4A-245D-4D7E-9FEE-96DCB3FEA807,Alive,NCI HRE Branch,University of North Carolina,United States,Cervical Squamous Cell Carcinoma,T3b,N1,Not available,Mar-72,C53.9,C53.9,NO,,Not available,30.0,0.17,1.86,53.9,RNA,,,,2009.0,Alive
s2786,9121A7A8-F610-4F7A-B620-FC0BBAE5AF21,UNCID_2093680.4e0401b2-6ad4-4709-aa43-f2af0afef259.sorted_genome_alignments.bam,55,4E0401B2-6AD4-4709-AA43-F2AF0AFEF259,29c52372-d3a7-4188-b468-67c3451c4f20,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,ASIAN,HG19,Primary Tumor,64ED8359-FB2A-4403-B863-7D5988DF5FFE,Alive,Asterand,University of North Carolina,Vietnam,Muscle invasive urothelial carcinoma (pT2 or above),T3,N0,Stage III,Mar-20,C67.9,C67.9,NO,NO,Not available,30.0,0.16,1.89,37.86,RNA,,,,2012.0,Alive
s17055,2BC4BE85-B517-4749-9EF3-EAC22C0CC7A1,UNCID_2658231.e0178b54-86f9-45e7-949d-2c4132ac9822.sorted_genome_alignments.bam,60,E0178B54-86F9-45E7-949D-2C4132AC9822,cf358fb8-866c-4780-a550-d6c1c30b8c63,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,8566DFB0-570B-4540-B4CD-EAEC48CC27FD,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T2,N0,Stage II,Mar-70,C22.0,C22.0,NO,NO,Not available,20.0,0.18,1.87,63.29,RNA,,,,2013.0,Alive
s14676,804AFD2C-908E-4618-8708-B4204C8B2E05,_1_TCGA-EQ-8122-01A-11R-2343-13_rnaseq.bam,71,66CD4DD6-154A-4006-BBE0-6556EDFA0688,4e921bc8-df5d-4f54-93d1-d5a433f91bdb,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,ECF749E3-3249-41FB-A8BB-2F1B4DA1492B,Alive,Christiana Healthcare,Canada's Michael Smith Genome Sciences Centre,United States,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T3,N1,Stage IIB,Mar-44,C16.3,C16.3,NO,,Not available,30.0,0.16,,297.2,RNA,DAC8EAD9-D484-4E10-A6CE-756CD14477B1,Primary Tumor Field,External,2011.0,Alive
s60,5BC9804E-9E68-4E2E-BF9D-92AFB715063C,UNCID_2114997.e3acad0b-f296-4aed-b08f-e88a3d5f9bf3.sorted_genome_alignments.bam,87,E3ACAD0B-F296-4AED-B08F-E88A3D5F9BF3,245e4254-dbc1-45bd-b5df-504d8c3822de,8.0,Uterine Carcinosarcoma,Not available,RNA-Seq,FEMALE,TCGA-UCS,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,235ED659-E33E-453A-8D7A-212B03B69EAD,Dead,Washington University,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-50,C54.1,C54.1,NO,NO,Progressive Disease,30.0,0.16,1.88,23.02,RNA,,,,,Dead
s4162,CF6714D3-8F31-490C-B594-0FC047776CF5,UNCID_1225727.67816085-c038-4c4f-86f0-b03e6da18aee.sorted_genome_alignments.bam,71,67816085-C038-4C4F-86F0-B03E6DA18AEE,6845076e-e940-4437-8618-81db4a447544,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19,Primary Tumor,95D6E1D3-91C1-40E5-986D-1C5ABB33A03F,Alive,Roswell Park,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T4,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,35.0,0.15,1.8,56.2,RNA,,,,2009.0,Alive
s11176,04B724EC-6A4D-4321-A1CC-783DDBBDBD1E,UNCID_1377208.e9b4a714-487c-40e5-943d-11301e5bc54c.sorted_genome_alignments.bam,71,E9B4A714-487C-40E5-943D-11301E5BC54C,a5bd7d50-9c14-49e6-89cf-6bf440c42309,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,CE8E86EC-52DD-45AD-B65F-CA10E5F782F4,Alive,Washington University - Cleveland Clinic,University of North Carolina,,Lung Acinar Adenocarcinoma,T2a,N0,Stage IB,Mar-55,C34.1,C34.1,NO,,Not available,40.0,0.17,,124.2,RNA,,,,2011.0,Alive
s17124,5E23B711-A91B-47ED-A34B-2E91F5627F48,TCGA-13-0890-01A-01W-0421-09_whole.bam,56,15B867FB-7A7B-4158-9ABD-91870BA77EB7,ee0a4a13-613e-4c5d-96c3-8083a013702d,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-OV,Illumina GA,Ovary,WHITE,NCBI36_WUGSC_variant,Primary Tumor,37981859-BA7A-4F93-8FCB-78615E696149,Alive,Memorial Sloan Kettering,Washington University School of Medicine,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,150.0,0.5,,385.0,Whole Genome Amplification (WGA) produced using Repli-G (Qiagen) DNA,,,,2003.0,Alive
s1280,346153E4-5DC2-4DE8-AEB9-BE1EDC9EF862,UNCID_2244738.74b2fff7-243f-4eb5-9c67-2ab77b3ca059.sorted_genome_alignments.bam,42,74B2FFF7-243F-4EB5-9C67-2AB77B3CA059,0e137272-a21c-4c5e-bfd1-a774b339a753,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,A48D2173-FE97-4FEA-8F4E-BA81B5F6A833,Alive,CHI-Penrose Colorado,University of North Carolina,United States,Cervical Squamous Cell Carcinoma,T1b,N0,Not available,Mar-72,C53.9,C53.9,NO,NO,Complete Remission/Response,30.0,0.17,1.96,49.39,RNA,4496D2C3-D5F4-41A7-ACDD-AA986353770B,Primary Tumor Field,External,2011.0,Alive
s10116,B3CD6762-C478-4936-B966-7B5418C8F5C6,UNCID_1079091.0e199130-3ee6-4172-93f9-db55c11e61b3.sorted_genome_alignments.bam,73,0E199130-3EE6-4172-93F9-DB55C11E61B3,ae343aae-7273-4c46-826d-01377bed5a75,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,33DD4458-C58E-486E-AB73-84F5915770CA,Alive,Washington University - Alabama,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-70,C34.1,C34.1,NO,,Not available,39.0,0.13,,145.2,RNA,,,,2011.0,Alive
s5473,30CAC8B3-F09F-4EEB-8DFF-E77E8B9C13FD,12dd02ea14d0a87df23ce3bef406fe27.bam,73,2290B078-6A5B-4C83-9DFB-B525BBF14E4E,5dd423e8-feaa-4568-a750-500948c41d6c,2361.0,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,2A5F4696-6E02-4FE9-B66D-8C2AE93B7C2F,Dead,Duke,Washington University School of Medicine,United States,Infiltrating Ductal Carcinoma,T2,N0,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.08,,32.75,DNA,,,,1998.0,Dead
s8881,F985BED8-D348-48BA-8B18-C41A4E5FDB12,UNCID_1182944.43c53585-76cc-48a1-a9b1-fe0f96912ff1.sorted_genome_alignments.bam,46,43C53585-76CC-48A1-A9B1-FE0F96912FF1,f6d3e963-5bff-40f6-8430-1c6fb5ec6503,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,A1DDDBED-C780-412A-B563-914F71E5C75D,Alive,University of Pittsburgh,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.15,1.7,101.8,RNA,,,,2010.0,Alive
s10024,DBF6ADAB-E681-4F73-9908-D4CD2CB4BBFA,UNCID_1086501.659acaaf-d086-4066-8d30-7e33de4b8825.sorted_genome_alignments.bam,66,659ACAAF-D086-4066-8D30-7E33DE4B8825,38007506-4865-41d4-83a9-1aa13648f459,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,096D8008-0B37-48C2-A938-A7864CBFB66C,Alive,International Genomics Consortium,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T3,N1,Stage IIIA,Mar-70,C34.8,C34.8,NO,,Not available,16.0,0.14,,95.7,RNA,,,,2011.0,Alive
s4315,D5CA1526-A5EA-460D-95C0-B65A83A35DC0,UNCID_1967427.f3004f55-be95-4c2c-92f8-9ec3e96701cd.sorted_genome_alignments.bam,65,F3004F55-BE95-4C2C-92F8-9EC3E96701CD,77ed36ad-222f-4693-8668-0ecf9073d6e8,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,0EEB2802-5276-4A2F-AE20-926A3FECED91,Alive,International Genomics Conosrtium,University of North Carolina,United States,Mixed serous and endometrioid,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,24.0,0.15,1.78,76.45,RNA,9CEF3365-5DD5-4284-AFEB-CC08DE2F1A8B,Primary Tumor Field,External,2011.0,Alive
s16248,3C8E3E7D-2B0B-4C0C-B386-E627B5BEEA7C,UNCID_1494188.1b31fa14-48de-4b39-adc6-5d6a3db0e70b.sorted_genome_alignments.bam,42,1B31FA14-48DE-4B39-ADC6-5D6A3DB0E70B,9f89510c-ed07-471f-b35e-7c87c237b9fe,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,4C4A6867-BABE-4032-A639-A9B31CDDDC6C,Alive,Vanderbilt University,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T1,NX,Not available,Mar-70,C09.9,C09.9,NO,,Not available,,0.13,,174.2,RNA,42BE550A-3B24-4CBA-8C8A-F1A47510CC32,Primary Tumor Field,EXTERNAL BEAM,2008.0,Alive
s10480,80179EF3-BA4B-4B30-BA19-1C386F95A062,UNCID_2121116.9f1395e0-478f-49dd-8814-1ee57308db0d.sorted_genome_alignments.bam,63,9F1395E0-478F-49DD-8814-1EE57308DB0D,b80ced5e-36b1-48d0-a8a9-0245aeb5f368,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,171E69FB-CE1C-43E9-9F05-D34EBF4DA682,Alive,Prince Charles Hospital,University of North Carolina,Australia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IIB,Mar-70,C34.1,C34.1,NO,NO,Complete Remission/Response,30.0,0.17,1.88,24.7,RNA,,,,2002.0,Alive
s3260,5F1B4C77-5775-4A38-B100-DC28CB8FB2B3,G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.bam,53,2B142863-B963-4CC9-8F8F-C72503C93390,5d54c742-5a8e-4c40-8d62-95e75e210ab8,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19_Broad_variant,Primary Tumor,2CD62676-762C-461D-B111-1F81E7CD5877,Alive,ABS - IUPUI,Broad Institute of MIT and Harvard,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3a,N2,Stage IV,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.08,,40.79,DNA,79AB7E62-6F27-4A0B-BD9D-6604C379142E,Distant Recurrence,OTHER: SPECIFY IN NOTES,2011.0,Alive
s16739,52ED1B2B-EEFA-4FBD-AE58-3D3307006983,UNCID_2313873.26e8978a-77bb-459f-b727-51d3fc361670.sorted_genome_alignments.bam,31,26E8978A-77BB-459F-B727-51D3FC361670,01cc571c-a47c-4548-9c14-5e51c79b095b,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,957CBAF2-52D1-4102-A87E-F1D0D5687C17,Alive,Alberta Health Services,University of North Carolina,Canada,Hepatocellular Carcinoma,T1,NX,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.17,1.83,64.36,RNA,,,,2013.0,Alive
s5199,AA90984A-1483-43A2-8B20-F1654E3F601E,TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted.bam,63,3D587F43-D9C5-4E3B-B245-60BB0AE92808,1200c8b7-a058-4c01-bbe2-04ec09a65245,,Uterine Corpus Endometrial Carcinoma,Not available,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19_Broad_variant,Primary Tumor,649DADDA-5823-4B0D-B5A2-49F501ADC029,Alive,MSKCC,Harvard Medical School,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.86,84.77,DNA,DC4F3B20-A952-41B7-B484-E35D5B0FB589,Primary Tumor Field,EXTERNAL BEAM,2002.0,Alive
s13513,4ABF3B47-09B2-46E1-8BCA-EB46790B3930,TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam,81,099EA705-3D94-4746-AF72-E21B31D0425A,36eaf209-c332-4321-b6aa-51a3368ecd79,,Colon Adenocarcinoma,Not available,WGS,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,Not available,HG18,Primary Tumor,9F9961F0-4EE2-4471-AE4A-A0122D630A28,Alive,Indivumed,Harvard Medical School,Germany,Colon Mucinous Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.9,C18.9,NO,,Not available,149.0,0.13,1.9,949.56,DNA,,,,2008.0,Alive
s86,680BF729-D240-40CB-98EC-37516A46EE25,UNCID_2139804.5ab14c08-9c7e-4eb8-83dd-96e374118ec2.sorted_genome_alignments.bam,90,5AB14C08-9C7E-4EB8-83DD-96E374118EC2,ddfdd05e-058c-4877-b389-724a6c101353,167.0,Uterine Carcinosarcoma,Not available,RNA-Seq,FEMALE,TCGA-UCS,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,240F0742-8B4D-44C5-9109-E39B6DA26FB5,Dead,Mayo Clinic - Rochester,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-50,C55.9,C55,NO,YES,Progressive Disease,30.0,0.17,1.9,58.85,RNA,,,,,Dead
s16067,C5AF6D48-7896-4FF9-A5F4-94C12D659442,UNCID_1482091.72b69370-b570-4715-8762-7eef0a732ec7.sorted_genome_alignments.bam,60,72B69370-B570-4715-8762-7EEF0A732EC7,b4e0c62d-f2f6-4243-9e0f-ae2ad4ca4bb8,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,C38A9E9D-5854-4827-9974-582C45EFC187,Alive,University of Pittsburgh,University of North Carolina,,Head and Neck Squamous Cell Carcinoma,T2,N0,Stage II,Mar-70,C04.9,C04.9,NO,,Not available,30.0,0.17,1.7,198.8,RNA,38184C44-5F50-4CA6-AF54-B49BF2E9D19C,Regional site,EXTERNAL BEAM,2010.0,Alive
s8276,4CD6FBBF-14AF-411E-8008-47DBAAA99B36,UNCID_2332053.03eb7467-7dd5-4228-86b9-7b3b31ba1496.sorted_genome_alignments.bam,52,03EB7467-7DD5-4228-86B9-7B3B31BA1496,e349d8aa-bb82-4ce8-b14c-61216289f25b,228.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,04BF359B-E535-467A-BAD7-4C1284C6ADF4,Dead,Henry Ford Hospital,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,YES,Progressive Disease,30.0,0.17,1.83,24.26,RNA,5FB33F7B-CB4D-4453-B214-4B74C040A036,Primary Tumor Field,External,2012.0,Dead
s4194,3B928EDA-C877-468B-B0CA-46CBF1EE3C8A,UNCID_2059414.acd9261f-37cf-44ca-86c4-e42d88d86b6c.sorted_genome_alignments.bam,72,ACD9261F-37CF-44CA-86C4-E42D88D86B6C,436b242c-ad5f-432e-a684-27bba4c1c8a2,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,531D3514-F2E4-49FA-A31B-DF25B26CB99F,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-40,C61.9,C61,NO,YES,Partial Remission/Response,30.0,0.16,1.84,30.1,RNA,,,,2003.0,Alive
s3597,A2C14576-771C-460F-A71B-E25651274CA1,TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted.bam,68,5644F0E3-3A3B-411A-B28D-C93C3BBD8F86,962dd3d5-8501-4658-8cb9-2424b476124c,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,8E53414F-455E-4665-AE0E-9E7405262A96,Alive,University of Pittsburgh,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3b,N1,Not available,Mar-50,C61.9,C61,NO,,Not available,35.0,0.15,1.9,176.7,DNA,,,,2009.0,Alive
s3079,0FF07006-7458-42F5-B1FD-D84DB4C2F25D,G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.bam,57,804FFA2E-158B-447D-945C-707684134C87,56d8a1b8-1268-4362-a7f1-77b76fbf1b59,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19_Broad_variant,Primary Tumor,577700D1-C366-41EF-8A0D-E50DEEFB5E3C,Alive,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3,N0,Stage III,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.08,1.95,72.54,DNA,,,,2010.0,Alive
s14679,82A3E711-B833-4607-8007-DD29E00EEA85,G39020.TCGA-BR-4280-01A-01D-A290-08.1.bam,78,388A8875-C3F5-494E-8456-28BE8D3626E1,e0916597-e489-45ef-a8f7-653a3c6591ef,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,HG19_Broad_variant,Primary Tumor,797D2D3A-F01C-4985-B27C-4E4C2838D34D,Alive,Asterand,Broad Institute of MIT and Harvard,Russia,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T2b,N1,Stage III,Mar-40,C16.9,C16.9,NO,,Not available,35.0,0.07,1.9,252.9,DNA,,,,2009.0,Alive
s8894,3253B987-8B36-43BC-953C-0617E7D06A01,UNCID_1188726.8764f098-42b1-404e-b1de-93a3a3998a19.sorted_genome_alignments.bam,77,8764F098-42B1-404E-B1DE-93A3A3998A19,2375ef64-8212-4ad4-97e8-bfa6d1db430f,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,1465CE1E-F267-4DAD-A327-3128456A6201,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,35.0,0.15,1.7,86.3,RNA,,,,2006.0,Alive
s4067,91603915-F02E-4CD1-B762-423615C83381,UNCID_2253515.a3f81069-d0a9-49af-bd22-24c6142241b6.sorted_genome_alignments.bam,55,A3F81069-D0A9-49AF-BD22-24C6142241B6,1583aea0-5d69-4165-9bef-d5bfdddf3a65,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,6C728891-8924-4A51-B3ED-F4B83D6C8DE4,Alive,University of North Carolina,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,Not available,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.16,1.82,17.42,RNA,,,,2013.0,Alive
s2979,DCB41921-93CD-465A-841A-9E6478BCBB96,UNCID_1469085.6AEC2686-FCEA-4D3E-8311-0B6CCAD4C000.sorted_genome_alignments.bam,66,6AEC2686-FCEA-4D3E-8311-0B6CCAD4C000,7b98b829-fdc7-4719-bee9-c83f6154019c,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,015E6B08-AB3C-4D1D-99E4-77B5E10BD7FC,Alive,BLN - University Of Chicago,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4,N3,Stage IV,Mar-20,C67.0,C67.0,NO,NO,Not available,20.0,0.16,1.81,37.51,RNA,,,,2012.0,Alive
s5038,D5FDAB7F-AAC2-4567-91A1-FB49C53ABAE1,UNCID_1608770.43abe272-41cb-4b54-b6f6-50a27c670e46.sorted_genome_alignments.bam,71,43ABE272-41CB-4B54-B6F6-50A27C670E46,7b9947d5-e86b-4006-8890-ea5209584a88,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,53D0521F-10D6-4F70-9277-D99025A6B963,Alive,MSKCC,University of North Carolina,,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.14,1.72,97.56,RNA,,,,2001.0,Alive
s5502,606408B7-5FAC-421C-BF07-5D3FA16EA033,UNCID_1117388.9eab0553-20cc-41bb-bcdb-9ade0578da82.sorted_genome_alignments.bam,69,9EAB0553-20CC-41BB-BCDB-9ADE0578DA82,bb8d42d3-ad65-4d88-ae1d-f9aadfc7962d,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,76F4BDBC-58C8-4424-865B-C6531D908DC3,Alive,MSKCC,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T2,N0 (i-),Stage IIA,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.16,1.9,39.22,RNA,DC16CC6F-20A3-44D0-B0FF-794D86EAD108,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s8661,7B1C155E-0372-4F54-81E2-4B7D65E79399,UNCID_2054781.10b6c170-88d1-4cea-87c7-b23d6810ea6a.sorted_genome_alignments.bam,49,10B6C170-88D1-4CEA-87C7-B23D6810EA6A,cfcd3835-bb09-400e-b7eb-55ac139d01f8,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,B434838F-2EB4-4D42-8D15-D35E62F15D3C,Alive,University of Florida,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.0,C71.0,NO,NO,Complete Remission/Response,30.0,0.16,1.88,23.79,RNA,,,,2012.0,Alive
s15796,AF988103-0F68-4BB3-B5D5-D2E1E20F176E,UNCID_1488083.7455b3db-3c26-45d9-bcf3-705f2af6829c.sorted_genome_alignments.bam,55,7455B3DB-3C26-45D9-BCF3-705F2AF6829C,13f63218-0949-41e6-a661-c844414c45b5,493.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,38A4AC42-BE08-4187-98C2-AF861218C3DB,Dead,University of Pittsburgh,University of North Carolina,,Head and Neck Squamous Cell Carcinoma,T4a,N2c,Stage IVA,Mar-70,C04.9,C04.9,NO,,Not available,41.0,0.15,1.8,118.3,RNA,578FE775-4113-4E22-A6F8-805DABD55433,Primary Tumor Field,EXTERNAL BEAM,2006.0,Dead
s9247,69F16737-B714-46AB-A3C4-D45071A9D4E2,UNCID_338844.TCGA-AK-3461-01A-02R-1277-07.110331_UNC11-SN627_0072_AB05NMABXX.1.trimmed.annotated.translated_to_genomic.bam,72,7FA313DA-8602-4476-B33C-8A84BCDFF739,08c1bb22-81f5-4a6d-98ce-f9c31d896eab,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,4B23249B-183D-4B9B-9A6A-987624127555,Alive,Fox Chase,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1a,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,30.0,0.14,1.8,72.3,RNA,,,,2007.0,Alive
s1630,20F9E828-D59D-48DD-B6EE-79EE64E87CCC,TCGA-IG-A4P3-01A-11R-A260-31_rnaseq.bam,48,CAE6C3B5-A4F3-4D45-9D53-9C7C2C735C32,6594acd5-4d2a-4cc5-8cf8-4064e252c5f6,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,784021B2-5F94-48F9-9DF7-854B4FBDF802,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Ukraine,Not available,T2,N1,Stage IIB,Mar-70,C15.4,C15.4,NO,NO,Not available,30.0,0.17,1.87,66.22,RNA,848194EA-74D2-4695-A5D9-FC634880709B,Not available,Not available,,Alive
s8508,7FBB0D14-827C-4ADC-9A4F-4B9855F91195,UNCID_2400623.c7554894-f361-4d97-8c1b-91925679143c.sorted_genome_alignments.bam,40,C7554894-F361-4D97-8C1B-91925679143C,ee6bf12f-8a73-49e2-b566-368b2b42165b,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,05C7E7CA-5394-4015-98E4-64B4EB4A80E5,Alive,The University of New South Wales,University of North Carolina,Australia,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.0,C71.0,NO,NO,Progressive Disease,30.0,0.15,1.89,44.32,RNA,,,,2012.0,Alive
s13375,5DF0C5C9-A1DB-4F57-8057-6C9E4416B84A,TCGA-AA-3693-01A-01D-0957-02_IlluminaGAII-DNASeq_whole.bam,77,232D0A9B-C1E1-435A-BB5F-D346243D420E,33522271-b2ca-4da4-a942-501ab9117c51,,Colon Adenocarcinoma,Not available,WGS,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG18,Primary Tumor,E2843875-A4DE-4D90-BDA2-0FBBC929757F,Alive,Indivumed,Harvard Medical School,Germany,Colon Adenocarcinoma,T4,N1,Stage IV,Mar-40,C18.7,C18.7,NO,,Not available,147.0,0.15,1.9,667.0,DNA,,,,2008.0,Alive
s6702,136FF78E-A9B2-497E-98A3-D9EAE7E9529D,UNCID_1157989.a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c.sorted_genome_alignments.bam,65,A4AE2BC2-BC93-4F5C-AEF7-730EB0E2BA0C,6f89509c-f802-482e-b4da-94553aa76fe9,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,C7F97F19-47AE-48D3-A90A-0162D3975747,Alive,Mayo,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T2,N0,Stage IIA,Mar-20,C50.9,C50.9,NO,,Not available,30.0,0.15,2.26,51.98,RNA,7926DA2C-4D80-45A5-8E14-24F769E48DF1,Primary Tumor Field,Not available,2001.0,Alive
s17581,8E98AB9E-0ECE-4FC3-B967-26E16B8D3E85,TCGA-30-1860-01A-01R-1568-13_rnaseq.bam,58,1B8EED7B-173E-4E38-80A4-A3A0AEA469A1,563853a2-9ac2-48be-adf3-1e547ee2b274,1366.0,Ovarian Serous Cystadenocarcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,5AE1AE22-B891-472A-B737-E48C73B91798,Dead,Harvard,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,103.0,0.15,1.8,335.0,RNA,10498612-21CB-499F-9A2D-701E15D53EAC,Primary Tumor Field,EXTERNAL BEAM,2002.0,Dead
s4153,4FF229A3-6637-4FDC-A3B6-079E28773187,TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.bam,56,9BF25BFC-4E07-4979-9169-F6CDADDB3A90,907b64d6-a26a-4092-a247-ac9af444d1c7,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,92888479-B534-432D-8F70-CAE857E0074B,Alive,International Genomics Consortium,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T2a,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,32.0,0.15,,333.3,DNA,,,,2011.0,Alive
s4645,3C0BA920-F1AD-4A00-ADF9-05A0EE532D5D,UNCID_1618107.245e65eb-ec7a-4a85-a524-194afbdf67ef.sorted_genome_alignments.bam,86,245E65EB-EC7A-4A85-A524-194AFBDF67EF,e4510c66-a60b-4b09-a4e8-74ec5b26a3a5,145.0,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,6D3FB251-74E8-40D5-8262-F265A5A3395A,Dead,Gynecologic Oncology Group,University of North Carolina,United States,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.17,2.36,103.73,RNA,,,,2008.0,Dead
s17331,33906A39-B8FD-46AA-9C18-923A24464095,TCGA-13-0885-01A-02R-1569-13_GRCh37-lite_rnaseq.bam,70,E0F48D4D-4C10-4B83-9A13-9427A08371D3,2a924999-1fbf-470a-97bd-fd2276a9a366,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,8486F0D0-2BB2-41A0-8B21-308407CE4ABA,Alive,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,120.0,0.16,1.8,254.0,RNA,,,,2000.0,Alive
s3210,0B16E18B-2AD5-4E16-BE5E-0CE96BB6F83D,UNCID_2448624.85f596e4-9591-49f5-8408-25e4ce16c7f7.sorted_genome_alignments.bam,69,85F596E4-9591-49F5-8408-25E4CE16C7F7,6aa72ca1-b378-4db4-b4ef-b12386683d1f,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,A85B114D-2F7B-4678-8508-E3BC04552093,Alive,Gundersen Lutheran Health System,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T2a,N0,Stage II,Mar-30,C67.9,C67.9,NO,NO,Complete Remission/Response,30.0,0.17,1.9,68.14,RNA,,,,2013.0,Alive
s13515,E8516B3D-FCFF-4F10-94A4-993B059AC4AA,TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina.bam,69,85E29049-A5E8-49FA-A576-E113C7B2C2E3,dca004bf-9c14-45a1-b186-ab3759f6c7fe,,Colon Adenocarcinoma,Not available,WGS,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,Not available,GRCh37-lite,Primary Tumor,A2DD99BF-3A02-42CD-9AA8-80A018584EE6,Alive,Indivumed,Baylor College of Medicine,Germany,Colon Adenocarcinoma,T3,N0,Stage II,Mar-40,C18.9,C18.9,NO,,Not available,131.0,0.15,1.9,417.96,DNA,,,,2007.0,Alive
s15005,6AAD87E8-EE4E-450A-8456-75696B589419,TCGA-IN-A6RI-01A-11R-A32D-31_rnaseq.bam,45,E2C6E8E2-BC36-40E9-8897-1D24FDB572C9,ec178822-d719-4e98-b864-16ec5aa005a4,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,815DB115-54ED-43AD-9DA8-0B1EFA93374A,Alive,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,United States,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T1b,N0,Stage I,Mar-40,C16.0,C16.0,NO,NO,Complete Remission/Response,30.0,0.18,1.91,65.62,RNA,,,,2012.0,Alive
s17821,7F891B3E-AD42-4DF3-9FC0-1C3C7CD22EE3,TCGA-23-1028-01A-01R-1564-13_GRCh37-lite_rnaseq.bam,43,8F6E45B3-2857-4EB8-A723-5429F7FD8F0C,df53c3c0-3605-4d2b-bdc7-96d9beab27ea,,Ovarian Serous Cystadenocarcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,4363B3C8-BFDB-4668-B72A-D15ED0F5BFFF,Alive,Cedars Sinai,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,97.0,0.14,1.8,243.0,RNA,,,,2004.0,Alive
s9795,B48A0424-D604-40FD-8B71-9430F4493722,UNCID_1189484.1cf6a04b-d795-4528-9a6d-fdf52c9a4a95.sorted_genome_alignments.bam,47,1CF6A04B-D795-4528-9A6D-FDF52C9A4A95,cdd8eb5c-bda8-4961-9db4-72e0c4907e95,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,2689F0BA-CCE5-45FB-8DB5-9832E88663F3,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,35.0,0.15,1.8,116.3,RNA,,,,2006.0,Alive
s17894,D3023878-3C9B-440C-AC5A-98FAE87AF720,TCGA-04-1648-01A-01R-1567-13_rnaseq.bam,57,9248AA41-9572-4B91-8E00-13AA0E3DCE12,cddce77f-21e6-4124-9f03-96fb5ca7cefa,871.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,BC979254-2B16-43AB-BA8D-7670A3B4AB3A,Dead,Gynecologic Oncology Group,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,118.0,0.15,1.8,377.0,RNA,,,,2003.0,Dead
s17764,ECE438AA-9812-4E1A-B491-673505C5B692,TCGA-04-1332-01A-01R-1564-13_GRCh37-lite_rnaseq.bam,70,08E7C700-7038-40B5-BEC0-2DD402E1A225,b46263ab-c3ca-4fda-a895-74c7e6e6fe22,1247.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,B8243412-B7B4-4A7B-B823-4B33488FF429,Dead,Gynecologic Oncology Group,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,100.0,0.16,1.8,36.0,RNA,,,,2002.0,Dead
s11081,6D139180-0E25-4F9C-8590-3EE5D043F7F8,UNCID_1964348.83ca9e67-060b-45ec-9ea9-076a64ae8062.sorted_genome_alignments.bam,71,83CA9E67-060B-45EC-9EA9-076A64AE8062,793649e5-f479-4d64-8723-2ef488fe0fd9,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,1454406F-934B-4073-814E-387008C99A2B,Alive,Thoraxklinik at University Hospital Heidelberg,University of North Carolina,Germany,Lung Adenocarcinoma Mixed Subtype,T2,N1,Stage IIB,Mar-55,C34.3,C34.3,NO,NO,Complete Remission/Response,30.0,0.18,1.82,32.55,RNA,,,,2007.0,Alive
s1738,C005EB75-B2B6-4314-A172-36F4A9F7BFEA,TCGA-L5-A43E-01A-11R-A24K-31_rnaseq.bam,74,28616399-0B80-4F76-8B7F-8EC85982E3FA,6969fe5a-5993-48e5-95c5-c5c7d3d08205,,Esophageal Carcinoma,Not available,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,5C8F603A-B8D3-407C-8E74-559C5F8C4D0E,Alive,University of Michigan,Canada's Michael Smith Genome Sciences Centre,United States,Not available,T1,N0,Stage I,Mar-40,C15.5,C15.5,NO,NO,Not available,30.0,0.16,1.98,34.68,RNA,,,,,Alive
s10806,948D9B38-F2D1-4412-856C-4C9963FA504D,UNCID_1083439.b2d849d8-f837-43e4-b06c-051f041172ae.sorted_genome_alignments.bam,72,B2D849D8-F837-43E4-B06C-051F041172AE,923b37e4-fcf7-46a0-8cb2-9139711fec7b,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,32342D96-3B04-4881-9E98-9CB63918FE48,Alive,International Genomics Consortium,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T1b,N0,Stage IA,Mar-40,C34.3,C34.3,NO,,Not available,36.0,0.15,,80.2,RNA,,,,2011.0,Alive
s3063,FE039493-42DD-42CD-929B-02352620C6AA,UNCID_2648761.d855e064-11e2-436f-8433-b114b4709247.sorted_genome_alignments.bam,82,D855E064-11E2-436F-8433-B114B4709247,cdfd86db-15e2-4d38-a717-2207e8de2d8f,388.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,098E5B61-7125-4F72-B2A4-E0FDC4327AC9,Dead,University of Southern California,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4a,N2,Stage IV,Mar-30,C67.9,C67.9,NO,YES,Progressive Disease,30.0,0.17,1.83,32.3,RNA,,,,2006.0,Dead
s15278,2D0414D3-AC4B-4A98-B582-C1BDA3DABC0B,_1_TCGA-CG-4306-01A-01R-1157-13_rnaseq.bam,90,D3BC5384-C0BC-4C5C-8051-4682FE37A160,73d177f7-8c0a-42f6-a73d-8073c0e6142b,31.0,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina GA,Stomach,Not available,GRCh37-lite,Primary Tumor,78785DB9-C3D5-4C26-BBEF-E741C4AAE429,Dead,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N2,Stage IV,Mar-40,C16.3,C16.3,NO,,Not available,36.0,0.15,1.8,206.3,RNA,,,,2006.0,Dead
s9785,5A8CD0E6-E0BF-4A61-82B9-A636CCA4899C,UNCID_1183807.4b68ecb0-6827-4f72-8844-94dfeb02c6f9.sorted_genome_alignments.bam,79,4B68ECB0-6827-4F72-8844-94DFEB02C6F9,c1b46fd8-1221-4641-a323-84bfb444a45f,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,A94D3642-623F-4183-B953-6E84642CEAB0,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,37.0,0.13,1.7,23.8,RNA,,,,2005.0,Alive
s16223,BC4F1A6B-8853-4E1C-98DF-19AA95720F75,UNCID_1487163.4d5ede35-ed46-42e1-8ad7-cc584d297eca.sorted_genome_alignments.bam,63,4D5EDE35-ED46-42E1-8AD7-CC584D297ECA,9eb1997f-14f5-4230-ae4f-1ef1943e1723,276.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,F1CBF326-7657-4C9B-9C8D-E2036E89FD07,Dead,University of Pittsburgh,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,TX,NX,Not available,Mar-70,C32.9,C32.9,NO,,Not available,31.0,0.16,1.8,37.8,RNA,,,,2010.0,Dead
s17280,3CE95963-7650-4FE7-9CBC-554EE9D56AA7,G48125.TCGA-13-1487-01A-01D-A312-08.2.bam,74,44EEBC04-C027-45AE-BECA-C4012B494F29,c9e28934-8379-4511-817c-d787f2c4ca3a,681.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,HG19_Broad_variant,Primary Tumor,BFF12F06-DABC-4424-AC53-65CA01D0A406,Dead,Memorial Sloan Kettering,Broad Institute of MIT and Harvard,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,124.0,0.07,1.9,298.97,DNA,,,,2002.0,Dead
s548,9D56B0E2-C95A-48D3-951B-F557726AF1E4,UNCID_2599158.58a189c0-9aa5-4f63-9b33-fb0dcfd61a77.sorted_genome_alignments.bam,75,58A189C0-9AA5-4F63-9B33-FB0DCFD61A77,51feca45-114e-4817-99d6-1c9842cd679a,,Thymoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-THYM,Illumina HiSeq,Thymus,WHITE,HG19,Primary Tumor,FC6CD4A7-FC35-4DC4-886F-ED72269B40EF,Alive,Thoraxklinik,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-81,C37.9,C37,NO,NO,Not available,30.0,0.17,1.92,58.08,RNA,05C47DCE-958F-4C30-9555-EAA7153FA184,Primary Tumor Field,External,,Alive
s2404,CBDC9AE5-E493-4CE3-8C79-E265ACF2FD2B,UNCID_2427911.cb14afc9-f89b-47e7-a218-1a4921480eb8.sorted_genome_alignments.bam,78,CB14AFC9-F89B-47E7-A218-1A4921480EB8,76e3ec27-2c64-4e38-96f1-30307893b825,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,C9B51F86-B26B-4329-BB28-A1298D9B7142,Alive,University of North Carolina,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-05,C49.2,C49.2,NO,,Not available,30.0,0.18,1.77,17.86,RNA,FC28B8CB-BA41-434C-983E-F5AE26B99C17,Primary Tumor Field,EXTERNAL BEAM,,Alive
s79,26695D5D-7402-4542-9801-3C9B8E764DA8,UNCID_2138134.e551561c-5794-4358-bc9f-0a970350f865.sorted_genome_alignments.bam,77,E551561C-5794-4358-BC9F-0A970350F865,ae10b73d-e7f4-4334-8452-167b60d71cb5,,Uterine Carcinosarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCS,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,0230F8FB-EA80-4678-9A5D-62AA36D37E59,Alive,University of Pittsburgh,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-50,C54.1,C54.1,NO,YES,Partial Remission/Response,30.0,0.18,1.84,57.55,RNA,2D374FD0-51BB-48FE-AE05-68A525AC02F1,Regional site,External,,Alive
s17841,1828508E-16EF-4742-B065-E9C67BE5EAF4,TCGA-25-2042-01A-01R-1568-13_rnaseq.bam,60,AE1E5F8D-CDD9-41F5-B56C-80DFE27E1B6C,818dc159-aba4-46bc-a4ed-68ee0f8c4461,396.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,AMERICAN INDIAN OR ALASKA NATIVE,NCBI36_BCCAGSC_variant,Primary Tumor,71484ED8-3496-48B2-81B8-888D04F10F0A,Dead,Mayo Clinic - Rochester,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,111.0,0.15,1.8,181.0,RNA,,,,2006.0,Dead
s16037,D86390D3-24C6-4E56-9B8A-D6B3EC75C989,TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.bam,69,C7EABDCF-81F2-4C87-946A-B5BA42056B04,96d0cefe-7949-4736-a7dc-1e4fa94765ec,985.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19_Broad_variant,Primary Tumor,E0E75203-3982-40B2-A057-FAA8433DFB7A,Dead,"University Health Network, Toronto",Harvard Medical School,Canada,Head and Neck Squamous Cell Carcinoma,T3,N0,Stage III,Mar-70,C14.8,C14.8,NO,,Not available,37.0,0.15,1.9,342.7,DNA,,,,2007.0,Dead
s6147,23DE13EF-114E-4E4F-9587-47A87A20E5A9,UNCID_1126576.2c75afc3-11b5-444d-b6e0-61d76b299f40.sorted_genome_alignments.bam,56,2C75AFC3-11B5-444D-B6E0-61D76B299F40,db4bc6aa-2e7d-4bcb-8519-a455f624d33b,1692.0,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,F225775E-E46F-4D1D-8B13-042E9776DD72,Dead,University of Pittsburgh,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N1b,Stage IIB,Mar-00,C50.8,C50.8,NO,,Not available,30.0,0.16,1.84,67.9,RNA,,,,2001.0,Dead
s10237,69311F2A-43CD-4FC2-8B2B-BAE7A7A6630D,UNCID_2075183.87d9eb58-9b87-462f-982d-8abc83f2205b.sorted_genome_alignments.bam,73,87D9EB58-9B87-462F-982D-8ABC83F2205B,77bd82a6-a859-4b8e-accc-c343ce9f4d38,88.0,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,87F48B57-3BD8-4310-924A-7D9D95B8DD11,Dead,Washington University - CHUV,University of North Carolina,Switzerland,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2b,N0,Stage IIA,Mar-70,C34.1,C34.1,NO,NO,Not available,30.0,0.16,1.84,16.29,RNA,,,,2010.0,Dead
s422,B0C2A695-A4C2-400C-AFBE-855DE1A90221,UNCID_2548123.f0b52bcf-d7b4-4daa-82bb-e13e2d753be9.sorted_genome_alignments.bam,53,F0B52BCF-D7B4-4DAA-82BB-E13E2D753BE9,ebe927e6-0a7e-4c97-ad73-f3c302cca7bc,885.0,Mesothelioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-MESO,Illumina HiSeq,Mesothelium,WHITE,HG19,Primary Tumor,B71B1FB6-3C73-46C8-AB3B-BDFAA4B66B67,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Not available,T3,N2,Stage III,Mar-52,C38.4,C45.0,NO,YES,Not available,30.0,0.17,1.88,53.76,RNA,,,,,Dead
s6349,BE3FC649-96F6-4D7F-9C7C-51D8FAC6B25D,UNCID_1145498.2b721e04-5452-4b34-b3df-c6cdd04e87b1.sorted_genome_alignments.bam,39,2B721E04-5452-4B34-B3DF-C6CDD04E87B1,4bf50455-9ab7-4521-a791-089f66d3b877,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,C2300B5B-43A7-43B8-8CD1-22FF7E89A21A,Alive,Duke,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T3,N1,Stage IIIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,1.88,41.22,RNA,,,,1996.0,Alive
s15983,46397DE1-C61D-4ED7-963B-E058CC271EA9,UNCID_2195714.e2b939fc-1126-4cf9-aed3-5f028dbb1dfc.sorted_genome_alignments.bam,52,E2B939FC-1126-4CF9-AED3-5F028DBB1DFC,3aea4cf5-ade6-4747-b1d1-c431564f5fa6,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,80ED0EFE-876C-4F58-AC25-9DE2F53D40A3,Alive,Emory University - Winship Cancer Inst.,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T4a,N2c,Stage IVA,Mar-70,C04.9,C04.9,NO,YES,Progressive Disease,30.0,0.18,1.85,61.27,RNA,6414D3B1-7A65-4089-98AA-203A72340837,Regional site,External,2013.0,Alive
s10855,8C7CCEBD-DC48-4889-B293-A9046E865AB2,UNCID_1379478.16b48e8d-f339-45b2-8182-fe27212bc8da.sorted_genome_alignments.bam,69,16B48E8D-F339-45B2-8182-FE27212BC8DA,aee86a89-0377-4080-b16c-408bfbe78687,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,E54EF0F0-38A5-4226-9A6A-C76AA12DE589,Alive,Washington University - Cleveland Clinic,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T1b,N0,Stage I,Mar-50,C34.1,C34.1,NO,,Not available,31.0,0.15,,57.2,RNA,,,,2011.0,Alive
s9473,79F46D5E-DA4D-4415-9F97-EC57A5659351,UNCID_1178867.445f363c-0c01-49d2-bc1e-72f5899d1e47.sorted_genome_alignments.bam,65,445F363C-0C01-49D2-BC1E-72F5899D1E47,83444c79-6aa5-4081-9143-2055a360e211,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,ACC1800F-A145-4CA5-BB4C-65DF60714A9F,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,40.0,0.14,1.8,41.3,RNA,,,,2005.0,Alive
s2922,2A801113-8404-4C17-9D60-508761EC1659,TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.bam,54,80DBF776-1B0B-454C-9DA6-9688816A294D,2a41b7d4-132f-4fb6-87b5-487c445379c7,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19_Broad_variant,Primary Tumor,C629CD55-54D7-4E31-AB90-955EBFF0B20A,Alive,ABS - IUPUI,MD Anderson - Institute for Applied Cancer Science,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,NX,Stage II,Mar-20,C67.9,C67.9,NO,NO,Not available,20.0,0.14,,37.3,DNA,,,,2011.0,Alive
s15441,DDB038AA-16C7-4291-B9A9-B24ECEC942BF,_1_TCGA-HU-8238-01A-11R-2343-13_rnaseq.bam,56,C6E7D5D6-D8C3-43CA-98CC-C23C9E0B3C72,ac77e22d-42c0-4e06-b904-0dd5b31eb0d8,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,B18AFF18-92EF-4092-A6A8-EF82FCE038C5,Alive,National Cancer Center Korea,Canada's Michael Smith Genome Sciences Centre,Korea South,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N2,Not available,Mar-11,C16.3,C16.3,NO,NO,Complete Remission/Response,42.0,0.15,,532.2,RNA,,,,2011.0,Alive
s11829,CBC2D220-27C5-44AB-8B7E-122C60479DBF,UNCID_2324365.53d0cb75-acca-47c0-855f-b45c9ffd1eac.sorted_genome_alignments.bam,44,53D0CB75-ACCA-47C0-855F-B45C9FFD1EAC,fb3aced2-4eb5-4b82-824f-e382a469bc15,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,9261FD37-5EEC-4D5F-851E-3AD4D6D5A21F,Alive,Saint Mary's Health Care,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1a,NX,Stage I,Mar-60,C64.9,C64.1,NO,,Not available,30.0,0.18,1.84,41.72,RNA,,,,2013.0,Alive
s15275,166AC33B-DBD0-430F-BF92-CECBC7CBB1B5,_1_TCGA-BR-8372-01A-11R-2343-13_rnaseq.bam,63,82A70DA7-F6EC-4F02-81EF-A4BDADF258FD,5b52f882-df12-42ec-a000-ff3b428ba05b,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,FAE10552-1D8A-4970-B733-5AA0F498FBC8,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T4b,N3a,Stage IIIC,Mar-44,C16.1,C16.1,NO,,Not available,40.0,0.17,,323.5,RNA,,,,2012.0,Alive
s17882,3D865220-B0B8-4CA4-B4A1-56E05DC83E6F,TCGA-29-1710-01A-02D-0926-12_Illumina.bam,54,6BA4DE87-C332-42B8-AF95-EB14A4C7F229,4261267c-7042-4c6e-83ed-12fb401003fc,951.0,Ovarian Serous Cystadenocarcinoma,Not available,WGS,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCM_variant,Primary Tumor,61513DA0-4EB3-4CAE-BFFF-7B05F3362488,Dead,Duke,Baylor College of Medicine,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,133.0,0.15,1.9,265.0,DNA,,,,2006.0,Dead
s10750,6EAE55C4-D8A8-49D5-A15E-E941078ECBB7,UNCID_2275739.376bf5b1-9205-46c8-aa7e-28e38de6cc4d.sorted_genome_alignments.bam,60,376BF5B1-9205-46C8-AA7E-28E38DE6CC4D,68b86559-38b2-41f2-b66e-c3c2b628b14d,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,6C206676-E511-4281-91F5-BFE91B3279A4,Alive,Christiana Healthcare,University of North Carolina,,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-40,C34.1,C34.1,NO,,Not available,153.0,0.15,1.8,288.3,RNA,A33297B6-1B28-4A0E-AF21-09030850C6B7,Distant Recurrence,EXTERNAL BEAM,2010.0,Alive
s14459,2CDABAE0-C924-481E-AD7E-BBE3F72F5C79,G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.bam,39,2C316B7E-6A82-4BA1-9F34-D8BFCF82D41E,8a24f1a3-4bab-4591-9676-7bee01d096c1,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,HG19_Broad_variant,Primary Tumor,5A5C4538-D75D-4DA5-8E8C-DD92766FEE50,Alive,Asterand,Broad Institute of MIT and Harvard,Vietnam,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T4a,N2,Stage IIIB,Mar-40,C16.3,C16.3,NO,,Not available,30.0,0.08,,25.07,DNA,,,,2012.0,Alive
s11527,F713A559-A5E9-4EE1-AFC9-745F645738FE,UNCID_1965271.bf1fd845-aa87-49e7-8bd9-1443d6a3799c.sorted_genome_alignments.bam,88,BF1FD845-AA87-49E7-8BD9-1443D6A3799C,362000e4-cf7c-48fc-93cc-8f5994b442ea,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,36576033-1B30-4D02-977B-983220FC8F32,Alive,International Genomics Consortium,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T1b,N0,Stage IA,Mar-40,C34.3,C34.3,NO,NO,Complete Remission/Response,30.0,0.17,1.9,21.55,RNA,64AB51F5-F53A-403A-8BA3-694141F508E7,Distant Recurrence,External,2012.0,Alive
s17090,DAE90A39-5E5B-4172-AA48-1ECE416CE6EA,UNCID_2326787.811d94b6-2802-44ff-915f-7344886d93bb.sorted_genome_alignments.bam,47,811D94B6-2802-44FF-915F-7344886D93BB,f5de6712-4de4-43de-8eb5-ec2a798c8438,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,D70C86B2-D403-4CB3-A381-076819B5B414,Alive,University of Utah,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,20.0,0.17,1.89,52.82,RNA,,,,2012.0,Alive
s6601,2DE82B4E-A5BB-4CD2-BF70-CC77C6D69415,UNCID_2251942.ca9882fa-7f02-4277-9786-b9394f451f7b.sorted_genome_alignments.bam,62,CA9882FA-7F02-4277-9786-B9394F451F7B,8c7e74e0-71ef-49b8-9217-94b8ef740ef9,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,C0495A7E-F518-469D-B716-3B431581FD7F,Alive,Christiana Healthcare,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N1,Stage IIB,Mar-00,C50.9,C50.9,YES,,Not available,400.0,0.15,1.79,6.91,RNA,D0E25CCC-163E-4D8E-822F-3703BDFF238E,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s9097,F2F48B29-6093-42D6-B24A-9C2E8CFFC833,UNCID_359113.TCGA-BP-4798-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.7.trimmed.annotated.translated_to_genomic.bam,74,E5276782-9AC4-454D-A7B3-72D6C12FBD5D,a5d34ea3-9362-4233-8d9e-1892839179b2,334.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,309083B8-041E-4C3D-BCF2-FA3E4F671C10,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,38.0,0.14,1.8,106.3,RNA,,,,2007.0,Dead
s6729,15BB7215-8885-42EB-AB84-BEB5A92A25E1,UNCID_1857749.b2b92b23-3f2a-4305-8c6c-27c91c67c072.sorted_genome_alignments.bam,46,B2B92B23-3F2A-4305-8C6C-27C91C67C072,75f6e476-233a-409c-a3ef-0240be569813,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,ASIAN,HG19,Primary Tumor,659EE487-4309-4D68-A9BC-9079EE87E4A9,Alive,ABS - Research Metrics Pakistan,University of North Carolina,Pakistan,Infiltrating Lobular Carcinoma,T2,N0,Stage IIA,Mar-20,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.8,24.52,RNA,,,,2011.0,Alive
s16771,E161BEE0-F308-43BA-9D4A-12D554FB2FD4,UNCID_2660684.9db8d89d-ef37-49a5-81ed-3ae95aa3c920.sorted_genome_alignments.bam,75,9DB8D89D-EF37-49A5-81ED-3AE95AA3C920,93afbfa1-4d03-4105-8dda-b095f0ab308a,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,24B87B32-13C6-4F3C-8DD1-775B15F5654B,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T2,N0,Stage II,Mar-70,C22.0,C22.0,NO,YES,Not available,30.0,0.17,1.87,96.18,RNA,,,,2008.0,Alive
s10794,915FE8ED-278A-43FB-90CD-986D5C65E9AD,TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted.bam,67,8DC8F884-F58B-4EFA-AE96-C87AB7F6D991,75dd635e-8e0c-4c0b-b21c-20f77770218d,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19_Broad_variant,Primary Tumor,AED669E8-23B6-4786-9398-6BB048815DFA,Alive,University of Pittsburgh,Harvard Medical School,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-40,C34.1,C34.1,NO,,Not available,30.0,0.14,1.9,168.4,DNA,B1859915-5AE6-41CF-A335-C12501CA2E70,Primary Tumor Field,IMPLANTS,2009.0,Alive
s13004,667DF88A-B041-4FE2-8E68-CF08AA0DB3EF,UNCID_271857.TCGA-AA-3672-01A-01R-0905-07.100810_UNC6-RDR300211_00022_FC_629L9AAXX.3.trimmed.annotated.translated_to_genomic.bam,90,737609FD-FA3F-4716-BA99-F4A8110E16A8,c46971a1-cbac-425d-bac2-f4142c92522e,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,496316BA-00B4-49FF-9B67-02273FBFA945,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N1,Stage III,Mar-40,C18.4,C18.4,NO,,Not available,125.0,0.14,1.8,734.3,RNA,,,,2006.0,Alive
s8850,44A142E9-A908-49AE-AEC5-0B3DFA64CCE8,UNCID_1159130.bd545b26-2f5e-4e5e-bda6-769900270267.sorted_genome_alignments.bam,48,BD545B26-2F5E-4E5E-BDA6-769900270267,b7719c71-de18-4a4d-99ef-67b788c6f77c,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,15541567-587C-4AB8-87FF-3D0DB7D0C47C,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,34.0,0.16,1.8,32.3,RNA,,,,2004.0,Alive
s4222,32484711-AE2D-45B4-96B5-72B7B23EF86E,UNCID_2481257.b3079945-f405-4810-b7cc-efa81b3b46ad.sorted_genome_alignments.bam,72,B3079945-F405-4810-B7CC-EFA81B3B46AD,f06c1ef4-bedd-4025-abf8-06f5e9c0821a,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,EF5058A4-054D-4FD2-876D-D3247D391C1B,Alive,University Medical Center Hamburg-Eppendorf,University of North Carolina,Germany,Prostate Adenocarcinoma Acinar Type,T3b,N1,Not available,Mar-40,C61.9,C61,NO,,Not available,30.0,0.16,1.86,42.56,RNA,,,,2013.0,Alive
s8308,E3505EB9-5321-4163-AD44-BBC1F04B10FB,UNCID_2407995.bdbde24d-9270-4e7b-84f3-1ba0b7d54e55.sorted_genome_alignments.bam,54,BDBDE24D-9270-4E7B-84F3-1BA0B7D54E55,63f4aa26-dec0-4309-8b75-6446a7241527,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,2930AD75-D51D-4958-B58F-F67080BF5910,Alive,The University of New South Wales,University of North Carolina,Australia,Oligodendroglioma,Not available,Not available,Not available,Mar-51,C71.0,C71.0,NO,NO,Complete Remission/Response,10.0,0.16,1.82,7.48,RNA,6CD89CD7-37A1-4F68-AB8F-835A5AEEDF86,Primary Tumor Field,External,2010.0,Alive
s3603,95CE00B3-CFC9-4400-AB07-DE043B39CCCF,TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted.bam,48,495CB006-3042-4F8A-9AFA-9C10415DBB26,4a3d9efe-f24e-4135-8a70-e202651e7a81,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,3EAE6B68-D333-4B36-9E70-D2BED19C1DFA,Alive,University of Pittsburgh,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,28.0,0.15,1.9,52.7,DNA,,,,2009.0,Alive
s15860,CD487E10-60AE-4CEF-918F-645E906FA626,UNCID_2657495.52dcc378-3f64-4baa-9721-bf760d8fbe47.sorted_genome_alignments.bam,69,52DCC378-3F64-4BAA-9721-BF760D8FBE47,3203d0ae-5fe9-4ff2-be0a-1d97f7684819,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,ECFA2AFF-9EBC-4246-8EE0-DEF546A024EF,Alive,Emory University - Winship Cancer Inst.,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,N1,Stage III,Mar-70,C06.0,C06.0,NO,YES,Progressive Disease,30.0,0.18,1.84,78.16,RNA,678A1DFA-F5CD-4C5A-944C-57012A76D9A2,Regional site,External,2013.0,Alive
s2569,B87ECCCD-209B-49BC-B49A-5C999D3DE4D2,UNCID_2435224.339a77f4-cb59-48bd-b342-370018be15f2.sorted_genome_alignments.bam,56,339A77F4-CB59-48BD-B342-370018BE15F2,ef273fe6-aab0-41eb-94f7-cca980bf789e,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,E9C18A21-A583-4031-80D6-4ABC8C67FC28,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-90,C48.0,C48.0,NO,YES,Not available,30.0,0.18,1.82,15.23,RNA,,,,,Alive
s728,3FD7815C-7E65-4C0C-97DC-63637C282D4F,UNCID_2635800.0c6c8f2a-c7e0-4310-9440-d21e00a28167.sorted_genome_alignments.bam,35,0C6C8F2A-C7E0-4310-9440-D21E00A28167,0bd2551f-4060-43b2-bee3-956e7e09db31,,Testicular Germ Cell Tumors,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-TGCT,Illumina HiSeq,Testis,WHITE,HG19,Primary Tumor,C4B91B29-081F-4C52-BEE4-E2A3FDDC9EAC,Alive,University of Ulm,University of North Carolina,Croatia,Not available,T1,NX,Stage IA,Mar-61,C62.9,C62.9,NO,NO,Not available,30.0,0.16,1.84,34.84,RNA,,,,,Alive
s10712,202036B5-E6DA-415A-8CCA-C825B6B61BA6,UNCID_1208091.38574f35-5845-4a7d-8657-da3d8757a0eb.sorted_genome_alignments.bam,74,38574F35-5845-4A7D-8657-DA3D8757A0EB,96d93e23-bb0d-46a8-9685-5ed0d6b83059,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,F6E030DC-ED9A-43C5-8D47-BF2F039E780D,Alive,Washington University - Alabama,University of North Carolina,United States,Lung Bronchioloalveolar Carcinoma Nonmucinous,T4,N0,Stage IIIA,Mar-52,C34.3,C34.3,NO,,Not available,32.0,0.14,,36.2,RNA,,,,2010.0,Alive
s15024,D6E0AC58-2714-4EC6-AB9D-A68B0079669E,_1_TCGA-D7-6519-01A-11R-1802-13_rnaseq.bam,64,0561FB66-FE14-45CC-AEEA-0E7E2955CC81,e37cae9e-0656-4b89-b326-739a5cc859e0,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,FA7426E1-FCFB-4B08-AD50-1D9E903A81FB,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Adenocarcinoma  Diffuse Type,T2,N1,Stage IIIB,Mar-45,C16.0,C16.0,NO,,Not available,34.0,0.15,1.8,184.2,RNA,659B8763-1226-49D0-8ED4-E5BDB14548E6,Distant site,EXTERNAL BEAM,2010.0,Alive
s5652,357F4990-50FB-4380-B3C7-B33D812406F5,UNCID_1122117.05329e4e-6623-4044-9abf-46f3ed4ccfd8.sorted_genome_alignments.bam,40,05329E4E-6623-4044-9ABF-46F3ED4CCFD8,5ea18514-51ad-4844-abea-15e82f0b10c9,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,644C9A14-09DA-4382-A6D1-DCE67F25A4FF,Alive,Roswell Park,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T1c,N1mi,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.75,67.97,RNA,FB33C7DC-7439-4DE4-B8CE-2F122C0D2BB8,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s13120,01249B8C-2E9E-4CEA-B39A-485863AB231A,UNCID_2153922.9abef075-5168-4a66-9826-fd61c94b8f6d.sorted_genome_alignments.bam,64,9ABEF075-5168-4A66-9826-FD61C94B8F6D,c83d38fc-e011-4f75-a100-96513611f3e9,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,69EF3E70-5D7A-4E30-ABDE-0F9F76EA3141,Alive,BLN - Baylor,University of North Carolina,United States,Colon Adenocarcinoma,T4b,N1a,Stage IIIC,Mar-40,C18.7,C18.7,NO,NO,Complete Remission/Response,30.0,0.17,2.23,24.87,RNA,,,,2011.0,Alive
s11521,B892DDC3-EB23-4527-95AA-B4B4513F3C11,UNCID_1898118.a49c5cb5-9a31-456d-b55d-904081633729.sorted_genome_alignments.bam,63,A49C5CB5-9A31-456D-B55D-904081633729,12c27db5-db2f-48dc-a2ca-9557b951f43e,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,A5BFF681-5B9E-4D3E-93D8-B7AE8F2FD233,Alive,Washington University - NYU,University of North Carolina,United States,Lung Acinar Adenocarcinoma,T3,N1,Stage IIIA,Mar-50,C34.3,C34.3,NO,YES,Not available,31.0,0.16,,30.2,RNA,411DC29A-8C31-4E66-8FF5-0A8675FA8495,Distant Recurrence,External,2012.0,Alive
s13054,D9241234-3C11-425B-BF16-E235084E70DA,UNCID_1595647.9d737cc8-0854-4559-ab65-b43485ddc035.sorted_genome_alignments.bam,63,9D737CC8-0854-4559-AB65-B43485DDC035,6f2b5a14-569c-4084-8c67-b1a44d787897,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,A09ABC20-4F93-4130-A23A-8413E6C32FE5,Alive,Indivumed,University of North Carolina,Germany,Colon Mucinous Adenocarcinoma,T3,N0,Stage IIA,Mar-80,C18.0,C18.0,NO,,Not available,110.0,0.15,1.73,239.76,RNA,,,,2009.0,Alive
s4769,94E31842-D1E3-47AD-BEE2-70890B17580F,6e7789618e7259fb52cad2908f02f68b.bam,59,C75CC75A-7496-420F-B526-EA63C77E9839,bd4284a7-260d-48b3-9b48-a1c578c30d27,669.0,Uterine Corpus Endometrial Carcinoma,Not available,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,33C21DCA-F3B3-48CD-9FC5-AD316598F23E,Dead,MSKCC,Washington University School of Medicine,,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.08,1.95,43.84,DNA,,,,2004.0,Dead
s15988,8F38B02A-6734-4130-82EE-65CEC0D27E05,UNCID_2197108.de1e3b30-f266-466c-919c-719e1284cbae.sorted_genome_alignments.bam,60,DE1E3B30-F266-466C-919C-719E1284CBAE,a3f98e70-7050-46cf-a679-ca7a83f4442f,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,B477DFB8-C039-49D5-9A0E-912946DC3AD1,Alive,University of Pittsburgh,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,N2b,Stage IVA,Mar-70,C32.9,C32.9,NO,NO,Complete Remission/Response,30.0,0.15,1.96,46.51,RNA,387EE71E-16F8-4BFD-B1D3-729A607CC7A8,Primary Tumor Field,External,2011.0,Alive
s3612,D4203E0E-C16E-4638-A239-378FFED98124,TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted.bam,60,9667EB66-775F-4C37-9309-FF73E55D553B,9f751c9d-ad41-4f02-b7f8-12423857d418,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,5BC98578-E4C7-4BE8-89DF-F26AA5D545A9,Alive,Roswell Park,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,30.0,0.14,1.9,59.4,DNA,,,,2009.0,Alive
s1013,CD9E7A66-CC62-44B8-A8C4-B28A85773A37,UNCID_2367134.dd851272-51a0-456c-87e6-b31dcdf4d36f.sorted_genome_alignments.bam,49,DD851272-51A0-456C-87E6-B31DCDF4D36F,3e69514f-78ea-4d70-97e6-12a9016e9bca,,Pheochromocytoma and Paraganglioma,Not available,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,9A62A9B2-E87F-494B-9DE1-227B9108EF46,Alive,Michigan University,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.16,1.85,39.88,RNA,,,,,Alive
s13480,94BCE557-7EE5-4752-A670-834F40999A6D,UNCID_2448655.fbb56fa6-5205-4a92-9154-6f1a3bc6da28.sorted_genome_alignments.bam,55,FBB56FA6-5205-4A92-9154-6F1A3BC6DA28,acd51808-870c-4684-a2de-aa0b058729e1,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,6DE3E241-606B-441E-9185-7E9F1CD1E61B,Alive,UNC,University of North Carolina,United States,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.4,C18.4,NO,NO,Complete Remission/Response,30.0,0.18,1.91,29.96,RNA,,,,2012.0,Alive
s841,342B0B57-EDC5-45AE-9C63-1977C0D382F4,UNCID_2486503.a9b54172-f05b-4d62-9cab-93ca84d23764.sorted_genome_alignments.bam,77,A9B54172-F05B-4D62-9CAB-93CA84D23764,1f5494c4-e26c-4512-96d9-30412b5b32ce,95.0,Pancreatic Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,185C0C7E-B148-43F0-8D44-C7508DBA85DD,Dead,UNC,University of North Carolina,United States,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,NO,Progressive Disease,10.0,0.16,1.79,13.84,RNA,,,,2013.0,Dead
s830,098055AE-878C-4AF6-BEFC-A5DD7B679DA4,UNCID_2445690.6a8e387e-eb2f-49a8-baca-2c81046ad383.sorted_genome_alignments.bam,75,6A8E387E-EB2F-49A8-BACA-2C81046AD383,a9c0f3a1-01eb-4f01-b58a-708b2960e685,,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,944E1C7D-5B7C-4E4C-9FD1-108C937580A0,Alive,University of Chicago,University of North Carolina,United States,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,NO,Complete Remission/Response,30.0,0.18,1.86,33.56,RNA,41A108F4-3679-49D2-B552-5695F2CEB15A,Primary Tumor Field,External,2013.0,Alive
s5281,44CD95F0-9E64-496D-B72D-26118C7C36FC,UNCID_1630988.fcf451be-340a-4479-86ed-d6757d680386.sorted_genome_alignments.bam,61,FCF451BE-340A-4479-86ED-D6757D680386,fe4db898-3a9f-4dff-adcb-7b8c30137350,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,B1645A83-57B7-4357-B977-63A5B6AEE39E,Alive,University of Pittsburgh,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.81,109.59,RNA,,,,2010.0,Alive
s2509,4F4B62B1-02E9-42C1-846C-005977FB0270,UNCID_2415829.cdbe7509-a13b-41de-99b4-a980bc4249bf.sorted_genome_alignments.bam,34,CDBE7509-A13B-41DE-99B4-A980BC4249BF,b61e39f5-f0dd-485e-8e22-d4fdea751f55,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,E36CE5CC-F8B6-47F8-8102-7A18053D3DFC,Alive,Washington University St. Louis,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-40,C49.3,C49.3,NO,NO,Not available,30.0,0.18,1.91,35.45,RNA,2BAE6A6F-007D-48F0-AB2F-7F7AB6080663,Primary Tumor Field,External,,Alive
s9097,F2F48B29-6093-42D6-B24A-9C2E8CFFC833,UNCID_359113.TCGA-BP-4798-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.7.trimmed.annotated.translated_to_genomic.bam,74,E5276782-9AC4-454D-A7B3-72D6C12FBD5D,a5d34ea3-9362-4233-8d9e-1892839179b2,334.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,309083B8-041E-4C3D-BCF2-FA3E4F671C10,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,38.0,0.14,1.8,106.3,RNA,,,,2007.0,Dead
s5174,BC0E4787-4098-4AE2-B5B0-A71DE6740D12,UNCID_617315.ab3e5a04-9d4c-4289-93ed-38dba3e619b2.111103_UNC6-RDR300211_00130_FC_638P5AAXX.1.trimmed.annotated.translated_to_genomic.bam,82,AB3E5A04-9D4C-4289-93ED-38DBA3E619B2,dffc7091-bc27-452c-ad94-1ee214107593,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,B6D24830-0D69-44D7-94CF-7DFDC49E52C4,Alive,Washington University,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.97,52.78,RNA,,,,2008.0,Alive
s6189,1C37723D-A9B2-4A81-BA48-A30E24DC8153,UNCID_1155848.5285c747-0cb2-4f6a-83d8-40e45f8e4f6e.sorted_genome_alignments.bam,45,5285C747-0CB2-4F6A-83D8-40E45F8E4F6E,fb3607eb-858e-4ecd-8477-95140658c6d2,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,BF8EB507-A277-4F3A-A605-313CD37F18B4,Alive,Asterand,University of North Carolina,Ukraine,Infiltrating Ductal Carcinoma,T2,N0 (i-),Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.85,61.12,RNA,1F1A22C3-9307-4C5F-8EA2-A29C7D429E58,Regional site,EXTERNAL BEAM,2011.0,Alive
s17090,DAE90A39-5E5B-4172-AA48-1ECE416CE6EA,UNCID_2326787.811d94b6-2802-44ff-915f-7344886d93bb.sorted_genome_alignments.bam,47,811D94B6-2802-44FF-915F-7344886D93BB,f5de6712-4de4-43de-8eb5-ec2a798c8438,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,D70C86B2-D403-4CB3-A381-076819B5B414,Alive,University of Utah,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,20.0,0.17,1.89,52.82,RNA,,,,2012.0,Alive
s16374,9B6F222E-3C4B-4975-A449-E834967AE058,UNCID_2197035.8be8302a-e3c9-4c70-bf8b-879950269b38.sorted_genome_alignments.bam,68,8BE8302A-E3C9-4C70-BF8B-879950269B38,4cacff9d-cc50-43a5-a227-16923ada7467,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,C205CDCB-CDFF-414E-9BE2-8C53DCCE3BA3,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,N0,Stage II,Mar-70,C06.9,C06.9,NO,YES,Complete Remission/Response,20.0,0.18,1.89,16.56,RNA,,,,2011.0,Alive
s17731,D918CC6C-B397-48FF-8BDC-E71BDE0B11B2,TCGA-61-2012-01A-01R-1568-13_rnaseq.bam,81,929C2BC4-4CEE-4F82-B336-918FE041A588,20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,0BEFD656-457C-4FA2-81C0-6C5A56F70196,Alive,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,135.0,0.13,1.8,487.0,RNA,8FF12E8C-3408-423B-ABB2-27198CD04420,Not available,Not available,2006.0,Alive
s521,8C68DC24-2B02-4D8A-A467-2B9D3FAA1205,UNCID_2585049.193ed19f-a946-40ef-a32a-9d345606dad9.sorted_genome_alignments.bam,59,193ED19F-A946-40EF-A32A-9D345606DAD9,91f67f4e-b8b1-4455-83a6-4d96d04e8ca9,,Thymoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THYM,Illumina HiSeq,Thymus,WHITE,HG19,Primary Tumor,6EDF0A96-A7AD-4733-A63D-379A803E6375,Alive,Thoraxklinik,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-82,C37.9,C37,NO,NO,Not available,30.0,0.17,1.88,74.93,RNA,6C6EC216-2BFC-4C40-B71E-3F427AB2D376,Primary Tumor Field,External,,Alive
s4744,2FBECF5B-E203-46E1-A92B-65A8F674DB52,UNCID_362779.TCGA-A5-A0VQ-01A-11R-A104-07.110209_UNC1-RDR301647_00038_FC_62J3UAAXX.3.trimmed.annotated.translated_to_genomic.bam,62,E8B8FE3E-29FF-4F1A-AF7A-D12B8CD5560D,23489245-48d7-4f19-8a42-e23b1181412b,,Uterine Corpus Endometrial Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,Not available,HG19,Primary Tumor,952CB6A5-7527-470A-978E-EDD44E3A368F,Alive,Cedars Sinai,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.88,102.54,RNA,3B8180B1-6258-46CA-8DF3-19BA5618AB5C,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s10114,69F9C36D-0D35-4B94-AD64-EF3CE2B261C1,UNCID_1072523.b6cbe950-44d8-4da9-ba79-116f25015278.sorted_genome_alignments.bam,65,B6CBE950-44D8-4DA9-BA79-116F25015278,bd15f523-45c4-4d7c-a3cc-4fb56abb0e54,1346.0,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,F9D568B1-6951-4EAF-8867-4C86BDAEAA04,Dead,Mayo Clinic - Rochester,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-70,C34.3,C34.3,NO,,Not available,60.0,0.15,1.8,265.3,RNA,,,,2004.0,Dead
s8591,7D29D050-20CA-4F3B-A5EE-93BD2A20D914,UNCID_1410356.eecd47a0-bde3-438b-b87a-f4e440228579.sorted_genome_alignments.bam,36,EECD47A0-BDE3-438B-B87A-F4E440228579,bbfb5399-8d43-4b75-bf90-23ec142697d7,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,3B1046D1-BC19-4B33-BBC6-64E0C2623E37,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,,Not available,38.0,0.15,1.8,157.3,RNA,D1E69F86-4491-4CBF-B37F-4FA4FF002D45,Primary Tumor Field,EXTERNAL BEAM,2006.0,Alive
s8349,D4F0A4E9-DE7C-498F-89E7-AAD71FB01915,TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted.bam,48,7732E26C-3B82-4D03-A331-82D8088CEB44,5af8ada5-86b5-4832-8a8e-e975ecca5515,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,9E0E239F-CED4-4CF3-BF3C-5EC8224D760B,Alive,Henry Ford Hospital,Harvard Medical School,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.9,C71.9,NO,,Not available,34.0,0.14,1.8,97.3,DNA,,,,2010.0,Alive
s5988,DD3971F6-BE26-420A-B568-6496D2BF6D79,UNCID_1119383.d0705a73-e6d0-4282-82b1-76d44bda242f.sorted_genome_alignments.bam,45,D0705A73-E6D0-4282-82B1-76D44BDA242F,bc0bc70f-c6cf-4dbc-9dc3-8b7bc5f381a4,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,5E429DD7-787C-4E7D-B672-B000B7B57929,Alive,Roswell Park,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N1mi,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.81,48.84,RNA,4215BF0B-2E69-49EA-8801-5539FE4BC44D,Regional site,EXTERNAL BEAM,2009.0,Alive
s17787,B48570B2-DEFC-4265-8866-12D9A8DB3675,TCGA-25-1318-01A-01R-1565-13_GRCh37-lite_rnaseq.bam,54,4D3E0164-1346-4E8E-B478-29BD8B1F1CE5,13319c20-02f6-4b5f-b24f-3d8f4084094c,1064.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,CED18B90-CBCC-4593-9EAF-2D91DAA9D756,Dead,Mayo Clinic - Rochester,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,177.0,0.15,1.8,291.0,RNA,,,,2000.0,Dead
s11374,39C3E7E3-3C7A-4D1B-A755-157EEC616CF9,UNCID_1110404.7b9dc578-8869-4322-a705-bfb9942d9b65.sorted_genome_alignments.bam,59,7B9DC578-8869-4322-A705-BFB9942D9B65,42ca54fc-c1ae-41cd-bca1-7fe9810db460,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,5593F581-3D45-4A4A-A525-BFAE1F4753A0,Alive,Christiana Healthcare,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-40,C34.1,C34.1,NO,,Not available,113.0,0.13,1.8,161.3,RNA,,,,2009.0,Alive
s729,52F6329C-CDC6-4196-A4A0-58952332905C,UNCID_1552290.d6b7779f-a245-48ee-b9a8-2570c023a531.sorted_genome_alignments.bam,57,D6B7779F-A245-48EE-B9A8-2570C023A531,2be42cc2-9b97-4821-afc2-d1e42eb3932d,,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PAAD,Illumina HiSeq,Pancreas,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4F54B5F4-61F6-4102-9F6D-0F5E3DFE090C,Alive,International Genomics Consortium,University of North Carolina,United States,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,NO,Not available,40.0,0.14,,122.2,RNA,,,,2011.0,Alive
s6300,D6C75927-4DC2-4DCA-B9FA-963966475F2A,UNCID_1118385.b908cd1b-b274-4b23-9cd5-b59d93a7a6c2.sorted_genome_alignments.bam,48,B908CD1B-B274-4B23-9CD5-B59D93A7A6C2,e8614b7d-132e-4b4e-b1ae-df8bb4f2d4d4,,Breast Invasive Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,ASIAN,HG19,Primary Tumor,142D082F-444C-4384-97C0-BBC78E228470,Alive,University of Miami,University of North Carolina,United States,Other  specify,T1b,N1a,Stage IIA,Mar-24,C50.9,C50.9,NO,,Not available,30.0,0.17,1.8,27.64,RNA,,,,2008.0,Alive
s499,AF62DE1C-8E03-433A-8B50-2C2249FDFE8A,UNCID_2579625.31681210-6e61-4d50-a9ce-ef771b0a4c82.sorted_genome_alignments.bam,73,31681210-6E61-4D50-A9CE-EF771B0A4C82,17e2bf75-4ce6-4cd7-94a1-434c5aa36549,,Thymoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THYM,Illumina HiSeq,Thymus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,E7A626A8-6012-4DB5-9286-AC106D3A354B,Alive,MSKCC,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-81,C38.1,C38.1,NO,NO,Not available,30.0,0.16,1.82,58.61,RNA,,,,,Alive
s729,52F6329C-CDC6-4196-A4A0-58952332905C,UNCID_1552290.d6b7779f-a245-48ee-b9a8-2570c023a531.sorted_genome_alignments.bam,57,D6B7779F-A245-48EE-B9A8-2570C023A531,2be42cc2-9b97-4821-afc2-d1e42eb3932d,,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PAAD,Illumina HiSeq,Pancreas,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4F54B5F4-61F6-4102-9F6D-0F5E3DFE090C,Alive,International Genomics Consortium,University of North Carolina,United States,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,NO,Not available,40.0,0.14,,122.2,RNA,,,,2011.0,Alive
s8451,541EAAC9-3C03-4FF8-90BB-D0144B6F8BDB,UNCID_2157136.cb9ff749-d103-418f-b0f3-52ef1f5fcb7d.sorted_genome_alignments.bam,70,CB9FF749-D103-418F-B0F3-52EF1F5FCB7D,76e54ef6-1799-4fd9-bec3-0ea960e8461e,919.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,78A57936-140F-4593-9BF4-30B850247FAB,Dead,University of Florida,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-51,C71.0,C71.0,NO,YES,Stable Disease,30.0,0.18,1.87,43.09,RNA,,,,2007.0,Dead
s1746,A09B6010-B7C7-47A4-B2C3-72E170BA7513,TCGA-L5-A4OJ-01A-11R-A260-31_rnaseq.bam,70,AB6F7E9B-59AE-4053-A1CB-2ACEF360223A,cb419344-6148-43d4-b549-570bd09b3e05,,Esophageal Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,4F03824A-79D6-40E8-A9E0-4079B1209F38,Alive,University of Michigan,Canada's Michael Smith Genome Sciences Centre,United States,Not available,T1,N0,Stage I,Mar-40,C15.5,C15.5,NO,NO,Not available,30.0,0.17,1.9,105.67,RNA,,,,,Alive
s2380,B8CBC4C4-5896-4E8C-9B98-197CE363240F,UNCID_2421808.157bb97b-f1ea-42c9-9ac6-0559b507f1cd.sorted_genome_alignments.bam,51,157BB97B-F1EA-42C9-9AC6-0559B507F1CD,969954a8-7f15-4052-9e6a-c5956115f3ad,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,F6D48B22-8D82-47B0-8D1E-675E235DCA98,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-58,C48.0,C48.0,NO,YES,Not available,30.0,0.16,2.0,18.68,RNA,,,,,Alive
s9986,4B3A769D-1CC8-4F8F-A0D4-E71757FA7664,UNCID_1031606.c291c855-abe4-4805-973f-e29ee22c4667.sorted_genome_alignments.bam,62,C291C855-ABE4-4805-973F-E29EE22C4667,b206617b-90a7-4467-b2ba-2000b2c6992d,2133.0,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,1789441D-1FDF-4F60-9721-9A3F38E2F4CC,Dead,Prince Charles Hospital,University of North Carolina,Australia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T4,N2,Stage IIIB,Mar-71,C34.9,C34.9,NO,,Not available,25.0,0.15,,41.2,RNA,,,,1996.0,Dead
s15089,8A326982-0E0B-4E6A-8143-D88F76689E12,_1_TCGA-CG-5719-01A-11R-1602-13_rnaseq.bam,54,08B05889-938F-47B3-A81E-E3192482C878,263f67e0-0a28-42e6-b3f3-1ddd0d397220,,Stomach Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,GRCh37-lite,Primary Tumor,606573EE-ED11-4DB5-ABAF-E842EC575EEE,Alive,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T4,N0,Stage IV,Mar-44,C16.2,C16.2,NO,,Not available,26.0,0.16,1.7,37.8,RNA,,,,2010.0,Alive
s2444,666B8675-93A4-46C2-A3C0-08D11AB65CD1,UNCID_2524079.bb1cc93d-af4e-4ef6-a787-778af409441a.sorted_genome_alignments.bam,53,BB1CC93D-AF4E-4EF6-A787-778AF409441A,3ed1862b-c6ef-4744-9123-bb1ee557f068,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,AB26B1F4-9062-49E4-B121-28D5F7FC61B6,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-90,C48.0,C48.0,NO,NO,Not available,30.0,0.18,1.92,58.45,RNA,,,,,Alive
s2486,8906CEFC-240D-4590-8D00-1004FA85FD22,459f50a1a35d272785306ecb71cc5754.bam,61,7D332CB1-BA25-47E4-8BF8-D25E14F40D59,2905cbd1-719b-46d9-b8af-8fe4927bc473,,Sarcoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,GRCh37-lite,Primary Tumor,5402D273-3B02-4BF7-A0A4-625A59FED4CC,Alive,International Genomics Consortium,Washington University School of Medicine,,Not available,Not available,Not available,Not available,Mar-58,C48.0,C48.0,NO,,Not available,30.0,0.08,,39.58,DNA,,,,,Alive
s4818,320E7A13-CED8-44D3-B082-54B3AD999B51,UNCID_1610433.c60df680-5bd6-48cc-a112-985f73d9092c.sorted_genome_alignments.bam,67,C60DF680-5BD6-48CC-A112-985F73D9092C,f7e06a10-74ca-4f52-a944-b3f22c016998,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,5B19AF28-1179-42CB-A474-856EF2048D5B,Alive,MSKCC,University of North Carolina,,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.14,1.75,22.19,RNA,6F0EA3FD-FA2D-4F7D-AFC5-E48D6D970A12,Regional site,EXTERNAL BEAM,2007.0,Alive
s2309,B41B6882-7CF8-49C6-AA56-8418D77C24CB,TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina.bam,89,ECF4E05A-0912-4B93-AD66-323002F0C845,0eda7373-8335-455f-b90a-8c3540f28088,,Rectum Adenocarcinoma,Not available,WGS,FEMALE,TCGA-READ,Illumina HiSeq,Colorectal,Not available,GRCh37-lite,Primary Tumor,DA897A5D-B2CC-419F-ACD7-473B4928C5D5,Alive,Indivumed,Baylor College of Medicine,Germany,Rectal Adenocarcinoma,T3,N0,Stage II,Mar-40,C20.9,C20,NO,,Not available,134.0,0.14,1.9,750.21,DNA,,,,2005.0,Alive
s801,57885BDA-B654-42DF-B7BB-717B4553E599,UNCID_2270073.2e691339-21b8-452d-a399-41247febd91f.sorted_genome_alignments.bam,64,2E691339-21B8-452D-A399-41247FEBD91F,6c0ea771-ea86-4db6-994a-2372b2b8f536,,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,08FC3507-8072-4FBB-A39E-46B0D51BA8D0,Alive,Alberta Health Services,University of North Carolina,Canada,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,,Complete Remission/Response,30.0,0.15,1.89,13.01,RNA,,,,2012.0,Alive
s13861,139416A7-DC49-4687-8340-754CF3114A7F,UNCID_258818.TCGA-AA-3543-01A-01R-0826-07.100603_UNC3-RDR300156_0007_61MM1AAXX.6.trimmed.annotated.translated_to_genomic.bam,84,33080658-BEBD-43B2-A4A1-0BE6ADBDE3A5,912b61a1-6a5b-451c-b753-9c3dac03e8cb,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,A12A7D70-CE5F-4F6D-8EAD-D17BA92431F5,Alive,Indivumed,University of North Carolina,Germany,Colon Mucinous Adenocarcinoma,T2,N0,Stage I,Mar-80,C18.2,C18.2,NO,,Not available,177.0,0.16,1.8,593.3,RNA,,,,2008.0,Alive
s4957,6FA097BC-2EFB-4253-83B0-0BE75D0ED9C4,UNCID_568044.4f4a8bd9-c07f-4930-8600-349ab60a37a7.110921_UNC6-RDR300211_00125_FC_634F4AAXX.2.trimmed.annotated.translated_to_genomic.bam,76,4F4A8BD9-C07F-4930-8600-349AB60A37A7,9205c164-7975-421a-90c3-edfe8def595c,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,62BFF77E-4FE6-4A9F-A867-345584608E7D,Alive,Roswell Park,University of North Carolina,United States,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.17,1.83,40.03,RNA,4D7C686B-7C92-4697-8556-D0817AAA93BB,Primary Tumor Field,IMPLANTS,2007.0,Alive
s13335,8007347A-D0EC-4CDF-A418-EB6051E782EB,UNCID_270366.TCGA-AA-3858-01A-01R-0905-07.100902_UNC7-RDR3001641_00025_FC_62EPOAAXX.8.trimmed.annotated.translated_to_genomic.bam,67,E60B2B3B-CFFB-408C-AE50-019B8DEBCD15,44c2854e-3f8c-48e1-b4d5-1b5778d4fce4,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,5EE6076C-F966-4B12-96FB-3A9B198122D9,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T2,N0,Stage I,Mar-40,C18.9,C18.9,NO,,Not available,136.0,0.15,1.8,442.3,RNA,,,,2009.0,Alive
s8853,7C056281-C224-4529-B0B9-D25C74D47AD2,UNCID_1164948.be4dfdf4-4e70-4117-9037-a6cf3e0faa0d.sorted_genome_alignments.bam,63,BE4DFDF4-4E70-4117-9037-A6CF3E0FAA0D,beef6a78-a57c-46f1-8f4e-6899f0ba2c6d,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,378583C9-EA75-481A-A545-E449F94D7873,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T2,NX,Stage II,Mar-10,C64.9,C64.9,NO,,Not available,33.0,0.14,1.7,49.8,RNA,,,,2004.0,Alive
s9202,285B10D1-8FCE-4245-ACF2-008F00884DC6,UNCID_1184284.c850962f-dc1f-413d-b438-39ad283e9cf9.sorted_genome_alignments.bam,32,C850962F-DC1F-413D-B438-39AD283E9CF9,5f53ace3-14ca-412a-af6c-98d8996f8177,571.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,454BB055-43D0-4F2B-A196-E5595BC654C6,Dead,Mayo Clinic - Rochester,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,28.0,0.14,1.8,58.8,RNA,,,,2004.0,Dead
s2826,30C77F2F-8285-4948-9496-8947FE1A2FFF,UNCID_2512540.347ce226-e621-4492-a821-c990b5ef4ff3.sorted_genome_alignments.bam,78,347CE226-E621-4492-A821-C990B5EF4FF3,95520295-90d3-4b4e-86b6-4bd856723315,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,E02F0582-9183-4E63-BFD5-48F7C1565DAF,Alive,Spectrum Health,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,Not available,Stage II,Mar-20,C67.9,C67.9,NO,NO,Complete Remission/Response,30.0,0.15,1.87,83.93,RNA,,,,2013.0,Alive
s9820,338FC37B-3E4B-4920-BE45-F3DCCF24F0F9,UNCID_1200883.cc541704-0f6c-413e-8049-77eaba992844.sorted_genome_alignments.bam,53,CC541704-0F6C-413E-8049-77EABA992844,7664c241-b369-4d76-9cd1-7f2bdc1d267f,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,068BFE4D-341C-49F7-B7A9-5D070DE00AB3,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,35.0,0.15,1.8,81.3,RNA,9EC9D019-02FE-428D-8F18-DE0CE7480F2E,Distant site,Not available,2002.0,Alive
s6664,6BDC6DB5-DDCB-4737-8D5B-34FD6573D7E2,UNCID_1128492.2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6.sorted_genome_alignments.bam,74,2D51AE30-4C8A-4C99-B216-FC4FBDA0FBB6,dbb2da92-99dd-400c-bc05-e87d7273656c,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,0EDB299D-861A-4141-9D5C-132D8C970547,Alive,Roswell Park,University of North Carolina,,Infiltrating Ductal Carcinoma,T1c,N2a,Stage IIIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,1.85,32.1,RNA,BD169F79-61EA-4201-866C-A99BFEB0CFC4,Primary Tumor Field,EXTERNAL BEAM,2008.0,Alive
s2563,DB0DF686-9F2A-467F-A6B2-A24488C35F8D,UNCID_2428934.f5968e01-320d-4ad7-844c-4fe139aa44b7.sorted_genome_alignments.bam,60,F5968E01-320D-4AD7-844C-4FE139AA44B7,f75d2589-fd7b-49a1-a1c8-0b4726b81f3c,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,46E59502-D5DF-428B-BEEF-6AD1439B86C6,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-58,C48.0,C48.0,NO,,Not available,30.0,0.16,1.9,7.53,RNA,,,,,Alive
s2698,CAC436D2-B3CB-4351-953E-084C7A431F0F,TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.bam,76,4BAD319F-9A5F-4257-863A-BCD8ED983EFE,cb664eef-be6f-44ef-aa90-6f6da0e6440a,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19_Broad_variant,Primary Tumor,29D79B83-FA80-490E-A8A1-C51C9AD061FE,Alive,University of Pittsburgh,MD Anderson - Institute for Applied Cancer Science,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3a,N3,Stage III,Mar-20,C67.2,C67.2,NO,NO,Stable Disease,30.0,0.15,,55.89,DNA,,,,2011.0,Alive
s18050,F1E0EA59-9BD1-49E0-9630-27B1C8D02EEE,TCGA-25-1324-01A-01R-1565-13_GRCh37-lite_rnaseq.bam,74,790C6D79-9F7D-4E9A-89DB-43B26FE16816,c73244fd-d486-439f-a94f-fb0bd4e9ac8f,1035.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,FEDFB74C-A7CD-4900-BDCB-93BDBD095C89,Dead,Mayo Clinic - Rochester,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,116.0,0.15,1.8,507.0,RNA,,,,2001.0,Dead
s2274,F201731A-19A5-4272-A4D4-FB13EE793A50,UNCID_265274.TCGA-AG-3593-01A-01R-0821-07.100914_UNC8-RDR3001640_00029_FC_62HPTAAXX.7.trimmed.annotated.translated_to_genomic.bam,72,BD33FAFA-9922-4EFE-9E1D-C8D8F6B8E7CC,10290e91-9784-4f94-8daa-b5d9a8b0efb9,,Rectum Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,EFFCA0F1-E81D-47CD-8287-392A2B6AB786,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C19.9,C19,NO,,Not available,146.0,0.17,1.8,483.3,RNA,70576A03-AF1B-4F84-B629-6F9D88A70FAC,Primary Tumor Field,External,2007.0,Alive
s10951,CA82AC75-7C70-4863-9930-5AF6CE5361FC,UNCID_1378742.47b76d43-afa5-4540-b129-64c997d726b4.sorted_genome_alignments.bam,42,47B76D43-AFA5-4540-B129-64C997D726B4,dc9eaaa0-0bfd-46d0-994f-310826879da4,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,35300581-D122-4221-814E-801512DF4984,Alive,Washington University - Cleveland Clinic,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T2a,N0,Stage IB,Mar-55,C34.2,C34.2,NO,,Not available,40.0,0.15,,69.2,RNA,,,,2011.0,Alive
s2038,A4DC3AD3-1851-468C-9E53-29E2F56D91A9,UNCID_1617956.83330c6e-b606-4646-809c-cc2af3c03a23.sorted_genome_alignments.bam,57,83330C6E-B606-4646-809C-CC2AF3C03A23,19e46a3d-18c5-4927-8501-2265e2d617b8,,Rectum Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,EEC9C9E3-6CB3-4589-B3A8-EA2337878599,Alive,Indivumed,University of North Carolina,Germany,Rectal Mucinous Adenocarcinoma,T3,N1,Stage III,Mar-80,C20.9,C20,NO,,Not available,30.0,0.17,1.88,38.08,RNA,,,,2005.0,Alive
s3132,384E33E5-B8E4-4523-9367-17F776AADCBB,UNCID_1106541.6491f391-9704-4249-bc81-d712e755ec74.sorted_genome_alignments.bam,69,6491F391-9704-4249-BC81-D712E755EC74,88a521ce-a5e9-4c6f-83d4-ec36a62fedb6,,Bladder Urothelial Carcinoma,Not available,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,C79F4327-675D-4651-994D-E683096DF9C3,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3b,N2,Stage IV,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.15,1.86,44.99,RNA,,,,2002.0,Alive
s3698,370E6D63-8165-4EB8-BB4F-69B8113D3EA1,UNCID_2136312.18c4e2fd-5696-4577-bd9d-019a402f7c81.sorted_genome_alignments.bam,58,18C4E2FD-5696-4577-BD9D-019A402F7C81,d39d1a49-fcc0-4f2c-9338-df904e7f6a09,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,912D618A-8003-41D6-A0AC-7051B6CCC31C,Alive,Roswell Park,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-50,C61.9,C61,NO,YES,Complete Remission/Response,30.0,0.17,2.02,15.94,RNA,0B360FC8-C6AC-47EF-A777-BD95C91DD297,Primary Tumor Field,External,2007.0,Alive
s15585,84CF634F-3F07-47CF-9299-7DCE8386C001,UNCID_2207482.167ccaf5-2115-4770-9ab7-ec54bb4d5528.sorted_genome_alignments.bam,63,167CCAF5-2115-4770-9AB7-EC54BB4D5528,43b99616-d7b4-404e-8912-4275f8d6dc55,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,0A1C832D-9A37-45AE-9357-EFBCD32C7150,Alive,International Genomics Consortium,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,N2c,Stage IVA,Mar-70,C01.9,C01,NO,,Not available,36.0,0.15,,134.5,RNA,DD0EF94B-DD0D-4D80-8396-23577ABC18D6,Primary Tumor Field,External,2011.0,Alive
s1368,DEF278F8-93EB-4373-A525-98B2CF12AF7A,TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted.bam,45,3B5905A9-4B73-4946-A10B-D3E7ECAFFC7C,b610d391-0c9d-4114-94d6-5e4aa4270122,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,WGS,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19_Broad_variant,Primary Tumor,24BACABF-8C6F-416A-B1F3-B0BAAA2F0AD9,Alive,Gynecologic Oncology Group,MD Anderson - Institute for Applied Cancer Science,United States,Cervical Squamous Cell Carcinoma,T2b,N1,Not available,Mar-71,C53.9,C53.9,NO,,Not available,20.0,0.17,,17.97,DNA,,,,2009.0,Alive
s13625,8C29937E-2954-497D-9148-E93F1DB2723B,UNCID_2304240.cbf0b795-ee73-4508-b82d-aab2b21a4f0e.sorted_genome_alignments.bam,69,CBF0B795-EE73-4508-B82D-AAB2B21A4F0E,cc15469c-7bad-4e86-9da3-ae0c72e9d380,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,A545FB9A-C386-4A80-9A25-660DC4F62904,Alive,MSKCC,University of North Carolina,,Colon Adenocarcinoma,T2,N0,Stage I,Mar-40,C18.0,C18.0,NO,,Not available,140.0,0.15,1.8,266.3,RNA,,,,2010.0,Alive
s2037,F4B9A1B7-4BB5-48BA-B138-EDC5106B76FE,UNCID_1617225.6e3fb6a1-d526-43b3-85f3-d995b5173fe5.sorted_genome_alignments.bam,71,6E3FB6A1-D526-43B3-85F3-D995B5173FE5,f2a8deb2-0e2c-4bbd-8fa1-99b7abb2f3aa,,Rectum Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,A119D591-6E9E-4744-A4B4-7640193B8FFC,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T3,N2,Stage III,Mar-40,C20.9,C20,NO,,Not available,30.0,0.15,1.96,23.21,RNA,,,,2002.0,Alive
s17806,1ABCEA87-E0FF-46AB-9C87-7D9A194637E4,TCGA-09-0366-01A-01R-1564-13_GRCh37-lite_rnaseq.bam,55,CFB1A6E0-F2D8-48BD-9303-FE7BE5276AB7,23771dab-2aab-4d2b-95e2-9af7092cee6b,1757.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,F2E6F90F-6117-406D-8106-2EF4B37E19D2,Dead,UCSF,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C48.1,C48.1,NO,,Not available,,0.19,1.8,269.0,RNA,,,,1999.0,Dead
s17789,0364480D-A994-4778-846C-029E9F906168,TCGA-25-1627-01A-01R-1566-13_GRCh37-lite_rnaseq.bam,73,0FC68715-C7FC-4481-A5BF-68A281F5EC64,cbe3309e-9b7b-4f62-87b5-0f5ed4218ada,394.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,C405E873-8EF5-43F6-8065-830FDB99825D,Dead,Mayo Clinic - Rochester,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,128.0,0.15,1.8,293.0,RNA,,,,2003.0,Dead
s3931,93B110CF-3F4B-4F72-8025-320B77838B0A,TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted.bam,63,83F4BDB9-ED8B-4472-87BB-74C901B1A350,3acd8328-76f7-4f43-9660-394b95748c3d,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,19C87DE2-7936-4277-8AA8-3942D36E7579,Alive,Indivumed,Harvard Medical School,Germany,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,28.0,0.14,1.9,30.7,DNA,,,,2008.0,Alive
s18141,5AF70C1F-43CD-4586-BD19-6143FB914029,TCGA-61-2088-01A-01R-1568-13_GRCh37-lite_rnaseq.bam,51,62FDEA50-F152-4F43-9130-A93079B5E61F,242943fe-1fa0-4a12-8f7e-9c6c4af1194d,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,29D36FC7-E849-42AA-BCC8-2FD9F7C9E24E,Alive,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,111.0,0.14,1.8,53.0,RNA,,,,2009.0,Alive
s16732,AF17C944-EF03-4775-AA32-3B279A76C853,UNCID_2247646.1be67822-b74f-4321-b7b9-2d85032d3ce6.sorted_genome_alignments.bam,61,1BE67822-B74F-4321-B7B9-2D85032D3CE6,010d5817-9a3f-4a06-8643-653116c044ff,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,63552745-EB7F-4948-A552-05B77F645DE4,Alive,BLN - Baylor,University of North Carolina,United States,Hepatocellular Carcinoma,T4,N0,Stage IIIC,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.16,1.84,43.43,RNA,,,,2013.0,Alive
s11722,6BF51EC8-C2EC-490F-8013-203B0F7DB857,UNCID_2193506.dc85f8ca-afc0-4cb5-a776-44721d5dc128.sorted_genome_alignments.bam,64,DC85F8CA-AFC0-4CB5-A776-44721D5DC128,8af42b33-6ab7-4ea0-860d-f3af9177ee2d,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,7E6F9D8D-5E6E-40B1-A674-76F34EFA63D1,Alive,University of Pittsburgh,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1a,N0,Stage I,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.15,2.1,6.92,RNA,,,,2012.0,Alive
s8354,0F660D53-1DAE-499D-8A76-F591E1110ACB,TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.bam,34,036EF90A-EACA-4105-9B7B-74C20BFA0BB9,a0bc5147-d9b4-41fd-8df3-a241d23722e8,2433.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,1B3185BF-9DEF-4B13-93F8-02CF3171464A,Dead,Duke,Harvard Medical School,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.9,C71.9,NO,,Not available,32.0,0.14,1.9,57.7,DNA,,,,2000.0,Dead
s1323,945920A7-F607-40E9-BC26-7360A39EAA0E,UNCID_2633275.be0d33e0-2aa6-48bb-b8e3-69259e28f8e3.sorted_genome_alignments.bam,51,BE0D33E0-2AA6-48BB-B8E3-69259E28F8E3,173174f8-9d95-40b0-9f88-a4bf4ccb521b,469.0,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,2CBEA378-8E25-4497-92E7-1230D90BFC70,Dead,Barretos Cancer Hospital,University of North Carolina,Brazil,Cervical Squamous Cell Carcinoma,T2b,NX,Not available,Mar-70,C53.9,C53.9,NO,NO,Progressive Disease,30.0,0.17,1.89,76.32,RNA,1B7A0A2A-F58B-41EE-A01C-82151D987F0F,Regional site,External,2009.0,Dead
s2226,4086114D-6130-4ABA-BFEB-30DF6F112562,UNCID_1796143.7beba335-8982-4dfe-8782-7ec8cbea91ed.sorted_genome_alignments.bam,69,7BEBA335-8982-4DFE-8782-7EC8CBEA91ED,016c9c14-4c88-49f5-a11a-dd4bc282f11e,,Rectum Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-READ,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,09342A83-DEE6-4299-A801-6955550307EB,Alive,MSKCC,University of North Carolina,,Rectal Adenocarcinoma,T1,N0,Stage I,Mar-40,C19.9,C19,NO,,Not available,110.0,0.14,1.8,323.3,RNA,,,,2010.0,Alive
s442,1FE535DF-2230-4B94-8413-6AD8F02C5550,UNCID_2562047.34787f03-da7e-4f3e-b33f-73b1bf51fb74.sorted_genome_alignments.bam,69,34787F03-DA7E-4F3E-B33F-73B1BF51FB74,1c848577-c3a4-4830-abfa-549992172396,385.0,Mesothelioma,Not available,RNA-Seq,MALE,TCGA-MESO,Illumina HiSeq,Mesothelium,WHITE,HG19,Primary Tumor,00718CAF-E2C8-4355-A23D-6B2DEF6B2278,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Not available,T2,N0,Stage II,Mar-52,C38.4,C45.0,NO,NO,Not available,30.0,0.17,1.89,37.22,RNA,523A6250-2D61-4DA2-A41C-FE20DC2585B2,Primary Tumor Field,External,,Dead
s13183,41B8F6A5-58F8-4E97-BBD3-A2587A70E30D,TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam,54,ACCC21A8-D026-40E4-AA2C-C0F998A1D370,80e677b1-5ebe-4069-a1a5-1538ffee6642,,Colon Adenocarcinoma,Not available,WGS,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,Not available,HG18,Primary Tumor,BA6E3333-3651-450E-A6EA-4E47CF0D18BF,Alive,Indivumed,Harvard Medical School,Germany,Colon Adenocarcinoma,T3,N0,Stage II,Mar-40,C18.7,C18.7,NO,,Not available,111.0,0.14,1.9,496.0,DNA,,,,2005.0,Alive
s10398,23891D36-873B-4329-9715-73920B129CD0,UNCID_1066318.c192c13f-7bc1-479f-b2e4-ba64b46b0d68.sorted_genome_alignments.bam,55,C192C13F-7BC1-479F-B2E4-BA64B46B0D68,0d3c11b5-856e-4d41-b94a-b2e32f9c5792,3149.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,43A62DBD-5E29-4BA5-A91E-5033F01F118F,Dead,Johns Hopkins,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-70,C34.3,C34.3,NO,,Not available,101.0,0.14,1.8,247.3,RNA,,,,2000.0,Dead
s15077,3D2DE830-769C-48D0-8EAF-C73BED59D088,TCGA-VQ-A8PF-01A-11R-A414-31_rnaseq.bam,76,70D42C42-4A50-4B43-A988-D39635A4D600,94037c4f-7acc-436b-8433-7213a385539a,76.0,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,GRCh37-lite,Primary Tumor,BB60C40C-00DA-41BA-8965-4788D58C2DE3,Dead,Barretos Cancer Hospital,Canada's Michael Smith Genome Sciences Centre,Brazil,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N3b,Stage IIIB,Mar-11,C16.2,C16.2,NO,NO,Complete Remission/Response,30.0,0.17,1.86,52.55,RNA,,,,2012.0,Dead
s3206,10E2DB17-DA79-4609-8827-C02358250540,UNCID_2400946.73afa387-c132-48d6-82da-26517c161f13.sorted_genome_alignments.bam,63,73AFA387-C132-48D6-82DA-26517C161F13,045fe498-6a07-41ff-9956-dc0fb0483e7f,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,ASIAN,HG19,Primary Tumor,06DFEA18-68E6-460D-A03F-02A92D49C171,Alive,Asterand,University of North Carolina,Vietnam,Muscle invasive urothelial carcinoma (pT2 or above),T3a,NX,Stage III,Mar-20,C67.9,C67.9,NO,NO,Complete Remission/Response,30.0,0.18,1.84,59.86,RNA,721486FE-E1AA-4111-B0B0-4FB3ADB9F277,Distant site,External,2013.0,Alive
s3811,7FEE8465-32E2-4BEF-BD48-102B2534003A,TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted.bam,63,CFC425B3-7570-4FD2-8DB6-611EF4D627DF,5dd69c3e-9a3d-450c-9f10-10b4d6daeeba,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,1FA3E5C2-E415-42FA-AEA3-F6C84959522A,Alive,International Genomics Consortium,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T2a,Not available,Not available,Mar-50,C61.9,C61,NO,,Not available,29.0,0.15,,242.7,DNA,,,,2010.0,Alive
s10045,7D305766-18D1-4FE8-B673-24B6CB971A4C,UNCID_1942476.4a3692a0-d9de-4cd3-9c4a-bbb087aa67c3.sorted_genome_alignments.bam,70,4A3692A0-D9DE-4CD3-9C4A-BBB087AA67C3,45aa07c3-cea4-456e-8000-b4572a2163a8,501.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,F00E664D-4418-4C3E-B904-ABE0D0C91617,Dead,Thoraxklinik at University Hospital Heidelberg,University of North Carolina,Germany,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-70,C34.1,C34.1,NO,YES,Complete Remission/Response,42.0,0.16,,239.2,RNA,,,,2010.0,Dead
s17123,70A76F1E-BD63-4A64-9927-1557A977FB28,TCGA-10-0937-01A-02R-1564-13_rnaseq.bam,44,6392A07A-79E2-4272-ABFE-329D1029BB09,a5030259-cf9c-4a58-8710-b9da8ee59320,608.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,8585D596-4D6B-4F6C-BB46-A2661F9CA05A,Dead,MD Anderson Cancer Center,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,109.0,0.15,1.8,164.0,RNA,,,,2005.0,Dead
s9568,AD992CD4-C4D5-4F87-B721-A2CBDF70F57D,TCGA-CJ-4899-01A-01D-2100-10_Illumina.bam,42,9C181313-5B4C-41C5-9AD5-A5A86FE609AA,900b5f21-e8fb-4a3f-b8e3-ef098716e508,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,ASIAN,GRCh37-lite,Primary Tumor,E2D40747-F751-4CCB-A45C-A60B06046DB1,Alive,MD Anderson Cancer Center,Baylor College of Medicine,,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.16,1.9,109.4,DNA,,,,2006.0,Alive
s1928,13803F59-6F9C-49A1-85CA-4A5C0C216ECC,TCGA-L5-A4OI-01A-11R-A36D-31_rnaseq.bam,79,DF2C969F-190E-4697-AA69-4C5B2B0F7F2B,cb2af13b-cbed-4657-8fd4-fed8db375cba,,Esophageal Carcinoma,Not available,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,1B1CBB34-DA71-4441-B1A1-C936E8F04C73,Alive,University of Michigan,Canada's Michael Smith Genome Sciences Centre,United States,Not available,T3,N3,Stage IIIC,Mar-40,C15.5,C15.5,NO,YES,Not available,30.0,0.16,1.92,88.69,RNA,,,,,Alive
s6739,5E7285CB-E03E-4CDF-8452-C74FAFCFFF93,UNCID_2307144.57728a07-cb68-45d9-ac86-eba57e674e1d.sorted_genome_alignments.bam,88,57728A07-CB68-45D9-AC86-EBA57E674E1D,96f02be7-f2df-483c-8968-a5bd2d887206,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,32915A08-0985-4232-BB08-A4B0850CB11C,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Infiltrating Lobular Carcinoma,T2,N0,Stage IIA,Mar-20,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.82,13.55,RNA,,,,2012.0,Alive
s4204,9E0FA4A3-D9DC-4370-941F-F0A6B34C4D99,UNCID_2314258.06c95ac2-2f97-4200-9a29-a3ff8cce8697.sorted_genome_alignments.bam,64,06C95AC2-2F97-4200-9A29-A3FF8CCE8697,607fd22b-f281-431b-848e-ae01e69567e2,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,46B8D214-DE2F-41CE-95B2-939F0C6450E4,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.16,1.96,22.7,RNA,,,,2013.0,Alive
s6351,55711F8E-BFBE-4352-BD9C-F18AF542A5C7,UNCID_1142709.dc4a013a-c52a-40ef-8aeb-e1163519cdb8.sorted_genome_alignments.bam,50,DC4A013A-C52A-40EF-8AEB-E1163519CDB8,08740d7f-5a5e-4dfa-bd48-7fbf228a7a28,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,5B94A116-7E70-41D4-8C6F-2BAE44E591AA,Alive,Duke,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N1b,Stage II,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.75,16.24,RNA,,,,1996.0,Alive
s15816,722A0148-ECB2-4591-8E76-075C46831FF6,UNCID_1490350.5ccbff06-0d11-4333-a4a1-c554965208e5.sorted_genome_alignments.bam,40,5CCBFF06-0D11-4333-A4A1-C554965208E5,16d52afb-a954-4cb3-b168-c1501208f691,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,736C3C8C-FF9F-4892-860F-04665A1F344B,Alive,Johns Hopkins,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,TX,NX,Not available,Mar-70,C09.9,C09.9,NO,,Not available,38.0,0.15,,277.2,RNA,706A59A9-8351-4463-BA39-DDE93D451064,Primary Tumor Field,External,2010.0,Alive
s1431,DF775BE6-47B1-43FE-B139-9E2CFBA30405,UNCID_2044178.0dadcb32-0c50-4d9b-8112-d4e533e789d6.sorted_genome_alignments.bam,38,0DADCB32-0C50-4D9B-8112-D4E533E789D6,2d34e9a3-298c-4365-b7a1-a507c7f069cd,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,2CAE861C-A035-49E8-9DC9-977F2DA23137,Alive,Asterand,University of North Carolina,Russia,Endometrioid Adenocarcinoma of Endocervix,T1b1,N0,Not available,Mar-80,C53.9,C53.9,NO,NO,Not available,30.0,0.17,1.83,84.53,RNA,,,,2012.0,Alive
s5763,71E7E608-AFD8-4011-849B-CD429A83A4D5,UNCID_2248012.9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126.sorted_genome_alignments.bam,55,9EC15BB0-29A1-4285-8D6B-F9E5FA1B5126,3e637872-f5e5-49d3-bb0d-9c16b8713382,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,E6142F96-4B9B-4691-8E7D-47D36BBDF37F,Alive,Candler,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T1c,NX,Stage IV,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.86,14.97,RNA,D11B1721-EDD8-4F57-98D6-8B5F3BBE1EEF,Primary Tumor Field,External,2013.0,Alive
s8388,6790C3CE-BFC7-4CF4-8403-FF88D4855919,UNCID_1406057.128dd28f-7f33-4fc2-a131-e64adbab6ba8.sorted_genome_alignments.bam,31,128DD28F-7F33-4FC2-A131-E64ADBAB6BA8,152eaa99-05f5-4d30-bfb1-494a9a900e49,2286.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,0F4D8393-18BD-4700-9EEA-E24EE16CF0F8,Dead,Henry Ford Hospital,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,,Not available,36.0,0.15,1.8,149.8,RNA,8C7BE1D2-33FC-44FD-9F85-88FE52CFA913,Primary Tumor Field,EXTERNAL BEAM,1996.0,Dead
s5432,DA871AD9-BE64-4CFA-8DE3-F946F137D697,UNCID_1966755.99e76a2e-9162-4345-9155-cc7267c0325b.sorted_genome_alignments.bam,67,99E76A2E-9162-4345-9155-CC7267C0325B,e31db89c-15ac-45a4-9788-afb339b0f3bc,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,576AB148-2110-4F35-948A-4A0D00B4F48E,Alive,Gynecologic Oncology Group,University of North Carolina,United States,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.16,1.86,87.75,RNA,,,,2010.0,Alive
s4326,ABD36BB8-7885-451C-BA5B-EC270C6D565D,UNCID_199320.TCGA-D1-A15Z-01A-11R-A118-07.110407_UNC6-RDR300211_00095_FC64GJRAAXX.7.trimmed.annotated.translated_to_genomic.bam,72,0CA45A1D-6CDC-48F5-8BDE-633CFD15D687,c5df9142-27f6-4d97-933e-c79ea9199362,58.0,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,7A961C2F-2E7F-4EB0-945B-9F0D59923962,Dead,Mayo Clinic,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.85,111.35,RNA,,,,2008.0,Dead
s6894,021D8468-4CD6-491C-8DAD-D31138B11110,UNCID_2247544.ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182.sorted_genome_alignments.bam,49,FFD6C7C5-D4C4-4EAD-9E55-DE8F6AA62182,7486a2b3-b09f-4e9c-9864-8b51b58d9fb3,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,31E5BC10-074B-4BB2-92F9-D9217C0EFC3B,Alive,International Genomics Consortium,University of North Carolina,United States,Infiltrating Lobular Carcinoma,T2,N3a,Stage IIIC,Mar-20,C50.9,C50.9,NO,NO,Not available,70.0,0.17,1.79,9.15,RNA,,,,2013.0,Alive
s15598,C8DAA1A0-14DD-4DA9-A23F-5F6C8BE686F1,UNCID_2347880.91c99cc3-23be-4cde-8a24-695d5ba5a1d8.sorted_genome_alignments.bam,61,91C99CC3-23BE-4CDE-8A24-695D5BA5A1D8,896e37fa-3a6a-481b-b790-5ee62bbdc9fa,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,285E2354-8EFD-4951-87CF-0E188D11423E,Alive,University of Pittsburgh,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,N2b,Stage IVA,Mar-70,C32.9,C32.9,NO,NO,Complete Remission/Response,30.0,0.18,1.92,55.65,RNA,465C74D8-2ACB-4060-8D6F-99DA14155904,Primary Tumor Field,External,2012.0,Alive
s15050,56BC5079-A9D1-4E7B-8E15-07096E5CB817,TCGA-BR-6455-01A-11R-1802-13_rnaseq.bam,59,E9300CD1-9B13-431A-B91C-833965418EF8,75a29059-4705-4a55-bc3d-f5923b24b358,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,59BD0192-A50B-4672-A17F-4DF138F58988,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N1,Stage IIB,Mar-40,C16.2,C16.2,NO,,Not available,40.0,0.15,1.8,205.2,RNA,,,,2011.0,Alive
s8462,BB39706F-F485-4120-932B-4EDD3550AB6C,UNCID_2276497.c5284e5c-9566-4248-a168-362eb039ffe7.sorted_genome_alignments.bam,21,C5284E5C-9566-4248-A168-362EB039FFE7,2fb951f1-00a0-4caf-ac93-096056e77b1f,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,61314349-61B0-4B96-9A08-10996B56802D,Alive,Cureline,University of North Carolina,Russia,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.0,C71.0,NO,,Complete Remission/Response,30.0,0.15,1.85,11.27,RNA,E60D6F80-BFEF-44DF-B32C-003941DE4C06,Not available,External,2013.0,Alive
s11524,0CCCAF20-6018-453D-B45E-44268E9AE9F9,UNCID_1910459.db1370cf-7ca5-45ed-bba6-751f28e39825.sorted_genome_alignments.bam,62,DB1370CF-7CA5-45ED-BBA6-751F28E39825,3ed05070-6633-4de5-9f72-090f93aa2e4d,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,DB809A73-5E5F-42F2-AB05-89BAC944411D,Alive,International Genomics Consortium,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T3,N0,Stage IIB,Mar-40,C34.1,C34.1,NO,NO,Not available,43.0,0.15,,241.2,RNA,,,,2012.0,Alive
s2949,2E4A31C8-A399-4C60-82DB-2653B3A15C1B,UNCID_1211908.1b08c8c9-5739-409d-9cbc-3b06ad1f60e6.sorted_genome_alignments.bam,80,1B08C8C9-5739-409D-9CBC-3B06AD1F60E6,cce62116-3dcd-400d-ada0-9839ca02466e,99.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,2356F78C-0653-468F-83DB-6CF6107BD259,Dead,BLN - University of Miami,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T4a,N0,Stage III,Mar-20,C67.5,C67.5,NO,,Not available,30.0,0.18,1.78,56.52,RNA,,,,2011.0,Dead
s814,ADF19D5F-8360-4723-AF44-183825423E24,UNCID_2316004.a221ced7-2d41-402a-b066-b1b3d7750fab.sorted_genome_alignments.bam,63,A221CED7-2D41-402A-B066-B1B3D7750FAB,56a1b8ff-a71c-4e5f-9c3c-d8162ff896aa,,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,13B7A6AE-5D87-4FCE-88B8-0C526B6301F1,Alive,Alberta Health Services,University of North Carolina,Canada,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.0,C25.0,NO,,Not available,80.0,0.15,1.83,31.91,RNA,,,,2012.0,Alive
s17720,31D17FDB-B4D6-4EA0-8D1F-29D1FD08E89B,TCGA-24-1544-01A-01R-1566-13_GRCh37-lite_rnaseq.bam,71,83333A5A-DE0B-4D72-B886-E5488C619827,21f6bf91-dfc6-4a59-8b76-88a0f95c7b47,820.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,CF7B9151-6479-41AF-986C-D9DB10E33CA6,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,149.0,0.16,1.8,217.0,RNA,,,,2000.0,Dead
s13852,BAC86D03-D449-4380-928A-BE0C94AC5062,UNCID_1619104.97a8318f-f4a8-4eb6-9984-336d3ed77547.sorted_genome_alignments.bam,57,97A8318F-F4A8-4EB6-9984-336D3ED77547,b079a153-62f9-4026-a2f8-a1390168bbb9,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,WHITE,HG19,Primary Tumor,45DC6D68-BE3D-4955-954C-46BF948054F4,Alive,Christiana Healthcare,University of North Carolina,,Colon Adenocarcinoma,T3,N1b,Stage IIIB,Mar-40,C18.2,C18.2,NO,,Not available,95.0,0.14,1.8,288.3,RNA,,,,2010.0,Alive
s14714,1C1E4A0C-2391-4FF6-B50C-F15EA245FD9E,TCGA-HU-A4G2-01A-11R-A251-31_rnaseq.bam,45,28FA0322-5B05-46FF-913D-738A24CDF255,3b17c66a-34ae-4b10-b907-4464d6d58383,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,C2C1E3D8-056A-4129-BD1C-40F7B88AEED2,Alive,National Cancer Center Korea,Canada's Michael Smith Genome Sciences Centre,Korea South,Stomach  Adenocarcinoma  Diffuse Type,T3,N1,Stage IIB,Mar-45,C16.3,C16.3,NO,NO,Complete Remission/Response,30.0,0.17,1.83,61.71,RNA,,,,2011.0,Alive
s2454,AD92AEB6-C4AA-4130-BD4A-0E710BE4FABD,UNCID_2532768.7deedd8d-0ca5-4866-b609-d9bf903d33c8.sorted_genome_alignments.bam,66,7DEEDD8D-0CA5-4866-B609-D9BF903D33C8,32377dd2-c2a2-44ff-8938-b8cfb35db79c,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,AE587287-A6C6-47B4-AB4D-EC4B9BC59FB9,Alive,Moffitt Cancer Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-90,C49.3,C49.3,NO,YES,Not available,30.0,0.16,1.88,33.67,RNA,AA75E107-B685-43B8-9632-44413A6ACA76,Primary Tumor Field,External,,Alive
s8877,D63C2284-8B75-4078-8B8B-B14EFB1D60FD,UNCID_1181098.3b28157c-86f4-4adf-be89-f28a48196f24.sorted_genome_alignments.bam,51,3B28157C-86F4-4ADF-BE89-F28A48196F24,88e7ce26-5b3f-4e4e-89b7-f706063fc467,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,753F0C0C-AC24-4E17-88F9-516366F7BEB1,Alive,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,32.0,0.17,1.8,44.3,RNA,,,,2006.0,Alive
s10829,8C36F3D3-753F-44FC-9A6E-0D8AD5B3742E,UNCID_1207136.af2f26d9-617a-42f3-a083-352d5e576460.sorted_genome_alignments.bam,53,AF2F26D9-617A-42F3-A083-352D5E576460,0a45f302-5748-48f3-9dc9-66c01843a68e,1379.0,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,2B87B12C-5CA7-4492-A2F6-26F9644E1D5A,Dead,International Genomics Consortium,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T1,N2,Stage IIIA,Mar-40,C34.1,C34.1,NO,,Not available,30.0,0.15,1.8,84.2,RNA,,,,2005.0,Dead
s17756,60DF2D16-67D2-4E8E-A9E9-16F6F6FFD807,TCGA-57-1582-01A-01R-1566-13_rnaseq.bam,50,CB7A4405-B9A5-4E1A-825F-C3EE205C8A90,4ea50685-3b63-440a-b037-597ef2529e7d,731.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,84EE744E-EE7F-46E4-B1BD-40524FFCC902,Dead,International Genomics Consortium,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,126.0,0.15,1.8,494.0,RNA,,,,2006.0,Dead
s8259,C770E65D-FB28-484E-A50B-AC794C8181E8,UNCID_2276267.46154213-1bd9-4de6-b396-bb0016d56bbd.sorted_genome_alignments.bam,29,46154213-1BD9-4DE6-B396-BB0016D56BBD,0c52a842-c220-486e-88de-8a4fec5d6a58,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,73A3916A-1326-4781-B9DD-B866484DFB69,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Astrocytoma,Not available,Not available,Not available,Mar-01,C71.0,C71.0,NO,,Partial Remission/Response,30.0,0.16,1.84,9.66,RNA,,,,2010.0,Alive
s8958,D5FED789-F109-4DDD-A42C-02A23770F4D2,UNCID_394203.4d605da9-57c9-4041-bb4c-af8e4e4eb918.110719_UNC11-SN627_0126_BC01YJABXX.7.trimmed.annotated.translated_to_genomic.bam,71,4D605DA9-57C9-4041-BB4C-AF8E4E4EB918,2ed3296a-5b10-40d8-8af4-90dc031657cd,683.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,2D970196-BEEE-4783-90A1-E313A789DD92,Dead,Fox Chase,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T3b,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,151.0,0.16,1.8,27.3,RNA,,,,2007.0,Dead
s151,96E07261-CE29-4510-9579-D53321B502A2,UNCID_2146368.a70e4d3e-993e-4ab7-95b9-1c52f452ef63.sorted_genome_alignments.bam,61,A70E4D3E-993E-4AB7-95B9-1C52F452EF63,1d5602a7-72e7-4dc6-b2db-2f778fcbf475,,Adrenocortical Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-ACC,Illumina HiSeq,Adrenal Gland,Not available,HG19,Primary Tumor,55EE2B0E-FEFF-4F93-982A-5B64820B7A34,Alive,University of Michigan,University of North Carolina,France,Not available,T2,N0,Stage II,Mar-70,C74.0,C74.0,NO,YES,Complete Remission/Response,30.0,0.17,1.89,75.84,RNA,,,,,Alive
s10277,168867CF-DE30-4B38-B0D6-C0D835B99E9E,UNCID_1069169.002e2fae-9e30-4800-b23e-8f23bd16ad56.sorted_genome_alignments.bam,70,002E2FAE-9E30-4800-B23E-8F23BD16AD56,a355bad1-bb49-4de5-892b-691ed0022d91,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,A75DDE6A-C75D-42C3-A456-DFF0F8D3C960,Alive,Indivumed,University of North Carolina,Germany,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IV,Mar-70,C34.1,C34.1,NO,,Not available,134.0,0.14,1.8,322.6,RNA,,,,2006.0,Alive
s1829,6206CD77-F531-44AE-A2F2-CE890EA0581E,TCGA-JY-A6FG-01A-11R-A336-31_rnaseq.bam,50,0C615C32-FC4C-44F0-AC26-494A8C444532,517738f6-ba1c-43b0-8d68-81a7c34118ea,1263.0,Esophageal Carcinoma,Not available,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,BAB4C3B5-78D5-4FD7-816C-F72886AB2244,Dead,University Health Network,Canada's Michael Smith Genome Sciences Centre,Canada,Not available,T3,N1,Stage III,Mar-70,C16.0,C16.0,NO,NO,Not available,30.0,0.17,1.9,55.83,RNA,,,,,Dead
s5716,207550D7-93B9-416E-A609-C90E96F3C5F6,UNCID_1166781.5a269a43-59a4-4718-878e-1086a07b13ee.sorted_genome_alignments.bam,68,5A269A43-59A4-4718-878E-1086A07B13EE,4e3699da-4367-4a43-9d66-a117d3ad460d,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,41DC8345-7968-42B2-AF20-8501B9D2223D,Alive,Cureline,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N2,Stage IIIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,1.81,25.69,RNA,,,,2010.0,Alive
s13610,76AC367B-3AF4-4020-8681-5A6DC58A4E90,UNCID_1874432.29845441-a5c0-4081-bb42-63c6ff483849.sorted_genome_alignments.bam,87,29845441-A5C0-4081-BB42-63C6FF483849,755d3bde-76c3-45c1-8427-8e4d5d686dc1,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,BFDF3D03-51AA-41EB-93BF-D39FF501A824,Alive,Harvard,University of North Carolina,United States,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.0,C18.0,NO,,Not available,40.0,0.15,1.8,79.2,RNA,,,,2008.0,Alive
s17297,9FDA313B-D2C9-417A-B4A4-FAAD1DCEA416,TCGA-23-1109-01A-01R-1564-13_rnaseq.bam,62,D47E074A-F78E-40C5-8AF4-F737CE010041,7c466a5f-a6b4-4d1a-a0f5-ddcd7ef90ff1,1562.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,146F9463-DE59-4418-9099-2425A6F86A0F,Dead,Cedars Sinai,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,105.0,0.15,1.8,218.0,RNA,9294A1C2-8B3A-40E0-8112-1DD01671610E,Local Recurrence,EXTERNAL BEAM,1999.0,Dead
s13022,C175A01B-EBA5-4C4D-B786-FC9F54A2FA60,TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted.bam,75,D02407DB-AECE-475A-AA3F-00653B1E7BEE,89a6384e-1cea-440b-9f17-d57cb0805174,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG18_Broad_variant,Primary Tumor,CBBD1187-E8F7-4E63-A8E2-3C19863E89F5,Alive,Christiana Healthcare,Harvard Medical School,,Colon Adenocarcinoma,T4,N0,Stage IIB,Mar-40,C18.9,C18.9,NO,,Not available,154.0,0.17,1.9,296.29,DNA,,,,2009.0,Alive
s3339,C701C8AC-6B40-463C-BCBA-55DCD4591EC0,UNCID_1780031.f7df4f7f-cd8e-44ba-b16f-203d6049c4fa.sorted_genome_alignments.bam,65,F7DF4F7F-CD8E-44BA-B16F-203D6049C4FA,917961e2-78ad-4182-9cdb-5efb09808111,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,7F7DE45F-A8CB-4273-82DB-FB3DC7E080A7,Alive,BLN - Baylor,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,N3,Stage IV,Mar-20,C67.9,C67.9,NO,NO,Progressive Disease,30.0,0.16,1.76,27.3,RNA,023BA78F-C50F-4E6A-ABB2-9F1C9BFA1B47,Regional site,External,2012.0,Alive
s4647,5C86FFC2-6982-423B-AD1E-1BC151A2B319,UNCID_1622336.4b998fee-a0c6-4039-824f-e5f43d5a3dbc.sorted_genome_alignments.bam,57,4B998FEE-A0C6-4039-824F-E5F43D5A3DBC,4abbd258-0f0c-4428-901d-625d47ad363a,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,ASIAN,HG19,Primary Tumor,771811E3-740E-42FE-BE9C-FD485997EAAE,Alive,Cedars Sinai,University of North Carolina,,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.16,1.82,72.46,RNA,A26A37C5-87CD-4B45-9568-2246C867381F,Primary Tumor Field,EXTERNAL BEAM,1997.0,Alive
s4131,01D186AB-6289-40DA-9715-4F766DA74B10,TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted.bam,50,9AA32D54-78ED-4DFC-ACA4-E1A88404F791,e27c50e2-2a41-4f8c-9ef8-2bc51fb0c23e,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,37103479-02BD-45E8-95B3-7A4A78523999,Alive,University of Pittsburgh,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,38.0,0.15,1.9,107.7,DNA,,,,2009.0,Alive
s14379,62DE9CF2-E5B7-4220-B619-BFB73C73E543,UNCID_1534597.e50235f8-f8cf-44c8-9d5e-ca5bbbb6291a.sorted_genome_alignments.bam,63,E50235F8-F8CF-44C8-9D5E-CA5BBBB6291A,ea3b5da2-6a12-400c-bf0f-e442f5ec1132,97.0,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,BD8A1623-5006-4E03-9EB7-0C5A6F9E73D0,Dead,Henry Ford Hospital,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,,0.19,1.8,62.8,RNA,1033ACC3-A066-48B3-B2F4-73712DD61E59,Primary Tumor Field,EXTERNAL BEAM,1998.0,Dead
s2317,29BA6453-73FB-4120-807C-544B2CB594A6,UNCID_1585829.ae609da5-fdb5-46d9-be09-46ac7d3f0220.sorted_genome_alignments.bam,69,AE609DA5-FDB5-46D9-BE09-46AC7D3F0220,6bc056f2-f06e-428f-aebc-85b780d880ed,,Rectum Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,983614CA-3D41-4539-A619-948D0D40FC06,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C19.9,C19,NO,,Not available,120.0,0.16,1.8,659.3,RNA,,,,2007.0,Alive
s6143,05E0C39A-3293-4144-B64A-51B287F715C4,UNCID_1124898.28199d71-9111-4763-a07f-66734769bb98.sorted_genome_alignments.bam,90,28199D71-9111-4763-A07F-66734769BB98,7dcf550c-90ce-4f63-aecd-0e46897e2a3e,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,D7E3B628-D5FD-4E79-9C4A-6409330FB8A7,Alive,International Genomics Consortium,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,NX,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.62,38.33,RNA,,,,2009.0,Alive
s18097,FF0682EC-7EFA-41F1-B4E0-A20B3347A8B4,TCGA-13-0919-01A-01R-1564-13_GRCh37-lite_rnaseq.bam,52,36E20DFD-0D88-47BD-BF1F-164E069019D1,45957be6-e4df-4245-acf8-39dfc118ee19,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,7BE971A8-031F-4DC0-A883-E1976F74EB21,Alive,Memorial Sloan Kettering,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,74.0,0.15,1.8,274.0,RNA,,,,2007.0,Alive
s3853,5381A871-6A77-437D-AEC6-92B4542C059C,UNCID_1849089.b7f3a96d-01f8-4ef2-a71d-2c684bd18812.sorted_genome_alignments.bam,59,B7F3A96D-01F8-4EF2-A71D-2C684BD18812,91e249a6-b0b0-487e-9fad-0e9f5798dcae,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19,Primary Tumor,D6520FF3-719D-4953-B5CB-06ED4D02A272,Alive,International Genomics Consortium,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-50,C61.9,C61,YES,,Not available,,0.14,,0.0,RNA,,,,2011.0,Alive
s2621,D0A4DC28-9A6E-4618-82E6-8B87DB174949,UNCID_2605031.f87b447f-041b-4650-b42b-d7bcfd8babe6.sorted_genome_alignments.bam,60,F87B447F-041B-4650-B42B-D7BCFD8BABE6,914df75d-25f5-4b2f-96c7-95861d7dfa30,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,5FF35D01-C4AB-408A-92CB-422AA4B3B4B5,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-05,C49.2,C49.2,NO,NO,Not available,30.0,0.17,1.83,43.15,RNA,E4F3950C-69A3-4CA7-A233-ACDD2E98D19A,Primary Tumor Field,External,,Alive
s6709,6C9F4B0E-D06D-493F-A393-522C70B93968,UNCID_1165299.aaddb80d-7710-4aab-8efc-e84da79f9c68.sorted_genome_alignments.bam,70,AADDB80D-7710-4AAB-8EFC-E84DA79F9C68,03c143e0-d8a1-4d60-a4a3-df0501fc6b6e,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,A3AC21E2-B92B-4597-A870-8444DDC6B4D6,Alive,Asterand,University of North Carolina,Russia,Mixed Histology (please specify),T1c,N2,Stage IIIA,Mar-22,C50.9,C50.9,NO,,Not available,30.0,0.16,1.78,55.37,RNA,,,,2010.0,Alive
s17970,FA8977EB-2FBB-4508-8ABA-1746B03A1D12,TCGA-57-1585-01A-01R-1566-13_GRCh37-lite_rnaseq.bam,57,06DF1324-BC1B-4BC3-BB01-4EF55A5AEEF5,5ed14506-f69a-4da8-9965-72d3270b9f72,53.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,1E9787C4-B4F7-481A-B44D-CF975EC8BFB7,Dead,International Genomics Consortium,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,111.0,0.15,1.8,253.0,RNA,,,,2007.0,Dead
s3193,3F18740B-A227-462D-BBC8-AD913232A35E,UNCID_2245038.791bcd93-c949-49b3-aaa4-4c8af82f5ec1.sorted_genome_alignments.bam,37,791BCD93-C949-49B3-AAA4-4C8AF82F5EC1,faf3c230-c661-4d6e-9b73-2b679bc6deff,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,ASIAN,HG19,Primary Tumor,938C0423-DC2C-4321-861A-56B474358624,Alive,Asterand,University of North Carolina,Vietnam,Muscle invasive urothelial carcinoma (pT2 or above),T2a,NX,Stage II,Mar-30,C67.9,C67.9,NO,NO,Complete Remission/Response,30.0,0.18,1.94,45.62,RNA,,,,2013.0,Alive
s5768,21BD40D3-4431-4FC8-8CFC-3ACAACE0C983,UNCID_2306948.2fb506f2-4b76-4c20-ae45-8939f2e14753.sorted_genome_alignments.bam,48,2FB506F2-4B76-4C20-AE45-8939F2E14753,e8ea576b-eb16-44f7-b241-daefc1375388,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,6F1FC322-359B-49FD-AC0D-CC7626F52604,Alive,Christiana Healthcare,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N1,Stage IIB,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.17,2.13,52.87,RNA,395D4E07-8431-402C-932F-61689DB69B9E,Primary Tumor Field,External,2013.0,Alive
s14898,290C70E9-10F1-4249-8B42-4541B57145CF,TCGA-CD-5799-01A-11R-1602-13_rnaseq.bam,45,80CF7DD0-91A5-484D-9592-12873910F0F1,c991697f-77f9-412a-9bd1-0e47f7387cb2,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,A3180E0E-EB99-49DD-8252-5FEA05A9885F,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T2,N1,Stage II,Mar-44,C16.3,C16.3,NO,,Not available,29.0,0.15,1.7,117.8,RNA,,,,2010.0,Alive
s5975,57A51C24-FBE8-4798-BD84-74F211625742,UNCID_1114541.16fcbaec-f629-4d04-ab61-3f9b782e710d.sorted_genome_alignments.bam,55,16FCBAEC-F629-4D04-AB61-3F9B782E710D,81e32f39-3aa0-468b-87ed-dd2eb6165ddf,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,F2B7091E-ED85-4546-8F11-307154153D31,Alive,University of Miami,University of North Carolina,United States,Other  specify,T2,N1b,Stage IIB,Mar-23,C50.9,C50.9,NO,,Not available,30.0,0.15,1.9,57.15,RNA,,,,2008.0,Alive
s13182,6843FB20-8F01-4121-9E2C-823E5CE9DA98,TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina.bam,81,154F80BD-984C-4792-BB89-20C4DA0C08E0,36eaf209-c332-4321-b6aa-51a3368ecd79,,Colon Adenocarcinoma,Not available,WGS,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,Not available,GRCh37-lite,Primary Tumor,9F9961F0-4EE2-4471-AE4A-A0122D630A28,Alive,Indivumed,Baylor College of Medicine,Germany,Colon Mucinous Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.9,C18.9,NO,,Not available,149.0,0.13,1.9,949.56,DNA,,,,2008.0,Alive
s9330,889FC63D-6D7A-4523-B0CA-1627D579439C,UNCID_1179985.a6fa5999-e4c2-4a09-9ead-8fa79e92ef3c.sorted_genome_alignments.bam,60,A6FA5999-E4C2-4A09-9EAD-8FA79E92EF3C,fdfaf862-46a4-4792-8487-810c6d1f9093,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,1593B8D4-1FBB-42A1-943F-376BC05AF4EA,Alive,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,N0,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,35.0,0.14,1.8,41.3,RNA,,,,2002.0,Alive
s16922,7D525F3F-D59D-46D8-AE1A-460796B2A1BD,UNCID_2310303.fe4a54d5-3270-4b53-a813-159b68764037.sorted_genome_alignments.bam,64,FE4A54D5-3270-4B53-A813-159B68764037,a6c0def6-7649-485a-a679-50dafb5eade5,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,DB785F76-45D8-49B5-AF40-57B01EEBCC1B,Alive,BLN - Baylor,University of North Carolina,United States,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.16,1.86,68.18,RNA,,,,2012.0,Alive
s13489,7C19894C-2896-4FC7-A3DF-C6E54B3D3548,UNCID_264089.TCGA-AA-A029-01A-01R-A00A-07.100810_UNC2-RDR300275_00019_FC_629FEAAXX.8.trimmed.annotated.translated_to_genomic.bam,67,9524EEA3-E02B-4C4A-91F6-9313C00151E6,93ca8937-97c0-4f6e-bdec-66d32f2a7b3d,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,35AAD6CA-2675-42B3-8847-E83F7F840C2B,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N0,Stage II,Mar-40,C18.0,C18.0,NO,,Not available,100.0,0.15,1.72,260.33,RNA,,,,2006.0,Alive
s1845,016144BF-5926-4EBC-83CA-9777BC6A99E4,TCGA-L5-A4OH-01A-11R-A260-31_rnaseq.bam,71,F080EAB0-E8A4-4BC9-9806-1580BC58A679,3fa7fc16-49da-4bf6-90c4-74df5cf68b65,,Esophageal Carcinoma,Not available,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,4029F7BA-1D2D-49B8-A37B-4D4A5D0ACB79,Alive,University of Michigan,Canada's Michael Smith Genome Sciences Centre,United States,Not available,T1,N0,Stage I,Mar-40,C15.5,C15.5,NO,NO,Not available,30.0,0.16,1.92,67.11,RNA,,,,,Alive
s15425,9955B88D-40C2-41CC-B76E-2A5C4FE64B7E,_1_TCGA-BR-4368-01A-01R-1157-13_rnaseq.bam,78,8C87A1A6-301E-4F12-B5F2-3DE6FA9EC658,449bf2be-b20e-4ad0-9ffb-910d83114018,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina GA,Stomach,WHITE,GRCh37-lite,Primary Tumor,87239062-9EA0-4987-AD13-5A2DDED4FF82,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T4,N2,Stage IV,Mar-40,C16.3,C16.3,NO,,Not available,30.0,0.14,1.7,221.3,RNA,,,,2008.0,Alive
s4617,312DD86A-5FC1-4446-BFD6-FE867E3617F2,TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.bam,74,3E67F5BD-C5A6-4CDD-8D71-78038D316447,5c22c8d6-5805-455c-8e1c-e6b8006738e4,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19_Broad_variant,Primary Tumor,CA213835-EFC5-4216-A762-A6B320B516BF,Alive,Mayo Clinic,Harvard Medical School,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.95,56.36,DNA,,,,2009.0,Alive
s15607,280B365A-3459-4FA2-9DAA-644B077065DD,G35155.TCGA-CR-6471-01A-11D-1870-08.2.bam,58,C087E87F-867C-45DD-8645-5AB774E4827C,eda29281-e803-4217-8603-d6a388408611,1202.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19_Broad_variant,Primary Tumor,4F845FB4-4724-455F-88F2-09DE7259A484,Dead,Vanderbilt University,Broad Institute of MIT and Harvard,United States,Head and Neck Squamous Cell Carcinoma,T4a,N1,Stage IVA,Mar-70,C14.8,C14.8,NO,,Not available,10.0,0.05,1.9,90.7,DNA,0B645599-8E25-453E-B8F5-450EC7E699D6,Regional site,EXTERNAL BEAM,2007.0,Dead
s3162,70001088-2486-474F-B1FB-E7C52D2F5AD3,UNCID_1468759.B8AFE780-F680-40DB-A941-E984660FF90C.sorted_genome_alignments.bam,59,B8AFE780-F680-40DB-A941-E984660FF90C,6d8d8169-0c1a-4cdb-be6f-9761c981a369,739.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,491A8898-7CC5-45D9-9502-FD24399C239D,Dead,BLN - University Of Chicago,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T2b,N2,Stage IV,Mar-20,C67.2,C67.2,NO,YES,Not available,30.0,0.16,1.84,37.17,RNA,,,,2010.0,Dead
s4673,CED437EF-87E3-4CE0-80AA-3E658DEA2CA7,UNCID_1635621.954c9805-885f-481a-9dac-024d4481256b.sorted_genome_alignments.bam,54,954C9805-885F-481A-9DAC-024D4481256B,5428c4b2-37c2-4f8c-a474-39fe1aacb26b,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,HG19,Primary Tumor,D9A2756B-472F-4EEE-9D76-91F4320F8A1A,Alive,University of Hawaii,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,20.0,0.16,1.89,52.63,RNA,,,,2004.0,Alive
s5474,6463E302-836B-4097-B6C5-ACF33FE1A733,157ae84a45d89d7cc89e89e59978db47.bam,58,DE2E4F39-3575-48BE-BD36-853F0989D5F2,17c1d42c-cb84-4655-a4cd-b54bae17ecaf,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,GRCh37-lite,Primary Tumor,3A36B403-EA38-49F9-9C28-710C5D141164,Alive,Roswell Park,Washington University School of Medicine,,Infiltrating Ductal Carcinoma,T2,N1a,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.08,1.98,67.88,DNA,597CFDF4-47EE-4CFD-8D2B-66BD1D75DE2B,Regional site,EXTERNAL BEAM,2010.0,Alive
s17780,A0EC7CAE-57AD-4F17-A53B-9F5E2D74E186,TCGA-24-1105-01A-01R-1565-13_rnaseq.bam,36,FD57ADC4-669C-4916-A2F5-E5F92CB0ADB6,7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2,1442.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,AE4AA065-8B1D-42A3-98EF-357E19C1F1E1,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,130.0,0.15,1.8,236.0,RNA,06461927-0E16-4D01-B765-C5F76574560D,Distant Recurrence,EXTERNAL BEAM,2001.0,Dead
s3738,BA1D892D-618E-47D1-BDE9-079A5A7A29E9,UNCID_2519592.66635f8c-2731-4231-9b71-f68f7d5f8072.sorted_genome_alignments.bam,51,66635F8C-2731-4231-9B71-F68F7D5F8072,84a5d5fc-7350-4846-a1bc-8bfadbcff8dc,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,44E15D3B-8CA2-44EE-82A2-1984E6C468F6,Alive,University of Kansas,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N1,Not available,Mar-40,C61.9,C61,NO,NO,Partial Remission/Response,30.0,0.16,1.82,37.86,RNA,D972C8BD-2F87-4158-8583-71831266C65E,Primary Tumor Field,External,2012.0,Alive
s11776,4D9A1F84-A989-4CAA-84D2-36D42C950675,TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina.bam,48,6BA5F81A-B7A0-4C18-A112-2E11094EEC85,71b35cd8-ecee-4599-bb24-b1ef78118423,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-KIRP,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,F3871637-192D-4324-9C59-CECFFF436356,Alive,UNC,Baylor College of Medicine,,Kidney Papillary Renal Cell Carcinoma,T2,NX,Not available,Mar-60,C64.9,C64.1,NO,,Not available,40.0,0.05,1.9,155.07,DNA,,,,2009.0,Alive
s437,2F577068-FD94-4F36-BFA2-392C76576A4B,UNCID_2561934.2efa5115-b02b-4a85-ae82-3054cd3d646a.sorted_genome_alignments.bam,77,2EFA5115-B02B-4A85-AE82-3054CD3D646A,7a92421e-4860-41c7-afd2-fa715357f023,795.0,Mesothelioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-MESO,Illumina HiSeq,Mesothelium,WHITE,HG19,Primary Tumor,F8D015D2-BD96-4F26-93CC-626041EC760A,Dead,University of Pennsylvania,University of North Carolina,United States,Not available,T1a,N0,Stage IA,Mar-52,C38.4,C45.0,NO,,Not available,30.0,0.17,1.9,9.85,RNA,,,,,Dead
s3318,FD90431C-74F3-4369-BEB1-BBE226AF184A,UNCID_1180068.09898301-3dac-4b86-af1b-6cbad9f2d380.sorted_genome_alignments.bam,75,09898301-3DAC-4B86-AF1B-6CBAD9F2D380,74b1e72d-fdd0-4d84-8858-3bb32d58ff7e,579.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,AD4E36CD-0036-4F63-BB06-D32B51ACAC7A,Dead,University of Pittsburgh,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T2b,N0,Stage II,Mar-20,C67.4,C67.4,NO,,Not available,30.0,0.17,1.9,90.13,RNA,,,,1999.0,Dead
s5093,15E265E0-D5D1-473D-92E8-8D47F1CA5C41,UNCID_1636552.a18fa5ae-5c28-426a-a7ae-d0c0b223991f.sorted_genome_alignments.bam,54,A18FA5AE-5C28-426A-A7AE-D0C0B223991F,0da7bbd4-ed8d-474b-b494-cb93c5fa811e,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,D0B88B1C-150D-4ABC-9F9E-8C51CB208EFA,Alive,Duke,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.78,57.66,RNA,,,,2007.0,Alive
s10014,DC5375E0-FF60-4FE8-BE1B-E6648179FD0C,UNCID_1072031.2a016a06-5097-49b5-85b2-8ea5291fed23.sorted_genome_alignments.bam,71,2A016A06-5097-49B5-85B2-8EA5291FED23,1ee543d5-b8c0-4f79-8373-6bb6319f2ee2,,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,75E00DD8-0AD9-4447-9407-0AB6AC0A7173,Alive,Indivumed,University of North Carolina,Germany,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IIB,Mar-70,C34.3,C34.3,NO,,Not available,124.0,0.13,1.8,121.6,RNA,,,,2006.0,Alive
s17270,DCC9C455-35F9-4EE5-AC8F-51BF63332C5B,TCGA-31-1950-01A-01R-1568-13_GRCh37-lite_rnaseq.bam,76,A32EBA80-DBE9-464E-8102-5F77A3C7E177,4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,5CE49570-CE22-4370-9D38-6CF43F808E81,Alive,Imperial College,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,106.0,0.16,1.8,697.0,RNA,,,,2007.0,Alive
s552,166C1DD6-3C1F-46D7-B705-49E7D0054904,UNCID_2599642.9a7ecc8d-e30f-4a87-860a-28b3490f6c3e.sorted_genome_alignments.bam,46,9A7ECC8D-E30F-4A87-860A-28B3490F6C3E,d6b1516a-8271-4071-8c56-d4538de63892,,Thymoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THYM,Illumina HiSeq,Thymus,WHITE,HG19,Primary Tumor,DC349335-C431-44D6-BFBD-BD85388382B8,Alive,Thoraxklinik,University of North Carolina,Germany,Not available,Not available,Not available,Not available,Mar-82,C38.1,C38.1,NO,NO,Not available,30.0,0.17,1.94,45.85,RNA,FFFC703D-2F2F-43A1-97D8-CEFE3EEA6EBC,Primary Tumor Field,External,,Alive
s5889,49E0E9FE-EDF7-4B13-BBE8-68A6823997DA,UNCID_1166750.45fe02d2-5d68-43c4-9cea-7da6e16a55a2.sorted_genome_alignments.bam,54,45FE02D2-5D68-43C4-9CEA-7DA6E16A55A2,dd96a9c7-899c-47cd-a0f9-b149ed07a5d6,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,940D64BD-8C96-476F-84F9-678D1ED3500F,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Infiltrating Ductal Carcinoma,T2,N1a,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.67,15.37,RNA,8B735435-06BF-4F0A-880B-532D5CA6D853,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s15320,E9AEF1AC-F3E2-4621-909C-EB04A4CE9D85,TCGA-CD-A486-01A-11R-A24K-31_rnaseq.bam,68,29F00132-41D9-4592-9193-29135A0F14DB,c63ae423-c90a-4cf4-aa42-653bb8fa3e69,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,49432F7B-44C0-4834-8BDE-BCD9B58AF2F8,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N0,Stage IIA,Mar-40,C16.0,C16.0,NO,NO,Complete Remission/Response,30.0,0.16,1.88,60.7,RNA,,,,2011.0,Alive
s6743,9E546B9E-3E0C-4A79-A18A-227F6CC1C1EB,UNCID_2624941.5e032694-2d7f-4e11-8800-0451ff71e5fe.sorted_genome_alignments.bam,64,5E032694-2D7F-4E11-8800-0451FF71E5FE,49a2fd48-744d-4d88-b9b4-8c778d4f48fd,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,27DAC66A-E5AC-41B4-95E6-4A9F209261EE,Alive,Albert Einstein Medical Center,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T2,N1mi,Stage IIB,Mar-00,C50.9,C50.9,NO,NO,Not available,30.0,0.17,1.92,32.37,RNA,FBDFCCD6-FB33-4827-8C3D-BA9F05070849,Primary Tumor Field,External,2013.0,Alive
s983,AE11FBA8-D0EB-4132-A5D2-509E839415B6,UNCID_2373814.07771c8c-332b-4a93-bb47-10195f148957.sorted_genome_alignments.bam,27,07771C8C-332B-4A93-BB47-10195F148957,2337ed44-c455-4df7-91a3-b30da0e54da4,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,BDDA4C01-744B-42E9-BEBB-65705DB11E58,Alive,Erasmus MC,University of North Carolina,France,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,30.0,0.17,1.98,56.54,RNA,,,,,Alive
s15552,89EDA062-8EA4-49A3-8D91-5E942CB55881,UNCID_1489441.c83939ad-c9eb-4d0e-8b4b-c8ce48f179f5.sorted_genome_alignments.bam,78,C83939AD-C9EB-4D0E-8B4B-C8CE48F179F5,a98263a5-cc90-4734-b6f1-f0108bfd5cac,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,9D258494-FB84-4435-AA3A-F5778AC061C5,Alive,Vanderbilt University,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,N1,Stage III,Mar-70,C05.0,C05.0,NO,,Not available,9.0,0.16,,61.2,RNA,C1BDE7B8-3CA8-42CF-8B7D-9780B69EF553,Not available,EXTERNAL BEAM,2010.0,Alive
s14246,72AE3F88-4088-4D46-B964-C9D794B19252,UNCID_1543376.2de8f5dd-decd-47f4-856a-bda678ee6ab8.sorted_genome_alignments.bam,62,2DE8F5DD-DECD-47F4-856A-BDA678EE6AB8,be3a7ef3-34ed-40e1-9d9c-187940596b26,480.0,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,3190BD1A-A83A-45F6-959A-863BBAE58FFE,Dead,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,126.0,0.16,1.8,37.7,RNA,90C706ED-D200-4FC6-ABCE-234746F7AD78,Primary Tumor Field,EXTERNAL BEAM,2008.0,Dead
s9284,92ABD11D-D3BA-4743-B005-F5A8FE6FC8EE,UNCID_462160.97b82ef4-290b-418c-a69d-f447d58686bb.110823_UNC10-SN254_0269_AC019UABXX.7.trimmed.annotated.translated_to_genomic.bam,43,97B82EF4-290B-418C-A69D-F447D58686BB,c4247ccb-8201-428e-a2e7-b5104f095588,,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,CB781DCC-029A-4497-86F7-69960412D6DE,Alive,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,32.0,0.16,1.7,27.13,RNA,,,,2006.0,Alive
s5336,A44AB124-96D9-43A8-8B81-7E516EC28EE9,UNCID_258120.TCGA-AP-A0LO-01A-11R-A040-07.101105_UNC5-RDR300700_00033_FC_62J7BAAXX.1.trimmed.annotated.translated_to_genomic.bam,45,E563CFB5-6904-45C6-ACBB-AC96BFB9770B,a081da6f-51f3-4555-a6b8-736f8c6cda39,1016.0,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,9846D8F3-5B22-48E9-B972-A0FE9F509FB4,Dead,MSKCC,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.14,2.02,124.86,RNA,ED646923-A759-4AE3-A882-C6928015194F,Local Recurrence,EXTERNAL BEAM,2005.0,Dead
s13078,FCF06999-D4B2-4C97-9049-68BB1A40DDDB,UNCID_1794644.e11b286b-e614-4ab3-8ad0-002a183dcb94.sorted_genome_alignments.bam,48,E11B286B-E614-4AB3-8AD0-002A183DCB94,aedde4a5-6520-40b9-9721-c9b826490b7a,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,0C749AE7-1564-4ADE-847F-376D21D1753B,Alive,MSKCC,University of North Carolina,United States,Colon Adenocarcinoma,T2,N0,Stage I,Mar-40,C18.2,C18.2,NO,,Not available,33.0,0.14,1.7,147.8,RNA,,,,2010.0,Alive
s11841,C8B147C2-33F3-45DE-A994-DE32372F477C,UNCID_2580954.fc64c379-1064-4bcd-a40e-305f2da1f1f7.sorted_genome_alignments.bam,62,FC64C379-1064-4BCD-A40E-305F2DA1F1F7,72cc3423-d214-4035-b934-0d4e4b806b6c,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,E490028C-E8F6-4C5D-AE9C-274334A8E86C,Alive,University Hospital Erlangen,University of North Carolina,Germany,Kidney Papillary Renal Cell Carcinoma,T1b,NX,Not available,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.18,1.92,55.48,RNA,,,,2007.0,Alive
s14132,6D3C4B54-8835-4363-8061-76F445FE531B,G17809.TCGA-06-5410-01A-01R-1849-01.4.bam,72,39580733-5FF1-43A1-B9FD-53B6F6E879BD,884f867b-4a8b-4b67-8fe4-ab3f068be84e,108.0,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,D1CBA561-6232-49D9-B0EA-46465EB75AFA,Dead,Henry Ford Hospital,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,136.0,0.15,1.8,33.2,RNA,,,,2010.0,Dead
s128,56F4D95C-64BC-489D-8764-B4BE0113DA2A,UNCID_2143442.d5597a19-f3ff-431b-85ba-d2f306fe2fab.sorted_genome_alignments.bam,14,D5597A19-F3FF-431B-85BA-D2F306FE2FAB,c4dd9501-c193-45fb-8535-a9d901520bdd,662.0,Adrenocortical Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ACC,Illumina HiSeq,Adrenal Gland,WHITE,HG19,Primary Tumor,3515D365-BE8A-496B-80D1-ABBDAF0F23F1,Dead,University of Michigan,University of North Carolina,Germany,Not available,T2,N0,Stage II,Mar-70,C74.0,C74.0,NO,YES,Not available,30.0,0.17,1.83,41.74,RNA,,,,,Dead
s15240,1EB9A50A-4C25-4D26-8B2C-563C1145A9EF,TCGA-CD-5813-01A-11R-1602-13_rnaseq.bam,60,B7C6631D-3A86-467F-A895-04D3B84759A2,152b9d8a-19fd-4665-b9e4-4fedfb1608cd,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,09E42E33-D2EC-406C-9A42-36D9D2EBD6C6,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach Intestinal Adenocarcinoma Mucinous Type,T3,N0,Stage II,Mar-80,C16.2,C16.2,NO,,Not available,33.0,0.13,1.8,30.0,RNA,,,,2010.0,Alive
s4419,4139F46D-AE94-47A2-A3AE-0B96262C6A89,TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted.bam,51,6BBEF031-7106-4D36-86A9-F8A2333448BB,284174fd-1320-4617-9e99-75bd75df9bf3,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19_Broad_variant,Primary Tumor,986AC6AC-087F-412B-BB0C-9BE10D104989,Alive,Cedars Sinai,Harvard Medical School,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.93,112.95,DNA,8937842E-0220-460C-9041-3196F24DA0A8,Primary Tumor Field,IMPLANTS,2009.0,Alive
s8021,EF8B8B6F-6812-446B-B27C-03DB8997900D,TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted.bam,64,77937F29-C94F-4251-A0AB-9D07DED92796,a9eb1022-ffd3-42de-a39d-2126fc7ec0ce,,Skin Cutaneous Melanoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-SKCM,Illumina HiSeq,Skin,WHITE,HG19_Broad_variant,Primary Tumor,239F69F7-E78A-4B09-BF00-E521F63A3BB4,Alive,University of Pittsburgh,Harvard Medical School,United States,Not available,T4b,N0,Stage IIC,Mar-44,C44.7,C44.7,NO,NO,Not available,30.0,0.17,,32.16,DNA,,,,2007.0,Alive
s1548,161D8430-426D-462D-B2BD-F12AE11F6199,UNCID_1668690.d7954ccb-a03f-45cb-a059-88fc217cb753.sorted_genome_alignments.bam,55,D7954CCB-A03F-45CB-A059-88FC217CB753,b7f2958f-256e-4c30-9c61-11e76ddb36ba,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,59F1684E-5631-4E1E-A1DC-91739F7C159C,Alive,International Genomics Consortium,University of North Carolina,United States,Endocervical Type of Adenocarcinoma,T2b,N0,Not available,Mar-40,C53.9,C53.9,NO,,Not available,20.0,0.15,1.72,13.68,RNA,9BCCD6FE-0399-4A33-8513-3E34602D415C,Primary Tumor Field,External,2011.0,Alive
s901,6BAB93EF-6D58-479C-8D30-804CBD135401,UNCID_2635552.f333abf0-a807-459c-8477-b1858510908d.sorted_genome_alignments.bam,74,F333ABF0-A807-459C-8477-B1858510908D,6a4e10b6-e6c4-4210-ae4d-0d8e8d0cb3ec,,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,60FF16B8-4C68-45B1-864B-39818F6DDE5C,Alive,Cureline,University of North Carolina,Russia,Pancreas-Adenocarcinoma Ductal Type,T3,N0,Stage IIA,Mar-00,C25.9,C25.9,NO,NO,Complete Remission/Response,20.0,0.17,1.85,26.73,RNA,,,,2013.0,Alive
s10489,FF8B4399-4CCC-4136-AB0F-7206E0C43AEB,UNCID_2542925.b9b42bfa-2222-4d21-a163-02f767c4db38.sorted_genome_alignments.bam,57,B9B42BFA-2222-4D21-A163-02F767C4DB38,b9fc1fcf-17dc-496c-a072-7664382bc9bb,826.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,FF206E85-427C-4BA2-8ACB-A1D603E9C02F,Dead,Johns Hopkins,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-70,C34.1,C34.1,NO,YES,Progressive Disease,30.0,0.17,1.83,33.93,RNA,,,,2000.0,Dead
s8531,FDC7BAB5-C807-4791-BE95-6A588E86A4B8,G35154.TCGA-HT-7602-01A-21D-2086-08.4.bam,21,88395C0E-4AFE-434D-8B20-5A3EEF8B7F00,799e9106-e62e-4681-8861-137f474ee8b8,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,0997BB1A-F0A4-4CB8-9714-5BAF9C391CE8,Alive,Case Western - St Joes,Broad Institute of MIT and Harvard,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.9,C71.9,NO,,Not available,38.0,0.05,,15.13,DNA,,,,2008.0,Alive
s3510,21D0FFE2-02EB-4C54-88F7-08D1CE2C5AAD,UNCID_2044229.32e41154-dbcb-474c-8605-67c0ae0ed85e.sorted_genome_alignments.bam,57,32E41154-DBCB-474C-8605-67C0AE0ED85E,8bfac5b9-fa2b-4b6e-9537-e9d8a2f0d1dc,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,5706AD0B-6D7F-45B3-B6CF-E2D766FEC9A9,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-40,C61.9,C61,NO,NO,Complete Remission/Response,30.0,0.16,1.86,50.42,RNA,,,,2012.0,Alive
s11782,6EAE65C7-1A89-44C9-A3C5-B7AF6D633F1B,TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina.bam,57,DDDEA2E4-B8C3-4157-9D92-6DE472E8375A,45bdcfd6-1e3f-4be8-b843-ae949e8e43eb,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,4306E07D-6FC1-4C69-ACB8-00A1DC78CAD8,Alive,BLN - Baylor,Baylor College of Medicine,United States,Kidney Papillary Renal Cell Carcinoma,T1a,NX,Stage I,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.08,,34.1,DNA,,,,2012.0,Alive
s17860,A5A38B79-004D-49DE-860D-9425560503BB,TCGA-61-2101-01A-01R-1568-13_GRCh37-lite_rnaseq.bam,55,95970BDB-E1F2-49DC-903B-C30088CEF71D,5d1a54fe-e0df-4c17-b623-b649a136dc82,1688.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,46D32513-DC68-4261-8E1B-26D407B6546A,Dead,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,141.0,0.15,1.8,378.0,RNA,2E12C990-CD4B-46FC-A84C-C6F3478884E1,Local Recurrence,EXTERNAL BEAM,1999.0,Dead
s13290,29CB7B55-D0DB-47EC-9B32-68A079393A9B,UNCID_2033464.9b00f3e1-6d27-47d6-b9ce-1389db097741.sorted_genome_alignments.bam,54,9B00F3E1-6D27-47D6-B9CE-1389DB097741,264c0d45-078a-4207-a101-71f99bcd237e,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,69125F72-2011-4B8A-A450-1EAE83B74266,Alive,Roswell Park,University of North Carolina,United States,Colon Adenocarcinoma,T3,N1,Stage IV,Mar-40,C18.7,C18.7,NO,,Not available,33.0,0.17,1.7,106.2,RNA,,,,2006.0,Alive
s13640,CEE8F283-1A06-49CD-957B-D440D5498E7C,UNCID_339908.TCGA-A6-2671-01A-01R-1410-07.110309_UNC3-RDR300156_00080_FC_62J42AAXX.2.trimmed.annotated.translated_to_genomic.bam,85,9515A5BC-B9BC-4333-9E95-D8740283BEE8,565e2726-4942-4726-89d3-c5e3797f7204,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,WHITE,HG19,Primary Tumor,81505915-6C01-4299-AE89-964DC20D93CB,Alive,Christiana Healthcare,University of North Carolina,,Colon Adenocarcinoma,T3,N2,Stage IV,Mar-40,C18.7,C18.7,NO,,Not available,131.0,0.14,1.8,400.0,RNA,,,,2009.0,Alive
s8728,14E33E97-C34E-49A8-B83D-7BBCF83A999F,UNCID_2400738.c44e9cfc-d595-4098-b55b-8275d7284f05.sorted_genome_alignments.bam,46,C44E9CFC-D595-4098-B55B-8275D7284F05,739cc9f1-71be-4f81-a5d1-eda673903e45,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,5C88E117-AC37-49A9-A3D9-A1059B6A3671,Alive,University of California San Francisco,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-50,C71.0,C71.0,NO,NO,Not available,30.0,0.17,1.88,15.12,RNA,,,,2012.0,Alive
s9589,2AAE162B-1941-42AE-99C1-60E2BF32E084,UNCID_1174653.08489083-0870-4546-a53f-c4064952b690.sorted_genome_alignments.bam,74,08489083-0870-4546-A53F-C4064952B690,a22d5ba2-5f11-49e9-911a-ec03b785fae5,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,9DDC30EF-891D-4BFC-A1DF-D5A2539B4376,Alive,UNC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,37.0,0.13,1.6,43.8,RNA,,,,2010.0,Alive
s4028,7605B0B9-A68B-4926-AFEC-0262E7867D5C,UNCID_1417309.51d276c8-e669-48c9-92d8-676a348249d5.sorted_genome_alignments.bam,57,51D276C8-E669-48C9-92D8-676A348249D5,ae3a0c92-148d-4f1c-8563-06ac1050f53e,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19,Primary Tumor,F32F7738-BAD4-40C9-B49F-084BB098A05A,Alive,University of Pittsburgh,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3a,N0,Not available,Mar-50,C61.9,C61,NO,,Not available,30.0,0.16,1.8,191.8,RNA,,,,2009.0,Alive
s5697,6BB53038-F5AA-429C-B3E1-B2B10FE8E9BD,UNCID_1148622.28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825.sorted_genome_alignments.bam,48,28F9B0D6-8B8F-4DD6-8A7D-73CDD374A825,18d35983-ea6a-4b70-a209-9bef37595956,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,C0819744-0DAD-4597-B9AC-9117497418A8,Alive,Walter Reed,University of North Carolina,,Infiltrating Ductal Carcinoma,T1c,N0 (i-),Stage IA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,1.76,40.41,RNA,B73451CC-DAA2-4F73-BF06-517DDECD777F,Primary Tumor Field,EXTERNAL BEAM,2007.0,Alive
s8408,168D96CB-BFFB-42F7-93B4-4324CF947BE0,UNCID_1652471.2d0cb65e-cd71-431a-9eaa-9e0844446d63.sorted_genome_alignments.bam,58,2D0CB65E-CD71-431A-9EAA-9E0844446D63,b027ab77-70eb-4877-91a3-702064d9cc8b,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,F83775F2-6DAF-4397-8E5C-A8D9F8D8C762,Alive,Case Western - St Joes,University of North Carolina,United States,Oligoastrocytoma,Not available,Not available,Not available,Mar-82,C71.0,C71.0,NO,,Not available,46.0,0.14,,26.2,RNA,,,,2008.0,Alive
s6343,962185F5-9925-4297-A1AF-66CD3935BC87,UNCID_1144002.c1dc3f35-324b-4a69-b32c-24652ccf9e3a.sorted_genome_alignments.bam,52,C1DC3F35-324B-4A69-B32C-24652CCF9E3A,13b860c3-8048-4dc9-9eb0-7480bc660837,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,78FEB5BE-F9D1-4CC6-BABA-274136B9487C,Alive,Cureline,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N0,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.14,1.81,29.65,RNA,,,,2010.0,Alive
s10488,FC33FEBB-508B-41B2-A4C2-41F1CD404C18,UNCID_2536813.c86cac86-41e9-453c-9de5-83d506990256.sorted_genome_alignments.bam,59,C86CAC86-41E9-453C-9DE5-83D506990256,a57414a5-fcdb-47b5-b07e-edc7dc460783,1114.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,68788942-0AF1-4C4A-9F7B-D53A13AB7C68,Dead,Johns Hopkins,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-70,C34.1,C34.1,NO,NO,Complete Remission/Response,30.0,0.17,1.92,23.18,RNA,,,,1998.0,Dead
s9755,AF54CBA8-DE75-42FD-A5E9-911E349851C1,UNCID_1169707.03b6775f-bf45-48ac-96f6-19d3173cb4f4.sorted_genome_alignments.bam,42,03B6775F-BF45-48AC-96F6-19D3173CB4F4,2309c424-26fa-4cc6-a22a-2dc0f989af59,646.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,03D973C5-E0CE-42EA-AFD7-9BE4F93A3BD1,Dead,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,39.0,0.14,1.6,11.3,RNA,9C5284C8-CEB9-4C60-A1A1-6F84715A88EE,Distant site,EXTERNAL BEAM,2005.0,Dead
s17782,29A90986-214F-4B69-9E9C-DBEC35AC010A,TCGA-24-1431-01A-01R-1566-13_GRCh37-lite_rnaseq.bam,67,0E968ED4-9FBD-482B-B91D-CE7190DC91ED,384170fc-e8be-426a-a54e-bf1ca61f2986,567.0,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,44F5F2B7-94AC-4BBD-8CA8-BB5BE4B0FBDB,Dead,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,176.0,0.16,1.8,490.0,RNA,,,,1999.0,Dead
s8953,2C6D0B50-C233-4FB2-BD84-D7615E16188B,UNCID_373198.TCGA-A3-3351-01A-02R-1325-07.110429_UNC14-SN744_0106_AB066TABXX.5.trimmed.annotated.translated_to_genomic.bam,42,A22EB94B-5118-4EEA-85F2-B0343112AF62,ee7011e7-f692-410a-ba35-efe1ec75cf8e,,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,AEB15066-810D-427C-A227-8111F36A793B,Alive,International Genomics Consortium,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T2a,N0,Stage II,Mar-10,C64.9,C64.9,NO,,Not available,38.0,0.15,1.8,191.0,RNA,,,,2007.0,Alive
s14516,4280DAD4-5402-49F9-878F-D850867AC98B,_1_TCGA-CD-8525-01A-11R-2343-13_rnaseq.bam,82,21DB6663-DEF9-49C6-9184-4479AAD5D6F1,39acb803-f282-422e-ac56-a3a50693d203,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,31B67C28-869B-44AC-90FE-9F0FFFA22DF1,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach Intestinal Adenocarcinoma Mucinous Type,T3,N1,Stage IIIA,Mar-80,C16.3,C16.3,NO,NO,Complete Remission/Response,39.0,0.15,,330.2,RNA,7D8E0F66-A896-48EF-BE99-A6ECAB38BA07,Regional site,External,2010.0,Alive
s10217,136A9424-9AE1-4C61-A192-B4F3EAAC917B,UNCID_1914402.25361c46-91f3-4b7b-80e0-ef8576ce00c1.sorted_genome_alignments.bam,76,25361C46-91F3-4B7B-80E0-EF8576CE00C1,a3583ffc-adb9-40f5-8ec5-8a4f6f432220,116.0,Lung Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,D227591F-C1B2-43F9-B83D-75499119C55C,Dead,Christiana Healthcare,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N1,Stage IIB,Mar-70,C34.2,C34.2,NO,,Not available,15.0,0.15,1.6,55.2,RNA,,,,2008.0,Dead
s16458,A2E11203-6535-4452-A01E-3E183E87AF63,UNCID_1709110.9e634d59-f421-4a8c-b840-21fd612de48f.sorted_genome_alignments.bam,42,9E634D59-F421-4A8C-B840-21FD612DE48F,f1c1502e-1bd6-425a-b651-454363809668,,Kidney Chromophobe,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KICH,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,05CC0766-7ED0-458E-B1D7-732B632C05A4,Alive,Harvard,University of North Carolina,United States,Kidney Chromophobe,T1a,NX,Stage I,Mar-17,C64.9,C64.9,NO,NO,Complete Remission/Response,41.0,0.15,,219.2,RNA,,,,2006.0,Alive
s11874,CEBCEED4-ED2A-4B65-A10F-3119EC7653D3,UNCID_1215851.f2d8ec72-3f79-4cc4-9999-935bc74d7f72.sorted_genome_alignments.bam,54,F2D8EC72-3F79-4CC4-9999-935BC74D7F72,91a605b2-929a-44ce-8522-2ff793ddf82f,658.0,Kidney Renal Papillary Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,Not available,HG19,Primary Tumor,5A9C4D75-5FA7-4806-8CC6-73717D1378F0,Dead,MSKCC,University of North Carolina,,Kidney Papillary Renal Cell Carcinoma,T3b,N0,Stage III,Mar-60,C64.9,C64.1,NO,,Not available,36.0,0.16,1.8,150.8,RNA,,,,2007.0,Dead
s16819,417998E0-73D1-4DE3-937B-640D2AC25C57,UNCID_2307045.914e6f58-48b5-40aa-9336-69166bd6970b.sorted_genome_alignments.bam,65,914E6F58-48B5-40AA-9336-69166BD6970B,87aa894e-7676-40b7-9557-6541446d8cea,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,00C2EEB7-B822-4DBD-A127-98AAD0C0F184,Alive,Alberta Health Services,University of North Carolina,Canada,Hepatocellular Carcinoma,T3b,N0,Stage IIIB,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.18,1.91,77.86,RNA,,,,2012.0,Alive
s16255,9A6D8FDB-6459-4217-9779-5D69FCA7ECC6,UNCID_1495601.f58d967f-8e2d-420b-9171-5e42dda50a34.sorted_genome_alignments.bam,64,F58D967F-8E2D-420B-9171-5E42DDA50A34,93b742eb-5fc3-4ce2-b7f6-c89f97e0dcc9,560.0,Head and Neck Squamous Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,54DCB9AC-FD35-49C2-A790-B1F016160183,Dead,MD Anderson Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,NX,Stage II,Mar-70,C14.8,C14.8,NO,,Not available,34.0,0.15,,94.2,RNA,,,,1997.0,Dead
s2815,F2BFF01D-6463-47B5-B4FA-1317BDC23E1B,UNCID_2491058.f4159732-6dd2-4614-b3e2-3a528fdfa527.sorted_genome_alignments.bam,60,F4159732-6DD2-4614-B3E2-3A528FDFA527,45eea556-e97b-4912-8aa9-7e5c709eb52b,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,61CF45DC-21EC-40A3-A72B-3EDD21895F6B,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3b,N0,Stage III,Mar-20,C67.2,C67.2,NO,YES,Complete Remission/Response,30.0,0.16,1.9,46.72,RNA,742059E9-ABF9-432B-A8FA-98AD2F6B979C,Local Recurrence,External,2000.0,Alive
s4903,0E77D667-6CDD-4C92-A341-626CEE93F080,UNCID_2090194.eb279337-8251-4442-905c-8a4be743f057.sorted_genome_alignments.bam,72,EB279337-8251-4442-905C-8A4BE743F057,5f764ac1-3de7-4cfd-a77a-d21baa418834,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,Not available,HG19,Primary Tumor,AC5073EA-51CF-466C-9B31-1D4FBB86F998,Alive,University Health Network,University of North Carolina,Canada,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.17,1.8,68.28,RNA,07E9B737-1DB7-4DF2-93AB-54BF56E18CB2,Not available,Not available,2011.0,Alive
s8489,A845160D-7623-44B6-A134-0C8FE847F031,UNCID_2340134.0c179490-c0fc-4ac1-abdb-f5256abf1ef6.sorted_genome_alignments.bam,58,0C179490-C0FC-4AC1-ABDB-F5256ABF1EF6,75dbc8fb-4db8-4764-824c-eccf3a223884,1578.0,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,0834A667-9692-43C9-8CD9-1DC222F658B9,Dead,Duke,University of North Carolina,United States,Oligodendroglioma,Not available,Not available,Not available,Mar-51,C71.0,C71.0,NO,YES,Stable Disease,30.0,0.18,1.91,37.11,RNA,4719F477-586A-4B29-B269-81F7EFB15653,Not available,External,2000.0,Dead
s14900,86EE8777-A18D-4761-B219-C389F82913E5,TCGA-CD-A4MH-01A-11R-A251-31_rnaseq.bam,86,388A263A-0700-4CBF-9435-580D00C5D589,23451ab5-a32b-4eec-9b8b-fd282282a0d4,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,50B06504-B835-4F19-A9AA-9F04F4ED11BE,Alive,ILSbio,Canada's Michael Smith Genome Sciences Centre,Vietnam,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),T3,N0,Stage IIA,Mar-45,C16.3,C16.3,NO,NO,Complete Remission/Response,30.0,0.17,1.9,43.49,RNA,428EDD00-5339-4570-BEA5-B3499A463791,Regional site,External,2011.0,Alive
s15973,5A0F1F4E-A78C-4BB9-BC71-23227CC3C033,UNCID_1500155.01f32254-9fcb-4d33-981c-39ee63af2fee.sorted_genome_alignments.bam,50,01F32254-9FCB-4D33-981C-39EE63AF2FEE,fb7672f9-5dab-4204-a137-c5fb84903892,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,CD1E5E88-5CA3-4F15-AE99-33457222C03B,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T2,N1,Stage III,Mar-70,C02.9,C02.9,NO,,Not available,27.0,0.15,,149.2,RNA,,,,2008.0,Alive
s1399,C4B7ED28-8B3D-4F4E-A2C0-551504321AA2,UNCID_1662336.6252138d-526e-4ed4-8369-7d6e4bde3fbe.sorted_genome_alignments.bam,53,6252138D-526E-4ED4-8369-7D6E4BDE3FBE,36605f5f-245c-41e5-a9db-705373da7923,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,ASIAN,HG19,Primary Tumor,11A01213-E1C4-4F74-B9C8-736D3E68EE62,Alive,University of Hawaii,University of North Carolina,United States,Cervical Squamous Cell Carcinoma,T1b1,N0,Not available,Mar-70,C53.9,C53.9,NO,,Not available,30.0,0.16,1.81,59.99,RNA,,,,2004.0,Alive
s454,1A037FD2-9F95-470B-8D80-221B5920AAB0,UNCID_2552632.97e5882f-3128-4459-a965-ad78ac2a80b5.sorted_genome_alignments.bam,47,97E5882F-3128-4459-A965-AD78AC2A80B5,3f19d238-1b55-4530-a9e2-8fda644d45a6,,Thymoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-THYM,Illumina HiSeq,Thymus,WHITE,HG19,Primary Tumor,1836DAAB-B521-40FB-8C0E-1222C12D9297,Alive,MD Anderson Cancer Center,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-83,C37.9,C37,NO,NO,Not available,30.0,0.17,1.87,60.58,RNA,,,,,Alive
s15585,84CF634F-3F07-47CF-9299-7DCE8386C001,UNCID_2207482.167ccaf5-2115-4770-9ab7-ec54bb4d5528.sorted_genome_alignments.bam,63,167CCAF5-2115-4770-9AB7-EC54BB4D5528,43b99616-d7b4-404e-8912-4275f8d6dc55,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,0A1C832D-9A37-45AE-9357-EFBCD32C7150,Alive,International Genomics Consortium,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T3,N2c,Stage IVA,Mar-70,C01.9,C01,NO,,Not available,36.0,0.15,,134.5,RNA,DD0EF94B-DD0D-4D80-8396-23577ABC18D6,Primary Tumor Field,External,2011.0,Alive
s1811,3EE40366-0F7A-4E3B-AF4B-E2B72F3DF2B8,93ea360c5937eacd6158ad8b9e05acb3.bam,63,F932DD2C-EAC3-40B3-9C43-387B8965D65D,0c78b1b5-f480-45ad-a253-19297bc886b4,,Esophageal Carcinoma,Not available,WGS,MALE,TCGA-ESCA,HiSeq X Ten,Esophagus,WHITE,GRCh37-lite_WUGSC_variant_2,Primary Tumor,B11F1BF7-3546-4F3C-872F-A4A910D910E7,Alive,University of Michigan,Washington University School of Medicine,United States,Not available,T1,N1,Stage IIB,Mar-40,C15.5,C15.5,NO,NO,Not available,30.0,0.08,,26.16,DNA,,,,,Alive
s74,CCDE6C06-1822-464A-BE1E-F55FC0B40329,UNCID_2138107.08dbecd4-ba05-4d62-b76c-62fddccdb167.sorted_genome_alignments.bam,62,08DBECD4-BA05-4D62-B76C-62FDDCCDB167,3af5b391-e72f-463d-a086-a86c6c30a51a,,Uterine Carcinosarcoma,Not available,RNA-Seq,FEMALE,TCGA-UCS,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,FAFB2550-3101-45B8-BFCD-4550EB031621,Alive,MSKCC,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-50,C55.9,C55,NO,NO,Complete Remission/Response,20.0,0.15,1.85,76.54,RNA,50A768E7-F985-4B88-BAE4-AEC794E8469A,Primary Tumor Field,Internal,,Alive
s8304,28201641-BBEE-46C5-87C9-45403691B5E5,UNCID_2407671.ea214bab-dd3f-4594-9c93-e60fa586b3a4.sorted_genome_alignments.bam,37,EA214BAB-DD3F-4594-9C93-E60FA586B3A4,50975570-c0d5-4ee7-9226-40b3db1bde84,,Brain Lower Grade Glioma,Not available,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,Not available,HG19,Primary Tumor,90F1B7E9-D3DA-491F-BC88-CD6025109DC3,Alive,Huntsman Cancer Institute,University of North Carolina,United States,Astrocytoma,Not available,Not available,Not available,Mar-00,C71.0,C71.0,NO,NO,Complete Remission/Response,30.0,0.16,1.81,8.23,RNA,,,,2011.0,Alive
s3198,3092587B-BDCF-4A33-B6BC-DE48591D10E4,UNCID_2305651.f6660fcd-6277-4eb7-8135-5aea56fedd7c.sorted_genome_alignments.bam,77,F6660FCD-6277-4EB7-8135-5AEA56FEDD7C,c80e71b3-7c6c-4e16-8446-6dfda780bc18,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,CB958D50-5538-4F82-987D-3FB103CD75C7,Alive,BLN - University Of Chicago,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3a,N0,Stage III,Mar-20,C67.3,C67.3,NO,NO,Complete Remission/Response,30.0,0.17,1.88,41.66,RNA,,,,2012.0,Alive
s1725,06FF5DA4-68CA-4DC0-AEE5-1714E02592EB,TCGA-IG-A4QS-01A-11R-A260-31_rnaseq.bam,71,8F13389E-3D3B-423F-8A78-0EB9C2373D06,990c6412-6dc0-4dba-a7c1-5bcb3751b1cc,,Esophageal Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-ESCA,Illumina HiSeq,Esophagus,WHITE,GRCh37-lite,Primary Tumor,6844EB62-0BC3-43AA-8C0E-4A1191011500,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Ukraine,Not available,T3,N2,Stage IIIB,Mar-40,C15.1,C15.9,NO,NO,Not available,30.0,0.16,1.85,47.36,RNA,,,,,Alive
s17993,AF4BD3BB-C833-4DA1-B00C-16E2E314EF4F,TCGA-24-1426-01A-01R-1565-13_GRCh37-lite_rnaseq.bam,43,8CD9ABEB-C09E-4281-A8C8-1B426796D51E,c8acee1b-6854-409b-86ab-bf69dbe22ab6,,Ovarian Serous Cystadenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,4A4EC9EB-D594-449B-ADFB-703AC1F25BB5,Alive,Washington University,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,90.0,0.17,1.8,269.0,RNA,,,,2008.0,Alive
s9402,A0248A92-E93E-4C0F-B6F0-885963A87DC7,UNCID_359372.TCGA-BP-4170-01A-02R-1289-07.110506_UNC9-SN296_0178_BC02MGABXX.1.trimmed.annotated.translated_to_genomic.bam,72,BA299DCF-8350-43F9-ABAA-06F7E42C4457,83bdd67b-3dfd-458b-aaa1-5a0b051056e8,2343.0,Kidney Renal Clear Cell Carcinoma,HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,1E225012-A846-4ED3-80A3-CBA2A0513FD9,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T1b,N0,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,30.0,0.14,1.8,10.3,RNA,,,,2003.0,Dead
s14706,8D322C4D-BFDB-40CC-A222-87FF33A87718,TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted.bam,76,86D8A371-57BB-4DC7-9872-0EB4542208DC,cad2adc1-0f41-4651-9c80-ae9961e2dc8d,,Stomach Adenocarcinoma,Not available,WGS,MALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,HG19_Broad_variant,Primary Tumor,3E5D09C6-8F98-4701-BD24-FCA581343DE8,Alive,Indivumed,Harvard Medical School,Germany,Not available,T3,N1,Stage IIB,Mar-55,C16.9,C16.9,NO,,Not available,40.0,0.14,1.9,128.2,DNA,,,,2010.0,Alive
s5506,8B5A9CC8-22E6-4EE5-882F-1B6349B52472,UNCID_1122280.1d8ecbae-6996-4d9d-bff8-ac761a8309ea.sorted_genome_alignments.bam,34,1D8ECBAE-6996-4D9D-BFF8-AC761A8309EA,b3354b72-2637-4edc-9a95-e55801d3ac13,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,ASIAN,HG19,Primary Tumor,6E7092AA-E92C-4D9B-8ED1-F8C32F39FE80,Alive,ILSbio,University of North Carolina,Vietnam,Infiltrating Ductal Carcinoma,T3,N3,Stage IIIC,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,1.8,41.1,RNA,,,,2010.0,Alive
s5414,8AF5DF1B-1F26-4CB3-B61F-6B27C6D6C209,UNCID_1609801.cc57fe2e-2370-4697-828f-eee51aacbe0b.sorted_genome_alignments.bam,56,CC57FE2E-2370-4697-828F-EEE51AACBE0B,60fcf50a-8598-475d-8dd0-6b3044661233,,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,90A221E7-8579-4AF2-9B39-40DE3C42F71C,Alive,MSKCC,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,2.17,126.48,RNA,,,,2005.0,Alive
s15134,DC3430F2-6090-4BC6-8EC0-21718B256EE1,TCGA-D7-8576-01A-11R-2343-13_rnaseq.bam,54,A9A69F94-128A-453F-819E-20C6A7E43091,ec8268c7-943d-451a-9036-f0196078b6c5,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,28BD43CF-A80C-495D-A4FF-E4F57B6D4970,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Intestinal Adenocarcinoma  Tubular Type,T3,N3a,Stage IIIB,Mar-11,C16.3,C16.3,NO,NO,Complete Remission/Response,36.0,0.13,,281.7,RNA,FA44E53B-C4D3-4326-9339-CFF8275DE044,Not available,External,2012.0,Alive
s6384,8BDE02C6-CDFF-4899-B99A-B1327CC34164,UNCID_1166667.07ac0536-240f-46be-9909-a8af1a22e2b8.sorted_genome_alignments.bam,51,07AC0536-240F-46BE-9909-A8AF1A22E2B8,c65b835a-2d38-4250-a173-0780d2c2cf58,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,558C43AD-12AD-42DD-94B2-80A607465FCB,Alive,Asterand,University of North Carolina,Russia,Mixed Histology (please specify),T2,N0,Stage IIA,Mar-22,C50.9,C50.9,NO,,Not available,30.0,0.17,1.83,38.33,RNA,,,,2011.0,Alive
s7884,CCB9A741-F796-4E1F-9FF5-23522FFCEBA9,UNCID_1214881.132fbce2-00f3-4ae7-ba18-03bd55529d5a.sorted_genome_alignments.bam,48,132FBCE2-00F3-4AE7-BA18-03BD55529D5A,27c9e7aa-1760-4cfc-95b0-a091d35d317b,,Skin Cutaneous Melanoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SKCM,Illumina HiSeq,Skin,WHITE,HG19,Primary Tumor,74A436C7-F7BA-4F98-BB12-D90B29C9DF68,Alive,Asterand,University of North Carolina,Russia,Not available,T4b,N0,Stage IIC,Mar-20,C44.9,C44.9,NO,NO,Not available,30.0,0.16,1.8,14.65,RNA,,,,2010.0,Alive
s13999,47C9FA81-F657-4A02-874C-5016CFB1FAA5,UNCID_1540654.67068dc6-6270-4e7b-a857-3008dadc2d59.sorted_genome_alignments.bam,45,67068DC6-6270-4E7B-A857-3008DADC2D59,d1547b99-3c96-4c62-8261-5111bcf860a9,,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,DE0CAAB5-1C9B-4826-A666-C024935BE29D,Alive,Henry Ford Hospital,Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,59.0,0.14,1.8,65.1,RNA,C3280EC5-7FDC-4DD6-991A-5D0C06FE3E11,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s13866,B2AD057E-5587-44D3-BB4E-55785037A9AB,UNCID_269023.TCGA-AA-3520-01A-01R-0821-07.100730_UNC2-RDR300275_00017_FC_629JTAAXX.3.trimmed.annotated.translated_to_genomic.bam,86,C4356A34-5215-4703-9671-D7CE0D83CF9D,5f1399ef-8100-49e7-806f-9f532e55c0ba,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,E00BA2F0-AA08-4FE7-8868-59AFFD52EEC5,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N0,Stage II,Mar-40,C18.2,C18.2,NO,,Not available,101.0,0.15,1.8,618.3,RNA,,,,2007.0,Alive
s18137,B10A3723-6E75-45C4-87D5-559DCA63051E,TCGA-31-1953-01A-01R-1568-13_GRCh37-lite_rnaseq.bam,52,7B31FC47-0299-4449-AA5B-622BA549371F,61feee94-3ac9-42fe-aaa3-dc6a3efe563c,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,ASIAN,GRCh37-lite,Primary Tumor,0918328B-5726-4429-A7DC-BB4D4869575B,Alive,Imperial College,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,133.0,0.17,1.8,445.0,RNA,,,,2008.0,Alive
s16721,3FFF4FA1-7002-4BA2-8CC6-9928DDC104FC,UNCID_2083531.5bd6ca42-16ca-484f-877f-cda4fb3f93a8.sorted_genome_alignments.bam,67,5BD6CA42-16CA-484F-877F-CDA4FB3F93A8,614c0ecf-6a84-4c86-8706-79be5bb00991,419.0,Liver Hepatocellular Carcinoma,Not available,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,Not available,HG19,Primary Tumor,1EF290A3-D054-4E3A-9683-8F99A2010E3E,Dead,Mayo Clinic - Rochester,University of North Carolina,United States,Hepatocellular Carcinoma,T3b,N0,Stage IIIB,Mar-70,C22.0,C22.0,NO,YES,Not available,30.0,0.16,1.84,64.42,RNA,,,,1998.0,Dead
s13720,2F9B181E-48D8-4085-AA93-D5EECEBA99C5,UNCID_1595798.ae6c345c-c825-4925-b597-816f4819894e.sorted_genome_alignments.bam,70,AE6C345C-C825-4925-B597-816F4819894E,af3a0634-4292-45bd-b948-6b6bd2d58090,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,75A6A64E-11F0-41C8-9CBA-179AE3333621,Alive,Indivumed,University of North Carolina,Germany,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.7,C18.7,NO,,Not available,90.0,0.15,1.66,261.66,RNA,,,,2008.0,Alive
s1578,600FCB5C-0255-4A5D-84E3-E4FA2BC0D873,UNCID_2153634.f7e2e36f-3018-4570-9ed2-f256048a9427.sorted_genome_alignments.bam,45,F7E2E36F-3018-4570-9ED2-F256048A9427,3223fec6-1d35-419a-8ee9-7c5885b8be1e,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,ASIAN,HG19,Primary Tumor,067A2E35-52E4-42E2-9C22-DB555589C0CF,Alive,ILSbio,University of North Carolina,Vietnam,Cervical Squamous Cell Carcinoma,T1b1,N0,Not available,Mar-70,C53.9,C53.9,NO,NO,Not available,20.0,0.17,1.83,51.5,RNA,74D7D053-F9AE-4CB3-B6BF-B00EBA95FF72,Regional site,External,2011.0,Alive
s13455,A5C8B50C-6506-4769-9000-6514B476E137,UNCID_1863701.580423c8-4aa9-4677-8d58-a09bc89bb11c.sorted_genome_alignments.bam,65,580423C8-4AA9-4677-8D58-A09BC89BB11C,e8e80df9-e3ba-4dec-b8fc-a5e80d8c6798,,Colon Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,77204666-6AD8-40B2-B121-601FD18BFFDB,Alive,International Genomics Consortium,University of North Carolina,United States,Colon Adenocarcinoma,T1,N0,Not available,Mar-40,C18.2,C18.2,NO,,Not available,18.0,0.14,1.8,119.2,RNA,,,,2010.0,Alive
s9428,746C0621-67F3-4B36-895D-06440EFF636A,UNCID_407296.08e3b38b-07cb-4288-b41e-d35497712449.110516_UNC16-SN851_0046_BC037JABXX.3.trimmed.annotated.translated_to_genomic.bam,62,08E3B38B-07CB-4288-B41E-D35497712449,8aaa4e25-5c12-4ace-96dc-91aaa0c4457c,333.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,B05A7F4B-BC56-4DA6-B810-79E7C3A5395E,Dead,University of Pittsburgh,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,45.0,0.15,1.5,133.3,RNA,0BDC5D4D-FB62-4584-A3A2-A0EB8264BA9B,Distant site,Not available,2008.0,Dead
s15740,32E20BEC-7E30-417F-B83F-B33FDF5DBD4C,UNCID_2523456.881eb331-76e2-4997-9ab0-13d8139a34b3.sorted_genome_alignments.bam,50,881EB331-76E2-4997-9AB0-13D8139A34B3,a2d42990-747c-4618-88dd-e2dece8e566f,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,4A339708-153A-4780-A265-70557765A754,Alive,UNC,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T4a,N3,Stage IVB,Mar-71,C10.9,C10.9,NO,NO,Complete Remission/Response,30.0,0.16,1.84,90.64,RNA,422C1D90-3502-458F-8695-B2374847C342,Primary Tumor Field,External,2013.0,Alive
s8916,D6665985-2888-41F3-8278-0AD93D5D222F,UNCID_1199080.c0520da1-6999-4dec-b750-06dbec9237dc.sorted_genome_alignments.bam,59,C0520DA1-6999-4DEC-B750-06DBEC9237DC,eeacbbdc-68c9-4dce-8999-e1dbcb86c14a,953.0,Kidney Renal Clear Cell Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,C5A4174A-CF6A-4E3B-A1DE-846EE8B0AC87,Dead,MSKCC,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,34.0,0.15,1.8,52.3,RNA,,,,2008.0,Dead
s5287,6F9903F8-1989-4AEF-977E-BECFB1101724,UNCID_1629895.0e70ff34-799d-4e88-9911-85357f2bb0a2.sorted_genome_alignments.bam,75,0E70FF34-799D-4E88-9911-85357F2BB0A2,b3d635b3-d7ac-4cf8-a318-0a9dd0073e89,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,9C617822-C9A8-42C5-AAB7-D6F22887C325,Alive,Mayo Clinic,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.9,59.74,RNA,,,,2009.0,Alive
s11688,CDECA8BE-2D18-4BF9-AEDE-0561D187B9CA,UNCID_1273448.5ff01070-167d-43b6-bb87-88b2f82b99ba.sorted_genome_alignments.bam,69,5FF01070-167D-43B6-BB87-88B2F82B99BA,e5641df6-0d4f-4613-a012-c953f8b2017e,,Kidney Renal Papillary Cell Carcinoma,Not available,RNA-Seq,MALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,F97765F8-6641-4CFD-BE61-8024F6947898,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1a,NX,Stage I,Mar-60,C64.9,C64.1,NO,,Not available,30.0,0.13,1.8,19.2,RNA,,,,2005.0,Alive
s3902,C408C643-C8FC-4637-B7B1-24EC1B8D0105,UNCID_2455936.560a04b3-0738-4a27-ad0f-c6a5a091c869.sorted_genome_alignments.bam,51,560A04B3-0738-4A27-AD0F-C6A5A091C869,86b82965-b19b-4285-b1a5-51a5d5267103,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,7A6297FE-B95F-44ED-A658-F2CA33D17435,Alive,University of California San Francisco,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-40,C61.9,C61,NO,NO,Not available,30.0,0.16,1.84,21.74,RNA,,,,,Alive
s4156,26E5268D-E95B-44DA-AE7C-DFB6FE50A127,TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted.bam,66,E847C3F1-CE33-494C-8D95-F82314C95F01,ce3585d3-7388-4d05-84c8-64e0883003b3,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,0F4B7D00-1C4C-4634-A45E-10F8949ABB43,Alive,International Genomics Consortium,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3b,Not available,Not available,Mar-50,C61.9,C61,NO,,Not available,31.0,0.16,,168.3,DNA,235C7601-D889-48F9-9B4D-10003F9DB2DD,Primary Tumor Field,External,2011.0,Alive
s5164,469F9EF2-E2DE-49FC-BF00-B21A8D0F3419,UNCID_364228.TCGA-D1-A165-01A-11R-A12I-07.110628_UNC2-RDR300275_00075_FC_70K9LAAXX.4.trimmed.annotated.translated_to_genomic.bam,64,6D1D9284-004E-4ED7-91DD-71F4FA919632,9bc2f33f-3067-4000-bc8a-1c5bb671d101,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,BA3D9CB2-0D1C-4F3B-B1B8-A6DD4AC9ADEF,Alive,Mayo Clinic,University of North Carolina,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.83,74.92,RNA,,,,2008.0,Alive
s3313,1CA77229-F208-4A7B-9A4D-60CD4507E83B,UNCID_1111235.c270c34c-0cfd-410e-ab3c-231033196d25.sorted_genome_alignments.bam,57,C270C34C-0CFD-410E-AB3C-231033196D25,ebc094a6-cdc9-4c02-b8ec-a181b25a364d,223.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,62C2BA8F-02E3-4100-86BC-5958038B4983,Dead,Christiana Healthcare,University of North Carolina,United States,Muscle invasive urothelial carcinoma (pT2 or above),T3,N0,Stage III,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.16,1.89,107.41,RNA,,,,2010.0,Dead
s6844,684946D7-D4BB-4A17-B270-C71471CA95C1,UNCID_1151604.f2563687-e055-41a8-8436-614fbad762d4.sorted_genome_alignments.bam,47,F2563687-E055-41A8-8436-614FBAD762D4,36449392-de76-4ee9-bc09-627a07e18727,,Breast Invasive Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,Not available,HG19,Primary Tumor,AC9318F5-9E1F-4340-8DA6-3815FFF8BFF5,Alive,Indivumed,University of North Carolina,Germany,Infiltrating Ductal Carcinoma,T2,N1,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.14,1.78,7.56,RNA,31E1897B-65F4-4842-8B8A-B76F8482942E,Primary Tumor Field,External,2007.0,Alive
s11715,4A32667A-DA6C-4E55-92DB-9DDEAFD80A71,UNCID_2097652.807abf86-60c9-42ae-a709-33e6d8709393.sorted_genome_alignments.bam,60,807ABF86-60C9-42AE-A709-33E6D8709393,1ef4526a-8089-46ba-aa7f-4300ab6bbbe9,,Kidney Renal Papillary Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-KIRP,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,394FCB2A-DBC7-4F1C-96FE-BD4320FB0B0B,Alive,Gundersen Lutheran,University of North Carolina,United States,Kidney Papillary Renal Cell Carcinoma,T1a,NX,Stage I,Mar-60,C64.9,C64.1,NO,NO,Complete Remission/Response,30.0,0.16,1.92,37.49,RNA,,,,2013.0,Alive
s2434,2CF7C3E9-0C05-472F-8EE8-B3824639D88E,UNCID_2483372.52ee3db2-b549-446c-a7e5-14a6a3e34ca8.sorted_genome_alignments.bam,76,52EE3DB2-B549-446C-A7E5-14A6A3E34CA8,98b4dd76-e6c4-4125-ba9e-9dc318ffb61c,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,2FC10297-1618-4EB0-9A66-630E40EA677F,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-58,C48.0,C48.0,NO,NO,Not available,30.0,0.17,1.94,14.9,RNA,,,,,Alive
s13495,E81F0A34-D5BE-4439-B31E-3CD387AD0844,UNCID_271889.TCGA-AA-3684-01A-02R-0905-07.100810_UNC6-RDR300211_00022_FC_629L9AAXX.4.trimmed.annotated.translated_to_genomic.bam,65,35A1E749-32C4-4D3B-8172-7C26CD7F591E,d761bc06-dee8-478a-be99-8af9c504e49c,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,47DDAD9D-1E43-4961-A5D1-55882F68B446,Alive,Indivumed,University of North Carolina,Germany,Colon Mucinous Adenocarcinoma,T4,N2,Stage IV,Mar-80,C18.0,C18.0,NO,,Not available,117.0,0.14,1.8,201.3,RNA,,,,2007.0,Alive
s16872,0B9E3097-FF39-4B04-8682-365E5789E42B,UNCID_1204966.68f75980-9246-46b2-82d2-41abd9a72998.sorted_genome_alignments.bam,81,68F75980-9246-46B2-82D2-41ABD9A72998,592ef526-176a-42e0-bbeb-fb62d369a343,1423.0,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,ADE2DF15-2ED2-4DEE-A710-E2814DE6E4EF,Dead,UNC,University of North Carolina,United States,Hepatocellular Carcinoma,T3,NX,Not available,Mar-70,C22.0,C22.0,NO,,Not available,30.0,0.16,1.82,43.37,RNA,,,,1999.0,Dead
s10823,E97BB392-B29C-4C1E-AECB-5BC9473C61D7,UNCID_1112588.31769d4d-64f5-4a2b-b8da-d5b2252badb3.sorted_genome_alignments.bam,66,31769D4D-64F5-4A2B-B8DA-D5B2252BADB3,e737f650-b72d-44e7-b750-558a56716803,,Lung Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,Not available,HG19,Primary Tumor,2A675528-1ABC-4220-A61A-25109850CE0D,Alive,Indivumed,University of North Carolina,Germany,Lung Adenocarcinoma Mixed Subtype,T2,N1,Stage IIB,Mar-55,C34.1,C34.1,NO,,Not available,158.0,0.13,1.8,31.3,RNA,,,,2008.0,Alive
s5725,A38429BB-34E9-4BF1-9798-83697F49A3C0,UNCID_1171568.678ba111-3b01-49b7-83d9-165ef0288a34.sorted_genome_alignments.bam,70,678BA111-3B01-49B7-83D9-165EF0288A34,4922cddc-575c-4b8a-8245-ce5f6876760c,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,27C9FA1C-E5E1-40D3-8D25-81F10D27D984,Alive,Asterand,University of North Carolina,Ukraine,Infiltrating Ductal Carcinoma,T2,N3,Stage IIIC,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.16,1.74,50.21,RNA,BF0CBEB8-1696-468C-B183-5EE4D72E45AC,Regional site,EXTERNAL BEAM,2010.0,Alive
s740,E0B2A8AF-9681-4CD7-901D-13EAAC649F16,UNCID_1573056.a76a8a5d-b85e-4494-9cf6-d6be34d3fdb9.sorted_genome_alignments.bam,53,A76A8A5D-B85E-4494-9CF6-D6BE34D3FDB9,01775b06-5836-469c-8537-120cb8cc94e9,486.0,Pancreatic Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-PAAD,Illumina HiSeq,Pancreas,WHITE,HG19,Primary Tumor,3AF7B231-6638-498F-B778-CEFB69B59968,Dead,Alberta Health Services,University of North Carolina,Canada,Pancreas-Adenocarcinoma Ductal Type,T3,N1,Stage IIB,Mar-00,C25.9,C25.9,NO,YES,Progressive Disease,40.0,0.14,,4.2,RNA,,,,2008.0,Dead
s8988,C7AE3574-3675-477A-9282-ADE9781962AD,UNCID_566258.7694eaf3-732e-4b23-b8fe-ce713c1a4b18.110926_UNC16-SN851_0092_BD0E5BABXX.3.trimmed.annotated.translated_to_genomic.bam,51,7694EAF3-732E-4B23-B8FE-CE713C1A4B18,0487fc41-386c-4d76-9084-daf959bf5e98,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,B5040DA2-0D96-422A-9760-98A95C136FE8,Alive,Mayo Clinic - Rochester,University of North Carolina,United States,Kidney Clear Cell Renal Carcinoma,T3b,N0,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,29.0,0.16,1.7,30.8,RNA,,,,2003.0,Alive
s9533,31612352-A283-454E-9B38-7BFD35FDE9F7,UNCID_358040.TCGA-CJ-4875-01A-01R-1305-07.110520_UNC9-SN296_0182_BD0C91ABXX.3.trimmed.annotated.translated_to_genomic.bam,67,02B2565A-F5D4-4487-A8B1-F6A9779BB567,818022ea-123e-438d-9671-542f479028f2,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,74ECE405-364B-4BD2-AF33-877E17F7B0D1,Alive,MD Anderson Cancer Center,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3a,NX,Stage IV,Mar-10,C64.9,C64.9,NO,,Not available,36.0,0.15,1.7,110.3,RNA,BDDEB998-197E-447B-81BA-BF7BFC3CC240,Distant site,EXTERNAL BEAM,2004.0,Alive
s1572,5EA4B9BC-9847-4F75-B68F-BA529E317612,UNCID_2043790.41c1975d-219d-4131-a77e-e70224ed6c41.sorted_genome_alignments.bam,31,41C1975D-219D-4131-A77E-E70224ED6C41,cfb61fd8-0bca-40b4-878c-cc914a289792,,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,WHITE,HG19,Primary Tumor,0D96E0B0-5ABD-4528-A733-354308E0CFEF,Alive,Asterand,University of North Carolina,Ukraine,Cervical Squamous Cell Carcinoma,T2a2,N1,Not available,Mar-70,C53.9,C53.9,NO,NO,Not available,30.0,0.18,1.81,58.82,RNA,A7674A6E-6C1A-42FC-88F0-4E9DF994CC18,Primary Tumor Field,External,2012.0,Alive
s1471,107A4D32-6A33-4E70-A01F-942E6D9B59D1,UNCID_2439576.5ad0c6f5-9be9-46f2-a705-fb9c616464ae.sorted_genome_alignments.bam,38,5AD0C6F5-9BE9-46F2-A705-FB9C616464AE,db44488e-4ed0-4082-bca0-bbfd22ff0537,582.0,Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-CESC,Illumina HiSeq,Cervix,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,HG19,Primary Tumor,7F18D32A-281B-472D-BA6B-37458A904F8D,Dead,NCI HRE Branch,University of North Carolina,United States,Cervical Squamous Cell Carcinoma,TX,NX,Not available,Mar-71,C53.9,C53.9,NO,NO,Not available,30.0,0.15,1.83,52.51,RNA,,,,2007.0,Dead
s4777,DAA92F08-7339-46A6-8A74-E6756C170ED5,TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.bam,55,4C9B54D0-A58E-44CF-8937-913A34F0788C,02b25675-094d-4098-96da-51d121380fec,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19_Broad_variant,Primary Tumor,550C6341-260A-4156-B00C-0AE9031D647F,Alive,Cedars Sinai,Harvard Medical School,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.17,1.87,88.28,DNA,,,,2010.0,Alive
s5379,C4002956-BDC1-4B16-810A-CCF4B006D29B,730dac4f2b9e3f7bc83f758dbd514583.bam,76,F7187888-F261-4A39-99B4-966FD7207117,a8614c49-c7f1-4de9-bd2f-4764b094d604,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,B5B941E3-F828-4091-B9B1-6B38D1493847,Alive,Cedars Sinai,Washington University School of Medicine,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.08,2.13,59.62,DNA,59DDEB88-4276-4E39-BD90-1B7A7E9DBB52,Primary Tumor Field,IMPLANTS,2003.0,Alive
s13771,9BBEE014-C09D-4B8E-B1A7-65E7CEFA519D,UNCID_1874473.ae0b0540-fcb6-4c9e-8835-2cb24933a01f.sorted_genome_alignments.bam,81,AE0B0540-FCB6-4C9E-8835-2CB24933A01F,c113808a-773f-4179-82d6-9083518404b5,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,DAD24ABD-0EB7-4534-A1F2-EBE38EC402F9,Alive,International Genomics Consortium,University of North Carolina,United States,Colon Adenocarcinoma,T2,N0,Stage I,Mar-40,C18.5,C18.5,NO,,Not available,37.0,0.14,1.7,124.2,RNA,,,,2011.0,Alive
s15066,9D27C2C1-C7F9-40BE-9EBE-50872392EAC1,TCGA-CG-5726-01A-11R-1602-13_rnaseq.bam,73,10719477-DCB2-4783-A9FF-343998D4D7A6,863ad936-e2a0-471c-8d95-3a548bb94afa,881.0,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,Not available,GRCh37-lite,Primary Tumor,C881739A-982C-436F-9BE2-4638DB792C53,Dead,Indivumed,Canada's Michael Smith Genome Sciences Centre,Germany,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),T1,N0,Stage IA,Mar-44,C16.3,C16.3,NO,,Not available,33.0,0.15,1.7,263.8,RNA,,,,2004.0,Dead
s16023,C575A79C-0BCA-4AE0-996B-A8316ADA661A,G35155.TCGA-CR-7369-01A-11D-2129-08.2.bam,59,F16A5C08-C9F8-442E-BA13-45681CACDA40,85a26115-1160-411b-8384-44eedc947fb2,1090.0,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19_Broad_variant,Primary Tumor,ED6AD3FC-0A81-4258-89A0-133AAA36709E,Dead,Vanderbilt University,Broad Institute of MIT and Harvard,United States,Head and Neck Squamous Cell Carcinoma,T4a,N2b,Stage IVA,Mar-70,C14.8,C14.8,NO,,Not available,17.0,0.05,,133.7,DNA,,,,2008.0,Dead
s15943,87D3A10E-3D61-42B2-AF9F-5FFE9514A053,UNCID_1488858.8af61a8a-17b0-402a-9fb7-38e70ecebab7.sorted_genome_alignments.bam,77,8AF61A8A-17B0-402A-9FB7-38E70ECEBAB7,2a7b4613-f908-4e78-98ed-857dcd7ed774,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,A07E086C-1D2D-4D92-A663-ECD7EA4DBD73,Alive,Medical College of Georgia,University of North Carolina,United States,Head and Neck Squamous Cell Carcinoma,T1,N0,Stage I,Mar-70,C02.9,C02.9,NO,,Not available,35.0,0.15,1.7,272.2,RNA,,,,2010.0,Alive
s3787,0DBB7308-269C-4AD8-97C7-E7475AE08189,TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted.bam,54,D2336094-05BD-4E89-84A3-91D641DC31D0,607200f5-df80-4f5d-90fb-fdc455a7415b,,Prostate Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,WHITE,HG19_Broad_variant,Primary Tumor,F93327F7-0290-4915-97BB-E31BAE2697DD,Alive,University of Pittsburgh,Harvard Medical School,United States,Prostate Adenocarcinoma Acinar Type,T3b,N1,Not available,Mar-50,C61.9,C61,NO,,Not available,38.0,0.15,1.9,347.7,DNA,,,,2010.0,Alive
s9604,58D19876-562C-4555-8395-9F82AC055F9A,UNCID_1184054.0d3d5230-7522-4e08-b470-748a04d544b3.sorted_genome_alignments.bam,58,0D3D5230-7522-4E08-B470-748A04D544B3,4c474c70-1d72-49e8-a8cc-a4145c5ab607,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,4EB18580-30AF-4C32-BB5B-1A8C87280212,Alive,Harvard,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T2,N0,Stage II,Mar-10,C64.9,C64.9,NO,,Not available,29.0,0.16,1.7,60.8,RNA,,,,2006.0,Alive
s16911,C333FC56-CEA3-4720-B073-736FA7C640EA,UNCID_2086813.9fc02f84-548e-42a4-8857-717cd8426575.sorted_genome_alignments.bam,59,9FC02F84-548E-42A4-8857-717CD8426575,2c8a1e74-33de-453f-8d1e-e226185e52fc,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,WHITE,HG19,Primary Tumor,74A3B091-F6DE-49FE-BE1D-7E091348DA2C,Alive,Alberta Health Services,University of North Carolina,Canada,Hepatocellular Carcinoma,T1,NX,Stage I,Mar-70,C22.0,C22.0,NO,YES,Not available,30.0,0.17,1.9,71.94,RNA,,,,2012.0,Alive
s6177,396BB054-1917-4202-B7A1-E4C210A0A95A,UNCID_1143727.d9f827bb-2498-49b0-aa85-71cb554eb926.sorted_genome_alignments.bam,55,D9F827BB-2498-49B0-AA85-71CB554EB926,60df7543-6da5-4c75-943b-5800c1e08234,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,A7CC9298-D6F1-48EF-A93A-9C75FC0CB800,Alive,Roswell Park,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N2,Stage IIIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.17,1.84,31.62,RNA,F63A992C-A3FF-4949-86BE-6556F627B1A3,Primary Tumor Field,EXTERNAL BEAM,2009.0,Alive
s14737,891C3FB0-CA82-4F2D-8C5E-42855C176B82,_1_TCGA-HU-A4H0-01A-11R-A251-31_rnaseq.bam,72,27B37399-0A77-400E-9DFF-0C9C26455144,fe45eaee-ff0c-4d52-b18c-04dc2d64d3b4,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,ASIAN,GRCh37-lite,Primary Tumor,568CBF5F-86DA-4420-9C70-324D11B8E481,Alive,National Cancer Center Korea,Canada's Michael Smith Genome Sciences Centre,Korea South,Stomach  Adenocarcinoma  Diffuse Type,T4a,N3b,Stage IIIC,Mar-45,C16.2,C16.2,NO,NO,Not available,20.0,0.15,1.81,61.75,RNA,,,,2011.0,Alive
s6483,58FC560C-A51A-45BB-9494-F5230DFA63D6,UNCID_1115822.79d0e02e-b518-4dce-8c20-00073d04e399.sorted_genome_alignments.bam,64,79D0E02E-B518-4DCE-8C20-00073D04E399,739cb132-51e9-41be-8064-311a13da0d74,,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,4068463B-8568-4BDB-8DB0-19390EC0C7F8,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Infiltrating Ductal Carcinoma,T1c,N0,Stage IA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.17,1.83,44.55,RNA,D72884C9-451B-40F9-A7FE-C1FA19833923,Primary Tumor Field,EXTERNAL BEAM,2010.0,Alive
s945,F875F7CC-A944-49FB-81E4-85F2E59FEFCF,UNCID_2364149.d9120f00-7f10-49d5-ae84-6177e9424c7c.sorted_genome_alignments.bam,36,D9120F00-7F10-49D5-AE84-6177E9424C7C,13b41b15-a785-4ab7-b864-ffff6d35dd45,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,D43F727A-96D6-40B8-86AE-7A3E0AA46853,Alive,National Institutes of Health,University of North Carolina,United States,Not available,Not available,Not available,Not available,8700/0,C74.9,C74.9,NO,NO,Complete Remission/Response,10.0,0.17,1.98,22.18,RNA,,,,,Alive
s14121,C856399E-41C8-447D-802B-C6F173FC29D2,G17489.TCGA-27-2524-01A-01R-1850-01.2.bam,56,8604DF30-9170-41E2-8DFB-2FEB813807AC,a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff,231.0,Glioblastoma Multiforme,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-GBM,Illumina HiSeq,Brain,WHITE,HG19_Broad_variant,Primary Tumor,F592D028-D302-4C96-9EF8-732A19762E22,Dead,"Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta",Broad Institute of MIT and Harvard,,Untreated primary (de novo) GBM,Not available,Not available,Not available,Mar-40,C71.9,C71.9,NO,,Not available,178.0,0.14,1.8,103.4,RNA,4139A31E-3494-4BCF-8AAB-CCBBF0580EF7,Primary Tumor Field,EXTERNAL BEAM,2008.0,Dead
s17525,4469FB9E-B975-40A0-B274-C2500F2984CC,TCGA-25-2409-01A-01R-1569-13_rnaseq.bam,71,4E5F3A15-68FD-4BE0-B368-E0BD04EAF872,dce71741-ccbe-40b7-a0b8-2048d07187a4,821.0,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,NCBI36_BCCAGSC_variant,Primary Tumor,3D0F2483-AE45-4B2F-BBA3-76A0EAECFF4F,Dead,Mayo Clinic - Rochester,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,159.0,0.14,1.8,347.0,RNA,,,,2005.0,Dead
s3914,84E6865D-DE2B-48BB-8CC2-58CEE3861EBA,UNCID_2599247.20e1a03e-b18b-41ed-aaf4-95a5aefb4fbf.sorted_genome_alignments.bam,72,20E1A03E-B18B-41ED-AAF4-95A5AEFB4FBF,c4ebb2eb-e1f0-4490-80f3-5cf0c40a3091,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,4CA78561-756F-4453-9CB1-34E119BCF140,Alive,University of Arizona,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,Not available,N0,Not available,Mar-40,C61.9,C61,NO,NO,Not available,30.0,0.16,1.81,40.88,RNA,,,,2012.0,Alive
s10403,2986C51F-4DB1-4C24-9065-463CBA2B3BDC,UNCID_1067619.d23adf22-4453-4144-9a70-2c60bad34d97.sorted_genome_alignments.bam,65,D23ADF22-4453-4144-9A70-2C60BAD34D97,fd881d58-c9c7-479b-b76b-1f3c2ab1b015,,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,C4A87AC6-5925-4C2B-AA66-22550D4C1871,Alive,Cureline,University of North Carolina,Russia,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T2,N0,Stage IB,Mar-70,C34.1,C34.1,NO,,Not available,166.0,0.15,1.8,81.6,RNA,,,,2006.0,Alive
s2234,5D73DFC6-81F9-48B7-B4BF-67EAE271DB6A,UNCID_1869209.4968e96b-0e78-4739-9b40-8595afb2a30b.sorted_genome_alignments.bam,60,4968E96B-0E78-4739-9B40-8595AFB2A30B,78499f63-fe28-4b99-9f0e-6002203c4596,,Rectum Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-READ,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,36DC518C-51AB-4D12-AA25-27E60646A125,Alive,Asterand,University of North Carolina,Russia,Rectal Adenocarcinoma,T3,N0,Stage IIIA,Mar-40,C20.9,C20,NO,,Not available,26.0,0.15,1.8,127.2,RNA,,,,2011.0,Alive
s9045,E6513711-B087-46E6-9D5C-4E58E2430A79,UNCID_1188528.cca8d66c-a538-40ee-ac28-6d90d12edf26.sorted_genome_alignments.bam,69,CCA8D66C-A538-40EE-AC28-6D90D12EDF26,b7143068-4afd-47ed-9e08-1894f886c503,587.0,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,HG19,Primary Tumor,EF5F633B-F9FA-49B1-8F69-BEE72F89F403,Dead,University of Pittsburgh,University of North Carolina,,Kidney Clear Cell Renal Carcinoma,T3b,N1,Stage III,Mar-10,C64.9,C64.9,NO,,Not available,31.0,0.14,1.8,161.3,RNA,,,,2009.0,Dead
s14611,98785371-4AF3-4D04-ACC8-5C53C8076618,TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted.bam,78,174658D3-1933-47FD-A883-5F4AFA169778,d139bd0c-2eeb-44ec-856b-e77cb03d294e,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,WGS,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,HG19_Broad_variant,Primary Tumor,1506E790-C21C-4419-B11B-14250C947FB5,Alive,Asterand,Harvard Medical School,Russia,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),TX,N1,Not available,Mar-40,C16.3,C16.3,NO,,Not available,31.0,0.14,1.9,65.9,DNA,,,,2008.0,Alive
s13599,DCFCC634-73DF-48B2-A5D7-32A18DFB7636,UNCID_1811292.b84b00dc-8f6c-4fed-b820-62b7f38a5376.sorted_genome_alignments.bam,34,B84B00DC-8F6C-4FED-B820-62B7F38A5376,a782f174-241d-42c6-9bc4-61cc39f8b397,,Colon Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,C281D8EB-0AAF-409C-B8D1-5681C8DC27BE,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Colon Adenocarcinoma,T3,N0,Stage IIA,Mar-40,C18.7,C18.7,NO,,Not available,26.0,0.15,1.8,179.2,RNA,,,,2011.0,Alive
s17642,21B56485-EA74-423D-B613-898FF9656B21,TCGA-59-2348-01A-01R-1569-13_GRCh37-lite_rnaseq.bam,59,7162D809-FF1A-4346-BB00-C8086386EC46,20cf00ea-d7da-42bb-bce7-f005f0b952eb,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,CBDAFA49-7DD7-4A42-B0A5-891AAD11A802,Alive,Roswell Park,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,143.0,0.14,1.8,658.0,RNA,,,,1994.0,Alive
s2823,60453D75-E0CC-4679-952C-D6F26085777F,UNCID_2511939.a9321523-588e-40f2-95d2-2501fd1b23ee.sorted_genome_alignments.bam,59,A9321523-588E-40F2-95D2-2501FD1B23EE,f6d916b0-8e4c-49cb-a0d4-883908f3284f,,Bladder Urothelial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,Not available,HG19,Primary Tumor,B83BAB59-8667-4920-9593-575997621B34,Alive,Erasmus MC,University of North Carolina,Netherlands,Muscle invasive urothelial carcinoma (pT2 or above),T3a,N0,Stage III,Mar-30,C67.9,C67.9,NO,YES,Complete Remission/Response,30.0,0.18,1.87,37.84,RNA,,,,2000.0,Alive
s16656,3F981341-7EA3-4D22-A767-7E07EE0FDD41,UNCID_2619194.2c10e17e-58c2-445c-9306-ca22625bdc38.sorted_genome_alignments.bam,66,2C10E17E-58C2-445C-9306-CA22625BDC38,03f5de7d-45a9-4a73-8c61-ed816d4a3ac5,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,51CD88E1-B32B-41B4-B971-EEF962F15720,Alive,Mayo Clinic - Rochester,University of North Carolina,Korea South,Hepatocellular Carcinoma,T1,N0,Stage I,Mar-70,C22.0,C22.0,NO,NO,Not available,30.0,0.16,1.82,66.6,RNA,,,,2010.0,Alive
s4338,AC9434E3-5314-4A6D-8AF6-EDC93C1F5E72,UNCID_2089988.69fbadaa-5a9f-4fc6-b676-e938179ee830.sorted_genome_alignments.bam,55,69FBADAA-5A9F-4FC6-B676-E938179EE830,7f91a0c5-d639-48ea-b3f7-b6f385e047ed,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19,Primary Tumor,029E5E0D-9F4E-4031-A5F2-0187C2B70879,Alive,International Genomics Conosrtium,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.15,1.8,63.6,RNA,,,,2011.0,Alive
s6026,31E07F77-2AF8-46E4-9876-41AF57F3E523,UNCID_1146306.09c248f8-cdd7-4c13-9085-26c56544bcf7.sorted_genome_alignments.bam,49,09C248F8-CDD7-4C13-9085-26C56544BCF7,045c13ef-3db7-4adf-b0a3-23338f0479f3,991.0,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,14423610-4958-43F4-9A75-1A61C1293024,Dead,Duke,University of North Carolina,United States,Infiltrating Ductal Carcinoma,T1c,N1,Stage IIA,Mar-00,C50.9,C50.9,NO,,Not available,30.0,0.15,1.88,57.56,RNA,,,,1990.0,Dead
s4561,243E7819-53A8-4C9C-A44D-E0E4141552A8,UNCID_559583.1d3ec463-a3c0-4aa5-8fc0-d221be3a0700.110928_UNC6-RDR300211_00126_FC_6348UAAXX.5.trimmed.annotated.translated_to_genomic.bam,68,1D3EC463-A3C0-4AA5-8FC0-D221BE3A0700,4284a85d-d9b6-40ee-aac4-c2c03554528e,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,Not available,HG19,Primary Tumor,AF843246-E00F-40F4-849F-3C5BA74A7479,Alive,Washington University,University of North Carolina,United States,Serous endometrial adenocarcinoma,Not available,Not available,Not available,Mar-41,C54.1,C54.1,NO,,Not available,30.0,0.16,1.81,79.18,RNA,,,,2003.0,Alive
s10826,85169A28-B35A-47BC-AF12-0F50361451D6,UNCID_1135912.bc6c762f-727f-43c8-a4bc-4c41351c7f13.sorted_genome_alignments.bam,66,BC6C762F-727F-43C8-A4BC-4C41351C7F13,0ea4920f-f4c8-4590-84b3-eb419824e144,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,CC72DC0D-9C39-4217-B5CB-8CAD390D7E86,Alive,UNC,University of North Carolina,United States,Lung Adenocarcinoma- Not Otherwise Specified (NOS),T2a,N0,Stage IB,Mar-40,C34.1,C34.1,NO,,Not available,135.0,0.15,1.8,381.3,RNA,,,,2002.0,Alive
s4198,6D434AEC-CEED-46E3-8FE3-288654FF2F51,UNCID_2173609.60448472-d440-4608-8fca-b54c41c5cde1.sorted_genome_alignments.bam,74,60448472-D440-4608-8FCA-B54C41C5CDE1,7466d120-6a6e-40a0-96d3-4979816d6278,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,ACCA09F5-D5AB-4699-B8FE-615A88F57B38,Alive,Asterand,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-40,C61.9,C61,NO,,Complete Remission/Response,30.0,0.15,1.81,43.83,RNA,,,,2012.0,Alive
s5257,E6094BBF-4620-439F-BF7C-CA6A6A7BD149,UNCID_1614699.c3c9142f-d5c8-44ef-90c2-9ae69846dc60.sorted_genome_alignments.bam,44,C3C9142F-D5C8-44EF-90C2-9AE69846DC60,490ae247-ee67-48d4-94ed-93df5b9bbefe,243.0,Uterine Corpus Endometrial Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,A8393121-29DF-4525-BF4F-FCE0DEAF25F5,Dead,Washington University,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,10.0,0.18,1.8,30.62,RNA,,,,2009.0,Dead
s2075,3E666810-9FE0-48F6-9EF9-9DD707BB2DC0,UNCID_1898237.8a6ee832-1496-4016-8780-0b842b960582.sorted_genome_alignments.bam,66,8A6EE832-1496-4016-8780-0B842B960582,ce2e0f1c-60ff-4f93-8bba-4f4d3ccac37c,,Rectum Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-READ,Illumina HiSeq,Colorectal,WHITE,HG19,Primary Tumor,A1B8D085-D504-4958-8F47-531D8D7E3D91,Alive,Christiana Healthcare,University of North Carolina,United States,Rectal Adenocarcinoma,T2,N1,Stage IIIA,Mar-40,C19.9,C19,NO,,Not available,29.0,0.14,1.8,89.2,RNA,,,,2010.0,Alive
s14583,AC847AEB-823E-4B5A-B935-B878B6721234,_1_TCGA-BR-8364-01A-11R-2343-13_rnaseq.bam,42,7AE9AFAA-ECB4-41A1-9459-8F4AD450BA73,632f51b3-8ef4-4b6e-a992-c81e554507ed,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,70A0C712-76C9-4F18-8C43-054A2773E8E1,Alive,Asterand,Canada's Michael Smith Genome Sciences Centre,Russia,Stomach  Adenocarcinoma  Diffuse Type,T4b,N2,Stage IIIC,Mar-45,C16.1,C16.1,NO,,Not available,38.0,0.13,,30.5,RNA,,,,2011.0,Alive
s16846,E34301A3-3816-4F4A-B3E2-82E8B4165265,UNCID_2659213.3e205fbf-b9e5-470d-9c6f-68ff88640c45.sorted_genome_alignments.bam,24,3E205FBF-B9E5-470D-9C6F-68FF88640C45,e2f6d3aa-b817-4193-a550-8e53265aa336,,Liver Hepatocellular Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LIHC,Illumina HiSeq,Liver,ASIAN,HG19,Primary Tumor,98EECA7B-4918-4176-927D-0AC1E48C5D7E,Alive,ILSbio,University of North Carolina,,Hepatocellular Carcinoma,T3,N0,Stage IIIA,Mar-70,C22.0,C22.0,NO,,Not available,30.0,0.16,1.89,87.59,RNA,,,,2010.0,Alive
s8249,BFD186F5-D4D6-49BC-8F52-392B6D55A4BC,UNCID_2221567.43d6f3d2-2bd6-41e1-9d85-735f5f60e25a.sorted_genome_alignments.bam,52,43D6F3D2-2BD6-41E1-9D85-735F5F60E25A,76cb16f9-37be-450e-b60a-5f0d0f1ec2bc,,Brain Lower Grade Glioma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LGG,Illumina HiSeq,Brain,WHITE,HG19,Primary Tumor,842DF84D-DA05-4AA5-91A4-C6893ECA2082,Alive,Fondazione-Besta,University of North Carolina,Italy,Oligodendroglioma,Not available,Not available,Not available,Mar-51,C71.0,C71.0,NO,NO,Not available,30.0,0.16,1.76,10.26,RNA,FBFD2D0E-F6CB-49BB-9B10-A62A867B3581,Primary Tumor Field,External,2013.0,Alive
s14841,A6B6659F-E422-485E-8E1A-632F8C11749B,TCGA-D7-6815-01A-11R-1884-13_rnaseq.bam,70,B01837F8-F585-4336-A49A-A5DF6932DB17,53086e20-a727-40d6-b42d-8030109b5130,,Stomach Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,B5F3D9A1-46B5-4A63-8F7D-9C993FE9340D,Alive,Greater Poland Cancer Center,Canada's Michael Smith Genome Sciences Centre,Poland,Stomach  Intestinal Adenocarcinoma  Tubular Type,T2,N2,Stage IIB,Mar-11,C16.2,C16.2,NO,,Not available,37.0,0.16,1.8,493.2,RNA,,,,2010.0,Alive
s11019,5BB50B82-F710-41DE-B4B2-B9757F428702,UNCID_1090263.aa29c7b0-8641-4a59-8b17-c007b3cb8726.sorted_genome_alignments.bam,53,AA29C7B0-8641-4A59-8B17-C007B3CB8726,fd5c44ef-ea50-4fba-9e8d-e371cf34ebdb,807.0,Lung Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-LUAD,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,98038913-75D0-41A6-AC67-A9263F5AB18A,Dead,Prince Charles Hospital,University of North Carolina,Australia,Lung Adenocarcinoma Mixed Subtype,T2,N2,Stage IIIA,Mar-55,C34.1,C34.1,NO,,Not available,40.0,0.16,,82.2,RNA,CEA1849B-13C0-4D25-A6C7-AEAE07D41D0B,Primary Tumor Field,EXTERNAL BEAM,2000.0,Dead
s12873,E53DB54A-BB1B-4C60-8214-AAA269ABD153,TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam,82,519A6BBF-68D8-4275-854A-5216FC4DFD15,6fa41234-9077-4d05-a295-6820f3bedf5b,,Colon Adenocarcinoma,Not available,WGS,MALE,TCGA-COAD,Illumina HiSeq,Colorectal,Not available,HG18,Primary Tumor,2151DC9E-F76A-4CFF-8A20-B7C107D59C27,Alive,Indivumed,Harvard Medical School,Germany,Colon Adenocarcinoma,T3,N0,Stage II,Mar-40,C18.4,C18.4,NO,,Not available,30.0,0.16,2.11,107.64,DNA,,,,2005.0,Alive
s954,DDE41DFF-047C-4251-8345-2300CBB27F4F,UNCID_2366760.4d7eab0f-9ff4-49b5-ac79-9bc65a808882.sorted_genome_alignments.bam,65,4D7EAB0F-9FF4-49B5-AC79-9BC65A808882,78bb46f4-060d-45f3-b877-754a9d695798,,Pheochromocytoma and Paraganglioma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-PCPG,Illumina HiSeq,Nervous System,WHITE,HG19,Primary Tumor,665A3EE4-2118-4C4B-9059-59AB19B3BB43,Alive,University of Pittsburgh,University of North Carolina,United States,Not available,Not available,Not available,Not available,Jan-93,C48.0,C48.0,NO,NO,Not available,30.0,0.15,1.87,13.7,RNA,,,,,Alive
s3046,BFD9FFB0-66BA-4B21-8501-8089EA05777F,UNCID_2539736.b7db14a4-5268-44e5-aed1-7200c6c82a2d.sorted_genome_alignments.bam,71,B7DB14A4-5268-44E5-AED1-7200C6C82A2D,bca645ae-a0c9-4005-b672-85d8920b6afb,590.0,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-BLCA,Illumina HiSeq,Bladder,WHITE,HG19,Primary Tumor,52097937-CBCB-43F8-A505-9B4DA32D5C6A,Dead,University of Sheffield,University of North Carolina,United Kingdom,Muscle invasive urothelial carcinoma (pT2 or above),T3,NX,Stage III,Mar-20,C67.2,C67.2,NO,,Not available,30.0,0.17,1.9,90.33,RNA,,,,2009.0,Dead
s2182,29E9E4B2-3790-4BAF-93DE-635201BF0CAF,UNCID_1580669.65b07800-1ecf-4988-9a74-1cfaf3fe03ea.sorted_genome_alignments.bam,63,65B07800-1ECF-4988-9A74-1CFAF3FE03EA,3124e819-292b-48e7-baac-8c5c4a86dc20,,Rectum Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-READ,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,2371705B-B1D3-41B8-A7CB-32D3D83D600F,Alive,Indivumed,University of North Carolina,Germany,Rectal Adenocarcinoma,T2,N0,Stage I,Mar-40,C19.9,C19,NO,,Not available,143.0,0.14,1.8,410.3,RNA,,,,2007.0,Alive
s2370,694A1742-344B-4659-98A2-F1B1B2444309,UNCID_2424004.f2a51101-e624-4b5f-970b-6ffe66a768e1.sorted_genome_alignments.bam,67,F2A51101-E624-4B5F-970B-6FFE66A768E1,ea3a524b-6ee3-4904-8924-29fcaa20985c,,Sarcoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-SARC,Illumina HiSeq,Mesenchymal,WHITE,HG19,Primary Tumor,910CD9B0-5BBE-47E5-8F4C-A6E8AA580281,Alive,Memorial Sloan Kettering,University of North Carolina,United States,Not available,Not available,Not available,Not available,Mar-90,C49.2,C49.2,NO,YES,Not available,30.0,0.16,1.8,20.5,RNA,B4AB05AF-4CD9-4AB5-97CA-423D12DF88BD,Distant Recurrence,External,,Alive
s6809,F4B29CB4-DC0A-4A4B-B895-42026F4EB7CF,UNCID_1126467.4dfbdec6-1911-412c-9873-f6782ab8ff66.sorted_genome_alignments.bam,39,4DFBDEC6-1911-412C-9873-F6782AB8FF66,f63722c1-a0bb-4bf9-8a10-1d76a8e1a0ba,2207.0,Breast Invasive Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,6A914B5F-5BC2-4152-B80E-FCC864A415B0,Dead,University of Pittsburgh,University of North Carolina,,Infiltrating Ductal Carcinoma,T3,N1,Stage IIIA,Mar-00,C50.3,C50.3,NO,,Not available,30.0,0.16,1.82,17.76,RNA,,,,2001.0,Dead
s11499,9FB9392F-D2DB-4A9F-B7C7-1DBFC8D3CE3F,UNCID_1227357.554a301f-fbc8-41f2-96e9-5da2ee943727.sorted_genome_alignments.bam,72,554A301F-FBC8-41F2-96E9-5DA2EE943727,3199cfe5-3be3-43cd-a36b-5cf2c7a9929f,,Lung Adenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,MALE,TCGA-LUAD,Illumina HiSeq,Lung,BLACK OR AFRICAN AMERICAN,HG19,Primary Tumor,478CC306-6AEE-4597-8834-1E5CF8B05A59,Alive,University of Pittsburgh,University of North Carolina,United States,Lung Adenocarcinoma Mixed Subtype,T2,N0,Stage IB,Mar-55,C34.1,C34.1,NO,,Not available,114.0,0.14,1.8,163.8,RNA,,,,2009.0,Alive
s9937,4A0C2DB0-F10B-41B1-8ACA-FCD712B7F672,TCGA-B0-5693-01A-11D-2103-10_Illumina.bam,47,FB194CA3-10AA-4DC5-8D08-619DDBD6D1B6,db058eb4-9c5e-4226-92d1-de24aea83630,,Kidney Renal Clear Cell Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-KIRC,Illumina HiSeq,Kidney,WHITE,GRCh37-lite,Primary Tumor,20A21A6F-F615-47F7-9935-B330B116D51B,Alive,University of Pittsburgh,Baylor College of Medicine,,Kidney Clear Cell Renal Carcinoma,T1b,NX,Stage I,Mar-10,C64.9,C64.9,NO,,Not available,38.0,0.14,1.9,344.4,DNA,,,,2003.0,Alive
s10583,4F1A05FE-CD69-40F2-80DE-BA6263DDBA8D,UNCID_2078282.e3e7210a-a45e-47dc-aa2c-46aa17d47314.sorted_genome_alignments.bam,57,E3E7210A-A45E-47DC-AA2C-46AA17D47314,e80a4625-1b5a-4abc-8ab9-978d1488b961,387.0,Lung Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-LUSC,Illumina HiSeq,Lung,WHITE,HG19,Primary Tumor,32165B3D-08B3-4601-85E2-684BE9DD8264,Dead,Washington University - CALGB,University of North Carolina,United States,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),T4,N2,Stage III,Mar-70,C34.3,C34.3,NO,YES,Not available,30.0,0.18,2.13,29.63,RNA,932EF2CB-66E4-4917-BDB9-BF1C3B9172A2,Not available,Not available,2006.0,Dead
s5406,EE8B25ED-CDB2-42F5-B718-EFF645ABE257,UNCID_1605440.d653b50c-d568-48a1-bbed-5e36fbf525ac.sorted_genome_alignments.bam,83,D653B50C-D568-48A1-BBED-5E36FBF525AC,db3a4986-55d5-4ecc-be73-59725dce3c33,456.0,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-UCEC,Illumina GA,Uterus,WHITE,HG19,Primary Tumor,E95DDE06-F397-4B0C-A854-DC91AA3C6F31,Dead,University of North Carolina,University of North Carolina,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.8,46.35,RNA,,,,2008.0,Dead
s13029,4A7F8872-1280-4A05-8448-A62EE6DE1108,TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam,77,85305E56-627C-4471-BD16-6818AD3751C2,abb0d53f-f74e-45dc-8fbb-40863016f3c6,,Colon Adenocarcinoma,Not available,WGS,FEMALE,TCGA-COAD,Illumina HiSeq,Colorectal,Not available,HG18,Primary Tumor,190FECAB-1EF1-43FA-87A2-104014EB2CE2,Alive,Indivumed,Harvard Medical School,Germany,Colon Adenocarcinoma,T3,N1,Stage III,Mar-40,C18.0,C18.0,NO,,Not available,123.0,0.15,1.9,353.96,DNA,,,,2006.0,Alive
s4411,BEF94A7D-D7F5-4172-9A0C-5B3DC033CA00,5b233e3c073c9b60910bddaec0e5ed79.bam,71,42DE1441-6F3C-4B4D-B8B8-AD91E4B1DBE2,d2aa7d70-a25f-4a9e-9d52-37e372461824,,Uterine Corpus Endometrial Carcinoma,Not available,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,BLACK OR AFRICAN AMERICAN,GRCh37-lite,Primary Tumor,FE5D8E64-98B1-4EA7-ADDA-F28D12349A7E,Alive,Duke,Washington University School of Medicine,United States,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,20.0,0.07,2.0,71.04,DNA,,,,2001.0,Alive
s14781,569A38B4-A9BF-4330-88CA-28368DD73892,TCGA-VQ-A928-01A-11R-A414-31_rnaseq.bam,49,E8F51FDD-9448-450E-9545-D3ADC93301C4,43b7a790-35a2-4786-b375-c3847d2aec62,174.0,Stomach Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-STAD,Illumina HiSeq,Stomach,WHITE,GRCh37-lite,Primary Tumor,46146A87-8F74-4908-93F4-05186C863C13,Dead,Barretos Cancer Hospital,Canada's Michael Smith Genome Sciences Centre,Brazil,Stomach Intestinal Adenocarcinoma Papillary Type,T3,N3,Stage IV,Mar-60,C16.2,C16.2,NO,YES,Progressive Disease,30.0,0.18,1.86,58.97,RNA,,,,2010.0,Dead
s5006,2C466122-C49E-4866-B9D4-FAF31DDE999C,TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted.bam,60,F186159C-DCE6-467C-AAAF-BB08FBAE6827,59e9029a-8ddd-4447-b35a-72bc39f82a30,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19_Broad_variant,Primary Tumor,7678C70D-A298-4472-89A0-427AF1E93D28,Alive,Christiana Healthcare,Harvard Medical School,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.9,79.7,DNA,,,,2010.0,Alive
s4589,7270B44F-635F-48BF-B3C4-8042B4557613,TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.bam,65,41896FDE-677E-419C-B8B9-0171D6669A4A,a2a2dbda-d10c-49c4-86a8-61baf6160cda,,Uterine Corpus Endometrial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-UCEC,Illumina HiSeq,Uterus,WHITE,HG19_Broad_variant,Primary Tumor,F6F9C40B-1E58-47A3-B518-9694FB5FF2CF,Alive,Cedars Sinai,Harvard Medical School,,Endometrioid endometrial adenocarcinoma,Not available,Not available,Not available,Mar-80,C54.1,C54.1,NO,,Not available,30.0,0.16,1.81,65.96,DNA,5582EC98-5525-41F6-8E13-2DA1ADD2BCB8,Primary Tumor Field,EXTERNAL BEAM,2006.0,Alive
s2735,46ADB3C9-AC82-4284-B0D1-F95B10435695,TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.bam,64,CD60EBC2-EF2A-4B47-8D42-C864AA095B8D,cede5274-279d-4021-8aca-5ecc4bf94d66,,Bladder Urothelial Carcinoma,NOT HISPANIC OR LATINO,WGS,FEMALE,TCGA-BLCA,Illumina HiSeq,Bladder,BLACK OR AFRICAN AMERICAN,HG19_Broad_variant,Primary Tumor,CBEDC0DB-39FD-4661-9531-CC24D422FAC4,Alive,Medical College of Georgia,Harvard Medical School,United States,Muscle invasive urothelial carcinoma (pT2 or above),Not available,NX,Stage IV,Mar-20,C67.9,C67.9,NO,,Not available,30.0,0.15,,54.46,DNA,,,,2010.0,Alive
s16217,485DD6DB-EA30-4421-AAF2-43F43E1E98EC,UNCID_1482971.19f3aa1f-1a64-4884-9598-9216caa66b70.sorted_genome_alignments.bam,64,19F3AA1F-1A64-4884-9598-9216CAA66B70,31243867-8e9f-46e9-a213-b83544eb8028,,Head and Neck Squamous Cell Carcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-HNSC,Illumina HiSeq,Head and Neck,WHITE,HG19,Primary Tumor,1737989D-8463-4761-B111-53E4FD396375,Alive,Greater Poland Cancer Center,University of North Carolina,Poland,Head and Neck Squamous Cell Carcinoma,T4a,N2b,Stage IVA,Mar-70,C32.9,C32.9,NO,,Not available,34.0,0.16,1.8,298.2,RNA,,,,2011.0,Alive
s12902,24ABA34A-F4B4-49DB-8476-C8E4BB81E8BC,UNCID_1592583.1fd3cdf4-a6be-4d65-830c-828c3d1a1074.sorted_genome_alignments.bam,87,1FD3CDF4-A6BE-4D65-830C-828C3D1A1074,cbdabbcd-d8f1-4d7c-9e18-ebd83d888c51,,Colon Adenocarcinoma,Not available,RNA-Seq,FEMALE,TCGA-COAD,Illumina GA,Colorectal,Not available,HG19,Primary Tumor,1A4601F8-E4D6-4C3D-A846-E3186295C137,Alive,Indivumed,University of North Carolina,Germany,Colon Mucinous Adenocarcinoma,T3,N1,Stage IIIB,Mar-80,C18.2,C18.2,NO,,Not available,103.0,0.15,1.8,175.3,RNA,,,,2009.0,Alive
s6696,422B2B68-03D6-4245-A6D0-713121FF91EE,UNCID_1150001.6d2744ba-4817-482b-ad46-2e4e0897ad88.sorted_genome_alignments.bam,53,6D2744BA-4817-482B-AD46-2E4E0897AD88,18eb4dfc-556f-4bf3-a411-4780209ed1e0,,Breast Invasive Carcinoma,Not available,RNA-Seq,FEMALE,TCGA-BRCA,Illumina HiSeq,Breast,WHITE,HG19,Primary Tumor,FC1F0AD4-8412-4143-8EBF-FA6592F396E9,Alive,University of Pittsburgh,University of North Carolina,,Infiltrating Ductal Carcinoma,T2,N1a,Stage IIB,Mar-00,C50.9,C50.9,NO,,Not available,20.0,0.16,1.93,37.54,RNA,F9F1D8C1-B2FA-4516-B98F-D50ACCB6C8C6,Primary Tumor Field,EXTERNAL BEAM,2007.0,Alive
s3690,43EC285C-7576-4D84-A5C6-35C0706D2FF5,UNCID_1987303.71160876-7965-4899-a8b2-c549cc25260b.sorted_genome_alignments.bam,65,71160876-7965-4899-A8B2-C549CC25260B,5089a8d2-a353-4150-8a6b-6478c5bb29bb,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,97B5133F-9D89-4E25-9C78-655C23655DBD,Alive,Cornell Medical College,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T2c,N0,Not available,Mar-40,C61.9,C61,NO,YES,Partial Remission/Response,30.0,0.16,1.86,14.0,RNA,,,,2006.0,Alive
s4198,6D434AEC-CEED-46E3-8FE3-288654FF2F51,UNCID_2173609.60448472-d440-4608-8fca-b54c41c5cde1.sorted_genome_alignments.bam,74,60448472-D440-4608-8FCA-B54C41C5CDE1,7466d120-6a6e-40a0-96d3-4979816d6278,,Prostate Adenocarcinoma,Not available,RNA-Seq,MALE,TCGA-PRAD,Illumina HiSeq,Prostate,Not available,HG19,Primary Tumor,ACCA09F5-D5AB-4699-B8FE-615A88F57B38,Alive,Asterand,University of North Carolina,United States,Prostate Adenocarcinoma Acinar Type,T3b,N0,Not available,Mar-40,C61.9,C61,NO,,Complete Remission/Response,30.0,0.15,1.81,43.83,RNA,,,,2012.0,Alive
s17643,40BE9753-46EA-4604-9777-F8CBD3144FB2,TCGA-61-1911-01A-01R-1567-13_GRCh37-lite_rnaseq.bam,55,1EC9CBC3-FD76-4D44-BE24-8FF296D3C4C9,93095c36-2263-438f-a619-a4a4d6ae13c7,,Ovarian Serous Cystadenocarcinoma,NOT HISPANIC OR LATINO,RNA-Seq,FEMALE,TCGA-OV,Illumina HiSeq,Ovary,WHITE,GRCh37-lite,Primary Tumor,7F7B442A-3985-4F4A-98B1-DA82670C957C,Alive,University of Pittsburgh,Canada's Michael Smith Genome Sciences Centre,,Serous Cystadenocarcinoma,Not available,Not available,Not available,Mar-41,C56.9,C56.9,NO,,Not available,118.0,0.14,1.8,552.0,RNA,,,,2005.0,Alive
